data_2n59_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n59 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' HG22 ' A' ' 21' ' ' ILE . 40.6 t . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.3 0.571 . . . . 1.02 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.5899999999999999 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.29999999999999999 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.8700000000000001 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.0099999999999998 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 1.04 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 1.04 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 1.1100000000000001 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.6699999999999999 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.68000000000000005 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.56000000000000005 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 2.5099999999999998 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 1.0600000000000001 109.994 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.435 ' OG1' HG23 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 1.02 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 1.0 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 2.3199999999999998 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.26000000000000001 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.568 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 1.1299999999999999 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 1.03 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.92000000000000004 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 1.04 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 1.0700000000000001 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.77 111.61 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.29999999999999999 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 1.0700000000000001 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.22 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.77000000000000002 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.90000000000000002 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.8799999999999999 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 1.24 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 1.0800000000000001 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 1.04 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.6699999999999999 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp . . . . . 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.8100000000000001 110.649 -177.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.504 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.562 -0.532 . . . . 1.1699999999999999 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 3.1200000000000001 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.9299999999999999 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 1.0900000000000001 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.28999999999999998 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 1.0600000000000001 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.31 109.27 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 1.1699999999999999 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.515 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 1.05 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 1.0900000000000001 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 1.0600000000000001 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.3300000000000001 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 2.1000000000000001 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.568 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 3.29 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 1.05 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.516 HG21 ' CG2' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 1.0600000000000001 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 33' ' ' LEU . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 1.05 113.104 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28999999999999998 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.6899999999999999 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.9199999999999999 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 1.0800000000000001 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.484 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 1.1100000000000001 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.88 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 1.3500000000000001 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.94999999999999996 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 1.1100000000000001 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.5900000000000001 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.8300000000000001 109.948 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.56999999999999995 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 1.04 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.65 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 1.01 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.9399999999999999 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 1.04 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.61 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.2200000000000002 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 1.02 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 1.53 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.38 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.40999999999999998 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.76000000000000001 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 1.0600000000000001 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 1.0600000000000001 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.507 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 1.05 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 2.3999999999999999 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.96999999999999997 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 2.3900000000000001 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.65 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.1299999999999999 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.80000000000000004 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 1.1200000000000001 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 1.25 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HZ2' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.8700000000000001 111.061 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' A' ' 21' ' ' ILE . 21.5 t . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.859 0.361 . . . . 1.02 110.563 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.5899999999999999 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.29999999999999999 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.8700000000000001 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 1.0800000000000001 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.0099999999999998 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 1.04 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 1.04 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 1.1100000000000001 112.141 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.6699999999999999 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.68000000000000005 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.56000000000000005 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 2.5099999999999998 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 109.857 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 1.02 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 2.3199999999999998 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.26000000000000001 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 7' ' ' GLU . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 1.1299999999999999 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.543 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 1.03 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.92000000000000004 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 1.04 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 1.0700000000000001 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.77 111.363 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.29999999999999999 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 1.0700000000000001 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.22 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.77000000000000002 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.90000000000000002 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.8799999999999999 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 1.24 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 1.0800000000000001 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 1.04 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.545 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.6699999999999999 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm . . . . . 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.8100000000000001 110.884 -175.11 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.422 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.1 mp . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.541 -0.17 . . . . 1.1699999999999999 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 3.1200000000000001 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.9299999999999999 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 1.0900000000000001 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.28999999999999998 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 1.0600000000000001 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.31 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 1.1699999999999999 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 1.05 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 1.0900000000000001 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 1.0600000000000001 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.3300000000000001 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 2.1000000000000001 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 3.29 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 1.05 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.479 HG21 ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 1.0600000000000001 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 1.05 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28999999999999998 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.6899999999999999 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.9199999999999999 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 1.0800000000000001 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.471 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 1.1100000000000001 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.88 112.986 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 1.1100000000000001 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.5900000000000001 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.8300000000000001 109.207 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.56999999999999995 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 1.04 109.468 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 1.01 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.9399999999999999 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 1.04 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.2200000000000002 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 1.02 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 1.53 109.785 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.38 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.40999999999999998 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.76000000000000001 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 83' ' ' PHE . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 1.0600000000000001 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 1.0600000000000001 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 1.05 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 2.3999999999999999 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.96999999999999997 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 2.3900000000000001 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.1299999999999999 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.80000000000000004 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.712 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 1.1200000000000001 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 1.25 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.712 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.8700000000000001 108.89 167.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 21' ' ' ILE . 43.6 t . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.649 -0.5 . . . . 1.02 109.649 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.5899999999999999 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.29999999999999999 112.426 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.8700000000000001 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.618 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 1.0800000000000001 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.0099999999999998 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 1.04 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 1.04 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 1.1100000000000001 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.6699999999999999 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.68000000000000005 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.56000000000000005 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 2.5099999999999998 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 1.0600000000000001 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' HG1' HG21 ' A' ' 66' ' ' VAL . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.486 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 2.3199999999999998 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.26000000000000001 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 1.1299999999999999 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.522 HD12 ' CD2' ' A' ' 31' ' ' TYR . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 1.03 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.92000000000000004 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 1.04 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' HG11 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 1.0700000000000001 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.77 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' HG23 ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.29999999999999999 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 1.0700000000000001 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.22 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.77000000000000002 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.90000000000000002 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8799999999999999 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 1.24 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 1.0800000000000001 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 1.04 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.6699999999999999 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.8100000000000001 110.53 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.966 -0.753 . . . . 1.1699999999999999 108.966 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 3.1200000000000001 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.9299999999999999 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 1.0900000000000001 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.28999999999999998 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 1.0600000000000001 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.401 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.31 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 1.1699999999999999 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 1.05 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG23 ' OD1' ' A' ' 26' ' ' ASP . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.0900000000000001 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 1.0600000000000001 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.3300000000000001 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.515 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 2.1000000000000001 109.647 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 3.29 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 1.05 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 1.0600000000000001 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 1.05 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28999999999999998 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.6899999999999999 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.9199999999999999 109.19 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' HG1' ' A' ' 16' ' ' THR . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 1.0800000000000001 111.502 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 1.1100000000000001 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.88 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.3500000000000001 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.94999999999999996 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 1.1100000000000001 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.8 t-20 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.5900000000000001 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HG2' ' HG3' ' A' ' 94' ' ' PRO . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.8300000000000001 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.484 ' HB2' HG22 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.56999999999999995 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 1.04 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.64 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 1.01 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.9399999999999999 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 1.04 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.2200000000000002 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 1.02 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 1.53 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.38 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.40999999999999998 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.76000000000000001 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 1.0600000000000001 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 1.0600000000000001 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 1.05 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 2.3999999999999999 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 2.3900000000000001 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.64 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 96' ' ' THR . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.1299999999999999 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.80000000000000004 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.4199999999999999 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 1.1200000000000001 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 97' ' ' VAL . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 1.25 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HZ1' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.8700000000000001 110.638 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.912 0.386 . . . . 1.02 110.407 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.5899999999999999 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.29999999999999999 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.63 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 1.0800000000000001 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.0099999999999998 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 1.04 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 1.04 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 1.1100000000000001 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.6699999999999999 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.68000000000000005 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.56000000000000005 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 2.5099999999999998 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 1.0600000000000001 110.094 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 1.02 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 1.0 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 23.0 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 2.3199999999999998 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.26000000000000001 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 1.1299999999999999 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 1.03 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.92000000000000004 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 1.04 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' HG11 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 1.0700000000000001 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.77 111.436 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.29999999999999999 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 1.0700000000000001 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.77000000000000002 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.53 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.90000000000000002 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.8799999999999999 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 1.24 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 1.0800000000000001 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 1.04 109.44 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.6699999999999999 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.8 mttt . . . . . 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.8100000000000001 110.081 178.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.172 -0.677 . . . . 1.1699999999999999 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 3.1200000000000001 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.9299999999999999 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 1.0900000000000001 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.28999999999999998 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 1.0600000000000001 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.41 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.31 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 1.1699999999999999 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 1.05 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 1.0900000000000001 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 1.0600000000000001 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.3300000000000001 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 2.1000000000000001 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 3.29 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 1.05 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 1.0600000000000001 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 1.05 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28999999999999998 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.6899999999999999 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.9199999999999999 108.833 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 1.0800000000000001 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 1.1100000000000001 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 71' ' ' SER . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.88 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 1.3500000000000001 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.447 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.94999999999999996 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.5900000000000001 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.8300000000000001 109.237 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.56999999999999995 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 1.04 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.638 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 1.01 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.9399999999999999 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 1.04 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.2200000000000002 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 1.02 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.502 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 1.53 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.76000000000000001 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 1.0600000000000001 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 1.0600000000000001 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.535 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 1.05 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 2.3999999999999999 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.96999999999999997 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.63 ' C ' HG23 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 2.3900000000000001 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.638 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.1299999999999999 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.80000000000000004 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.4199999999999999 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 1.1200000000000001 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 1.25 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.8700000000000001 110.794 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 21' ' ' ILE . 27.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.797 -0.446 . . . . 1.02 109.797 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.5899999999999999 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.29999999999999999 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.8700000000000001 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 1.0800000000000001 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG3' HG21 ' A' ' 20' ' ' VAL . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.0099999999999998 112.272 -176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 1.04 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 1.04 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 1.1100000000000001 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.6699999999999999 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.68000000000000005 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.56000000000000005 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 2.5099999999999998 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 1.02 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.573 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 2.3199999999999998 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.26000000000000001 111.423 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.48 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 1.1299999999999999 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.614 HG21 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 1.03 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.92000000000000004 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 1.04 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 1.0700000000000001 112.162 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.77 111.975 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.29999999999999999 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 1.0700000000000001 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.22 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.77000000000000002 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.90000000000000002 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.8799999999999999 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.591 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 1.24 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' N ' HD23 ' A' ' 33' ' ' LEU . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 1.0800000000000001 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 1.04 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.6699999999999999 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.7 tttt . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.8100000000000001 110.008 179.037 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.535 -0.543 . . . . 1.1699999999999999 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 3.1200000000000001 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.9299999999999999 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 1.0900000000000001 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.28999999999999998 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 1.0600000000000001 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.31 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.496 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 1.1699999999999999 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 1.05 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 1.0900000000000001 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 1.0600000000000001 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.3300000000000001 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 2.1000000000000001 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 3.29 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 1.05 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 1.0600000000000001 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 1.05 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28999999999999998 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.6899999999999999 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.9199999999999999 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG23 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 1.0800000000000001 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 1.1100000000000001 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.88 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 1.3500000000000001 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.94999999999999996 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 1.1100000000000001 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.5900000000000001 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.8300000000000001 109.689 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.56999999999999995 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 1.04 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 1.01 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.9399999999999999 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 1.04 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 1.02 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 1.53 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' HG11 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.38 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.40999999999999998 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 1.0600000000000001 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 1.0600000000000001 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 1.05 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 2.3999999999999999 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.96999999999999997 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 2.3900000000000001 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.573 ' CD2' HD12 ' A' ' 17' ' ' LEU . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.1299999999999999 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.80000000000000004 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.795 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.4199999999999999 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 1.1200000000000001 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 1.25 113.865 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.795 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.8700000000000001 111.703 -171.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.485 HG11 HG13 ' A' ' 81' ' ' VAL . 18.2 t . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.047 0.451 . . . . 1.02 111.028 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.5899999999999999 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.29999999999999999 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.8700000000000001 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 1.0800000000000001 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 20' ' ' VAL . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.0099999999999998 112.04 -173.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 1.04 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 1.04 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 1.1100000000000001 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.6699999999999999 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.68000000000000005 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.56000000000000005 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 2.5099999999999998 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 1.0600000000000001 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 1.02 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 2.3199999999999998 109.971 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.26000000000000001 111.272 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.674 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 1.1299999999999999 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 31' ' ' TYR . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 1.03 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.92000000000000004 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.712 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 1.04 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 1.0700000000000001 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.77 111.378 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.29999999999999999 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 1.0700000000000001 110.574 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.22 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.77000000000000002 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.8799999999999999 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 1.24 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 1.0800000000000001 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 1.04 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 109.851 177.688 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.344 -0.243 . . . . 1.1699999999999999 110.344 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 3.1200000000000001 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.9299999999999999 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 1.0900000000000001 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.28999999999999998 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 1.0600000000000001 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.31 109.188 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 1.0900000000000001 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 1.0600000000000001 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.3300000000000001 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 2.1000000000000001 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 3.29 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 1.05 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 1.0600000000000001 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 1.05 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28999999999999998 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.6899999999999999 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.9199999999999999 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 1.0800000000000001 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 1.1100000000000001 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.88 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 1.3500000000000001 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 1.1100000000000001 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.5900000000000001 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.8300000000000001 109.271 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.56999999999999995 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 1.04 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.625 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 1.01 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.9399999999999999 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 1.04 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.2200000000000002 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 1.02 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 1.53 109.66 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.38 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.40999999999999998 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.76000000000000001 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 1.0600000000000001 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 1.0600000000000001 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 1.05 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 2.3999999999999999 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.96999999999999997 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.601 ' C ' HG22 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 2.3900000000000001 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.625 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.1299999999999999 108.931 169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.80000000000000004 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.766 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.4199999999999999 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 1.1200000000000001 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 1.25 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.8700000000000001 110.654 -171.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG22 ' A' ' 21' ' ' ILE . 39.7 t . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.987 -0.375 . . . . 1.02 109.987 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' THR . 15.5 mm100 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.5899999999999999 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.29999999999999999 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.8700000000000001 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.642 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 1.0800000000000001 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.0099999999999998 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 1.04 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 1.04 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.6699999999999999 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.68000000000000005 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.56000000000000005 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 2.5099999999999998 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 1.0600000000000001 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 1.02 109.381 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.613 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 1.0 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 9.5 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 2.3199999999999998 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.26000000000000001 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.595 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 1.1299999999999999 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 31' ' ' TYR . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 1.03 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.436 HG21 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.92000000000000004 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 1.04 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 1.0700000000000001 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.77 111.3 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.29999999999999999 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 1.0700000000000001 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.22 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.77000000000000002 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.90000000000000002 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.8799999999999999 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 1.24 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 1.0800000000000001 109.967 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 1.04 110.224 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.8100000000000001 110.9 -175.021 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.29 -0.633 . . . . 1.1699999999999999 109.29 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 3.1200000000000001 111.851 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 1.0900000000000001 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.28999999999999998 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 1.0600000000000001 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 1.1699999999999999 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 1.05 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.3300000000000001 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 2.1000000000000001 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 3.29 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 1.05 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 20' ' ' VAL . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 1.0600000000000001 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 1.05 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28999999999999998 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.575 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.6899999999999999 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.9199999999999999 109.174 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 1.0800000000000001 111.151 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 1.1100000000000001 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.88 112.299 -170.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 1.3500000000000001 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.94999999999999996 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 1.1100000000000001 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.5900000000000001 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.8300000000000001 109.761 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.56999999999999995 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.628 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 1.01 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.9399999999999999 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 1.04 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.614 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.2200000000000002 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 1.02 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 1.53 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.38 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.40999999999999998 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.76000000000000001 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 83' ' ' PHE . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 1.0600000000000001 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 1.0600000000000001 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 1.05 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 2.3999999999999999 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.96999999999999997 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.642 ' C ' HG23 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 2.3900000000000001 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.628 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB3' HG22 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.1299999999999999 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.80000000000000004 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.4199999999999999 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 1.1200000000000001 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 97' ' ' VAL . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 1.25 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 96' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.8700000000000001 111.607 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' H ' HG23 ' A' ' 86' ' ' VAL . 44.1 t . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 109.999 -0.371 . . . . 1.02 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.5899999999999999 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.29999999999999999 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.8700000000000001 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 1.0800000000000001 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 1.04 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 1.04 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 1.1100000000000001 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.6699999999999999 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.68000000000000005 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.56000000000000005 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 2.5099999999999998 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 1.0600000000000001 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 1.02 109.239 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 2.3199999999999998 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.26000000000000001 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 7' ' ' GLU . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 1.1299999999999999 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 1.03 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.92000000000000004 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 1.04 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 1.0700000000000001 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.77 111.513 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.482 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.29999999999999999 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 1.0700000000000001 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.22 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.77000000000000002 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.54 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.90000000000000002 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.8799999999999999 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 1.24 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 1.0800000000000001 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 1.04 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 19.6 ttpt . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.8100000000000001 110.238 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.984 -0.376 . . . . 1.1699999999999999 109.984 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 3.1200000000000001 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.9299999999999999 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 1.0900000000000001 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.28999999999999998 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 1.0600000000000001 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.403 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.31 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 1.1699999999999999 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 1.05 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.411 HD13 HG22 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 1.0900000000000001 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 1.0600000000000001 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 2.1000000000000001 109.696 175.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 3.29 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 1.05 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 1.0600000000000001 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 1.05 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28999999999999998 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.6899999999999999 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.9199999999999999 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 1.0800000000000001 110.792 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 1.1100000000000001 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.88 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 1.3500000000000001 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.94999999999999996 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 1.1100000000000001 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.5900000000000001 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.8300000000000001 109.56 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.56999999999999995 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.783 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.67 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 1.01 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.9399999999999999 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 1.04 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.716 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.2200000000000002 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 1.02 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 1.53 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.38 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.40999999999999998 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.76000000000000001 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 1.0600000000000001 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 1.0600000000000001 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.566 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 1.05 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 2.3999999999999999 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.96999999999999997 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 2.3900000000000001 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 1.0 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.1299999999999999 109.625 170.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.80000000000000004 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.4199999999999999 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 1.1200000000000001 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 1.25 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.677 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.8700000000000001 111.854 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 81' ' ' VAL . 22.6 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.904 0.383 . . . . 1.02 110.441 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.5899999999999999 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.29999999999999999 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.8700000000000001 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 1.0800000000000001 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.0099999999999998 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 1.04 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 1.04 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.6699999999999999 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.68000000000000005 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.56000000000000005 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 2.5099999999999998 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 1.0600000000000001 110.259 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 ' OG1' HG23 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 1.02 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 48.1 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 2.3199999999999998 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.26000000000000001 111.026 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.704 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 1.1299999999999999 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.537 HD12 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 1.03 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.92000000000000004 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 1.04 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 1.0700000000000001 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.77 111.6 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.29999999999999999 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 1.0700000000000001 110.65 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.22 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.90000000000000002 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.8799999999999999 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 1.24 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 1.0800000000000001 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 1.04 110.296 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.6699999999999999 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.8100000000000001 110.536 -176.853 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.1699999999999999 109.966 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 3.1200000000000001 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.9299999999999999 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 1.0900000000000001 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.28999999999999998 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 1.0600000000000001 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.31 109.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 1.1699999999999999 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 1.05 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 1.0900000000000001 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 1.0600000000000001 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.3300000000000001 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 2.1000000000000001 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.704 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 3.29 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 1.05 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.576 HG23 ' CG2' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 1.0600000000000001 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 1.05 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28999999999999998 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.6899999999999999 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.9199999999999999 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 1.0800000000000001 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' N ' HD21 ' A' ' 67' ' ' LEU . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 1.1100000000000001 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.88 112.075 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 1.3500000000000001 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.94999999999999996 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 1.1100000000000001 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.5900000000000001 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.8300000000000001 109.429 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 1.04 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 1.01 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.9399999999999999 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 1.04 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.649 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.2200000000000002 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 1.02 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 1.53 109.653 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.38 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.40999999999999998 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.76000000000000001 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 1.0600000000000001 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 1.0600000000000001 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 1.05 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 2.3999999999999999 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 2.3900000000000001 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.1299999999999999 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.80000000000000004 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 98' ' ' LYS . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.165 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 97' ' ' VAL . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 1.25 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.8700000000000001 111.669 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 21' ' ' ILE . 21.5 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 1.02 111.661 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.5899999999999999 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.29999999999999999 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.8700000000000001 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.645 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 1.0800000000000001 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.0099999999999998 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 1.04 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 1.04 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 1.1100000000000001 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.6699999999999999 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.68000000000000005 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.56000000000000005 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 2.5099999999999998 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 1.0600000000000001 109.739 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 1.02 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 2.3199999999999998 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.26000000000000001 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 1.1299999999999999 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' A' ' 31' ' ' TYR . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 1.03 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.92000000000000004 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 1.04 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 1.0700000000000001 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.77 111.563 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.29999999999999999 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 1.0700000000000001 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.22 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.77000000000000002 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.90000000000000002 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 1.24 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 1.0800000000000001 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 1.04 110.143 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.6699999999999999 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.8100000000000001 110.236 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.626 -0.509 . . . . 1.1699999999999999 109.626 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 3.1200000000000001 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.9299999999999999 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 1.0900000000000001 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.28999999999999998 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 1.0600000000000001 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.31 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 1.1699999999999999 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 1.05 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 1.0900000000000001 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 1.0600000000000001 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.3300000000000001 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 2.1000000000000001 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 3.29 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 1.05 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 1.0600000000000001 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 1.05 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28999999999999998 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.6899999999999999 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.9199999999999999 109.661 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 1.0800000000000001 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 1.1100000000000001 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.88 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 1.3500000000000001 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.94999999999999996 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 1.1100000000000001 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.5900000000000001 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.8300000000000001 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.56999999999999995 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 1.04 109.661 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 1.01 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.9399999999999999 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 1.04 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.2200000000000002 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 1.53 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' O ' HG13 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.38 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.40999999999999998 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.76000000000000001 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 1.0600000000000001 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 1.0600000000000001 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.57 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 1.05 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 2.3999999999999999 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.96999999999999997 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.684 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 2.3900000000000001 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.656 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.1299999999999999 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.80000000000000004 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.4199999999999999 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.413 ' OG1' HD12 ' A' ' 92' ' ' LEU . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 1.1200000000000001 111.654 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 1.25 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.719 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.8700000000000001 111.598 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 21' ' ' ILE . 41.1 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.744 0.306 . . . . 1.02 110.525 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.5899999999999999 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.29999999999999999 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.8700000000000001 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 1.0800000000000001 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.0099999999999998 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 1.04 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 1.1100000000000001 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.6699999999999999 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.68000000000000005 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.56000000000000005 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 2.5099999999999998 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 1.0600000000000001 110.267 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 1.02 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 2.3199999999999998 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.26000000000000001 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 1.1299999999999999 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 1.03 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.92000000000000004 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 1.04 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 1.0700000000000001 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.77 111.7 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.29999999999999999 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 1.0700000000000001 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.22 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.77000000000000002 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.90000000000000002 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.8799999999999999 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 1.24 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 1.0800000000000001 110.622 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 1.04 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.6699999999999999 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.8100000000000001 110.255 -179.08 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.496 -0.557 . . . . 1.1699999999999999 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 3.1200000000000001 112.521 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.9299999999999999 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 1.0900000000000001 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.28999999999999998 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 1.0600000000000001 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.31 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 1.1699999999999999 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 1.05 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 1.0900000000000001 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 1.0600000000000001 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.3300000000000001 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 2.1000000000000001 109.699 173.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 3.29 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 1.05 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 18' ' ' GLN . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 1.0600000000000001 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 1.05 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.6899999999999999 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.9199999999999999 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.41 HG23 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 1.0800000000000001 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 1.1100000000000001 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.88 111.691 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 1.3500000000000001 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.94999999999999996 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 1.1100000000000001 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.5900000000000001 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.8300000000000001 110.042 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.56999999999999995 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.656 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 1.01 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.9399999999999999 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.684 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 1.04 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.2200000000000002 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 1.02 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 1.53 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.492 ' O ' HG11 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.38 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.40999999999999998 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.76000000000000001 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 1.0600000000000001 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.56 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 1.05 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.7 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 2.3999999999999999 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG22 ' A' ' 6' ' ' VAL . 19.6 p30 -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 2.3900000000000001 112.17 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.656 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.1299999999999999 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.80000000000000004 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.4199999999999999 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 1.1200000000000001 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 1.25 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.572 176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.47 HG13 HG12 ' A' ' 81' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.883 0.373 . . . . 1.02 110.145 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.5899999999999999 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.29999999999999999 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 107.403 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 1.0800000000000001 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 20' ' ' VAL . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.0099999999999998 112.598 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 1.04 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 1.04 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 1.1100000000000001 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.6699999999999999 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.68000000000000005 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.56000000000000005 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 2.5099999999999998 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 1.0600000000000001 110.116 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.42 ' HG1' HG21 ' A' ' 66' ' ' VAL . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 1.02 109.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HG3' HG21 ' A' ' 61' ' ' THR . 2.2 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 2.3199999999999998 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.26000000000000001 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 1.1299999999999999 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 1.03 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.92000000000000004 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 1.04 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.77 110.964 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.29999999999999999 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 1.0700000000000001 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.22 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.77000000000000002 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.90000000000000002 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.8799999999999999 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 1.24 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 1.0800000000000001 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 1.04 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.6699999999999999 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.8100000000000001 110.494 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 109.422 -0.584 . . . . 1.1699999999999999 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 3.1200000000000001 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.9299999999999999 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 1.0900000000000001 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.28999999999999998 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 1.0600000000000001 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 1.1699999999999999 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 1.05 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 1.0900000000000001 110.72 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 1.0600000000000001 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.3300000000000001 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 2.1000000000000001 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 3.29 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 1.05 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 1.0600000000000001 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 1.05 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28999999999999998 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.6899999999999999 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.9199999999999999 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG21 ' HG1' ' A' ' 16' ' ' THR . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 1.0800000000000001 111.258 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 1.1100000000000001 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.88 112.362 -171.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 1.3500000000000001 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.94999999999999996 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 1.1100000000000001 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.5900000000000001 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.8300000000000001 109.627 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.56999999999999995 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 1.04 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.607 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 1.01 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.9399999999999999 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 1.04 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.2200000000000002 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 1.53 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG11 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.38 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.40999999999999998 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.76000000000000001 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 1.0600000000000001 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 1.0600000000000001 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 1.05 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 2.3999999999999999 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 2.3900000000000001 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' HB2' HG22 ' A' ' 96' ' ' THR . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.1299999999999999 109.182 170.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.80000000000000004 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.694 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.4199999999999999 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 93' ' ' ASP . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 1.1200000000000001 111.922 174.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 1.25 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.8700000000000001 110.162 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.47 ' CG1' HG21 ' A' ' 21' ' ' ILE . 22.1 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 1.02 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.5899999999999999 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.29999999999999999 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.8700000000000001 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 1.0800000000000001 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.0099999999999998 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 1.04 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 1.04 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.6699999999999999 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.68000000000000005 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.56000000000000005 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 2.5099999999999998 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 1.0600000000000001 110.454 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 1.02 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 1.0 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.519 HE21 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 2.3199999999999998 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.26000000000000001 111.592 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 1.1299999999999999 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.52 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.92000000000000004 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 1.04 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 1.0700000000000001 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.77 111.706 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.523 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.29999999999999999 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 1.0700000000000001 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.22 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.77000000000000002 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.90000000000000002 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.8799999999999999 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 1.24 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' N ' HD23 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 1.0800000000000001 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 1.04 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.6699999999999999 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt . . . . . 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.8100000000000001 110.431 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.8 -0.815 . . . . 1.1699999999999999 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 3.1200000000000001 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.9299999999999999 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 1.0900000000000001 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.28999999999999998 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 1.0600000000000001 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.31 109.145 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 1.1699999999999999 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 1.05 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 1.0900000000000001 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 1.0600000000000001 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.3300000000000001 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 2.1000000000000001 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 3.29 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 1.05 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.519 HG23 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 1.0600000000000001 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 1.05 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28999999999999998 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.9199999999999999 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 1.0800000000000001 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 1.1100000000000001 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.88 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 1.3500000000000001 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.94999999999999996 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.5900000000000001 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.8300000000000001 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.417 ' HB2' HG23 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.56999999999999995 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 1.04 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 1.01 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.9399999999999999 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 1.04 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.2200000000000002 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 1.02 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 1.53 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.38 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.40999999999999998 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.76000000000000001 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 1.0600000000000001 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 1.0600000000000001 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.566 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 1.05 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 44.1 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 2.3999999999999999 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 2.3900000000000001 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.59 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.80000000000000004 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.811 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.4199999999999999 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 1.1200000000000001 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 1.25 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.811 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.8700000000000001 111.839 -170.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.519 ' CG1' HG22 ' A' ' 21' ' ' ILE . 20.3 t . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.999 0.428 . . . . 1.02 111.068 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.5899999999999999 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.29999999999999999 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.8700000000000001 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 1.0800000000000001 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.0099999999999998 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 1.04 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 1.04 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 1.1100000000000001 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.6699999999999999 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.68000000000000005 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.56000000000000005 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 2.5099999999999998 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 1.0600000000000001 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 1.02 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.512 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 1.0 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.2 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 2.3199999999999998 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.26000000000000001 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 7' ' ' GLU . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 1.1299999999999999 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 1.03 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.92000000000000004 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 1.04 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 1.0700000000000001 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.77 111.199 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.496 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.29999999999999999 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 1.0700000000000001 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.22 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.77000000000000002 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.90000000000000002 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 1.24 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 1.0800000000000001 110.245 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 1.04 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.6699999999999999 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.8100000000000001 110.317 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.974 -0.38 . . . . 1.1699999999999999 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 3.1200000000000001 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.9299999999999999 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 1.0900000000000001 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.28999999999999998 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 1.0600000000000001 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.31 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 1.1699999999999999 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 1.05 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 1.0900000000000001 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 1.0600000000000001 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.3300000000000001 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 2.1000000000000001 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 3.29 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 1.05 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 20' ' ' VAL . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 1.0600000000000001 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 1.05 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28999999999999998 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.6899999999999999 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.603 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 1.0800000000000001 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 1.1100000000000001 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.88 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 1.3500000000000001 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.94999999999999996 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 1.1100000000000001 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.5900000000000001 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.8300000000000001 109.712 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.51 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.56999999999999995 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 1.01 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.9399999999999999 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 1.04 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.2200000000000002 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 1.02 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 1.53 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.40999999999999998 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.76000000000000001 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 1.0600000000000001 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 1.0600000000000001 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 1.05 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 2.3999999999999999 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.96999999999999997 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.702 ' C ' HG22 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 2.3900000000000001 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 1.0 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.1299999999999999 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.80000000000000004 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.82 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.4199999999999999 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 1.1200000000000001 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 1.25 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.8700000000000001 110.986 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.504 ' CG1' HG22 ' A' ' 21' ' ' ILE . 39.9 t . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 1.02 109.923 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.5899999999999999 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.29999999999999999 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.8700000000000001 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.654 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 1.0800000000000001 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.0099999999999998 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 1.04 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 1.04 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 1.1100000000000001 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.6699999999999999 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.68000000000000005 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.56000000000000005 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 2.5099999999999998 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 1.0600000000000001 109.643 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 1.02 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 2.3199999999999998 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.26000000000000001 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG22 ' HG3' ' A' ' 7' ' ' GLU . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 1.1299999999999999 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 1.03 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.92000000000000004 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 1.04 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 1.0700000000000001 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.77 112.657 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.29999999999999999 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 1.0700000000000001 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.22 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.77000000000000002 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.90000000000000002 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 1.24 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 1.0800000000000001 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 1.04 110.1 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.445 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.8100000000000001 110.645 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.501 -0.185 . . . . 1.1699999999999999 110.501 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 3.1200000000000001 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.9299999999999999 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.28999999999999998 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 1.0600000000000001 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.31 109.476 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 1.1699999999999999 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 1.05 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.467 HG22 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 1.0900000000000001 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 1.0600000000000001 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.3300000000000001 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 2.1000000000000001 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 3.29 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 1.05 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 1.0600000000000001 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG22 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 1.05 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28999999999999998 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.6899999999999999 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.9199999999999999 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 1.0800000000000001 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 1.1100000000000001 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.88 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 1.3500000000000001 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.94999999999999996 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 1.1100000000000001 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.5 t-20 -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.5900000000000001 110.492 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.8300000000000001 109.984 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.56999999999999995 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 1.04 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.617 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 1.01 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.9399999999999999 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 1.04 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.2200000000000002 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 1.02 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' O ' HG11 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.38 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.40999999999999998 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 1.0600000000000001 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 1.0600000000000001 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 2.3999999999999999 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.654 ' C ' HG22 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 2.3900000000000001 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.617 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.1299999999999999 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.80000000000000004 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.473 ' HA ' ' HZ2' ' A' ' 98' ' ' LYS . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.112 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 1.1200000000000001 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HZ2' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.8700000000000001 111.469 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.524 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.767 -0.457 . . . . 1.02 109.767 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.5899999999999999 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.29999999999999999 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.8700000000000001 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 1.0800000000000001 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 20' ' ' VAL . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.0099999999999998 111.971 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 1.04 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 1.04 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 1.1100000000000001 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.6699999999999999 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.68000000000000005 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.56000000000000005 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 2.5099999999999998 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 1.0600000000000001 109.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 ' OG1' HG23 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 1.02 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 1.0 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.643 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 2.3199999999999998 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.26000000000000001 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 7' ' ' GLU . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 1.1299999999999999 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 31' ' ' TYR . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 1.03 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.92000000000000004 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 1.04 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 1.0700000000000001 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.77 112.731 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.29999999999999999 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 1.0700000000000001 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.22 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.77000000000000002 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.90000000000000002 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.8799999999999999 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 1.24 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 1.0800000000000001 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 1.04 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.6699999999999999 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.8100000000000001 110.896 -177.28 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.525 ' C ' ' HD2' ' A' ' 47' ' ' LYS . 5.4 mp . . . . . 0 C--O 1.227 -0.089 0 N-CA-C 110.722 -0.103 . . . . 1.1699999999999999 110.722 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 3.1200000000000001 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.9299999999999999 109.758 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 1.0900000000000001 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.28999999999999998 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 1.0600000000000001 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.31 109.018 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 1.1699999999999999 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 1.05 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 110.147 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 1.0600000000000001 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.3300000000000001 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 2.1000000000000001 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 3.29 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 1.05 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.643 ' CG2' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 1.0600000000000001 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 33' ' ' LEU . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 1.05 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28999999999999998 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.6899999999999999 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.9199999999999999 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 1.0800000000000001 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 1.1100000000000001 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.88 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 1.3500000000000001 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.94999999999999996 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 1.1100000000000001 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.5900000000000001 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.8300000000000001 110.22 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.56999999999999995 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 1.04 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 1.01 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.9399999999999999 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 1.04 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.2200000000000002 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 1.02 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 1.53 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.38 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.40999999999999998 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.76000000000000001 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 1.0600000000000001 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 1.0600000000000001 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.541 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 1.05 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 2.3999999999999999 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.96999999999999997 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.0 t-20 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 2.3900000000000001 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 96' ' ' THR . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.1299999999999999 109.387 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.80000000000000004 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.4199999999999999 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 93' ' ' ASP . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 111.653 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 1.25 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.42 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.8700000000000001 112.862 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' A' ' 21' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.948 -0.39 . . . . 1.02 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.5899999999999999 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.29999999999999999 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.644 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 1.0800000000000001 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.563 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.0099999999999998 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 1.04 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 1.04 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 1.1100000000000001 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.6699999999999999 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.68000000000000005 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.56000000000000005 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 2.5099999999999998 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 1.0600000000000001 110.124 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 1.02 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.3 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 2.3199999999999998 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.26000000000000001 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 1.1299999999999999 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' A' ' 31' ' ' TYR . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 1.03 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.92000000000000004 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 1.04 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 1.0700000000000001 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.77 111.662 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.29999999999999999 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 1.0700000000000001 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.22 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.77000000000000002 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 1.24 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 1.0800000000000001 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 1.04 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.6699999999999999 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.8100000000000001 111.226 -176.149 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 110.203 -0.295 . . . . 1.1699999999999999 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 3.1200000000000001 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.9299999999999999 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 1.0900000000000001 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.28999999999999998 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 1.0600000000000001 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.426 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.31 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 1.1699999999999999 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 1.05 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 1.0900000000000001 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 1.0600000000000001 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.3300000000000001 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 2.1000000000000001 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 3.29 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 1.05 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 1.05 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28999999999999998 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.6899999999999999 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.9199999999999999 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 1.0800000000000001 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 1.1100000000000001 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.88 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 1.3500000000000001 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.5900000000000001 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.8300000000000001 109.078 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.56999999999999995 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 1.04 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.633 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 1.01 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.9399999999999999 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 1.04 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.2200000000000002 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 1.02 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 1.53 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' O ' HG11 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.38 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.40999999999999998 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.76000000000000001 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 1.0600000000000001 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 1.0600000000000001 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 1.05 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 2.3999999999999999 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.644 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 2.3900000000000001 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.633 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 96' ' ' THR . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.1299999999999999 109.085 170.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.80000000000000004 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.4199999999999999 111.547 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 93' ' ' ASP . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 1.1200000000000001 111.146 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 1.25 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.613 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.8700000000000001 111.303 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 HG12 ' A' ' 81' ' ' VAL . 38.4 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.801 0.334 . . . . 1.02 110.12 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.5899999999999999 108.098 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.29999999999999999 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.8700000000000001 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.63 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 1.0800000000000001 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' HG22 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.0099999999999998 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 1.04 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 1.04 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 1.1100000000000001 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.6699999999999999 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.68000000000000005 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.56000000000000005 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 2.5099999999999998 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 1.0600000000000001 109.865 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 1.02 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 2.3199999999999998 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.26000000000000001 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 7' ' ' GLU . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 1.1299999999999999 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.536 HD13 ' CD2' ' A' ' 31' ' ' TYR . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 1.03 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.92000000000000004 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 1.04 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 1.0700000000000001 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.77 111.073 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.29999999999999999 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 1.0700000000000001 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.22 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.77000000000000002 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.90000000000000002 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 1.24 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 1.0800000000000001 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 1.04 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.6699999999999999 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 tttm . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.8100000000000001 111.097 -171.612 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.621 0.248 . . . . 1.1699999999999999 110.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 3.1200000000000001 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.9299999999999999 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 1.0900000000000001 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.28999999999999998 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.31 108.924 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 1.1699999999999999 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 1.0900000000000001 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 1.0600000000000001 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.3300000000000001 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.547 ' HA ' ' NE2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 2.1000000000000001 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 3.29 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 1.05 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 1.0600000000000001 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 1.05 112.192 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 64' ' ' ASN . 0.8 OUTLIER -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.6899999999999999 109.503 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.9199999999999999 109.842 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 1.0800000000000001 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 1.1100000000000001 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.88 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 1.3500000000000001 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.94999999999999996 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.8300000000000001 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 109.223 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 1.04 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.593 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 1.01 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.675 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.9399999999999999 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 1.04 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.2200000000000002 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 1.02 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 1.53 109.445 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.38 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.76000000000000001 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 1.0600000000000001 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 1.0600000000000001 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 1.05 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.96999999999999997 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.63 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 2.3900000000000001 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.6 ' CD2' HD11 ' A' ' 17' ' ' LEU . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 1.0 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.1299999999999999 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.80000000000000004 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.4199999999999999 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 1.25 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? . . . . . 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.8700000000000001 111.499 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 81' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.9 0.381 . . . . 1.02 110.453 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.5899999999999999 108.364 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.29999999999999999 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.8700000000000001 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.721 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.0099999999999998 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 1.04 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 1.04 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 1.1100000000000001 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.6699999999999999 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.68000000000000005 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.56000000000000005 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 2.5099999999999998 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 1.0600000000000001 110.245 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 1.02 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 1.0 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 2.3199999999999998 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.26000000000000001 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 7' ' ' GLU . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 1.1299999999999999 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 31' ' ' TYR . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 1.03 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.92000000000000004 107.221 168.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 1.04 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 1.0700000000000001 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.77 112.078 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.29999999999999999 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 1.0700000000000001 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.22 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.77000000000000002 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.8799999999999999 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 1.24 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 1.0800000000000001 109.963 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 1.04 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.6699999999999999 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 7.5 mtmp? . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.8100000000000001 110.557 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.8 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.203 -0.666 . . . . 1.1699999999999999 109.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 3.1200000000000001 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.9299999999999999 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 1.0900000000000001 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.28999999999999998 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 1.0600000000000001 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.31 109.766 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 1.1699999999999999 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 1.05 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 1.0900000000000001 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 1.0600000000000001 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.3300000000000001 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.545 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 2.1000000000000001 109.859 177.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 3.29 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 1.05 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 20' ' ' VAL . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 1.0600000000000001 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 1.05 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28999999999999998 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.6899999999999999 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG13 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.9199999999999999 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 1.0800000000000001 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 1.1100000000000001 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.88 111.96 -173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 1.3500000000000001 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.94999999999999996 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 3.5 t-20 -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 110.106 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.8300000000000001 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.56999999999999995 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 1.04 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.616 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 1.01 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.9399999999999999 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 1.04 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.2200000000000002 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 1.02 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 1.53 109.247 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.40999999999999998 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.76000000000000001 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 1.0600000000000001 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 1.0600000000000001 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 1.05 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.9 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 2.3999999999999999 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.96999999999999997 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.721 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 2.3900000000000001 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.616 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.1299999999999999 109.012 168.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.80000000000000004 112.173 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.76 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 1.1200000000000001 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 1.25 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.8700000000000001 111.746 -168.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG1' HG22 ' A' ' 21' ' ' ILE . 34.9 t . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.912 0.387 . . . . 1.02 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.5899999999999999 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.29999999999999999 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.8700000000000001 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.0099999999999998 112.33 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 1.04 107.206 168.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 1.04 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 1.1100000000000001 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.6699999999999999 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.68000000000000005 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.56000000000000005 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 2.5099999999999998 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 1.0600000000000001 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 1.02 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 2.3199999999999998 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.26000000000000001 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG23 ' HG3' ' A' ' 7' ' ' GLU . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 1.1299999999999999 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 1.03 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.92000000000000004 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 1.04 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 1.0700000000000001 112.601 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.77 112.09 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.29999999999999999 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 1.0700000000000001 110.457 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.22 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.77000000000000002 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.90000000000000002 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.8799999999999999 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 1.24 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 1.0800000000000001 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 1.04 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.306 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.8100000000000001 111.13 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.569 -0.53 . . . . 1.1699999999999999 109.569 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 3.1200000000000001 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.9299999999999999 109.737 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.28999999999999998 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 1.0600000000000001 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.31 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 1.1699999999999999 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 1.05 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 1.0900000000000001 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 1.0600000000000001 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.3300000000000001 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 2.1000000000000001 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 3.29 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 1.05 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 1.0600000000000001 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 1.05 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28999999999999998 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.6899999999999999 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.9199999999999999 109.962 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 1.0800000000000001 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 1.1100000000000001 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.88 112.163 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 1.3500000000000001 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.94999999999999996 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 1.1100000000000001 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.5900000000000001 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.8300000000000001 109.392 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.56999999999999995 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 1.04 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.611 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 1.01 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.9399999999999999 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 1.04 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.2200000000000002 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 1.02 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 1.53 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.514 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.38 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.40999999999999998 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 1.0600000000000001 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 1.05 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.643 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 2.3999999999999999 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.96999999999999997 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 2.3900000000000001 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.611 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 1.0 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' HB3' HG22 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.1299999999999999 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.80000000000000004 113.164 -174.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.529 ' HA ' ' HZ3' ' A' ' 98' ' ' LYS . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.4199999999999999 110.595 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 1.1200000000000001 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 1.25 111.631 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HZ3' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.8700000000000001 111.991 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.752 0.311 . . . . 4.1100000000000003 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' HG22 ' A' ' 21' ' ' ILE . 40.6 t -90.86 152.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.3 0.571 . . . . 1.02 109.788 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.504 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.5899999999999999 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.29999999999999999 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.8700000000000001 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 1.0800000000000001 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.0099999999999998 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 1.04 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 1.04 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 1.1100000000000001 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.6699999999999999 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.68000000000000005 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.56000000000000005 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 2.5099999999999998 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 1.0600000000000001 109.994 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.435 ' OG1' HG23 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 1.02 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 1.0 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 2.3199999999999998 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.26000000000000001 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.568 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 1.1299999999999999 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 1.03 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.504 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.92000000000000004 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 1.04 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 1.0700000000000001 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.77 111.61 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.29999999999999999 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 1.0700000000000001 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.22 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.77000000000000002 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.90000000000000002 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.8799999999999999 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 1.24 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 1.0800000000000001 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 1.04 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.6699999999999999 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -112.56 121.99 46.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.8100000000000001 110.649 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -130.21 108.41 10.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 1.2 110.437 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.08 -163.44 9.91 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.875 -0.679 . . . . 0.95999999999999996 111.647 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.76 -17.66 64.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.75 0.309 . . . . 1.8 111.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.2 -7.85 57.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 1.98 111.396 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.24 -170.42 14.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.629 -0.796 . . . . 1.3600000000000001 112.637 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -108.49 114.98 29.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.661 0.267 . . . . 1.54 110.761 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 m -106.21 143.39 34.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.741 0.305 . . . . 1.4199999999999999 110.201 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -112.06 112.42 24.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.288 -0.415 . . . . 3.4399999999999999 110.645 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.504 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp -99.12 134.48 37.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.562 -0.532 . . . . 1.1699999999999999 109.562 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 3.1200000000000001 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.9299999999999999 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 1.0900000000000001 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.28999999999999998 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 1.0600000000000001 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.31 109.27 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 1.1699999999999999 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.515 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 1.05 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 1.0900000000000001 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 1.0600000000000001 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.3300000000000001 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 2.1000000000000001 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.568 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 3.29 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 1.05 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.516 HG21 ' CG2' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 1.0600000000000001 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 33' ' ' LEU . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 1.05 113.104 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28999999999999998 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.6899999999999999 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.9199999999999999 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 1.0800000000000001 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 1.1100000000000001 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.88 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 1.3500000000000001 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.94999999999999996 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 1.1100000000000001 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.5900000000000001 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.8300000000000001 109.948 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.56999999999999995 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 1.04 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 1.01 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.9399999999999999 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 1.04 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.61 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.2200000000000002 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 1.02 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 1.53 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.38 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.40999999999999998 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.76000000000000001 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 1.0600000000000001 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 1.0600000000000001 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.507 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 1.05 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 2.3999999999999999 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.96999999999999997 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 2.3900000000000001 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.65 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.1299999999999999 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.80000000000000004 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' HA ' ' HZ2' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 1.1200000000000001 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 1.25 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HZ2' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -65.44 81.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.8700000000000001 111.061 175.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.65 18.18 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.236 -0.893 . . . . 1.4399999999999999 111.967 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.27 132.29 35.33 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.122 -0.696 . . . . 4.1299999999999999 109.122 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.965 -0.541 . . . . 7.4500000000000002 110.843 -176.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' H2 ' ' HB ' ' A' ' 86' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 111.56 0.207 . . . . 4.1100000000000003 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' A' ' 21' ' ' ILE . 21.5 t -93.15 150.03 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.513 -0.475 . . . . 1.02 110.563 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.5899999999999999 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.29999999999999999 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.8700000000000001 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 1.0800000000000001 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.0099999999999998 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 1.04 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 1.04 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 1.1100000000000001 112.141 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.6699999999999999 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.68000000000000005 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.56000000000000005 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 2.5099999999999998 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 109.857 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 1.02 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 2.3199999999999998 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.26000000000000001 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 7' ' ' GLU . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 1.1299999999999999 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.543 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 1.03 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.92000000000000004 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 1.04 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 1.0700000000000001 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.77 111.363 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.29999999999999999 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 1.0700000000000001 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.22 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.77000000000000002 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.90000000000000002 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.8799999999999999 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 1.24 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 1.0800000000000001 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 1.04 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.545 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.6699999999999999 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -119.25 134.55 55.14 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.8100000000000001 110.884 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' A' ' 43' ' ' THR . . . -148.36 113.33 5.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 1.2 110.871 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.61 -161.97 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.828 -0.909 . . . . 0.95999999999999996 110.828 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.95 67.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.095 0.448 . . . . 1.8 110.784 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.67 -1.14 41.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.36 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.37 -164.09 13.58 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.878 -0.677 . . . . 1.3600000000000001 112.419 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.403 HG22 ' HB1' ' A' ' 38' ' ' ALA . 21.8 p -107.85 141.35 39.57 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.886 0.374 . . . . 1.54 110.906 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -128.18 144.33 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.273 -0.421 . . . . 1.4199999999999999 110.041 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -117.19 112.42 20.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.21 -0.292 . . . . 3.4399999999999999 110.21 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.1 mp -107.36 140.09 26.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.542 -0.299 . . . . 1.1699999999999999 110.541 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 3.1200000000000001 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.9299999999999999 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 1.0900000000000001 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.28999999999999998 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 1.0600000000000001 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.31 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 1.1699999999999999 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 1.05 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 1.0900000000000001 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 1.0600000000000001 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.3300000000000001 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 2.1000000000000001 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 3.29 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 1.05 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.479 HG21 ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 1.0600000000000001 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 1.05 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28999999999999998 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.6899999999999999 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.9199999999999999 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 1.0800000000000001 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.471 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 1.1100000000000001 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.421 ' OH ' HD22 ' A' ' 99' ' ' LEU . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.88 112.986 -169.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 1.1100000000000001 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.471 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.5900000000000001 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.8300000000000001 109.207 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.56999999999999995 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 1.04 109.468 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 1.01 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.9399999999999999 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 1.04 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.2200000000000002 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 1.02 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 1.53 109.785 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.38 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.40999999999999998 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.76000000000000001 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' HB ' ' H2 ' ' A' ' 1' ' ' MET . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 1.0600000000000001 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 1.0600000000000001 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 1.05 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 2.3999999999999999 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.96999999999999997 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 2.3900000000000001 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.1299999999999999 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.80000000000000004 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.712 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 1.1200000000000001 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 1.25 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.712 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -125.89 83.42 2.16 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.8700000000000001 108.89 167.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.8 mm? 76.83 -58.82 0.5 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.001 -1.0 . . . . 1.4399999999999999 112.272 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -129.18 169.38 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.531 0.205 . . . . 4.1299999999999999 110.585 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.481 -0.771 . . . . 7.4500000000000002 109.829 177.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.84 0.352 . . . . 4.1100000000000003 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 21' ' ' ILE . 43.6 t -108.9 153.74 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.649 -0.5 . . . . 1.02 109.649 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.5899999999999999 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.29999999999999999 112.426 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.8700000000000001 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.618 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 1.0800000000000001 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.0099999999999998 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 1.04 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 1.04 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 1.1100000000000001 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.6699999999999999 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.68000000000000005 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.56000000000000005 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 2.5099999999999998 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 1.0600000000000001 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' HG1' HG21 ' A' ' 66' ' ' VAL . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.486 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 2.3199999999999998 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.26000000000000001 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 1.1299999999999999 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.522 HD12 ' CD2' ' A' ' 31' ' ' TYR . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 1.03 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.92000000000000004 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 1.04 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' HG11 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 1.0700000000000001 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.77 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' HG23 ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.29999999999999999 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 1.0700000000000001 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.22 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.77000000000000002 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.90000000000000002 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8799999999999999 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 1.24 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 1.0800000000000001 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 1.04 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.6699999999999999 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -136.1 138.51 42.13 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.8100000000000001 110.53 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 74' ' ' ARG . . . -149.71 114.93 5.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.693 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.8 -162.01 9.83 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.737 -0.744 . . . . 0.95999999999999996 112.342 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.9 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 1.8 111.564 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.05 12.8 16.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.989 0.423 . . . . 1.98 110.853 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 -168.93 28.95 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 1.3600000000000001 111.98 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 p -96.51 153.53 17.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.854 0.359 . . . . 1.54 110.478 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.4 m -149.47 149.14 30.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 1.4199999999999999 110.11 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -124.31 133.7 53.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 3.4399999999999999 111.144 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -122.65 134.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.966 -0.753 . . . . 1.1699999999999999 108.966 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 3.1200000000000001 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.9299999999999999 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 1.0900000000000001 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.28999999999999998 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 1.0600000000000001 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.401 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.31 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 1.1699999999999999 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 1.05 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG23 ' OD1' ' A' ' 26' ' ' ASP . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.0900000000000001 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 1.0600000000000001 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.3300000000000001 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.515 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 2.1000000000000001 109.647 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 3.29 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 1.05 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 1.0600000000000001 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 1.05 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28999999999999998 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.6899999999999999 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.9199999999999999 109.19 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' HG1' ' A' ' 16' ' ' THR . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 1.0800000000000001 111.502 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 1.1100000000000001 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.88 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.3500000000000001 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.94999999999999996 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 1.1100000000000001 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.8 t-20 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.5900000000000001 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.8300000000000001 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.484 ' HB2' HG22 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.56999999999999995 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 1.04 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.64 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 1.01 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.9399999999999999 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 1.04 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.2200000000000002 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 1.02 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 1.53 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.38 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.40999999999999998 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.76000000000000001 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 1.0600000000000001 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 1.0600000000000001 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 1.05 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 2.3999999999999999 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.618 ' C ' HG22 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 2.3900000000000001 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.64 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 96' ' ' THR . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.1299999999999999 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.80000000000000004 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.4199999999999999 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 1.1200000000000001 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 97' ' ' VAL . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 1.25 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.81 69.99 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.8700000000000001 110.638 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.7 mm? 73.28 -64.08 0.41 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.999 -1.001 . . . . 1.4399999999999999 110.807 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.08 -43.85 0.34 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.345 -0.389 . . . . 4.1299999999999999 110.246 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.412 -0.804 . . . . 7.4500000000000002 110.512 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' HG22 ' A' ' 86' ' ' VAL . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.797 0.332 . . . . 4.1100000000000003 110.531 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t -95.16 151.37 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.201 -0.454 . . . . 1.02 110.407 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.5899999999999999 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.29999999999999999 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.63 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 1.0800000000000001 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.0099999999999998 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 1.04 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 1.04 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 1.1100000000000001 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.6699999999999999 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.68000000000000005 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.56000000000000005 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 2.5099999999999998 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 1.0600000000000001 110.094 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 1.02 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 1.0 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 23.0 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 2.3199999999999998 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.26000000000000001 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 1.1299999999999999 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 1.03 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.92000000000000004 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 1.04 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' HG11 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 1.0700000000000001 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.77 111.436 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.29999999999999999 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 1.0700000000000001 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.22 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.77000000000000002 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.53 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.90000000000000002 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.8799999999999999 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 1.24 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 1.0800000000000001 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 1.04 109.44 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.6699999999999999 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' THR . 21.8 mttt -90.99 156.98 17.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.8100000000000001 110.081 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.45 104.69 3.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.068 -0.969 . . . . 1.2 110.013 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.5 -161.63 12.58 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.303 -0.862 . . . . 0.95999999999999996 111.385 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.88 66.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.795 0.331 . . . . 1.8 111.106 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.57 -26.02 32.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 1.98 111.559 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.61 -164.87 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.558 -0.829 . . . . 1.3600000000000001 112.618 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 72.3 p -97.35 153.72 17.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.474 0.178 . . . . 1.54 110.883 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -138.38 123.24 18.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.489 0.185 . . . . 1.4199999999999999 110.859 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -93.91 135.66 35.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 3.4399999999999999 112.065 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.33 139.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.2 -0.909 . . . . 1.1699999999999999 109.172 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 3.1200000000000001 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.9299999999999999 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 1.0900000000000001 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.28999999999999998 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 1.0600000000000001 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.41 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.31 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 1.1699999999999999 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 1.05 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 1.0900000000000001 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 1.0600000000000001 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.3300000000000001 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 2.1000000000000001 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 3.29 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 1.05 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 1.0600000000000001 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 1.05 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28999999999999998 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.6899999999999999 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.9199999999999999 108.833 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 1.0800000000000001 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 1.1100000000000001 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' HH ' ' CD2' ' A' ' 99' ' ' LEU . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.88 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 1.3500000000000001 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.447 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.94999999999999996 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 1.1100000000000001 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.5900000000000001 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.8300000000000001 109.237 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.56999999999999995 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 1.04 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.638 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 1.01 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.9399999999999999 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 1.04 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.2200000000000002 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 1.02 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.502 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 1.53 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG13 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.76000000000000001 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 1.0600000000000001 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 1.0600000000000001 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.535 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 1.05 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 2.3999999999999999 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.96999999999999997 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.63 ' C ' HG23 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 2.3900000000000001 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.638 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.1299999999999999 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.80000000000000004 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.4199999999999999 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 1.1200000000000001 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 1.25 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -75.13 60.54 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.8700000000000001 110.794 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.505 ' CD2' ' HH ' ' A' ' 69' ' ' TYR . 3.4 mm? 71.69 -59.38 0.55 Allowed 'General case' 0 C--O 1.231 0.126 0 O-C-N 123.898 0.749 . . . . 1.4399999999999999 111.629 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -138.53 -65.18 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.124 -0.325 . . . . 4.1299999999999999 110.124 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.626 -0.702 . . . . 7.4500000000000002 110.325 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.852 0.358 . . . . 4.1100000000000003 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 21' ' ' ILE . 27.5 t -93.22 156.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 1.02 109.797 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.5899999999999999 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.29999999999999999 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.8700000000000001 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 1.0800000000000001 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG3' HG21 ' A' ' 20' ' ' VAL . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.0099999999999998 112.272 -176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 1.04 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 1.04 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 1.1100000000000001 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.6699999999999999 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.68000000000000005 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.56000000000000005 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 2.5099999999999998 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 1.0600000000000001 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 1.02 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.573 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 1.0 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 2.3199999999999998 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.26000000000000001 111.423 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.48 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 1.1299999999999999 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.614 HG21 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 1.03 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.92000000000000004 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 1.04 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 1.0700000000000001 112.162 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.77 111.975 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.29999999999999999 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 1.0700000000000001 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.22 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.77000000000000002 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.90000000000000002 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.8799999999999999 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.591 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 1.24 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' N ' HD23 ' A' ' 33' ' ' LEU . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 1.0800000000000001 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 1.04 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.6699999999999999 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 43' ' ' THR . 28.7 tttt -108.23 137.88 45.46 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.8100000000000001 110.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.57 106.69 3.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.996 -0.547 . . . . 1.2 110.655 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.72 -167.27 11.55 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.618 -0.801 . . . . 0.95999999999999996 111.689 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.26 67.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.106 0.479 . . . . 1.8 110.97 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.64 -9.93 56.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 1.98 111.546 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.93 -174.18 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 1.3600000000000001 112.78 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 27.4 p -102.95 132.36 49.24 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.263 0.225 . . . . 1.54 110.62 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 m -111.31 146.51 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.713 0.292 . . . . 1.4199999999999999 110.608 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -109.12 120.81 43.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.717 0.77 . . . . 3.4399999999999999 112.332 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp -121.13 120.46 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.193 -1.367 . . . . 1.1699999999999999 109.535 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 3.1200000000000001 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.9299999999999999 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 1.0900000000000001 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.28999999999999998 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 1.0600000000000001 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.31 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.496 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 1.1699999999999999 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 1.05 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 1.0900000000000001 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 1.0600000000000001 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.3300000000000001 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 2.1000000000000001 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 3.29 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 1.05 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 1.0600000000000001 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 1.05 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28999999999999998 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.6899999999999999 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG12 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.9199999999999999 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG23 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 1.0800000000000001 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 1.1100000000000001 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.88 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 1.3500000000000001 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.94999999999999996 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 1.1100000000000001 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.5900000000000001 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.8300000000000001 109.689 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.56999999999999995 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 1.04 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 1.01 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.9399999999999999 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 1.04 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 1.02 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 1.53 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' HG11 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.38 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.40999999999999998 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 1.0600000000000001 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 1.0600000000000001 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 1.05 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 2.3999999999999999 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.96999999999999997 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 2.3900000000000001 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.573 ' CD2' HD12 ' A' ' 17' ' ' LEU . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.1299999999999999 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.80000000000000004 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.795 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.4199999999999999 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 1.1200000000000001 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 1.25 113.865 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.795 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.59 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.8700000000000001 111.703 -171.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.55 34.06 20.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.026 -0.988 . . . . 1.4399999999999999 111.631 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.73 138.8 44.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 4.1299999999999999 110.188 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.826 -0.606 . . . . 7.4500000000000002 109.861 177.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' HG3' ' A' ' 25' ' ' ARG . 61.9 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.682 0.253 . . . . 4.1100000000000003 111.682 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.485 HG11 HG13 ' A' ' 81' ' ' VAL . 18.2 t -97.31 146.05 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.342 -0.543 . . . . 1.02 111.028 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.5899999999999999 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.29999999999999999 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.8700000000000001 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 1.0800000000000001 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 20' ' ' VAL . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.0099999999999998 112.04 -173.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 1.04 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 1.04 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 1.1100000000000001 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.6699999999999999 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.68000000000000005 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.56000000000000005 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 2.5099999999999998 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 1.0600000000000001 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 1.02 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 2.3199999999999998 109.971 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.26000000000000001 111.272 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.674 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 1.1299999999999999 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 31' ' ' TYR . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 1.03 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.92000000000000004 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.712 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 1.04 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 1.0700000000000001 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.415 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.77 111.378 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.29999999999999999 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 1.0700000000000001 110.574 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.22 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.77000000000000002 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.743 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.8799999999999999 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 1.24 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 1.0800000000000001 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 1.04 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.5 ttpt -103.64 136.7 42.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 109.851 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 43' ' ' THR . . . -141.14 122.57 14.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.353 0.597 . . . . 1.2 111.228 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.93 -165.15 11.52 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.227 -1.149 . . . . 0.95999999999999996 110.227 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -17.98 63.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.346 0.573 . . . . 1.8 110.657 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.64 -7.44 59.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.589 . . . . 1.98 110.929 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.24 -173.91 15.2 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.904 -0.665 . . . . 1.3600000000000001 112.322 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 36.1 p -100.67 137.41 39.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.662 0.267 . . . . 1.54 110.487 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m -120.58 122.68 41.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.802 -0.444 . . . . 1.4199999999999999 109.802 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -96.73 133.21 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 3.4399999999999999 110.361 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp -122.64 129.88 74.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.356 -0.838 . . . . 1.1699999999999999 110.344 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 3.1200000000000001 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.9299999999999999 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 1.0900000000000001 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.28999999999999998 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 1.0600000000000001 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.31 109.188 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 1.05 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 1.0900000000000001 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 1.0600000000000001 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.3300000000000001 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 2.1000000000000001 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.674 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 3.29 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 1.05 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 1.0600000000000001 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 1.05 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' HD22 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28999999999999998 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.6899999999999999 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.9199999999999999 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 1.0800000000000001 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 1.1100000000000001 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.88 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 1.3500000000000001 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 1.1100000000000001 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.5900000000000001 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.8300000000000001 109.271 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.56999999999999995 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 1.04 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.625 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 1.01 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.9399999999999999 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 1.04 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.743 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.2200000000000002 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 1.02 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 1.53 109.66 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.38 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.40999999999999998 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.76000000000000001 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 1.0600000000000001 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 1.0600000000000001 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 1.05 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 2.3999999999999999 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.96999999999999997 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.601 ' C ' HG22 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 2.3900000000000001 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.625 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.1299999999999999 108.931 169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.80000000000000004 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.766 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.4199999999999999 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 1.1200000000000001 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 1.25 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -74.5 82.73 1.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.8700000000000001 110.654 -171.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 64.92 56.01 1.12 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.646 -1.161 . . . . 1.4399999999999999 111.444 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.39 -71.73 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 4.1299999999999999 109.949 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.66 -0.686 . . . . 7.4500000000000002 109.461 176.704 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.914 0.388 . . . . 4.1100000000000003 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG22 ' A' ' 21' ' ' ILE . 39.7 t -98.66 152.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 1.02 109.987 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' THR . 15.5 mm100 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.5899999999999999 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.29999999999999999 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.8700000000000001 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.642 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 1.0800000000000001 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.0099999999999998 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 1.04 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 1.04 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.6699999999999999 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.68000000000000005 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.56000000000000005 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 2.5099999999999998 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 1.0600000000000001 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 1.02 109.381 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.613 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 1.0 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 9.5 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 2.3199999999999998 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.26000000000000001 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.595 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 1.1299999999999999 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 31' ' ' TYR . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 1.03 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.436 HG21 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.92000000000000004 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 1.04 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 1.0700000000000001 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.77 111.3 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.29999999999999999 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 1.0700000000000001 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.22 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.77000000000000002 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.90000000000000002 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.8799999999999999 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 1.24 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 1.0800000000000001 109.967 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 1.04 110.224 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -116.19 134.38 54.99 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.8100000000000001 110.9 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 74' ' ' ARG . . . -144.75 138.58 27.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.747 -0.66 . . . . 1.2 110.349 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.1 16.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.463 -0.875 . . . . 0.95999999999999996 111.743 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.62 -17.0 63.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.8 110.592 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.74 13.2 25.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.016 -0.538 . . . . 1.98 111.364 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.24 -171.82 15.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.641 -0.79 . . . . 1.3600000000000001 112.797 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.31 152.55 26.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.643 0.259 . . . . 1.54 110.964 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 m -140.92 157.14 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.321 -0.4 . . . . 1.4199999999999999 110.496 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -127.46 111.63 14.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.945 0.402 . . . . 3.4399999999999999 110.731 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.01 131.28 58.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.29 -0.633 . . . . 1.1699999999999999 109.29 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 3.1200000000000001 111.851 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 1.0900000000000001 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.28999999999999998 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 1.0600000000000001 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 1.1699999999999999 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 1.05 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.3300000000000001 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 2.1000000000000001 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.595 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 3.29 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 1.05 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 20' ' ' VAL . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 1.0600000000000001 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 1.05 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28999999999999998 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.575 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.6899999999999999 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.9199999999999999 109.174 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 1.0800000000000001 111.151 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 1.1100000000000001 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.695 ' OH ' HD13 ' A' ' 99' ' ' LEU . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.88 112.299 -170.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 1.3500000000000001 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.94999999999999996 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 1.1100000000000001 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.5900000000000001 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.8300000000000001 109.761 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.56999999999999995 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.628 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 1.01 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.9399999999999999 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 1.04 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.614 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.2200000000000002 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 1.02 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 1.53 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.38 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.40999999999999998 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.76000000000000001 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 83' ' ' PHE . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 1.0600000000000001 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 1.0600000000000001 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 1.05 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 2.3999999999999999 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.96999999999999997 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.642 ' C ' HG23 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 2.3900000000000001 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.628 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB3' HG22 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.1299999999999999 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.80000000000000004 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.4199999999999999 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 1.1200000000000001 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 97' ' ' VAL . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 1.25 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -74.57 49.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.8700000000000001 111.607 -178.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.695 HD13 ' OH ' ' A' ' 69' ' ' TYR . 1.3 mt 63.97 34.76 11.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.758 -0.656 . . . . 1.4399999999999999 112.404 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -82.19 112.5 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.751 -0.659 . . . . 4.1299999999999999 109.955 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.726 -0.654 . . . . 7.4500000000000002 109.837 -177.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptm . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.331 0.586 . . . . 4.1100000000000003 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.528 ' H ' HG23 ' A' ' 86' ' ' VAL . 44.1 t -128.13 157.63 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.72 -0.673 . . . . 1.02 109.999 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.5899999999999999 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.29999999999999999 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.8700000000000001 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 1.0800000000000001 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 1.04 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 1.04 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 1.1100000000000001 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.6699999999999999 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.68000000000000005 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.56000000000000005 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 2.5099999999999998 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 1.0600000000000001 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 1.02 109.239 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 2.3199999999999998 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.26000000000000001 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 7' ' ' GLU . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 1.1299999999999999 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 1.03 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.92000000000000004 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 1.04 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 1.0700000000000001 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.77 111.513 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.482 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.29999999999999999 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 1.0700000000000001 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.22 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.77000000000000002 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.54 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.90000000000000002 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.8799999999999999 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 1.24 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 1.0800000000000001 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 1.04 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.6 ttpt -114.1 132.57 56.0 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.8100000000000001 110.238 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -137.34 104.81 5.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.052 0.454 . . . . 1.2 110.376 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.13 -161.41 9.37 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.702 -0.681 . . . . 0.95999999999999996 111.561 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.99 -19.97 66.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.42 . . . . 1.8 110.657 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.32 9.48 23.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.919 -0.582 . . . . 1.98 111.247 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 -167.46 31.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.886 -0.673 . . . . 1.3600000000000001 112.289 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 41.5 p -97.17 133.78 41.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.783 0.325 . . . . 1.54 110.339 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -125.4 137.01 54.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.45 -0.341 . . . . 1.4199999999999999 110.363 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -106.36 112.62 25.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 3.4399999999999999 110.985 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -112.36 135.33 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.72 -0.673 . . . . 1.1699999999999999 109.984 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 3.1200000000000001 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.9299999999999999 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 1.0900000000000001 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.28999999999999998 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 1.0600000000000001 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.403 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.31 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 1.1699999999999999 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 1.05 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.411 HD13 HG22 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 1.0900000000000001 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 1.0600000000000001 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 2.1000000000000001 109.696 175.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 3.29 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 1.05 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 1.0600000000000001 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 1.05 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28999999999999998 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.6899999999999999 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.9199999999999999 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 1.0800000000000001 110.792 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 1.1100000000000001 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.88 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 1.3500000000000001 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.94999999999999996 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 1.1100000000000001 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.5900000000000001 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.8300000000000001 109.56 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.56999999999999995 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.783 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.67 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 1.01 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.9399999999999999 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 1.04 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.716 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.2200000000000002 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 1.02 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 1.53 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.38 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.40999999999999998 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.76000000000000001 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 1.0600000000000001 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 1.0600000000000001 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.566 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 1.05 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 2.3999999999999999 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.96999999999999997 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 2.3900000000000001 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 1.0 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.1299999999999999 109.625 170.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.80000000000000004 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.4199999999999999 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 1.1200000000000001 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 1.25 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.677 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.78 77.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.8700000000000001 111.854 -175.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 61.88 42.1 10.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.486 -0.779 . . . . 1.4399999999999999 111.926 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.55 114.64 17.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 4.1299999999999999 110.086 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.593 -0.718 . . . . 7.4500000000000002 109.682 179.165 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.802 0.334 . . . . 4.1100000000000003 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 81' ' ' VAL . 22.6 t -97.31 148.6 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 1.02 110.441 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.5899999999999999 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.29999999999999999 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.8700000000000001 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 1.0800000000000001 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.0099999999999998 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 1.04 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 1.04 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.6699999999999999 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.68000000000000005 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.56000000000000005 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 2.5099999999999998 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 1.0600000000000001 110.259 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 ' OG1' HG23 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 1.02 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 48.1 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 2.3199999999999998 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.26000000000000001 111.026 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.704 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 1.1299999999999999 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.537 HD12 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 1.03 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.92000000000000004 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 1.04 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 1.0700000000000001 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.77 111.6 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.29999999999999999 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 1.0700000000000001 110.65 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.22 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.77000000000000002 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.90000000000000002 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.8799999999999999 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 1.24 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 1.0800000000000001 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 1.04 110.296 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.6699999999999999 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -112.23 139.51 47.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.8100000000000001 110.536 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.07 105.48 3.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.115 -0.493 . . . . 1.2 110.41 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.74 -162.49 9.84 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.954 -0.641 . . . . 0.95999999999999996 111.951 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.23 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 1.8 111.11 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.14 -1.01 47.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 1.98 110.883 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.69 -166.7 12.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.848 -0.692 . . . . 1.3600000000000001 112.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 p -99.52 135.7 40.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.881 0.372 . . . . 1.54 110.65 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.8 m -128.16 138.21 52.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.133 -0.485 . . . . 1.4199999999999999 110.378 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -111.71 118.0 34.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 3.4399999999999999 110.362 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.79 133.84 62.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.921 -0.582 . . . . 1.1699999999999999 109.966 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 3.1200000000000001 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.9299999999999999 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 1.0900000000000001 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.28999999999999998 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 1.0600000000000001 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.31 109.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 1.1699999999999999 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 1.05 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 1.0900000000000001 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 1.0600000000000001 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.3300000000000001 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 2.1000000000000001 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.704 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 3.29 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 1.05 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.576 HG23 ' CG2' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 1.0600000000000001 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 1.05 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28999999999999998 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.6899999999999999 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.9199999999999999 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 1.0800000000000001 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' N ' HD21 ' A' ' 67' ' ' LEU . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 1.1100000000000001 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.514 ' HH ' ' CD2' ' A' ' 99' ' ' LEU . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.88 112.075 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 1.3500000000000001 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.94999999999999996 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 1.1100000000000001 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.5900000000000001 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.8300000000000001 109.429 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.56999999999999995 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 1.04 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 1.01 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.9399999999999999 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 1.04 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.649 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.2200000000000002 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 1.02 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 1.53 109.653 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.38 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.40999999999999998 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.76000000000000001 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 1.0600000000000001 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 1.0600000000000001 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 1.05 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 2.3999999999999999 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 2.3900000000000001 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.1299999999999999 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.80000000000000004 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 98' ' ' LYS . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.165 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 97' ' ' VAL . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 1.25 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -68.68 75.6 0.28 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.8700000000000001 111.669 -178.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.514 ' CD2' ' HH ' ' A' ' 69' ' ' TYR . 3.8 mm? 65.53 42.79 3.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.051 -0.977 . . . . 1.4399999999999999 112.485 170.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -91.77 147.23 23.14 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.217 -0.661 . . . . 4.1299999999999999 109.217 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.77 -0.633 . . . . 7.4500000000000002 109.542 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 tmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.525 -0.546 . . . . 4.1100000000000003 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 21' ' ' ILE . 21.5 t -102.11 151.27 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 1.02 111.661 -173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.5899999999999999 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.29999999999999999 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.8700000000000001 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.645 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 1.0800000000000001 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.0099999999999998 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 1.04 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 1.04 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 1.1100000000000001 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.6699999999999999 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.68000000000000005 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.56000000000000005 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 2.5099999999999998 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 1.0600000000000001 109.739 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 1.02 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 2.3199999999999998 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.26000000000000001 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 1.1299999999999999 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' A' ' 31' ' ' TYR . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 1.03 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.92000000000000004 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 1.04 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 1.0700000000000001 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.77 111.563 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.29999999999999999 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 1.0700000000000001 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.22 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.77000000000000002 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.90000000000000002 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 1.24 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 1.0800000000000001 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 1.04 110.143 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.6699999999999999 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt -117.98 129.48 55.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.8100000000000001 110.236 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.54 105.28 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 1.2 110.13 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.13 -162.28 11.54 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.95999999999999996 112.037 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.6 70.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 1.8 111.195 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.57 13.09 10.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 1.98 111.253 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.48 -160.91 23.82 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.701 -0.762 . . . . 1.3600000000000001 112.369 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -94.43 150.89 19.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.791 0.329 . . . . 1.54 111.025 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.4 m -130.16 157.75 41.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.085 -0.507 . . . . 1.4199999999999999 110.085 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 45' ' ' ARG . 16.9 mmt180 -120.54 112.19 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.162 0.506 . . . . 3.4399999999999999 111.798 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.04 130.32 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 1.1699999999999999 109.626 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 3.1200000000000001 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.9299999999999999 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 1.0900000000000001 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.28999999999999998 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 1.0600000000000001 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.31 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 1.1699999999999999 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 1.05 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 1.0900000000000001 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 1.0600000000000001 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.3300000000000001 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 2.1000000000000001 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 3.29 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 1.05 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 1.0600000000000001 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 1.05 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28999999999999998 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.6899999999999999 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.9199999999999999 109.661 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 1.0800000000000001 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 1.1100000000000001 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.88 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 1.3500000000000001 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.94999999999999996 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 1.1100000000000001 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.5900000000000001 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.8300000000000001 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.56999999999999995 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 1.04 109.661 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 1.01 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.9399999999999999 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 1.04 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.722 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.2200000000000002 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 1.02 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 1.53 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' O ' HG13 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.38 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.40999999999999998 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.76000000000000001 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 1.0600000000000001 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 1.0600000000000001 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.57 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 1.05 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 2.3999999999999999 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.96999999999999997 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.684 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 2.3900000000000001 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.1299999999999999 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.80000000000000004 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.4199999999999999 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 101' ' ' HIS . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 1.1200000000000001 111.654 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 1.25 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.719 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.49 70.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.8700000000000001 111.598 -176.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.45 56.45 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.495 -0.775 . . . . 1.4399999999999999 111.564 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 62.79 72.91 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.503 -0.771 . . . . 4.1299999999999999 111.351 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 72.5 t60 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.688 -0.672 . . . . 7.4500000000000002 109.829 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.909 0.385 . . . . 4.1100000000000003 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 21' ' ' ILE . 41.1 t -104.25 152.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 1.02 110.525 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.5899999999999999 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.29999999999999999 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.8700000000000001 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 1.0800000000000001 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.0099999999999998 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 1.04 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 1.1100000000000001 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.6699999999999999 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.68000000000000005 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.56000000000000005 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 2.5099999999999998 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 1.0600000000000001 110.267 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 1.02 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 2.3199999999999998 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.26000000000000001 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 1.1299999999999999 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 1.03 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.92000000000000004 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 1.04 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 1.0700000000000001 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.77 111.7 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.29999999999999999 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 1.0700000000000001 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.22 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.77000000000000002 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.90000000000000002 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.8799999999999999 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 1.24 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 1.0800000000000001 110.622 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 1.04 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.6699999999999999 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.6 ttpt -108.19 132.21 53.87 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.8100000000000001 110.255 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -137.17 105.61 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.778 -0.646 . . . . 1.2 109.81 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.86 -161.53 9.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.785 -0.721 . . . . 0.95999999999999996 112.313 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.66 -17.46 64.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.055 0.455 . . . . 1.8 110.811 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.41 12.94 25.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 1.98 110.772 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.04 -168.58 34.15 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.88 -0.676 . . . . 1.3600000000000001 112.594 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 40.8 p -94.09 154.21 17.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.616 0.246 . . . . 1.54 110.387 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -148.47 137.23 21.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.199 -0.297 . . . . 1.4199999999999999 110.199 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -99.74 114.3 27.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.305 -0.407 . . . . 3.4399999999999999 110.788 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 65' ' ' VAL . 5.2 mp -112.42 133.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 1.1699999999999999 109.496 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 3.1200000000000001 112.521 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.9299999999999999 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 1.0900000000000001 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.28999999999999998 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 1.0600000000000001 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.31 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 1.1699999999999999 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 1.05 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 1.0900000000000001 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 1.0600000000000001 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.3300000000000001 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 2.1000000000000001 109.699 173.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 3.29 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 1.05 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 18' ' ' GLN . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 1.0600000000000001 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 1.05 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.6899999999999999 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.9199999999999999 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 HG23 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 1.0800000000000001 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 1.1100000000000001 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' HH ' ' CD2' ' A' ' 99' ' ' LEU . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.88 111.691 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 1.3500000000000001 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.94999999999999996 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 1.1100000000000001 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.5900000000000001 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.8300000000000001 110.042 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.56999999999999995 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 1.04 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.656 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 1.01 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.9399999999999999 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.684 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 1.04 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.2200000000000002 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 1.02 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 1.53 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.492 ' O ' HG11 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.38 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.40999999999999998 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.76000000000000001 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 1.0600000000000001 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.56 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 1.05 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.7 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 2.3999999999999999 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG22 ' A' ' 6' ' ' VAL . 19.6 p30 -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 2.3900000000000001 112.17 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.1299999999999999 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.80000000000000004 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.4199999999999999 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 1.1200000000000001 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 1.25 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.34 63.11 0.24 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.572 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.454 ' CD2' ' HH ' ' A' ' 69' ' ' TYR . 3.4 mm? 60.39 45.52 10.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.6 -0.727 . . . . 1.4399999999999999 111.466 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 58.78 58.07 3.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.719 -0.673 . . . . 4.1299999999999999 111.773 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.162 -0.923 . . . . 7.4500000000000002 110.823 178.468 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' HB ' ' A' ' 86' ' ' VAL . 24.6 mmt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.533 0.197 . . . . 4.1100000000000003 111.533 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG13 HG12 ' A' ' 81' ' ' VAL . 22.0 t -109.79 148.46 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 1.02 110.145 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.5899999999999999 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.29999999999999999 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 107.403 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 1.0800000000000001 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 20' ' ' VAL . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.0099999999999998 112.598 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 1.04 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 1.04 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 1.1100000000000001 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.6699999999999999 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.68000000000000005 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.56000000000000005 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 2.5099999999999998 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 1.0600000000000001 110.116 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.42 ' HG1' HG21 ' A' ' 66' ' ' VAL . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 1.02 109.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HG3' HG21 ' A' ' 61' ' ' THR . 2.2 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 2.3199999999999998 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.26000000000000001 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 1.1299999999999999 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 1.03 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.92000000000000004 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 1.04 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.77 110.964 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.29999999999999999 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 1.0700000000000001 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.22 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.77000000000000002 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.90000000000000002 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.8799999999999999 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 1.24 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 1.0800000000000001 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 1.04 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.6699999999999999 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt -108.5 147.15 32.12 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.8100000000000001 110.494 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -151.34 123.61 8.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.138 -0.937 . . . . 1.2 111.031 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.88 -163.45 10.7 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.967 -0.853 . . . . 0.95999999999999996 110.967 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.41 -25.09 66.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.021 0.439 . . . . 1.8 110.803 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.72 -6.96 58.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 1.98 111.333 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.59 -163.76 12.25 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 1.3600000000000001 112.238 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -105.55 160.47 15.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.385 -0.228 . . . . 1.54 110.385 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -144.38 138.07 27.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.513 0.197 . . . . 1.4199999999999999 110.831 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -101.96 117.76 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 3.4399999999999999 111.563 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -113.48 130.25 67.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.422 -0.584 . . . . 1.1699999999999999 109.422 174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 3.1200000000000001 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.9299999999999999 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 1.0900000000000001 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.28999999999999998 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 1.0600000000000001 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 1.1699999999999999 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 1.05 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 1.0900000000000001 110.72 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 1.0600000000000001 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.3300000000000001 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 2.1000000000000001 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 3.29 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 1.05 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 1.0600000000000001 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 1.05 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28999999999999998 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.6899999999999999 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.9199999999999999 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG21 ' HG1' ' A' ' 16' ' ' THR . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 1.0800000000000001 111.258 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 1.1100000000000001 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.564 ' HH ' HD22 ' A' ' 99' ' ' LEU . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.88 112.362 -171.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 1.3500000000000001 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.94999999999999996 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 1.1100000000000001 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.5900000000000001 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.8300000000000001 109.627 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.56999999999999995 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 1.04 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.607 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 1.01 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.9399999999999999 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 1.04 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.2200000000000002 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 1.53 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG11 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.38 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.40999999999999998 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.76000000000000001 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 1.0600000000000001 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 1.0600000000000001 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 1.05 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 2.3999999999999999 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 2.3900000000000001 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' HB2' HG22 ' A' ' 96' ' ' THR . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.1299999999999999 109.182 170.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.80000000000000004 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.694 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.4199999999999999 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 93' ' ' ASP . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 1.1200000000000001 111.922 174.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 1.25 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.694 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -77.67 78.0 4.19 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.8700000000000001 110.162 -176.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.564 HD22 ' HH ' ' A' ' 69' ' ' TYR . 3.4 mm? 77.93 122.21 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.068 -1.424 . . . . 1.4399999999999999 111.054 172.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -51.34 126.43 16.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.166 -1.379 . . . . 4.1299999999999999 112.843 -171.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.086 -0.961 . . . . 7.4500000000000002 111.704 173.58 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.78 0.324 . . . . 4.1100000000000003 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' CG1' HG21 ' A' ' 21' ' ' ILE . 22.1 t -97.19 155.66 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 1.02 110.967 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.5899999999999999 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.29999999999999999 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.8700000000000001 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 1.0800000000000001 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.0099999999999998 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 1.04 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 1.04 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.6699999999999999 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.68000000000000005 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.56000000000000005 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 2.5099999999999998 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 1.0600000000000001 110.454 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 1.02 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 1.0 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.519 HE21 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 2.3199999999999998 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.26000000000000001 111.592 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 1.1299999999999999 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.52 HD11 ' CD2' ' A' ' 31' ' ' TYR . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.92000000000000004 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 1.04 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 1.0700000000000001 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.77 111.706 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.523 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.29999999999999999 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 1.0700000000000001 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.22 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.77000000000000002 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.90000000000000002 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.8799999999999999 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 1.24 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' N ' HD23 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 1.0800000000000001 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 1.04 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.6699999999999999 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt -108.19 150.64 26.98 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.8100000000000001 110.431 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.18 104.85 3.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.223 -0.899 . . . . 1.2 110.616 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.51 -164.45 13.29 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.098 -0.801 . . . . 0.95999999999999996 111.098 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.82 61.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 1.8 111.249 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.9 -8.33 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 1.98 111.228 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.62 -175.21 19.12 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.442 -0.885 . . . . 1.3600000000000001 113.306 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.4 p -97.92 137.94 36.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.656 0.265 . . . . 1.54 111.039 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -127.94 137.91 52.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.251 -0.431 . . . . 1.4199999999999999 110.166 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -113.45 122.3 46.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.474 0.654 . . . . 3.4399999999999999 112.181 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp -105.99 137.68 34.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 1.1699999999999999 108.8 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 3.1200000000000001 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.9299999999999999 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 1.0900000000000001 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.28999999999999998 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 1.0600000000000001 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.31 109.145 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 1.1699999999999999 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 1.05 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 1.0900000000000001 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 1.0600000000000001 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.3300000000000001 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 2.1000000000000001 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.552 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 3.29 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 1.05 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.519 HG23 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 1.0600000000000001 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 1.05 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28999999999999998 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG12 HG23 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.9199999999999999 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 1.0800000000000001 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 1.1100000000000001 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.88 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 1.3500000000000001 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.94999999999999996 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.5900000000000001 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.8300000000000001 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' HB2' HG23 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.56999999999999995 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 1.04 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 1.01 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.9399999999999999 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 1.04 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.2200000000000002 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 1.02 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 1.53 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.38 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.40999999999999998 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.76000000000000001 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 1.0600000000000001 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 1.0600000000000001 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.566 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 1.05 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 44.1 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 2.3999999999999999 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 2.3900000000000001 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.59 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.80000000000000004 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.811 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.4199999999999999 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 1.1200000000000001 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 1.25 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.811 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -61.88 89.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.8700000000000001 111.839 -170.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 71.28 -66.13 0.31 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.317 1.01 . . . . 1.4399999999999999 112.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -107.34 130.33 54.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.984 0.421 . . . . 4.1299999999999999 110.806 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.691 -0.671 . . . . 7.4500000000000002 109.851 -179.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.058 -0.349 . . . . 4.1100000000000003 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.519 ' CG1' HG22 ' A' ' 21' ' ' ILE . 20.3 t -121.03 152.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.02 111.068 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.5899999999999999 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.29999999999999999 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.8700000000000001 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 1.0800000000000001 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.0099999999999998 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 1.04 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 1.04 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 1.1100000000000001 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.6699999999999999 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.68000000000000005 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.56000000000000005 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 2.5099999999999998 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 1.0600000000000001 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 1.02 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.512 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 1.0 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.2 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 2.3199999999999998 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.26000000000000001 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 7' ' ' GLU . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 1.1299999999999999 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 1.03 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.92000000000000004 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 1.04 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 1.0700000000000001 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.77 111.199 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.496 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.29999999999999999 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 1.0700000000000001 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.22 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.77000000000000002 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' CD2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.90000000000000002 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 1.24 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 1.0800000000000001 110.245 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 1.04 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.6699999999999999 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt -118.21 135.58 54.17 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.8100000000000001 110.317 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.16 105.89 3.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 1.2 110.653 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.64 -167.62 12.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.565 -0.826 . . . . 0.95999999999999996 111.513 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.08 -22.13 66.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.435 . . . . 1.8 110.675 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.66 -1.73 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.935 -0.575 . . . . 1.98 111.474 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -170.89 13.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.836 -0.697 . . . . 1.3600000000000001 112.766 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.2 p -100.43 158.6 15.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 110.404 -0.221 . . . . 1.54 110.404 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -148.76 147.83 29.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.633 0.254 . . . . 1.4199999999999999 110.317 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -110.87 113.06 25.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 3.4399999999999999 111.019 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -105.08 116.22 48.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.298 -0.41 . . . . 1.1699999999999999 109.974 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 3.1200000000000001 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.9299999999999999 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 1.0900000000000001 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.28999999999999998 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 1.0600000000000001 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.31 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 1.1699999999999999 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 1.05 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 1.0900000000000001 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 1.0600000000000001 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.3300000000000001 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 2.1000000000000001 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 3.29 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 1.05 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 20' ' ' VAL . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 1.0600000000000001 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.463 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 1.05 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28999999999999998 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.6899999999999999 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.9199999999999999 109.603 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 1.0800000000000001 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 1.1100000000000001 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.88 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 1.3500000000000001 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.94999999999999996 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 1.1100000000000001 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.446 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.5900000000000001 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.8300000000000001 109.712 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.51 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.56999999999999995 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 1.01 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.9399999999999999 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 1.04 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.2200000000000002 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 1.02 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 1.53 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.38 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.40999999999999998 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.76000000000000001 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 1.0600000000000001 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 1.0600000000000001 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 1.05 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 2.3999999999999999 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.96999999999999997 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.702 ' C ' HG22 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 2.3900000000000001 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 1.0 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.1299999999999999 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HG3' ' HB1' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.80000000000000004 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.82 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.4199999999999999 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 1.1200000000000001 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 1.25 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -76.02 76.09 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.8700000000000001 110.986 -174.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 73.97 -55.07 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.913 -1.039 . . . . 1.4399999999999999 112.458 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.16 149.19 24.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.179 -0.304 . . . . 4.1299999999999999 110.179 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.9 t60 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.401 -0.809 . . . . 7.4500000000000002 109.606 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.666 0.27 . . . . 4.1100000000000003 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' CG1' HG22 ' A' ' 21' ' ' ILE . 39.9 t -93.5 154.03 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 1.02 109.923 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.5899999999999999 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.29999999999999999 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.8700000000000001 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.654 HG22 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 1.0800000000000001 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.0099999999999998 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 1.04 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 1.04 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 1.1100000000000001 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.6699999999999999 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.68000000000000005 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.56000000000000005 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 2.5099999999999998 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 1.0600000000000001 109.643 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 1.02 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 2.3199999999999998 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.26000000000000001 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG22 ' HG3' ' A' ' 7' ' ' GLU . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 1.1299999999999999 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 1.03 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.92000000000000004 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 1.04 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 1.0700000000000001 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.77 112.657 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.29999999999999999 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 1.0700000000000001 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.22 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.77000000000000002 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.90000000000000002 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 1.24 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 1.0800000000000001 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 1.04 110.1 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.445 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt -112.57 138.31 49.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.8100000000000001 110.645 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.55 120.0 7.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 1.2 110.471 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.15 -162.34 10.78 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.814 -0.708 . . . . 0.95999999999999996 111.487 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.45 -17.03 64.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.332 0.587 . . . . 1.8 110.404 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.61 12.96 21.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.98 110.837 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.98 -170.97 30.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.842 -0.694 . . . . 1.3600000000000001 112.848 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 32.2 p -104.48 140.14 38.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.575 -0.312 . . . . 1.54 110.223 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -134.55 130.84 37.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.74 -0.384 . . . . 1.4199999999999999 110.366 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -102.74 121.59 42.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.505 0.669 . . . . 3.4399999999999999 109.739 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.55 127.18 69.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.022 -0.99 . . . . 1.1699999999999999 110.501 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 3.1200000000000001 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.9299999999999999 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.28999999999999998 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 1.0600000000000001 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.31 109.476 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 1.1699999999999999 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 1.05 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.467 HG22 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 1.0900000000000001 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 1.0600000000000001 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.3300000000000001 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 2.1000000000000001 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 3.29 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 1.05 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 1.0600000000000001 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG22 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 1.05 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28999999999999998 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.6899999999999999 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.9199999999999999 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 1.0800000000000001 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 1.1100000000000001 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.88 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 1.3500000000000001 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.94999999999999996 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 1.1100000000000001 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.5 t-20 -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.5900000000000001 110.492 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.8300000000000001 109.984 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.56999999999999995 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 1.04 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.617 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 1.01 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.9399999999999999 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 1.04 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.2200000000000002 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 1.02 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' O ' HG11 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.38 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.40999999999999998 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 1.0600000000000001 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 1.0600000000000001 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 2.3999999999999999 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.654 ' C ' HG22 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 2.3900000000000001 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.1299999999999999 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.80000000000000004 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.473 ' HA ' ' HZ2' ' A' ' 98' ' ' LYS . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.112 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 1.1200000000000001 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HZ2' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -73.13 71.5 1.15 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.8700000000000001 111.469 -177.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 73.12 -60.05 0.55 Allowed 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.153 -0.93 . . . . 1.4399999999999999 112.544 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -161.6 -70.96 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 4.1299999999999999 109.647 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.5 t60 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.438 -0.792 . . . . 7.4500000000000002 109.393 -179.388 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.882 0.372 . . . . 4.1100000000000003 110.488 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.524 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t -98.91 157.0 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.03 -0.532 . . . . 1.02 109.767 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.5899999999999999 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.29999999999999999 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.8700000000000001 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 1.0800000000000001 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 20' ' ' VAL . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.0099999999999998 111.971 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 1.04 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 1.04 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 1.1100000000000001 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.6699999999999999 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.68000000000000005 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.56000000000000005 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 2.5099999999999998 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 1.0600000000000001 109.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 ' OG1' HG23 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 1.02 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 1.0 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.643 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 2.3199999999999998 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.26000000000000001 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 7' ' ' GLU . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 1.1299999999999999 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 31' ' ' TYR . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 1.03 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.92000000000000004 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 1.04 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 1.0700000000000001 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.77 112.731 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.29999999999999999 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 1.0700000000000001 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.22 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.77000000000000002 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.526 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.90000000000000002 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.8799999999999999 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 1.24 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 1.0800000000000001 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 1.04 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.6699999999999999 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -118.02 133.75 55.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.8100000000000001 110.896 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -144.5 118.88 9.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 1.2 110.002 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.65 -163.16 9.88 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.41 -0.676 . . . . 0.95999999999999996 111.41 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.8 111.115 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.15 54.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 1.98 111.167 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -163.84 12.18 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.649 -0.786 . . . . 1.3600000000000001 112.625 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -106.87 149.18 27.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.695 0.283 . . . . 1.54 111.145 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -145.64 139.2 26.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.367 -0.378 . . . . 1.4199999999999999 110.311 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -111.43 113.08 25.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.843 -0.429 . . . . 3.4399999999999999 109.843 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.525 ' C ' ' HD2' ' A' ' 47' ' ' LYS . 5.4 mp -104.26 132.32 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.804 -0.18 . . . . 1.1699999999999999 110.722 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 3.1200000000000001 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.9299999999999999 109.758 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 1.0900000000000001 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.28999999999999998 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 1.0600000000000001 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.31 109.018 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 1.1699999999999999 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.535 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 1.05 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 110.147 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 1.0600000000000001 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.3300000000000001 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 2.1000000000000001 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 3.29 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 1.05 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.643 ' CG2' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 1.0600000000000001 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 33' ' ' LEU . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 1.05 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA3' HD11 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28999999999999998 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.6899999999999999 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG12 HG23 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.9199999999999999 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 1.0800000000000001 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 1.1100000000000001 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.88 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 1.3500000000000001 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.94999999999999996 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 1.1100000000000001 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.5900000000000001 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.8300000000000001 110.22 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.56999999999999995 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 1.04 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 1.01 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.9399999999999999 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 1.04 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.2200000000000002 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 1.02 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 1.53 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.38 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.40999999999999998 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.76000000000000001 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 1.0600000000000001 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 1.0600000000000001 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.541 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 1.05 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 2.3999999999999999 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.96999999999999997 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.0 t-20 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 2.3900000000000001 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 96' ' ' THR . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.1299999999999999 109.387 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.80000000000000004 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.4199999999999999 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 93' ' ' ASP . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 111.653 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 1.25 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.42 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -49.31 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.8700000000000001 112.862 -177.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 62.2 34.56 16.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.357 -0.838 . . . . 1.4399999999999999 111.744 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.1 147.4 32.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.973 -0.38 . . . . 4.1299999999999999 109.973 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.493 -0.765 . . . . 7.4500000000000002 109.865 179.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.049 0.452 . . . . 4.1100000000000003 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' A' ' 21' ' ' ILE . 47.5 t -105.36 160.18 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.729 -0.669 . . . . 1.02 109.948 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.5899999999999999 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.29999999999999999 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.644 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 1.0800000000000001 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.563 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.0099999999999998 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 1.04 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 1.04 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 1.1100000000000001 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.6699999999999999 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.68000000000000005 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.56000000000000005 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 2.5099999999999998 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 1.0600000000000001 110.124 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 1.02 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.3 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 2.3199999999999998 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.26000000000000001 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 1.1299999999999999 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' A' ' 31' ' ' TYR . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 1.03 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.92000000000000004 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 1.04 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 1.0700000000000001 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.77 111.662 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.29999999999999999 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 1.0700000000000001 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.22 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.77000000000000002 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.699 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 1.24 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 1.0800000000000001 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 1.04 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.6699999999999999 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -102.46 155.2 18.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.8100000000000001 111.226 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.92 104.07 3.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.813 -1.085 . . . . 1.2 109.427 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.18 -160.78 8.45 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.95999999999999996 111.654 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.48 69.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.994 0.426 . . . . 1.8 111.178 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.77 1.08 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 1.98 111.273 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -161.05 21.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.882 -0.675 . . . . 1.3600000000000001 111.961 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -95.6 134.63 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.049 -0.352 . . . . 1.54 110.049 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.2 m -134.25 142.79 47.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.521 0.2 . . . . 1.4199999999999999 110.831 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -106.33 134.88 48.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.354 -0.385 . . . . 3.4399999999999999 110.592 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp -125.35 138.53 54.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.203 -0.295 . . . . 1.1699999999999999 110.203 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 3.1200000000000001 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.477 ' NE2' HG21 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.9299999999999999 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 1.0900000000000001 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.28999999999999998 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 1.0600000000000001 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.426 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.31 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 1.1699999999999999 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 1.05 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 1.0900000000000001 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 1.0600000000000001 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.3300000000000001 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 2.1000000000000001 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 3.29 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 1.05 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 HG21 HG21 ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 1.05 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28999999999999998 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.6899999999999999 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 HG21 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.9199999999999999 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 1.0800000000000001 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 1.1100000000000001 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.88 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 1.3500000000000001 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.5900000000000001 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.8300000000000001 109.078 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.412 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.56999999999999995 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 1.04 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.633 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 1.01 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.9399999999999999 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 1.04 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.2200000000000002 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 1.02 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 1.53 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' O ' HG11 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.38 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.40999999999999998 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.76000000000000001 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 1.0600000000000001 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 1.0600000000000001 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 1.05 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 2.3999999999999999 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.644 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 2.3900000000000001 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.633 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 96' ' ' THR . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.1299999999999999 109.085 170.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.80000000000000004 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.4199999999999999 111.547 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 93' ' ' ASP . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 1.1200000000000001 111.146 175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 1.25 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.613 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -69.17 71.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.8700000000000001 111.303 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 4.0 mm? 73.26 -67.96 0.24 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.397 -0.82 . . . . 1.4399999999999999 111.395 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -178.73 -41.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.588 -0.523 . . . . 4.1299999999999999 109.588 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.223 -0.894 . . . . 7.4500000000000002 110.226 175.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.722 0.296 . . . . 4.1100000000000003 110.401 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 HG12 ' A' ' 81' ' ' VAL . 38.4 t -90.97 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.38 -0.373 . . . . 1.02 110.12 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.5899999999999999 108.098 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.29999999999999999 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.8700000000000001 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.63 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 1.0800000000000001 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' HG3' HG22 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.0099999999999998 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 1.04 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 1.04 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 1.1100000000000001 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.6699999999999999 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.68000000000000005 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.56000000000000005 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 2.5099999999999998 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 1.0600000000000001 109.865 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 1.02 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 2.3199999999999998 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.26000000000000001 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 7' ' ' GLU . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 1.1299999999999999 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.536 HD13 ' CD2' ' A' ' 31' ' ' TYR . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 1.03 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.92000000000000004 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 1.04 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 1.0700000000000001 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.77 111.073 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.29999999999999999 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 1.0700000000000001 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.22 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.77000000000000002 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.90000000000000002 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 1.24 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 1.0800000000000001 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 1.04 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.6699999999999999 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.3 tttm -112.22 139.55 47.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.8100000000000001 111.097 -171.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.71 121.96 8.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.695 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.3 -162.85 12.44 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.522 -0.631 . . . . 0.95999999999999996 111.522 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.61 67.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.004 0.43 . . . . 1.8 110.899 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 1.98 111.261 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 -176.94 30.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.867 -0.682 . . . . 1.3600000000000001 113.094 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 33.5 p -101.05 134.87 43.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.543 -0.328 . . . . 1.54 110.253 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 t -119.35 136.45 54.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.689 0.28 . . . . 1.4199999999999999 110.397 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -102.15 127.29 49.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.155 -0.475 . . . . 3.4399999999999999 109.724 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.34 127.46 70.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.548 -0.751 . . . . 1.1699999999999999 110.38 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 3.1200000000000001 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.9299999999999999 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 1.0900000000000001 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.28999999999999998 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.31 108.924 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 1.1699999999999999 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 1.0900000000000001 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 1.0600000000000001 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.3300000000000001 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.547 ' HA ' ' NE2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 2.1000000000000001 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 3.29 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 1.05 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 1.0600000000000001 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 1.05 112.192 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 64' ' ' ASN . 0.8 OUTLIER -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.6899999999999999 109.503 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.9199999999999999 109.842 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 1.0800000000000001 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 1.1100000000000001 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.88 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 1.3500000000000001 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.94999999999999996 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.8300000000000001 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 109.223 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 1.04 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.593 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 1.01 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.675 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.9399999999999999 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 1.04 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.2200000000000002 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 1.02 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 1.53 109.445 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.38 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.76000000000000001 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 1.0600000000000001 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 1.0600000000000001 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 1.05 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.96999999999999997 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.63 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 2.3900000000000001 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.6 ' CD2' HD11 ' A' ' 17' ' ' LEU . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 1.0 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.1299999999999999 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.80000000000000004 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.4199999999999999 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 1.25 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? -70.05 74.33 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.8700000000000001 111.499 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 63.77 65.08 0.74 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.948 0.404 . . . . 1.4399999999999999 110.307 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 73.51 -70.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.973 -1.012 . . . . 4.1299999999999999 110.765 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.2 -0.905 . . . . 7.4500000000000002 109.893 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.017 0.437 . . . . 4.1100000000000003 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 81' ' ' VAL . 22.0 t -105.33 148.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.883 -0.599 . . . . 1.02 110.453 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.5899999999999999 108.364 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.29999999999999999 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.8700000000000001 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.721 HG23 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 1.0800000000000001 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.0099999999999998 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 1.04 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 1.04 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 1.1100000000000001 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.6699999999999999 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.68000000000000005 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.56000000000000005 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 2.5099999999999998 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 1.0600000000000001 110.245 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 1.02 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 1.0 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 2.3199999999999998 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.26000000000000001 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 7' ' ' GLU . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 1.1299999999999999 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 31' ' ' TYR . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 1.03 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.92000000000000004 107.221 168.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 1.04 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 1.0700000000000001 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.77 112.078 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.29999999999999999 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 1.0700000000000001 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.22 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.77000000000000002 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.8799999999999999 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 1.24 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 1.0800000000000001 109.963 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 1.04 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.6699999999999999 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 7.5 mtmp? -99.01 152.98 19.22 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.8100000000000001 110.557 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 105.77 3.28 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.634 -0.712 . . . . 1.2 110.534 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.01 -162.94 9.55 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.488 -0.863 . . . . 0.95999999999999996 112.323 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.91 66.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 1.8 111.299 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.48 4.82 52.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 1.98 110.897 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.06 -168.14 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 1.3600000000000001 112.39 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -95.63 156.52 16.29 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.635 0.255 . . . . 1.54 110.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 39.4 m -148.44 162.62 39.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.391 -0.225 . . . . 1.4199999999999999 110.391 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -136.01 129.03 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.796 0.808 . . . . 3.4399999999999999 111.891 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.8 mp -112.69 131.53 63.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.484 -1.235 . . . . 1.1699999999999999 109.203 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 3.1200000000000001 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.9299999999999999 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 1.0900000000000001 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.28999999999999998 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 1.0600000000000001 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.31 109.766 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 1.1699999999999999 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 1.05 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 1.0900000000000001 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 1.0600000000000001 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.3300000000000001 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.545 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 2.1000000000000001 109.859 177.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 3.29 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 1.05 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 20' ' ' VAL . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 1.0600000000000001 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 1.05 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28999999999999998 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.6899999999999999 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG13 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.9199999999999999 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 1.0800000000000001 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 1.1100000000000001 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' HH ' HD22 ' A' ' 99' ' ' LEU . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.88 111.96 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 1.3500000000000001 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.94999999999999996 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 3.5 t-20 -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 110.106 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.8300000000000001 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.56999999999999995 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 1.04 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.616 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 1.01 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.9399999999999999 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 1.04 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.2200000000000002 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 1.02 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 1.53 109.247 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.40999999999999998 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.76000000000000001 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 1.0600000000000001 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 1.0600000000000001 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 1.05 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.9 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 2.3999999999999999 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.96999999999999997 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.721 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 2.3900000000000001 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.616 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.1299999999999999 109.012 168.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.80000000000000004 112.173 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.76 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 1.1200000000000001 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 1.25 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -56.26 95.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.8700000000000001 111.746 -168.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.559 HD22 ' HH ' ' A' ' 69' ' ' TYR . 3.3 mm? 63.36 29.01 15.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.902 -1.045 . . . . 1.4399999999999999 111.796 170.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.9 156.89 17.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.262 -0.644 . . . . 4.1299999999999999 109.262 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 119.127 -0.463 . . . . 7.4500000000000002 110.209 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.948 0.404 . . . . 4.1100000000000003 110.563 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG1' HG22 ' A' ' 21' ' ' ILE . 34.9 t -103.63 152.48 6.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.831 -0.622 . . . . 1.02 110.694 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.5899999999999999 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.29999999999999999 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.8700000000000001 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.0099999999999998 112.33 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 100' ' ' GLU . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 1.04 107.206 168.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 1.04 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 1.1100000000000001 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.6699999999999999 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.68000000000000005 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.56000000000000005 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 2.5099999999999998 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 1.0600000000000001 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 1.02 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 2.3199999999999998 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.26000000000000001 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG23 ' HG3' ' A' ' 7' ' ' GLU . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 1.1299999999999999 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.563 HG22 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 1.03 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.92000000000000004 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 1.04 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 1.0700000000000001 112.601 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.77 112.09 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.29999999999999999 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 1.0700000000000001 110.457 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.22 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.77000000000000002 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CD2' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.90000000000000002 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.8799999999999999 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 1.24 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 1.0800000000000001 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 1.04 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HB2' ' NH1' ' A' ' 45' ' ' ARG . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.306 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt -113.14 135.35 53.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.8100000000000001 111.13 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.95 105.17 3.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.819 -0.628 . . . . 1.2 110.584 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.45 -162.82 10.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.131 -1.033 . . . . 0.95999999999999996 112.496 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.03 70.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 1.8 110.917 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.15 59.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 1.98 111.103 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.78 -174.7 15.37 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.709 -0.757 . . . . 1.3600000000000001 112.807 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.424 HG23 ' CB ' ' A' ' 38' ' ' ALA . 19.9 p -103.64 132.12 50.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.287 . . . . 1.54 110.312 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' HB2' ' CE ' ' A' ' 37' ' ' LYS . 45.2 m -143.42 139.21 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.513 -0.475 . . . . 1.4199999999999999 110.644 176.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 36' ' ' ASP . 15.8 tpt180 -103.63 137.11 42.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.27 0.557 . . . . 3.4399999999999999 110.358 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -122.66 141.84 41.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.243 -0.89 . . . . 1.1699999999999999 109.569 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 3.1200000000000001 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.9299999999999999 109.737 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.28999999999999998 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 1.0600000000000001 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.31 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 1.1699999999999999 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 1.05 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 1.0900000000000001 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 1.0600000000000001 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.3300000000000001 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 2.1000000000000001 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 3.29 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 1.05 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 1.0600000000000001 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 1.05 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28999999999999998 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.6899999999999999 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.9199999999999999 109.962 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 1.0800000000000001 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 67' ' ' LEU . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 1.1100000000000001 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HH ' HD22 ' A' ' 99' ' ' LEU . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.88 112.163 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 1.3500000000000001 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.94999999999999996 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 1.1100000000000001 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.5900000000000001 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.8300000000000001 109.392 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.56999999999999995 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 1.04 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.611 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 1.01 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.9399999999999999 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 1.04 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.2200000000000002 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 1.02 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 1.53 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.514 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.38 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.40999999999999998 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 1.0600000000000001 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 1.05 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.643 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 2.3999999999999999 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.96999999999999997 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 2.3900000000000001 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.611 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 1.0 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.543 ' HB3' HG22 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.1299999999999999 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.80000000000000004 113.164 -174.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' HA ' ' HZ3' ' A' ' 98' ' ' LYS . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.4199999999999999 110.595 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 1.1200000000000001 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 1.25 111.631 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HZ3' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -68.54 82.1 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.8700000000000001 111.991 -175.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 HD22 ' HH ' ' A' ' 69' ' ' TYR . 3.6 mm? 67.2 39.94 2.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.926 -1.034 . . . . 1.4399999999999999 111.985 168.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 6.5 tp10 -79.74 148.77 31.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.889 -0.596 . . . . 4.1299999999999999 109.82 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.28 -0.867 . . . . 7.4500000000000002 110.358 -179.01 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 40.6 t . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.3 0.571 . . . . 0.15 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.03 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.3 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.87 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 0.33 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.01 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 0.17 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.22 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 0.33 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.22 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.61 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.48 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 1.85 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 0.23 109.994 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.24 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 0.17 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 1.77 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.19 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 0.45 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 0.14 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.2 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 0.16 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 0.25 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.18 111.61 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.26 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 0.45 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.21 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.23 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.18 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.615 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.26 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 0.55 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 0.25 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 0.23 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.67 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp . . . . . 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.34 110.649 -177.664 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.562 -0.532 . . . . 0.45 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 2.74 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.63 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 0.39 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.26 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 0.38 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.26 109.27 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.43 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 0.23 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 0.33 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 0.22 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.33 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 1.48 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 2.72 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 0.15 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 0.19 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 0.16 113.104 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.17 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.29 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 0.3 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 0.26 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.33 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 0.99 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.54 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.32 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.5 109.948 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.35 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 0.16 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 0.16 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.35 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 0.22 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.615 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.22 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 0.13 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 0.82 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.34 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.41 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.43 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 0.24 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 0.25 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 0.14 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 1.88 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.97 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.664 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 1.87 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.17 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.577 ' HB3' HG23 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.13 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.4 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.42 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 0.31 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 0.64 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.4 111.061 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' HG11 ' A' ' 81' ' ' VAL . 21.5 t . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.859 0.361 . . . . 0.15 110.563 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.03 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.3 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.87 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 0.33 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.01 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 0.17 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.22 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 0.33 112.141 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.22 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.61 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.48 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 1.85 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 0.23 109.857 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 0.24 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 0.17 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 1.77 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.19 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 0.45 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.59 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 0.14 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.2 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 0.16 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 0.25 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.18 111.363 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.26 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 0.45 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.21 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.23 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.18 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.26 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 0.55 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 0.25 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.23 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.67 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm . . . . . 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.34 110.884 -175.11 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 65' ' ' VAL . 5.1 mp . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.541 -0.17 . . . . 0.45 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 2.74 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.63 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.39 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.26 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 0.38 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.26 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 0.43 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 0.23 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.33 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 0.22 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.33 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.489 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 1.48 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 2.72 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 0.15 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 0.19 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 0.16 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.17 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.29 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 0.3 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 0.26 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.33 112.986 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 0.99 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.54 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.5 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.32 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.5 109.207 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 97' ' ' VAL . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.35 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 0.16 109.468 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 0.16 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.35 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 0.22 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.22 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 0.13 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 87' ' ' THR . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 0.82 109.785 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' O ' HG12 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.34 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.41 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.43 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 83' ' ' PHE . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 0.24 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 0.25 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.14 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 1.88 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.97 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 1.87 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.636 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 0.17 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.13 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.4 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.42 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 0.31 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 0.64 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.707 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.4 108.89 167.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.589 ' CG1' HG23 ' A' ' 21' ' ' ILE . 43.6 t . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.649 -0.5 . . . . 0.15 109.649 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.03 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.3 112.426 -178.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.87 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 0.33 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.01 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 0.17 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 0.22 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 0.33 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.22 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.61 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.48 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 1.85 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 0.23 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 0.24 109.486 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 0.17 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG22 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 1.77 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 0.45 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.589 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 0.14 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.2 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 0.16 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 0.25 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.18 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.26 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 0.45 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.21 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.23 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.604 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.18 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.629 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 0.55 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 0.25 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 0.23 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.67 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.34 110.53 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.966 -0.753 . . . . 0.45 108.966 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 2.74 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.63 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.39 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.26 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 0.38 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.26 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 0.43 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 0.23 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 0.33 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 0.22 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.33 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 2.0 mm-40 -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 1.48 109.647 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 2.72 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 0.15 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 0.16 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.629 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.17 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 46' ' ' ILE . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.29 109.19 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 0.3 111.502 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 0.26 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.33 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.99 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.54 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 0.5 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.8 t-20 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.32 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.426 ' HG2' ' HG3' ' A' ' 94' ' ' PRO . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.5 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' HG21 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.35 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 0.16 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 0.16 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.35 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 0.22 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.22 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 0.13 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 0.82 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.34 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.41 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.43 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 0.24 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 0.14 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 1.88 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.97 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.624 ' C ' HG21 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 1.87 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 95' ' ' GLU . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.13 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.426 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.4 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.42 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 0.31 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 75' ' ' TYR . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 0.64 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.4 110.638 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.912 0.386 . . . . 0.15 110.407 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.03 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.3 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.87 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 0.33 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.01 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 0.17 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 0.22 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 0.33 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.22 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.61 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.48 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 1.85 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 0.23 110.094 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 0.24 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 0.17 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.7 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 1.77 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.19 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.572 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 0.45 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 0.14 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.553 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.2 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 0.16 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 0.25 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.18 111.436 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.26 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 0.45 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.21 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.23 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.18 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.26 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 0.55 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 0.25 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 0.23 109.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.67 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HE2' HD12 ' A' ' 67' ' ' LEU . 21.8 mttt . . . . . 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.34 110.081 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 37' ' ' LYS . 5.2 mp . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.45 109.172 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 2.74 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.63 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.39 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.26 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 0.38 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.26 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 0.43 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.33 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 1.48 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 2.72 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 0.15 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 0.19 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.17 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 46' ' ' ILE . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.29 108.833 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 0.3 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 0.26 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 71' ' ' SER . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.33 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 0.99 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.454 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.54 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 0.5 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.32 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.5 109.237 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 97' ' ' VAL . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.35 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 0.16 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 0.16 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.35 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 0.22 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.22 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 0.13 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 0.82 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.34 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.41 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.43 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 0.24 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.25 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 0.14 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 1.88 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.97 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 1.87 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 0.17 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.13 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.4 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.42 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 0.31 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 0.64 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.67 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.4 110.794 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 21' ' ' ILE . 27.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.15 109.797 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.03 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.3 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.87 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 0.33 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.01 112.272 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 0.17 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 0.22 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 0.33 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.22 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.61 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.48 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 1.85 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 0.23 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.427 ' OG1' HG22 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 0.24 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 0.17 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 61' ' ' THR . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 1.77 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.19 111.423 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 0.45 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.646 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 0.14 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.2 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 0.16 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 0.25 112.162 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.18 111.975 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.26 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 0.45 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.21 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.23 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.18 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.26 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 0.55 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.25 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 0.23 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.67 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.7 tttt . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.34 110.008 179.037 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.535 -0.543 . . . . 0.45 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 2.74 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.63 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 0.39 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.26 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 0.38 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.26 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 0.43 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 0.23 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 0.33 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 0.22 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.33 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 1.48 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 2.72 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.15 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 0.16 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.596 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.17 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.29 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 0.3 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 0.26 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.33 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 0.99 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.54 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.5 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.32 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.5 109.689 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.401 ' HB2' HG21 ' A' ' 97' ' ' VAL . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.35 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 0.16 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 0.16 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.35 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 0.22 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.641 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.22 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 0.13 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 0.82 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.34 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.41 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 0.24 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 0.25 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.589 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 0.14 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 1.88 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.97 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.87 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 0.17 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.13 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.4 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.796 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.42 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 0.31 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 75' ' ' TYR . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 0.64 113.865 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.796 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.4 111.703 -171.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.612 ' CG1' HG11 ' A' ' 81' ' ' VAL . 18.2 t . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.047 0.451 . . . . 0.15 111.028 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.03 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.3 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.87 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 0.33 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.01 112.04 -173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 0.17 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 0.22 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 0.33 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.22 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.61 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.48 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 1.85 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 0.23 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 0.24 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 0.17 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.527 ' CB ' HG22 ' A' ' 61' ' ' THR . 18.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 1.77 109.971 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' H ' HD22 ' A' ' 33' ' ' LEU . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.19 111.272 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.694 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 0.45 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.591 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 0.14 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.2 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 0.16 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 0.25 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.18 111.378 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.26 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 0.45 110.574 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.21 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.23 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.18 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.26 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 0.55 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 0.25 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 0.23 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.67 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.34 109.851 177.688 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.344 -0.243 . . . . 0.45 110.344 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 2.74 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.63 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 0.39 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.38 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.429 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.26 109.188 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 0.43 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.826 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 0.33 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 0.22 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.33 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 1.48 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 2.72 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 0.15 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 0.19 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 0.16 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.17 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.29 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 0.3 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.61 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 0.26 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.33 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 0.99 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.54 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 0.5 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.32 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.5 109.271 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.35 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.637 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 0.16 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.35 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 0.22 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.22 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 0.13 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 87' ' ' THR . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 0.82 109.66 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.34 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.41 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.43 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 0.24 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 0.25 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.571 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 0.14 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 1.88 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.97 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.609 ' C ' HG21 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 1.87 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.637 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 0.17 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.13 108.931 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.4 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.42 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 0.31 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 75' ' ' TYR . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 0.64 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.783 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.4 110.654 -171.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.7 t . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.987 -0.375 . . . . 0.15 109.987 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 84.9 mm-40 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.03 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.3 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.87 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 0.33 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.01 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 0.17 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 0.22 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 0.33 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.22 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.61 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.48 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 1.85 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 0.23 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.404 ' OG1' HG22 ' A' ' 66' ' ' VAL . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 0.24 109.381 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 0.17 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 42.4 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 1.77 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.19 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 0.45 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 0.14 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.2 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 0.16 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 0.25 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.18 111.3 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.26 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 0.45 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.21 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.23 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.18 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.622 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.26 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 0.55 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 0.25 109.967 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 0.23 110.224 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.67 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.34 110.9 -175.021 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.29 -0.633 . . . . 0.45 109.29 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 2.74 111.851 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.63 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 0.39 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.26 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 0.38 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.26 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 0.43 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 0.23 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 0.22 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.33 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 1.48 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 2.72 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 0.15 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 HG12 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 0.16 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.17 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 46' ' ' ILE . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.29 109.174 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 0.3 111.151 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 0.26 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.33 112.299 -170.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 0.99 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.54 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 0.5 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.32 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.5 109.761 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' HB2' HG21 ' A' ' 97' ' ' VAL . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.35 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 0.16 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.642 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 0.16 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.35 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 0.22 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.622 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.22 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 0.13 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.548 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 0.82 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.34 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.41 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.43 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 0.24 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 0.25 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.573 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 0.14 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 1.88 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.97 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 1.87 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.642 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 0.17 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' HG23 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.13 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.4 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.42 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.31 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 75' ' ' TYR . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 0.64 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.4 111.607 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.613 ' CG1' HG23 ' A' ' 21' ' ' ILE . 44.1 t . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 109.999 -0.371 . . . . 0.15 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.03 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.3 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.87 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.602 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 0.33 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.01 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 0.17 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 0.22 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 0.33 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.22 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.61 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.48 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 1.85 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 0.23 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 66' ' ' VAL . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 0.24 109.239 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.625 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 0.17 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 1.77 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.19 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 0.45 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.613 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 0.14 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.2 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 0.16 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 0.25 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.18 111.513 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.26 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 0.45 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.21 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.23 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.577 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.18 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.26 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 0.55 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 0.25 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 0.23 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.67 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 19.6 ttpt . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.34 110.238 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.984 -0.376 . . . . 0.45 109.984 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 2.74 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.63 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 0.39 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.26 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 0.38 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.26 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 0.43 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 0.23 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 0.33 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 0.22 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.33 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 1.48 109.696 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 2.72 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 0.15 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 0.19 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 0.16 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.17 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.29 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 0.3 110.792 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 0.26 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.33 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 0.99 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.54 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 0.5 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.32 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.5 109.56 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.35 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 0.16 109.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.685 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 0.16 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.35 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 0.22 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.704 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.22 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 0.13 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 0.82 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.34 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.41 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.43 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 0.24 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 0.25 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.61 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 0.14 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 1.88 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.97 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 1.87 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 0.17 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 92' ' ' LEU . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.13 109.625 170.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.4 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.42 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 0.31 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 0.64 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.4 111.854 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.15 110.441 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.03 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.3 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.87 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.674 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 0.33 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.01 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 0.17 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 0.22 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 0.33 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.22 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.61 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.48 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 1.85 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 0.23 110.259 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.403 ' OG1' HG22 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 0.24 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.579 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 0.17 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.637 ' CB ' HG22 ' A' ' 61' ' ' THR . 43.4 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 1.77 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.19 111.026 171.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.719 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 0.45 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 0.14 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.2 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 0.16 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 0.25 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.18 111.6 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.26 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 0.45 110.65 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.21 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.23 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.18 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.26 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.55 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 0.25 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 0.23 110.296 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.67 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.34 110.536 -176.853 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 109.966 -0.383 . . . . 0.45 109.966 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 2.74 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.63 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 0.39 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.26 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 0.38 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.26 109.245 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 0.43 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.33 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.33 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 1.48 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.719 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 2.72 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.763 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 0.15 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 0.19 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 0.16 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.17 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.29 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 0.3 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 0.26 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.33 112.075 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 0.99 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.54 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.5 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.32 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.35 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 0.16 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 0.16 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.35 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 0.22 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.22 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 0.13 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 87' ' ' THR . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 0.82 109.653 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG12 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.34 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.41 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.43 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 0.24 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 0.25 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 0.14 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 1.88 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.97 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.674 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 1.87 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 0.17 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.13 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.4 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.42 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 0.31 111.165 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 75' ' ' TYR . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 0.64 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.4 111.669 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 21' ' ' ILE . 21.5 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 0.15 111.661 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.03 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.3 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.87 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 0.33 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.01 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 0.17 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 0.22 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 0.33 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.22 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.61 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.48 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 1.85 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.23 109.739 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 0.24 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 0.17 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 1.77 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.19 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 0.45 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.619 HG23 ' CG1' ' A' ' 2' ' ' VAL . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 0.14 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.2 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.716 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 0.16 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 0.25 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.18 111.563 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.26 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 0.45 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.21 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.23 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.18 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.26 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 0.55 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 0.25 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 0.23 110.143 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.67 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.453 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.34 110.236 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.626 -0.509 . . . . 0.45 109.626 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 2.74 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.63 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 0.39 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.26 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 0.38 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.486 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.26 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 0.43 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 0.23 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 0.33 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 0.22 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.33 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 1.48 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 2.72 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 0.15 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 0.19 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 0.16 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.17 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 46' ' ' ILE . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.29 109.661 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 0.3 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 0.26 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.33 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 0.99 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.54 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.5 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.32 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.5 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 97' ' ' VAL . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.35 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 0.16 109.661 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 0.16 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.35 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 0.22 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.22 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.726 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 0.13 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 0.82 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.536 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.34 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.41 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.43 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 0.24 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.25 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 0.14 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 1.88 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.97 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 1.87 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 0.17 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.13 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.4 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.42 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 0.31 111.654 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 0.64 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.73 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.4 111.598 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.647 ' CG1' HG23 ' A' ' 21' ' ' ILE . 41.1 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.744 0.306 . . . . 0.15 110.525 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.03 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.3 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.87 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 0.33 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.01 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 0.17 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 0.22 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 0.33 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.22 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.61 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.48 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 1.85 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 0.23 110.267 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 0.24 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 0.17 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 1.77 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.19 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 0.45 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.647 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 0.14 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.2 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 0.16 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 24' ' ' VAL . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 0.25 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.18 111.7 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.26 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 0.45 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.21 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.23 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.18 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 0.55 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 0.25 110.622 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 0.23 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.67 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.34 110.255 -179.08 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.497 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.496 -0.557 . . . . 0.45 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 2.74 112.521 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.63 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.39 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.26 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.26 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 0.43 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 0.23 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 0.33 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 0.22 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.33 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 1.48 109.699 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 2.72 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 0.15 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 0.19 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 0.16 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.17 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.29 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG22 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 0.3 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 0.26 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.33 111.691 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 0.99 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.54 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 0.5 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.32 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.5 110.042 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.35 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 0.16 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 0.16 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.35 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 0.22 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.22 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 0.13 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 0.82 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.34 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.41 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.43 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 0.24 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 0.25 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 1.88 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.97 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 1.87 112.17 -177.032 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.668 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 0.17 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.13 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.4 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.42 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 0.31 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 0.64 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HE3' ' H ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.572 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG11 ' A' ' 81' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.15 110.145 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.03 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.3 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.87 107.403 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.665 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 0.33 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.01 112.598 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 0.17 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 0.22 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 0.33 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.22 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.61 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.48 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 1.85 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 0.23 110.116 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 0.24 109.114 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 0.17 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.417 ' HB2' HG22 ' A' ' 61' ' ' THR . 8.3 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.19 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 0.45 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.582 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 0.14 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 59' ' ' ARG . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.2 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 0.16 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 0.25 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.18 110.964 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.26 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 0.45 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.21 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.23 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.18 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.26 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 0.55 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 0.25 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 0.23 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.67 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.34 110.494 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 2.74 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.63 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 0.39 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.26 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 0.38 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.26 109.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 0.43 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.23 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 0.33 110.72 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.22 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.33 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 1.48 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 2.72 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 0.15 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 0.19 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 0.16 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.17 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.29 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 0.3 111.258 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 0.26 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.33 112.362 -171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 0.99 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.54 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 0.5 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.32 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.5 109.627 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.35 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 0.16 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 0.16 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.35 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 0.22 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.22 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 0.13 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 0.82 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.34 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.41 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.43 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 0.24 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 0.25 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.617 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 0.14 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 1.88 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.97 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.665 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 1.87 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.62 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 0.17 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.13 109.182 170.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.4 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.715 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.42 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 0.31 111.922 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 0.64 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.715 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.4 110.162 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.1 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 0.15 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.03 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.3 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.87 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 0.33 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.01 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 0.17 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 0.22 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 0.33 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.22 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.61 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.48 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 1.85 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 0.23 110.454 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 0.24 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 0.17 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.788 HE21 HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 1.77 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.19 111.592 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.569 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 0.45 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.588 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 0.14 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.2 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 0.16 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 0.25 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.18 111.706 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.26 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 0.45 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.21 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.23 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.18 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.26 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.55 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 0.25 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.594 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 0.23 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.67 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt . . . . . 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.34 110.431 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.8 -0.815 . . . . 0.45 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 2.74 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.63 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.26 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 0.38 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.26 109.145 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 0.43 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 0.23 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 0.33 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.22 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.33 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 1.48 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 2.72 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 0.15 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.788 HG21 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 0.19 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 0.16 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.17 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.29 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 0.3 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 0.26 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.33 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 0.99 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.54 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.5 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.32 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.5 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.486 ' HB2' HG21 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.35 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 0.16 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 0.16 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.35 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 0.22 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.22 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 0.13 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 0.82 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.34 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.41 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.43 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.24 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.608 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 0.14 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.729 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 6.9 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 1.88 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.97 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.686 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 1.87 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 0.17 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.13 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.4 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.818 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.42 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 0.31 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 0.64 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.4 111.839 -170.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG23 ' A' ' 21' ' ' ILE . 20.3 t . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.999 0.428 . . . . 0.15 111.068 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.03 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.3 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.87 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.718 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 0.33 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.01 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 0.17 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 0.22 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 0.33 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.22 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.61 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.48 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 1.85 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.23 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 0.24 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 0.17 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 61' ' ' THR . 3.4 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 1.77 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.19 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 0.45 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 0.14 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.2 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 0.16 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 0.25 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.18 111.199 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.26 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 0.45 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.21 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.23 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.18 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.26 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 0.55 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 0.25 110.245 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.23 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.67 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.34 110.317 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.974 -0.38 . . . . 0.45 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 2.74 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.63 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 0.39 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.26 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 0.38 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.26 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 0.43 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 0.23 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 0.33 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.22 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.33 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 1.48 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 2.72 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.697 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.15 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 0.19 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 0.16 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.17 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG21 HG21 ' A' ' 46' ' ' ILE . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.29 109.603 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 0.3 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 0.26 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.33 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.453 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 0.99 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.54 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 0.5 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.32 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.5 109.712 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.35 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 0.16 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.657 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 0.16 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.35 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 0.22 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.22 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 0.13 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 0.82 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.539 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.34 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.41 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.43 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 0.24 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 0.25 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.14 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 1.88 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.97 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.718 ' C ' HG21 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 1.87 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 0.17 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.13 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.4 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.839 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.42 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 0.31 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' TYR . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 0.64 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.839 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.4 110.986 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.9 t . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 0.15 109.923 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.586 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.03 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.3 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.87 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 0.33 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.01 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 0.17 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.22 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 0.33 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.22 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.61 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.48 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 1.85 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 0.23 109.643 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 0.24 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 0.17 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' CB ' HG22 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 1.77 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.19 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 0.45 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 0.14 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.2 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 0.16 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 0.25 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.18 112.657 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.26 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 0.45 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.21 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.23 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.63 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.18 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.26 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 0.55 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 0.25 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 0.23 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.67 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.34 110.645 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.501 -0.185 . . . . 0.45 110.501 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 2.74 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.63 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 0.39 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.26 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 0.38 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.26 109.476 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 0.43 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 0.23 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.33 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 0.22 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.33 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 1.48 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 2.72 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.15 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 0.19 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 0.16 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.17 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.29 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 0.3 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 0.26 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.33 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 0.99 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.54 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.0 OUTLIER -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.32 110.492 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.5 109.984 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.35 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 0.16 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 0.16 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.35 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 0.22 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.22 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 0.13 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 0.82 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.34 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.41 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.43 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 0.24 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 0.25 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.585 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 0.14 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 1.88 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.97 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 1.87 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 0.17 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.13 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.4 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.42 111.112 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 0.31 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 0.64 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HE3' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.4 111.469 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.767 -0.457 . . . . 0.15 109.767 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.03 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.3 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.87 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 0.33 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.01 111.971 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 0.17 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 0.22 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.33 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.22 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.61 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.48 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 1.85 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 0.23 109.956 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 0.24 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.588 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 0.17 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HB2' HG22 ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 1.77 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.19 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 61' ' ' THR . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 0.45 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 0.14 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.2 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 0.16 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 0.25 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.18 112.731 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.26 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.21 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.23 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.18 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.26 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 0.55 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 0.23 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.34 110.896 -177.28 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.641 HG21 HG11 ' A' ' 65' ' ' VAL . 5.4 mp . . . . . 0 C--O 1.227 -0.089 0 N-CA-C 110.722 -0.103 . . . . 0.45 110.722 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 2.74 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.43 ' NE2' HG12 ' A' ' 65' ' ' VAL . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.63 109.758 172.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 0.39 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.26 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 0.38 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.417 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.26 109.018 -176.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 0.43 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 0.23 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 0.33 110.147 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 0.22 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.33 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 1.48 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 2.72 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 0.15 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 0.19 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 0.16 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.17 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.29 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 0.3 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 0.26 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.33 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.99 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.54 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.5 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.32 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.5 110.22 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.35 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 0.16 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 0.16 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.35 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 0.22 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.22 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 0.13 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 0.82 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.588 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.34 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.41 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.43 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 0.24 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.14 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 1.88 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.97 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 2.8 t30 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 1.87 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.17 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.13 109.387 170.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.4 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.42 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 0.31 111.653 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 0.64 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.489 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.4 112.862 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.948 -0.39 . . . . 0.15 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.03 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.3 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.87 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 0.33 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.01 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 0.17 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 0.22 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 0.33 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.22 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.61 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.48 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 1.85 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 0.23 110.124 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.24 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 0.17 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.8 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 1.77 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.19 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.56 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 0.45 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 0.14 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.2 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 0.16 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.25 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.18 111.662 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.26 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 0.45 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.21 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.23 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.18 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 0.55 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 0.25 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 0.23 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.67 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD12 ' A' ' 67' ' ' LEU . 32.9 mtmt . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.34 111.226 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 110.203 -0.295 . . . . 0.45 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 2.74 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.518 ' NE2' HG22 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.63 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 0.39 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.26 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 0.38 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.26 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 0.43 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 0.23 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 0.22 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.33 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 1.48 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 2.72 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 0.15 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 0.19 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 0.16 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.17 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG22 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.29 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 0.3 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 0.26 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.33 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 0.99 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.54 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 0.5 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.32 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.5 109.078 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.35 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 0.16 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.35 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 0.22 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.22 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 0.13 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 0.82 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.34 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.41 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.43 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 0.24 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 0.25 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 0.14 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 1.88 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.97 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.658 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 1.87 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.647 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 0.17 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.13 109.085 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.4 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.42 111.547 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 0.31 111.146 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 0.64 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.622 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.4 111.303 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.608 ' CG1' HG23 ' A' ' 21' ' ' ILE . 38.4 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.801 0.334 . . . . 0.15 110.12 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.03 108.098 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.3 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.87 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 0.33 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.01 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 0.17 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 0.22 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.33 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.22 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.61 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.48 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 1.85 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 0.23 109.865 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 0.24 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.59 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 0.17 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 1.77 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.19 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 0.45 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.608 HG23 ' CG1' ' A' ' 2' ' ' VAL . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 0.14 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 59' ' ' ARG . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.2 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 0.16 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 0.25 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.18 111.073 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.26 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 0.45 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.21 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.23 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.18 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.26 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 0.55 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.25 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 0.23 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.67 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 tttm . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.34 111.097 -171.612 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.621 0.248 . . . . 0.45 110.38 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 2.74 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.63 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 0.39 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.26 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 0.38 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.26 108.924 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 0.43 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 0.23 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 0.33 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 0.22 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.33 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 1.48 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 2.72 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.82 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 0.15 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 79' ' ' LEU . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 0.16 112.192 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 3.5 m-20 -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.17 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 46' ' ' ILE . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.29 109.842 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 0.3 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 0.26 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.33 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 0.99 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.54 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.5 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.32 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.5 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' HB2' HG21 ' A' ' 97' ' ' VAL . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.35 109.223 173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 0.16 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.35 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 0.22 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.68 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.22 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 0.13 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 87' ' ' THR . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 0.82 109.445 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.541 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.34 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.41 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.43 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 0.24 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 0.25 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 0.14 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 1.88 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.97 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.639 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 1.87 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 0.17 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.13 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.4 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.42 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 0.31 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 0.64 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? . . . . . 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.4 111.499 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.0 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.15 110.453 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.03 108.364 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.3 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.87 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 0.33 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.01 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 0.17 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 0.22 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 0.33 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.22 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.61 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.48 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 1.85 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 0.23 110.245 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 0.24 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 0.17 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 1.77 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.19 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' THR . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 0.45 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 0.14 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.2 107.221 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 0.25 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.18 112.078 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.26 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 0.45 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.21 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.23 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.18 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.26 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 0.55 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 0.25 109.963 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 0.23 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.67 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD3' HD12 ' A' ' 67' ' ' LEU . 7.5 mtmp? . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.34 110.557 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 HG11 ' A' ' 65' ' ' VAL . 4.8 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.203 -0.666 . . . . 0.45 109.203 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 2.74 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.63 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 0.39 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.26 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 0.38 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.26 109.766 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 0.43 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 0.23 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 0.33 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 0.22 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.33 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.559 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.5 mm-40 -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 1.48 109.859 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 2.72 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 0.15 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 0.19 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 0.16 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.17 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.29 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 0.3 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 ' HD3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 0.26 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.33 111.96 -173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 0.99 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.54 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 0.5 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.1 OUTLIER -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.32 110.106 -177.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.5 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.35 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 0.16 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.63 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 0.16 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.35 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.583 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 0.22 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.22 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 0.13 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 0.82 109.247 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' O ' HG12 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.34 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.41 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.43 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 0.24 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 0.25 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.582 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.14 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.7 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 1.88 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.97 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.73 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 1.87 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.63 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.17 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.13 109.012 168.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.4 112.173 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.769 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.42 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 0.31 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 0.64 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.4 111.746 -168.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG1' HG23 ' A' ' 21' ' ' ILE . 34.9 t . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.912 0.387 . . . . 0.15 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.03 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.3 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.87 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 0.33 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.01 112.33 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 0.17 107.206 168.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 0.22 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 0.33 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.22 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.61 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.48 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 1.85 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 0.23 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 0.24 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 0.17 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 1.77 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.19 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 61' ' ' THR . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 0.45 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 0.14 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.2 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 0.16 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 0.25 112.601 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.18 112.09 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.26 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 0.45 110.457 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.21 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.23 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.18 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.26 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.556 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 0.55 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 0.23 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.67 110.306 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.34 111.13 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.569 -0.53 . . . . 0.45 109.569 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 2.74 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' OE1' HG22 ' A' ' 65' ' ' VAL . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.63 109.737 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.39 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.26 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.26 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.43 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 0.23 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 0.33 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 0.22 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.33 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 1.48 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 2.72 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 0.15 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 0.19 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 0.16 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.17 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 HG21 ' A' ' 46' ' ' ILE . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.29 109.962 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 0.3 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.639 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 0.26 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.33 112.163 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.99 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.54 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.5 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.32 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.5 109.392 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.35 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 0.16 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.624 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 0.16 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.35 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 0.22 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.22 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 0.13 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 0.82 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.534 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.34 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.41 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.43 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 0.24 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 0.25 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.14 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 1.88 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.97 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 1.87 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 0.17 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.13 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.4 113.164 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.42 110.595 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 0.31 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 75' ' ' TYR . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 0.64 111.631 170.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.4 111.991 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.752 0.311 . . . . 3.75 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 40.6 t -90.86 152.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.3 0.571 . . . . 0.15 109.788 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.03 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.3 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.87 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 0.33 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.01 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 0.17 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.22 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 0.33 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.22 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.61 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.48 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 1.85 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 0.23 109.994 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.24 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 0.17 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 1.77 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.19 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 0.45 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 0.14 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.2 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 0.16 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 0.25 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.18 111.61 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.26 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 0.45 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.21 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.23 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.18 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.615 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.26 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 0.55 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 0.25 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 0.23 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.67 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -112.56 121.99 46.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.34 110.649 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -130.21 108.41 10.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 0.6 110.437 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.08 -163.44 9.91 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.875 -0.679 . . . . 0.96 111.647 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.76 -17.66 64.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.75 0.309 . . . . 1.57 111.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.2 -7.85 57.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 1.72 111.396 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.24 -170.42 14.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.629 -0.796 . . . . 1.21 112.637 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -108.49 114.98 29.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.661 0.267 . . . . 1.14 110.761 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 m -106.21 143.39 34.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.741 0.305 . . . . 1.15 110.201 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -112.06 112.42 24.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.288 -0.415 . . . . 3.08 110.645 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp -99.12 134.48 37.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.562 -0.532 . . . . 0.45 109.562 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 2.74 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.63 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 0.39 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.26 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 0.38 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.26 109.27 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.43 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 0.23 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 0.33 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 0.22 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.33 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 1.48 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 2.72 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 0.15 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 0.19 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 0.16 113.104 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.17 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.29 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 0.3 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 0.26 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.33 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 0.99 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.54 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.32 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.5 109.948 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.35 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 0.16 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 0.16 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.35 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 0.22 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.615 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.22 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 0.13 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 0.82 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.34 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.41 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.43 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 0.24 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 0.25 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 0.14 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 1.88 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.97 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.664 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 1.87 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.17 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.577 ' HB3' HG23 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.13 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.4 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.42 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 0.31 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 0.64 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -65.44 81.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.4 111.061 175.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.65 18.18 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.236 -0.893 . . . . 1.33 111.967 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.27 132.29 35.33 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.122 -0.696 . . . . 4.13 109.122 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.965 -0.541 . . . . 6.69 110.843 -176.441 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' H3 ' ' HB ' ' A' ' 86' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 111.56 0.207 . . . . 3.75 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' HG11 ' A' ' 81' ' ' VAL . 21.5 t -93.15 150.03 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.513 -0.475 . . . . 0.15 110.563 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.03 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.3 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.87 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 0.33 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.01 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 0.17 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.22 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 0.33 112.141 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.22 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.61 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.48 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 1.85 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 0.23 109.857 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 0.24 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 0.17 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 1.77 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.19 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 0.45 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.59 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 0.14 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.2 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 0.16 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 0.25 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.18 111.363 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.26 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 0.45 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.21 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.23 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.18 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.26 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 0.55 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 0.25 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.23 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.67 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -119.25 134.55 55.14 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.34 110.884 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -148.36 113.33 5.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.6 110.871 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.61 -161.97 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.828 -0.909 . . . . 0.96 110.828 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.95 67.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.095 0.448 . . . . 1.57 110.784 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.67 -1.14 41.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 1.72 111.36 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.37 -164.09 13.58 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.878 -0.677 . . . . 1.21 112.419 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 p -107.85 141.35 39.57 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.886 0.374 . . . . 1.14 110.906 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -128.18 144.33 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.273 -0.421 . . . . 1.15 110.041 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -117.19 112.42 20.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.21 -0.292 . . . . 3.08 110.21 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 65' ' ' VAL . 5.1 mp -107.36 140.09 26.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.542 -0.299 . . . . 0.45 110.541 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 2.74 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.63 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.39 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.26 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 0.38 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.26 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 0.43 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 0.23 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.33 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 0.22 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.33 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 1.48 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 2.72 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 0.15 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 0.19 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 0.16 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.17 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.29 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 0.3 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 0.26 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.33 112.986 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 0.99 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.54 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.5 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.32 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.5 109.207 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 97' ' ' VAL . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.35 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 0.16 109.468 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 0.16 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.35 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 0.22 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.22 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 0.13 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 87' ' ' THR . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 0.82 109.785 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' O ' HG12 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.34 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.41 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.43 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 83' ' ' PHE . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 0.24 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 0.25 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.14 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 1.88 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.97 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 1.87 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.636 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 0.17 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.13 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.4 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.42 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 0.31 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 0.64 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.707 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -125.89 83.42 2.16 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.4 108.89 167.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 mm? 76.83 -58.82 0.5 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.001 -1.0 . . . . 1.33 112.272 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -129.18 169.38 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.531 0.205 . . . . 4.13 110.585 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.481 -0.771 . . . . 6.69 109.829 177.953 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.84 0.352 . . . . 3.75 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.589 ' CG1' HG23 ' A' ' 21' ' ' ILE . 43.6 t -108.9 153.74 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.649 -0.5 . . . . 0.15 109.649 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.03 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.3 112.426 -178.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.87 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 0.33 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.01 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 0.17 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 0.22 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 0.33 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.22 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.61 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.48 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 1.85 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 0.23 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 0.24 109.486 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 0.17 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG22 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 1.77 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 0.45 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.589 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 0.14 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.2 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 0.16 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 0.25 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.18 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.26 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 0.45 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.21 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.23 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.604 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.18 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.629 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 0.55 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 0.25 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 0.23 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.67 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -136.1 138.51 42.13 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.34 110.53 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 74' ' ' ARG . . . -149.71 114.93 5.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 0.6 110.693 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.8 -162.01 9.83 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.737 -0.744 . . . . 0.96 112.342 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.9 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 1.57 111.564 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.05 12.8 16.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.989 0.423 . . . . 1.72 110.853 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 -168.93 28.95 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 1.21 111.98 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 p -96.51 153.53 17.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.854 0.359 . . . . 1.14 110.478 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.4 m -149.47 149.14 30.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 1.15 110.11 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -124.31 133.7 53.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 3.08 111.144 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp -122.65 134.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.45 108.966 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 2.74 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.63 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.39 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.26 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 0.38 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.26 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 0.43 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 0.23 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 0.33 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 0.22 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.33 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 2.0 mm-40 -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 1.48 109.647 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 2.72 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 0.15 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 0.16 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.629 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.17 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 46' ' ' ILE . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.29 109.19 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 0.3 111.502 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 0.26 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.33 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.99 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.54 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 0.5 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.2 t30 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.32 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.5 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' HG21 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.35 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 0.16 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 0.16 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.35 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 0.22 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.22 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 0.13 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 0.82 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.34 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.41 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.43 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 0.24 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 0.14 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 1.88 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.97 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.624 ' C ' HG21 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 1.87 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 95' ' ' GLU . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.13 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.426 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.4 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.42 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 0.31 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 75' ' ' TYR . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 0.64 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.81 69.99 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.4 110.638 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.7 mm? 73.28 -64.08 0.41 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.999 -1.001 . . . . 1.33 110.807 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.08 -43.85 0.34 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.345 -0.389 . . . . 4.13 110.246 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.412 -0.804 . . . . 6.69 110.512 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 86' ' ' VAL . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.797 0.332 . . . . 3.75 110.531 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t -95.16 151.37 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.201 -0.454 . . . . 0.15 110.407 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.03 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.3 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.87 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 0.33 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.01 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 0.17 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 0.22 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 0.33 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.22 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.61 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.48 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 1.85 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 0.23 110.094 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 0.24 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 0.17 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.7 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 1.77 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.19 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.572 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 0.45 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 0.14 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.553 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.2 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 0.16 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 0.25 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.18 111.436 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.26 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 0.45 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.21 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.23 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.18 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.26 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 0.55 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 0.25 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 0.23 109.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.67 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HE2' HD12 ' A' ' 67' ' ' LEU . 21.8 mttt -90.99 156.98 17.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.34 110.081 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.45 104.69 3.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.068 -0.969 . . . . 0.6 110.013 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.5 -161.63 12.58 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.303 -0.862 . . . . 0.96 111.385 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.88 66.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.795 0.331 . . . . 1.57 111.106 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.57 -26.02 32.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 1.72 111.559 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.61 -164.87 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.558 -0.829 . . . . 1.21 112.618 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 72.3 p -97.35 153.72 17.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.474 0.178 . . . . 1.14 110.883 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -138.38 123.24 18.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.489 0.185 . . . . 1.15 110.859 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -93.91 135.66 35.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 3.08 112.065 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 37' ' ' LYS . 5.2 mp -129.33 139.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.2 -0.909 . . . . 0.45 109.172 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 2.74 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.63 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.39 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.26 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 0.38 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.26 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 0.43 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.33 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 1.48 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 2.72 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 0.15 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 0.19 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.17 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 46' ' ' ILE . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.29 108.833 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 0.3 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 0.26 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 71' ' ' SER . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.33 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 0.99 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.454 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.54 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 0.5 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.32 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.5 109.237 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 97' ' ' VAL . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.35 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 0.16 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 0.16 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.35 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 0.22 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.22 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 0.13 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 0.82 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.34 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.41 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.43 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 0.24 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.25 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 0.14 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 1.88 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.97 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 1.87 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 0.17 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.13 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.4 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.42 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 0.31 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 0.64 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.67 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -75.13 60.54 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.4 110.794 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.4 mm? 71.69 -59.38 0.55 Allowed 'General case' 0 C--O 1.231 0.126 0 O-C-N 123.898 0.749 . . . . 1.33 111.629 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -138.53 -65.18 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.124 -0.325 . . . . 4.13 110.124 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.626 -0.702 . . . . 6.69 110.325 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.852 0.358 . . . . 3.75 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 21' ' ' ILE . 27.5 t -93.22 156.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.15 109.797 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.03 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.3 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.87 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 0.33 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.01 112.272 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 0.17 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 0.22 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 0.33 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.22 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.61 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.48 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 1.85 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 0.23 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.427 ' OG1' HG22 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 0.24 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 0.17 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 61' ' ' THR . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 1.77 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.19 111.423 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 0.45 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.646 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 0.14 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.2 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 0.16 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 0.25 112.162 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.18 111.975 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.26 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 0.45 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.21 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.23 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.18 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.26 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 0.55 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.25 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 0.23 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.67 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' THR . 28.7 tttt -108.23 137.88 45.46 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.34 110.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.57 106.69 3.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.996 -0.547 . . . . 0.6 110.655 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.72 -167.27 11.55 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.618 -0.801 . . . . 0.96 111.689 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.26 67.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.106 0.479 . . . . 1.57 110.97 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.64 -9.93 56.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 1.72 111.546 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.93 -174.18 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 1.21 112.78 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 27.4 p -102.95 132.36 49.24 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.263 0.225 . . . . 1.14 110.62 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 m -111.31 146.51 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.713 0.292 . . . . 1.15 110.608 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -109.12 120.81 43.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.717 0.77 . . . . 3.08 112.332 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mp -121.13 120.46 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.193 -1.367 . . . . 0.45 109.535 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 2.74 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.63 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 0.39 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.26 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 0.38 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.26 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 0.43 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 0.23 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 0.33 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 0.22 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.33 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 1.48 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 2.72 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.15 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 0.16 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.596 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.17 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.29 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 0.3 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 0.26 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.33 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 0.99 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.54 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.5 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.32 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.5 109.689 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.401 ' HB2' HG21 ' A' ' 97' ' ' VAL . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.35 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 0.16 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 0.16 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.35 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 0.22 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.641 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.22 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 0.13 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 0.82 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.34 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.41 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.43 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 0.24 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 0.25 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.589 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 0.14 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 1.88 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.97 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.87 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 0.17 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.13 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.4 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.796 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.42 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 0.31 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 75' ' ' TYR . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 0.64 113.865 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.796 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.59 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.4 111.703 -171.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.55 34.06 20.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.026 -0.988 . . . . 1.33 111.631 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.73 138.8 44.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 4.13 110.188 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.826 -0.606 . . . . 6.69 109.861 177.587 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' HG3' ' A' ' 25' ' ' ARG . 61.9 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.682 0.253 . . . . 3.75 111.682 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 ' CG1' HG11 ' A' ' 81' ' ' VAL . 18.2 t -97.31 146.05 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.342 -0.543 . . . . 0.15 111.028 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.03 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.3 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.87 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 0.33 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.01 112.04 -173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 0.17 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 0.22 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 0.33 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.22 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.61 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.48 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 1.85 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 0.23 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 0.24 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 0.17 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.527 ' CB ' HG22 ' A' ' 61' ' ' THR . 18.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 1.77 109.971 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' H ' HD22 ' A' ' 33' ' ' LEU . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.19 111.272 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.694 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 0.45 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.591 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 0.14 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.2 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 0.16 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 0.25 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.18 111.378 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.26 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 0.45 110.574 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.21 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.23 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.18 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.26 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 0.55 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 0.25 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 0.23 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.67 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.5 ttpt -103.64 136.7 42.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.34 109.851 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 43' ' ' THR . . . -141.14 122.57 14.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.353 0.597 . . . . 0.6 111.228 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.93 -165.15 11.52 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.227 -1.149 . . . . 0.96 110.227 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -17.98 63.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.346 0.573 . . . . 1.57 110.657 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.64 -7.44 59.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.589 . . . . 1.72 110.929 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.24 -173.91 15.2 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.904 -0.665 . . . . 1.21 112.322 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 36.1 p -100.67 137.41 39.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.662 0.267 . . . . 1.14 110.487 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m -120.58 122.68 41.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.802 -0.444 . . . . 1.15 109.802 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -96.73 133.21 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 3.08 110.361 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp -122.64 129.88 74.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.356 -0.838 . . . . 0.45 110.344 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 2.74 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.63 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 0.39 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.38 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.429 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.26 109.188 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 0.43 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.826 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 0.33 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 0.22 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.33 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 1.48 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 2.72 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 0.15 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 0.19 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 0.16 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.17 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.29 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 0.3 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.61 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 0.26 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.33 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 0.99 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.54 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 0.5 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.32 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.5 109.271 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.35 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.637 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 0.16 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.35 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 0.22 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.22 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 0.13 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 87' ' ' THR . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 0.82 109.66 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.34 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.41 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.43 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 0.24 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 0.25 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.571 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 0.14 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 1.88 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.97 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.609 ' C ' HG21 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 1.87 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.637 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 0.17 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.13 108.931 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.4 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.42 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 0.31 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 75' ' ' TYR . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 0.64 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.783 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -74.5 82.73 1.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.4 110.654 -171.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 64.92 56.01 1.12 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.646 -1.161 . . . . 1.33 111.444 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.39 -71.73 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 4.13 109.949 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.66 -0.686 . . . . 6.69 109.461 176.704 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.914 0.388 . . . . 3.75 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.7 t -98.66 152.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.15 109.987 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 15.5 mm100 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.03 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.3 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.87 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 0.33 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.01 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 0.17 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 0.22 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 0.33 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.22 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.61 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.48 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 1.85 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 0.23 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.404 ' OG1' HG22 ' A' ' 66' ' ' VAL . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 0.24 109.381 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 0.17 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 42.4 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 1.77 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.19 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 0.45 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 0.14 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.2 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 0.16 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 0.25 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.18 111.3 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.26 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 0.45 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.21 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.23 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.18 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.622 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.26 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 0.55 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 0.25 109.967 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 0.23 110.224 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.67 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -116.19 134.38 54.99 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.34 110.9 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -144.75 138.58 27.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.747 -0.66 . . . . 0.6 110.349 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.1 16.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.463 -0.875 . . . . 0.96 111.743 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.62 -17.0 63.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.57 110.592 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.74 13.2 25.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.016 -0.538 . . . . 1.72 111.364 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.24 -171.82 15.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.641 -0.79 . . . . 1.21 112.797 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.31 152.55 26.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.643 0.259 . . . . 1.14 110.964 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 m -140.92 157.14 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.321 -0.4 . . . . 1.15 110.496 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -127.46 111.63 14.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.945 0.402 . . . . 3.08 110.731 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp -108.01 131.28 58.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.29 -0.633 . . . . 0.45 109.29 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 2.74 111.851 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.63 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 0.39 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.26 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 0.38 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.26 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 0.43 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 0.23 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 0.22 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.33 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 1.48 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 2.72 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 0.15 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 HG12 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 0.16 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.17 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 46' ' ' ILE . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.29 109.174 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 0.3 111.151 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 0.26 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.624 ' OH ' HD11 ' A' ' 99' ' ' LEU . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.33 112.299 -170.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 0.99 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.54 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 0.5 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.32 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.5 109.761 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' HB2' HG21 ' A' ' 97' ' ' VAL . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.35 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 0.16 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.642 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 0.16 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.35 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 0.22 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.622 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.22 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 0.13 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.548 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 0.82 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.34 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.41 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.43 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 2' ' ' VAL . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 0.24 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 0.25 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.573 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 0.14 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 1.88 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.97 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 1.87 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.642 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 0.17 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' HG23 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.13 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.4 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.42 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.31 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 75' ' ' TYR . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 0.64 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -74.57 49.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.4 111.607 -178.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.624 HD11 ' OH ' ' A' ' 69' ' ' TYR . 1.3 mt 63.97 34.76 11.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.758 -0.656 . . . . 1.33 112.404 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -82.19 112.5 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.751 -0.659 . . . . 4.13 109.955 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.726 -0.654 . . . . 6.69 109.837 -177.266 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 18.8 ptm . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.331 0.586 . . . . 3.75 110.815 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.734 ' H ' HG21 ' A' ' 86' ' ' VAL . 44.1 t -128.13 157.63 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.72 -0.673 . . . . 0.15 109.999 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.03 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.3 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.87 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.602 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 0.33 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.01 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 0.17 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 0.22 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 0.33 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.22 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.61 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.48 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 1.85 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 0.23 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 66' ' ' VAL . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 0.24 109.239 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.625 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 0.17 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 1.77 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.19 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 0.45 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.613 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 0.14 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.2 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 0.16 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 0.25 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.18 111.513 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.26 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 0.45 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.21 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.23 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.577 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.18 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.26 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 0.55 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 0.25 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 0.23 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.67 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.6 ttpt -114.1 132.57 56.0 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.34 110.238 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -137.34 104.81 5.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.052 0.454 . . . . 0.6 110.376 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.13 -161.41 9.37 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.702 -0.681 . . . . 0.96 111.561 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.99 -19.97 66.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.42 . . . . 1.57 110.657 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.32 9.48 23.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.919 -0.582 . . . . 1.72 111.247 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 -167.46 31.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.886 -0.673 . . . . 1.21 112.289 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 41.5 p -97.17 133.78 41.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.783 0.325 . . . . 1.14 110.339 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -125.4 137.01 54.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.45 -0.341 . . . . 1.15 110.363 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -106.36 112.62 25.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 3.08 110.985 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -112.36 135.33 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.72 -0.673 . . . . 0.45 109.984 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 2.74 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.63 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 0.39 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.26 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 0.38 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.26 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 0.43 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 0.23 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 0.33 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 0.22 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.33 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 1.48 109.696 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 2.72 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 0.15 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 0.19 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 0.16 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.17 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.29 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 0.3 110.792 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 0.26 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.33 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 0.99 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.54 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 0.5 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.32 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.5 109.56 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.35 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 0.16 109.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.685 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 0.16 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.35 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 0.22 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.704 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.22 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 0.13 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 0.82 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.34 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.41 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.43 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.734 HG21 ' H ' ' A' ' 2' ' ' VAL . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 0.24 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 0.25 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.61 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 0.14 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 1.88 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.97 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 1.87 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 0.17 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 92' ' ' LEU . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.13 109.625 170.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.4 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.42 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 0.31 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 0.64 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.78 77.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.4 111.854 -175.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 61.88 42.1 10.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.486 -0.779 . . . . 1.33 111.926 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.55 114.64 17.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 4.13 110.086 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.593 -0.718 . . . . 6.69 109.682 179.165 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.802 0.334 . . . . 3.75 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.6 t -97.31 148.6 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.15 110.441 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.03 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.3 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.87 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.674 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 0.33 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.01 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 0.17 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 0.22 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 0.33 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.22 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.61 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.48 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 1.85 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 0.23 110.259 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.403 ' OG1' HG22 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 0.24 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.579 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 0.17 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.637 ' CB ' HG22 ' A' ' 61' ' ' THR . 43.4 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 1.77 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.19 111.026 171.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.719 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 0.45 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 0.14 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.2 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 0.16 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 0.25 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.18 111.6 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.26 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 0.45 110.65 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.21 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.23 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.18 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.26 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.55 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 0.25 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 0.23 110.296 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.67 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -112.23 139.51 47.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.34 110.536 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.07 105.48 3.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.115 -0.493 . . . . 0.6 110.41 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.74 -162.49 9.84 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.954 -0.641 . . . . 0.96 111.951 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.23 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 1.57 111.11 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.14 -1.01 47.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 1.72 110.883 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.69 -166.7 12.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.848 -0.692 . . . . 1.21 112.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 p -99.52 135.7 40.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.881 0.372 . . . . 1.14 110.65 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.8 m -128.16 138.21 52.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.133 -0.485 . . . . 1.15 110.378 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -111.71 118.0 34.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 3.08 110.362 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.79 133.84 62.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.921 -0.582 . . . . 0.45 109.966 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 2.74 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.63 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 0.39 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.26 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 0.38 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.26 109.245 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 0.43 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.33 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.33 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 1.48 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.719 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 2.72 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.763 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 0.15 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 0.19 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 0.16 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.17 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.29 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 0.3 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 0.26 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.33 112.075 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 0.99 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.54 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.5 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.32 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.35 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 0.16 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 0.16 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.35 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 0.22 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.22 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 0.13 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 87' ' ' THR . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 0.82 109.653 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG12 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.34 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.41 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.43 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 0.24 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 0.25 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 0.14 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 1.88 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.97 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.674 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 1.87 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 0.17 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.13 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.4 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.42 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 0.31 111.165 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 75' ' ' TYR . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 0.64 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.68 75.6 0.28 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.4 111.669 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 65.53 42.79 3.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.051 -0.977 . . . . 1.33 112.485 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -91.77 147.23 23.14 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.217 -0.661 . . . . 4.13 109.217 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.77 -0.633 . . . . 6.69 109.542 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 tmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.525 -0.546 . . . . 3.75 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 21' ' ' ILE . 21.5 t -102.11 151.27 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 0.15 111.661 -173.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.03 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.3 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.87 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 0.33 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.01 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 0.17 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 0.22 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 0.33 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.22 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.61 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.48 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 1.85 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.23 109.739 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 0.24 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 0.17 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 1.77 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.19 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 0.45 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.619 HG23 ' CG1' ' A' ' 2' ' ' VAL . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 0.14 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.2 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.716 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 0.16 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 0.25 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.18 111.563 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.26 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 0.45 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.21 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.23 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.18 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.26 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 0.55 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 0.25 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 0.23 110.143 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.67 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.453 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt -117.98 129.48 55.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.34 110.236 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.54 105.28 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 0.6 110.13 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.13 -162.28 11.54 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.96 112.037 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.6 70.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 1.57 111.195 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.57 13.09 10.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 1.72 111.253 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.48 -160.91 23.82 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.701 -0.762 . . . . 1.21 112.369 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -94.43 150.89 19.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.791 0.329 . . . . 1.14 111.025 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . 22.4 m -130.16 157.75 41.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.085 -0.507 . . . . 1.15 110.085 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 45' ' ' ARG . 16.9 mmt180 -120.54 112.19 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.162 0.506 . . . . 3.08 111.798 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp -119.04 130.32 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.45 109.626 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 2.74 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.63 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 0.39 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.26 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 0.38 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.486 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.26 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 0.43 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 0.23 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 0.33 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 0.22 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.33 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 1.48 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 2.72 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 0.15 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 0.19 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 0.16 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.17 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 46' ' ' ILE . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.29 109.661 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 0.3 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 0.26 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.33 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 0.99 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.54 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.5 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.32 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.5 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 97' ' ' VAL . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.35 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 0.16 109.661 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 0.16 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.35 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 0.22 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.22 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.726 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 0.13 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 0.82 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.536 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.34 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.41 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.43 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 0.24 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.25 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 0.14 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 1.88 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.97 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 1.87 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 0.17 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.13 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.4 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.42 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 101' ' ' HIS . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 0.31 111.654 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 0.64 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.73 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.49 70.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.4 111.598 -176.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.45 56.45 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.495 -0.775 . . . . 1.33 111.564 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 62.79 72.91 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.503 -0.771 . . . . 4.13 111.351 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 72.5 t60 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.688 -0.672 . . . . 6.69 109.829 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.909 0.385 . . . . 3.75 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.647 ' CG1' HG23 ' A' ' 21' ' ' ILE . 41.1 t -104.25 152.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.15 110.525 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.03 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.3 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.87 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 0.33 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.01 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 0.17 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 0.22 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 0.33 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.22 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.61 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.48 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 1.85 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 0.23 110.267 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 0.24 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 0.17 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 1.77 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.19 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 0.45 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.647 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 0.14 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.2 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 0.16 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 24' ' ' VAL . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 0.25 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.18 111.7 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.26 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 0.45 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.21 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.23 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.18 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 0.55 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 0.25 110.622 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 0.23 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.67 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.6 ttpt -108.19 132.21 53.87 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.34 110.255 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -137.17 105.61 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.778 -0.646 . . . . 0.6 109.81 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.86 -161.53 9.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.785 -0.721 . . . . 0.96 112.313 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.66 -17.46 64.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.055 0.455 . . . . 1.57 110.811 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.41 12.94 25.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 1.72 110.772 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.04 -168.58 34.15 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.88 -0.676 . . . . 1.21 112.594 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 40.8 p -94.09 154.21 17.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.616 0.246 . . . . 1.14 110.387 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -148.47 137.23 21.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.199 -0.297 . . . . 1.15 110.199 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -99.74 114.3 27.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.305 -0.407 . . . . 3.08 110.788 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp -112.42 133.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.45 109.496 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 2.74 112.521 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.63 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.39 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.26 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.26 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 0.43 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 0.23 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 0.33 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 0.22 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.33 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 1.48 109.699 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 2.72 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 0.15 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 0.19 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 0.16 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.17 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.29 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG22 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 0.3 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 0.26 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.33 111.691 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 0.99 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.54 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 0.5 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.32 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.5 110.042 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.35 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 0.16 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 0.16 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.35 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 0.22 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.22 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 0.13 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 0.82 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.34 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.41 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.43 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 0.24 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 0.25 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 0.14 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 1.88 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.97 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 1.87 112.17 -177.032 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.668 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 0.17 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.13 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.4 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.42 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 0.31 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 0.64 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HE3' ' H ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.34 63.11 0.24 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.4 110.572 176.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 60.39 45.52 10.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.6 -0.727 . . . . 1.33 111.466 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 58.78 58.07 3.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.719 -0.673 . . . . 4.13 111.773 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.162 -0.923 . . . . 6.69 110.823 178.468 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' HB ' ' A' ' 86' ' ' VAL . 24.6 mmt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.533 0.197 . . . . 3.75 111.533 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG11 ' A' ' 81' ' ' VAL . 22.0 t -109.79 148.46 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.15 110.145 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.03 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.3 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.87 107.403 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.665 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 0.33 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.01 112.598 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 0.17 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 0.22 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 0.33 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.22 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.61 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.48 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 1.85 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 0.23 110.116 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 0.24 109.114 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 0.17 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.417 ' HB2' HG22 ' A' ' 61' ' ' THR . 8.3 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.19 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 0.45 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.582 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 0.14 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 59' ' ' ARG . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.2 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 0.16 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 0.25 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.18 110.964 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.26 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 0.45 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.21 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.23 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.18 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.26 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 0.55 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 0.25 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 0.23 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.67 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt -108.5 147.15 32.12 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.34 110.494 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -151.34 123.61 8.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.138 -0.937 . . . . 0.6 111.031 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.88 -163.45 10.7 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.967 -0.853 . . . . 0.96 110.967 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.41 -25.09 66.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.021 0.439 . . . . 1.57 110.803 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.72 -6.96 58.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 1.72 111.333 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.59 -163.76 12.25 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 1.21 112.238 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -105.55 160.47 15.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.385 -0.228 . . . . 1.14 110.385 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -144.38 138.07 27.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.513 0.197 . . . . 1.15 110.831 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -101.96 117.76 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 3.08 111.563 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -113.48 130.25 67.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 174.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 2.74 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.63 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 0.39 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.26 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 0.38 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.26 109.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 0.43 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.23 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 0.33 110.72 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.22 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.33 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 1.48 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 2.72 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 0.15 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 0.19 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 0.16 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.17 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.29 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 0.3 111.258 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 0.26 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.33 112.362 -171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 0.99 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.54 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 0.5 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.32 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.5 109.627 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.35 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 0.16 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 0.16 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.35 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 0.22 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.22 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 0.13 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 0.82 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.34 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.41 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.43 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 0.24 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 0.25 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.617 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 0.14 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 1.88 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.97 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.665 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 1.87 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.62 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 0.17 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.13 109.182 170.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.4 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.715 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.42 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 0.31 111.922 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 0.64 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.715 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -77.67 78.0 4.19 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.4 110.162 -176.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.4 mm? 77.93 122.21 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.068 -1.424 . . . . 1.33 111.054 172.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -51.34 126.43 16.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.166 -1.379 . . . . 4.13 112.843 -171.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.086 -0.961 . . . . 6.69 111.704 173.58 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.78 0.324 . . . . 3.75 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.1 t -97.19 155.66 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 0.15 110.967 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.03 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.3 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.87 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 0.33 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.01 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 0.17 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 0.22 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 0.33 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.22 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.61 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.48 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 1.85 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 0.23 110.454 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 0.24 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 0.17 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.788 HE21 HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 1.77 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.19 111.592 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.569 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 0.45 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.588 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 0.14 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.2 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 0.16 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 0.25 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.18 111.706 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.26 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 0.45 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.21 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.23 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.18 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.26 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.55 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 0.25 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.594 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 0.23 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.67 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt -108.19 150.64 26.98 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.34 110.431 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.18 104.85 3.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.223 -0.899 . . . . 0.6 110.616 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.51 -164.45 13.29 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.098 -0.801 . . . . 0.96 111.098 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.82 61.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 1.57 111.249 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.9 -8.33 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 1.72 111.228 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.62 -175.21 19.12 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.442 -0.885 . . . . 1.21 113.306 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.4 p -97.92 137.94 36.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.656 0.265 . . . . 1.14 111.039 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -127.94 137.91 52.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.251 -0.431 . . . . 1.15 110.166 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -113.45 122.3 46.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.474 0.654 . . . . 3.08 112.181 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp -105.99 137.68 34.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.45 108.8 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 2.74 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.63 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.26 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 0.38 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.26 109.145 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 0.43 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 0.23 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 0.33 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.22 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.33 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 1.48 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 2.72 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 0.15 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.788 HG21 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 0.19 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 0.16 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.17 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.29 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 0.3 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 0.26 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.33 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 0.99 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.54 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.5 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.32 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.5 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.486 ' HB2' HG21 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.35 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 0.16 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 0.16 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.35 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 0.22 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.22 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 0.13 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 0.82 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.34 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.41 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.43 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.24 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.608 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 0.14 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.729 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 6.9 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 1.88 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.97 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.686 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 1.87 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 0.17 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.13 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.4 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.818 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.42 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 0.31 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 0.64 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -61.88 89.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.4 111.839 -170.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 71.28 -66.13 0.31 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.317 1.01 . . . . 1.33 112.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -107.34 130.33 54.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.984 0.421 . . . . 4.13 110.806 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.691 -0.671 . . . . 6.69 109.851 -179.472 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.058 -0.349 . . . . 3.75 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG23 ' A' ' 21' ' ' ILE . 20.3 t -121.03 152.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 0.15 111.068 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.03 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.3 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.87 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.718 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 0.33 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.01 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 0.17 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 0.22 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 0.33 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.22 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.61 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.48 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 1.85 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.23 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 0.24 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 0.17 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 61' ' ' THR . 3.4 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 1.77 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.19 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 0.45 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 0.14 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.2 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 0.16 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 0.25 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.18 111.199 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.26 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 0.45 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.21 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.23 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.18 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.26 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 0.55 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 0.25 110.245 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.23 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.67 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt -118.21 135.58 54.17 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.34 110.317 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.16 105.89 3.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.6 110.653 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.64 -167.62 12.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.565 -0.826 . . . . 0.96 111.513 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.08 -22.13 66.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.435 . . . . 1.57 110.675 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.66 -1.73 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.935 -0.575 . . . . 1.72 111.474 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -170.89 13.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.836 -0.697 . . . . 1.21 112.766 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.2 p -100.43 158.6 15.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 110.404 -0.221 . . . . 1.14 110.404 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -148.76 147.83 29.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.633 0.254 . . . . 1.15 110.317 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -110.87 113.06 25.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 3.08 111.019 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -105.08 116.22 48.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.298 -0.41 . . . . 0.45 109.974 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 2.74 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.63 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 0.39 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.26 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 0.38 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.26 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 0.43 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 0.23 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 0.33 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.22 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.33 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 1.48 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 2.72 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.697 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.15 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 0.19 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 0.16 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.17 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG21 HG21 ' A' ' 46' ' ' ILE . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.29 109.603 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 0.3 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 0.26 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.33 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.453 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 0.99 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.54 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 0.5 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.32 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.5 109.712 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.35 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 0.16 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.657 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 0.16 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.35 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 0.22 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.22 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 0.13 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 0.82 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.539 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.34 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.41 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.43 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 0.24 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 0.25 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.14 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 1.88 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.97 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.718 ' C ' HG21 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 1.87 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 0.17 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.13 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.4 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.839 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.42 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 0.31 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' TYR . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 0.64 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.839 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -76.02 76.09 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.4 110.986 -174.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 73.97 -55.07 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.913 -1.039 . . . . 1.33 112.458 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.16 149.19 24.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.179 -0.304 . . . . 4.13 110.179 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.518 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.9 t60 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.401 -0.809 . . . . 6.69 109.606 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.666 0.27 . . . . 3.75 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.9 t -93.5 154.03 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 0.15 109.923 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.586 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.03 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.3 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.87 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 0.33 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.01 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 0.17 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.22 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 0.33 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.22 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.61 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.48 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 1.85 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 0.23 109.643 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 0.24 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 0.17 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' CB ' HG22 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 1.77 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.19 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 0.45 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 0.14 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.2 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 0.16 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 0.25 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.18 112.657 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.26 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 0.45 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.21 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.23 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.63 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.18 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.26 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 0.55 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 0.25 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 0.23 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.67 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt -112.57 138.31 49.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.34 110.645 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.55 120.0 7.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.6 110.471 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.15 -162.34 10.78 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.814 -0.708 . . . . 0.96 111.487 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.45 -17.03 64.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.332 0.587 . . . . 1.57 110.404 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.61 12.96 21.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.72 110.837 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.98 -170.97 30.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.842 -0.694 . . . . 1.21 112.848 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 32.2 p -104.48 140.14 38.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.575 -0.312 . . . . 1.14 110.223 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB3' ' CE ' ' A' ' 37' ' ' LYS . 22.7 t -134.55 130.84 37.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.74 -0.384 . . . . 1.15 110.366 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -102.74 121.59 42.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.505 0.669 . . . . 3.08 109.739 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp -112.55 127.18 69.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.022 -0.99 . . . . 0.45 110.501 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 2.74 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.63 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 0.39 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.26 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 0.38 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.26 109.476 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 0.43 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 0.23 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.33 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 0.22 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.33 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 1.48 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 2.72 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.15 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 0.19 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 0.16 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.17 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.29 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 0.3 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 0.26 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.33 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 0.99 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.54 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.5 t-20 -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.32 110.492 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.5 109.984 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.35 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 0.16 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 0.16 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.35 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 0.22 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.22 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 0.13 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 0.82 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.34 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.41 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.43 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 2' ' ' VAL . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 0.24 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 0.25 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.585 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 0.14 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 1.88 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.97 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 1.87 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 0.17 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.13 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.4 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.42 111.112 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 0.31 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 0.64 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HE3' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -73.13 71.5 1.15 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.4 111.469 -177.014 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 73.12 -60.05 0.55 Allowed 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.153 -0.93 . . . . 1.33 112.544 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -161.6 -70.96 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 4.13 109.647 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.5 t60 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.438 -0.792 . . . . 6.69 109.393 -179.388 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.882 0.372 . . . . 3.75 110.488 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t -98.91 157.0 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.03 -0.532 . . . . 0.15 109.767 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.03 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.3 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.87 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 0.33 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.01 111.971 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 0.17 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 0.22 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.33 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.22 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.61 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.48 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 1.85 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 0.23 109.956 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 0.24 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.588 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 0.17 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HB2' HG22 ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 1.77 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.19 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 61' ' ' THR . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 0.45 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 0.14 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.2 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 0.16 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 0.25 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.18 112.731 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.26 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.21 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.23 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.18 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.26 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 0.55 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 0.23 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -118.02 133.75 55.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.34 110.896 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -144.5 118.88 9.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.6 110.002 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.65 -163.16 9.88 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.41 -0.676 . . . . 0.96 111.41 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.57 111.115 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.15 54.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 1.72 111.167 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -163.84 12.18 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.649 -0.786 . . . . 1.21 112.625 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -106.87 149.18 27.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.695 0.283 . . . . 1.14 111.145 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -145.64 139.2 26.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.367 -0.378 . . . . 1.15 110.311 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -111.43 113.08 25.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.843 -0.429 . . . . 3.08 109.843 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.641 HG21 HG11 ' A' ' 65' ' ' VAL . 5.4 mp -104.26 132.32 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.804 -0.18 . . . . 0.45 110.722 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 2.74 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' NE2' HG12 ' A' ' 65' ' ' VAL . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.63 109.758 172.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 0.39 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.26 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 0.38 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.417 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.26 109.018 -176.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 0.43 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 0.23 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 0.33 110.147 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 0.22 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.33 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 1.48 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 2.72 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 0.15 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 0.19 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 0.16 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.17 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.29 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 0.3 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 0.26 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.33 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.99 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.54 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.5 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.32 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.5 110.22 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.35 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 0.16 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 0.16 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.35 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 0.22 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.22 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 0.13 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 0.82 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.588 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.34 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.41 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.43 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 0.24 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.14 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 1.88 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.97 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 2.8 t30 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 1.87 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.17 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.13 109.387 170.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.4 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.42 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 0.31 111.653 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 0.64 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -49.31 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.4 112.862 -177.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 62.2 34.56 16.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.357 -0.838 . . . . 1.33 111.744 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.1 147.4 32.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.973 -0.38 . . . . 4.13 109.973 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.493 -0.765 . . . . 6.69 109.865 179.199 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.049 0.452 . . . . 3.75 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 47.5 t -105.36 160.18 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.729 -0.669 . . . . 0.15 109.948 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.03 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.3 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.87 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 0.33 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.01 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 0.17 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 0.22 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 0.33 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.22 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.61 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.48 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 1.85 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 0.23 110.124 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.24 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 0.17 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.8 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 1.77 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.19 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.56 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 0.45 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 0.14 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.2 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 0.16 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.25 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.18 111.662 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.26 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 0.45 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.21 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.23 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.18 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 0.55 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 0.25 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 0.23 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.67 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 44' ' ' SER . 32.9 mtmt -102.46 155.2 18.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.34 111.226 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -148.92 104.07 3.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.813 -1.085 . . . . 0.6 109.427 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.18 -160.78 8.45 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.96 111.654 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.48 69.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.994 0.426 . . . . 1.57 111.178 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.77 1.08 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 1.72 111.273 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -161.05 21.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.882 -0.675 . . . . 1.21 111.961 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 66.8 p -95.6 134.63 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.049 -0.352 . . . . 1.14 110.049 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' CE ' ' A' ' 37' ' ' LYS . 31.2 m -134.25 142.79 47.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.521 0.2 . . . . 1.15 110.831 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -106.33 134.88 48.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.354 -0.385 . . . . 3.08 110.592 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp -125.35 138.53 54.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.203 -0.295 . . . . 0.45 110.203 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 2.74 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.518 ' NE2' HG22 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.63 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 0.39 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.26 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 0.38 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.26 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 0.43 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 0.23 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 0.22 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.33 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 1.48 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 2.72 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 0.15 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 0.19 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 0.16 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.17 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG22 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.29 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 0.3 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 0.26 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.33 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 0.99 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.54 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 0.5 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.32 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.5 109.078 173.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.35 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 0.16 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.35 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 0.22 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.22 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 0.13 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 0.82 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.34 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.41 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.43 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 0.24 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 0.25 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 0.14 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 1.88 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.97 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.658 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 1.87 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.647 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 0.17 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.13 109.085 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.4 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.42 111.547 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 0.31 111.146 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 0.64 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.622 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -69.17 71.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.4 111.303 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 4.0 mm? 73.26 -67.96 0.24 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.397 -0.82 . . . . 1.33 111.395 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -178.73 -41.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.588 -0.523 . . . . 4.13 109.588 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.223 -0.894 . . . . 6.69 110.226 175.946 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.722 0.296 . . . . 3.75 110.401 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' CG1' HG23 ' A' ' 21' ' ' ILE . 38.4 t -90.97 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.38 -0.373 . . . . 0.15 110.12 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.03 108.098 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.3 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.87 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 0.33 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.01 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 0.17 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 0.22 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.33 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.22 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.61 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.48 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 1.85 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 0.23 109.865 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 0.24 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.59 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 0.17 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 1.77 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.19 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 0.45 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.608 HG23 ' CG1' ' A' ' 2' ' ' VAL . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 0.14 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 59' ' ' ARG . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.2 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 0.16 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 0.25 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.18 111.073 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.26 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 0.45 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.21 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.23 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.18 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.26 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 0.55 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.25 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 0.23 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.67 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.3 tttm -112.22 139.55 47.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.34 111.097 -171.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.71 121.96 8.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.107 -0.497 . . . . 0.6 110.695 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.3 -162.85 12.44 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.522 -0.631 . . . . 0.96 111.522 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.61 67.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.004 0.43 . . . . 1.57 110.899 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 1.72 111.261 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 -176.94 30.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.867 -0.682 . . . . 1.21 113.094 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 33.5 p -101.05 134.87 43.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.543 -0.328 . . . . 1.14 110.253 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 t -119.35 136.45 54.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.689 0.28 . . . . 1.15 110.397 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -102.15 127.29 49.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.155 -0.475 . . . . 3.08 109.724 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 65' ' ' VAL . 5.2 mp -126.34 127.46 70.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.548 -0.751 . . . . 0.45 110.38 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 2.74 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.63 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 0.39 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.26 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 0.38 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.26 108.924 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 0.43 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 0.23 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 0.33 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 0.22 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.33 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 1.48 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 2.72 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.82 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 0.15 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 79' ' ' LEU . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 0.16 112.192 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 3.5 m-20 -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.17 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 46' ' ' ILE . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.29 109.842 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 0.3 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 0.26 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.33 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 0.99 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.54 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.5 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.32 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.5 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' HB2' HG21 ' A' ' 97' ' ' VAL . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.35 109.223 173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 0.16 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.35 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 0.22 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.68 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.22 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 0.13 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 87' ' ' THR . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 0.82 109.445 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.541 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.34 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.41 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.43 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 0.24 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 0.25 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 0.14 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 1.88 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.97 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.639 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 1.87 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 0.17 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.13 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.4 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.42 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 0.31 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 0.64 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? -70.05 74.33 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.4 111.499 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 63.77 65.08 0.74 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.948 0.404 . . . . 1.33 110.307 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 73.51 -70.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.973 -1.012 . . . . 4.13 110.765 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.2 -0.905 . . . . 6.69 109.893 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.017 0.437 . . . . 3.75 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.0 t -105.33 148.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.883 -0.599 . . . . 0.15 110.453 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.03 108.364 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.3 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.87 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 0.33 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.01 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 0.17 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 0.22 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 0.33 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.22 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.61 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.48 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 1.85 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 0.23 110.245 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 0.24 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 0.17 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 1.77 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.19 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' THR . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 0.45 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 0.14 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.2 107.221 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 0.25 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.18 112.078 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.26 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 0.45 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.21 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.23 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.18 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.26 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 0.55 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 0.25 109.963 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 0.23 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.67 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD3' HD12 ' A' ' 67' ' ' LEU . 7.5 mtmp? -99.01 152.98 19.22 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.34 110.557 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 105.77 3.28 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.634 -0.712 . . . . 0.6 110.534 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.01 -162.94 9.55 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.488 -0.863 . . . . 0.96 112.323 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.91 66.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 1.57 111.299 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.48 4.82 52.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 1.72 110.897 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.06 -168.14 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 1.21 112.39 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -95.63 156.52 16.29 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.635 0.255 . . . . 1.14 110.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 39.4 m -148.44 162.62 39.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.391 -0.225 . . . . 1.15 110.391 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -136.01 129.03 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.796 0.808 . . . . 3.08 111.891 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 HG11 ' A' ' 65' ' ' VAL . 4.8 mp -112.69 131.53 63.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.484 -1.235 . . . . 0.45 109.203 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 2.74 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.63 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 0.39 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.26 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 0.38 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.26 109.766 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 0.43 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 0.23 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 0.33 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 0.22 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.33 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.559 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.5 mm-40 -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 1.48 109.859 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 2.72 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 0.15 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 0.19 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 0.16 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.17 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.29 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 0.3 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 ' HD3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 0.26 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.33 111.96 -173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 0.99 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.54 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 0.5 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 3.5 t-20 -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.32 110.106 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.5 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.35 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 0.16 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.63 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 0.16 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.35 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.583 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 0.22 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.22 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 0.13 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 0.82 109.247 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' O ' HG12 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.34 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.41 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.43 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 0.24 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 0.25 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.582 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.14 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.7 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 1.88 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.97 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.73 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 1.87 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.63 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.17 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.13 109.012 168.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.4 112.173 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.769 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.42 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 0.31 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 0.64 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -56.26 95.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.4 111.746 -168.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 63.36 29.01 15.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.902 -1.045 . . . . 1.33 111.796 170.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.9 156.89 17.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.262 -0.644 . . . . 4.13 109.262 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 119.127 -0.463 . . . . 6.69 110.209 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.948 0.404 . . . . 3.75 110.563 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG1' HG23 ' A' ' 21' ' ' ILE . 34.9 t -103.63 152.48 6.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.831 -0.622 . . . . 0.15 110.694 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.03 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.3 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.87 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 0.33 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.01 112.33 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' GLU . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 0.17 107.206 168.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 0.22 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 0.33 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.22 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.61 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.48 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 1.85 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 0.23 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 0.24 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 0.17 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 1.77 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.19 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 61' ' ' THR . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 0.45 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 0.14 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.2 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 0.16 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 0.25 112.601 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.18 112.09 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.26 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 0.45 110.457 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.21 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.23 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.18 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.26 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.556 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 0.55 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 0.23 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' NH1' ' A' ' 45' ' ' ARG . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.67 110.306 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt -113.14 135.35 53.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.34 111.13 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.95 105.17 3.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.819 -0.628 . . . . 0.6 110.584 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.45 -162.82 10.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.131 -1.033 . . . . 0.96 112.496 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.03 70.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 1.57 110.917 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.15 59.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 1.72 111.103 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.78 -174.7 15.37 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.709 -0.757 . . . . 1.21 112.807 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 38' ' ' ALA . 19.9 p -103.64 132.12 50.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.287 . . . . 1.14 110.312 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' LYS . 45.2 m -143.42 139.21 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.513 -0.475 . . . . 1.15 110.644 176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' NH1' ' HB2' ' A' ' 36' ' ' ASP . 15.8 tpt180 -103.63 137.11 42.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.27 0.557 . . . . 3.08 110.358 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -122.66 141.84 41.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.243 -0.89 . . . . 0.45 109.569 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 2.74 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' OE1' HG22 ' A' ' 65' ' ' VAL . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.63 109.737 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.39 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.26 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.26 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.43 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 0.23 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 0.33 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 0.22 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.33 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 1.48 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 2.72 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 0.15 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 0.19 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 0.16 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.17 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 HG21 ' A' ' 46' ' ' ILE . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.29 109.962 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 0.3 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.639 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 0.26 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.33 112.163 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.99 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.54 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.5 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.32 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.5 109.392 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.35 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 0.16 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 0.16 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.35 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 0.22 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.22 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 0.13 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 0.82 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.534 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.34 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.41 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.43 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 0.24 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 0.25 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.14 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 1.88 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.97 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 1.87 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 0.17 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.13 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.4 113.164 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.42 110.595 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 0.31 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 75' ' ' TYR . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 0.64 111.631 170.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.54 82.1 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.4 111.991 -175.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.2 39.94 2.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.926 -1.034 . . . . 1.33 111.985 168.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 6.5 tp10 -79.74 148.77 31.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.889 -0.596 . . . . 4.13 109.82 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.28 -0.867 . . . . 6.69 110.358 -179.01 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 40.6 t . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 121.3 0.571 . . . . 0.14999999999999999 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.0299999999999998 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.29999999999999999 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.8700000000000001 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 0.33000000000000002 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.0099999999999998 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 0.17000000000000001 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.22 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 0.33000000000000002 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.22 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.60999999999999999 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.47999999999999998 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 1.8500000000000001 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 0.23000000000000001 109.994 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.23999999999999999 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 0.17000000000000001 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 1.77 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.19 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 0.45000000000000001 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 0.14000000000000001 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.20000000000000001 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 0.16 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 0.25 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.1800000000000002 111.61 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.26000000000000001 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 0.45000000000000001 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.20999999999999999 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.23000000000000001 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.17999999999999999 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.615 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.26 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 0.55000000000000004 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 0.25 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 0.23000000000000001 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.6699999999999999 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp . . . . . 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.3400000000000001 110.649 -177.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.562 -0.532 . . . . 0.45000000000000001 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 2.7400000000000002 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.6299999999999999 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 0.39000000000000001 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.26000000000000001 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 0.38 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.26000000000000001 109.27 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.42999999999999999 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 0.23000000000000001 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 0.33000000000000002 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 0.22 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.3300000000000001 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 1.48 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 2.7200000000000002 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 0.14999999999999999 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 0.19 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 0.16 113.104 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28000000000000003 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.1699999999999999 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.29 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 0.29999999999999999 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 0.26000000000000001 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.33000000000000002 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 0.98999999999999999 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.54000000000000004 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.3200000000000001 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.5 109.948 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.34999999999999998 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 0.16 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 0.16 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.3500000000000001 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 0.22 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.615 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.2200000000000002 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 0.13 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 0.81999999999999995 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.34000000000000002 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.40999999999999998 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.42999999999999999 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 0.23999999999999999 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 0.25 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 0.14000000000000001 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 1.8799999999999999 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.96999999999999997 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.664 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 1.8700000000000001 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.17000000000000001 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.577 ' HB3' HG23 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.1299999999999999 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.40000000000000002 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 0.31 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 0.64000000000000001 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.3999999999999999 111.061 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' HG11 ' A' ' 81' ' ' VAL . 21.5 t . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.859 0.361 . . . . 0.14999999999999999 110.563 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.0299999999999998 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.29999999999999999 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.8700000000000001 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 0.33000000000000002 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.0099999999999998 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 0.17000000000000001 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.22 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 0.33000000000000002 112.141 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.22 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.60999999999999999 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.47999999999999998 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 1.8500000000000001 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 0.23000000000000001 109.857 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 0.23999999999999999 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 1.77 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.19 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 0.45000000000000001 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.59 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 0.14000000000000001 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.20000000000000001 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 0.16 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 0.25 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.1800000000000002 111.363 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.26000000000000001 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 0.45000000000000001 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.20999999999999999 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.23000000000000001 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.26 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 0.55000000000000004 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 0.25 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.23000000000000001 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.6699999999999999 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm . . . . . 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.3400000000000001 110.884 -175.11 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 65' ' ' VAL . 5.1 mp . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.541 -0.17 . . . . 0.45000000000000001 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 2.7400000000000002 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.6299999999999999 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.39000000000000001 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.26000000000000001 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 0.38 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.26000000000000001 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 0.42999999999999999 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 0.23000000000000001 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.33000000000000002 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 0.22 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.3300000000000001 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.489 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 1.48 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 2.7200000000000002 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 0.14999999999999999 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 0.19 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 0.16 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.1699999999999999 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.29 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 0.29999999999999999 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 0.26000000000000001 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.33000000000000002 112.986 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 0.98999999999999999 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.54000000000000004 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.5 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.3200000000000001 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.5 109.207 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 97' ' ' VAL . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.34999999999999998 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 0.16 109.468 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 0.16 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.3500000000000001 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 0.22 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.2200000000000002 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 0.13 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 87' ' ' THR . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 0.81999999999999995 109.785 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' O ' HG12 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.34000000000000002 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.40999999999999998 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.42999999999999999 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 83' ' ' PHE . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 0.23999999999999999 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 0.25 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.14000000000000001 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 1.8799999999999999 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.96999999999999997 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 1.8700000000000001 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.636 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 0.17000000000000001 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.1299999999999999 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.40000000000000002 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 0.31 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 0.64000000000000001 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.707 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.3999999999999999 108.89 167.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.589 ' CG1' HG23 ' A' ' 21' ' ' ILE . 43.6 t . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 109.649 -0.5 . . . . 0.14999999999999999 109.649 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.0299999999999998 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.29999999999999999 112.426 -178.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.8700000000000001 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 0.33000000000000002 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.0099999999999998 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 0.17000000000000001 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 0.22 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 0.33000000000000002 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.22 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.60999999999999999 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.47999999999999998 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 1.8500000000000001 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 0.23000000000000001 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 0.23999999999999999 109.486 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 0.17000000000000001 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG22 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 1.77 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 0.45000000000000001 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.589 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 0.14000000000000001 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.20000000000000001 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 0.16 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 0.25 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.1800000000000002 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.26000000000000001 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 0.45000000000000001 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.20999999999999999 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.23000000000000001 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.604 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.17999999999999999 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.629 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 0.55000000000000004 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 0.25 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 0.23000000000000001 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.6699999999999999 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.3400000000000001 110.53 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.966 -0.753 . . . . 0.45000000000000001 108.966 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 2.7400000000000002 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.6299999999999999 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.39000000000000001 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.26000000000000001 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 0.38 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.26000000000000001 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 0.42999999999999999 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 0.23000000000000001 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 0.33000000000000002 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 0.22 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.3300000000000001 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 1.48 109.647 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 2.7200000000000002 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 0.14999999999999999 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 0.16 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.629 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28000000000000003 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.1699999999999999 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 46' ' ' ILE . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.29 109.19 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 0.29999999999999999 111.502 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 0.26000000000000001 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.33000000000000002 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.98999999999999999 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.54000000000000004 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 0.5 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.8 t-20 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.3200000000000001 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.426 ' HG2' ' HG3' ' A' ' 94' ' ' PRO . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.5 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' HG21 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.34999999999999998 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 0.16 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 0.16 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.3500000000000001 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 0.22 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.2200000000000002 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 0.13 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 0.81999999999999995 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.34000000000000002 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.40999999999999998 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.42999999999999999 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 0.23999999999999999 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 0.14000000000000001 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 1.8799999999999999 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.624 ' C ' HG21 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 1.8700000000000001 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 0.17000000000000001 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 95' ' ' GLU . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.1299999999999999 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.426 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.40000000000000002 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.4199999999999999 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 0.31 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 75' ' ' TYR . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 0.64000000000000001 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.3999999999999999 110.638 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.912 0.386 . . . . 0.14999999999999999 110.407 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.0299999999999998 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.29999999999999999 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 0.33000000000000002 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.0099999999999998 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 0.17000000000000001 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 0.22 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 0.33000000000000002 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.22 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.60999999999999999 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.47999999999999998 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 1.8500000000000001 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 0.23000000000000001 110.094 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 0.23999999999999999 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 0.17000000000000001 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 23.0 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 1.77 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.19 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.572 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 0.45000000000000001 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 0.14000000000000001 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.553 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.20000000000000001 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 0.16 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 0.25 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.1800000000000002 111.436 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.26000000000000001 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 0.45000000000000001 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.20999999999999999 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.23000000000000001 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.17999999999999999 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.26 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 0.55000000000000004 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 0.25 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 0.23000000000000001 109.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.6699999999999999 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HE2' HD12 ' A' ' 67' ' ' LEU . 21.8 mttt . . . . . 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.3400000000000001 110.081 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 37' ' ' LYS . 5.2 mp . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.45000000000000001 109.172 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 2.7400000000000002 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.6299999999999999 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.39000000000000001 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 0.38 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.26000000000000001 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 0.42999999999999999 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 0.23000000000000001 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 0.33000000000000002 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.3300000000000001 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 1.48 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 2.7200000000000002 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 0.14999999999999999 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 0.19 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28000000000000003 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.1699999999999999 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 46' ' ' ILE . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.29 108.833 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 0.26000000000000001 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 71' ' ' SER . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.33000000000000002 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 0.98999999999999999 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.454 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.54000000000000004 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 0.5 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.3200000000000001 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.5 109.237 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 97' ' ' VAL . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.34999999999999998 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 0.16 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 0.16 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.3500000000000001 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 0.22 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.2200000000000002 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 0.13 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 0.81999999999999995 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.34000000000000002 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.42999999999999999 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 0.23999999999999999 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.25 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 0.14000000000000001 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 1.8799999999999999 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.96999999999999997 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 1.8700000000000001 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 0.17000000000000001 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.1299999999999999 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.40000000000000002 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.4199999999999999 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 0.31 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 0.64000000000000001 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.67 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.3999999999999999 110.794 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 21' ' ' ILE . 27.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.14999999999999999 109.797 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.0299999999999998 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.29999999999999999 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.8700000000000001 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 0.33000000000000002 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.0099999999999998 112.272 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 0.17000000000000001 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 0.22 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 0.33000000000000002 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.22 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.60999999999999999 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.47999999999999998 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 1.8500000000000001 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 0.23000000000000001 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.427 ' OG1' HG22 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 0.23999999999999999 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 0.17000000000000001 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 61' ' ' THR . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 1.77 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.19 111.423 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 0.45000000000000001 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.646 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 0.14000000000000001 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.20000000000000001 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 0.16 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 0.25 112.162 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.1800000000000002 111.975 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.26000000000000001 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 0.45000000000000001 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.20999999999999999 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.23000000000000001 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.26 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 0.55000000000000004 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.25 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 0.23000000000000001 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.6699999999999999 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.7 tttt . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.3400000000000001 110.008 179.037 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.535 -0.543 . . . . 0.45000000000000001 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 2.7400000000000002 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.6299999999999999 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 0.39000000000000001 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.26000000000000001 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 0.38 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.26000000000000001 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 0.42999999999999999 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 0.23000000000000001 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 0.33000000000000002 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 0.22 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.3300000000000001 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 1.48 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 2.7200000000000002 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.14999999999999999 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 0.16 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28000000000000003 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.596 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.1699999999999999 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.29 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 0.29999999999999999 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 0.26000000000000001 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.33000000000000002 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 0.98999999999999999 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.54000000000000004 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.5 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.3200000000000001 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.5 109.689 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.401 ' HB2' HG21 ' A' ' 97' ' ' VAL . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.34999999999999998 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 0.16 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 0.16 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.3500000000000001 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 0.22 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.641 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 0.13 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 0.81999999999999995 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.34000000000000002 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.40999999999999998 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.42999999999999999 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 0.23999999999999999 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 0.25 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.589 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 0.14000000000000001 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 1.8799999999999999 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.96999999999999997 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.8700000000000001 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 0.17000000000000001 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.1299999999999999 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.40000000000000002 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.796 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.4199999999999999 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 0.31 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 75' ' ' TYR . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 0.64000000000000001 113.865 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.796 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.3999999999999999 111.703 -171.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.612 ' CG1' HG11 ' A' ' 81' ' ' VAL . 18.2 t . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.047 0.451 . . . . 0.14999999999999999 111.028 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.0299999999999998 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.29999999999999999 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.8700000000000001 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 0.33000000000000002 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.0099999999999998 112.04 -173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 0.17000000000000001 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 0.22 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 0.33000000000000002 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.22 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.60999999999999999 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.47999999999999998 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 1.8500000000000001 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 0.23000000000000001 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 0.23999999999999999 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 0.17000000000000001 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.527 ' CB ' HG22 ' A' ' 61' ' ' THR . 63.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 1.77 109.971 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' H ' HD22 ' A' ' 33' ' ' LEU . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.19 111.272 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.694 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 0.45000000000000001 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.591 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 0.14000000000000001 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.20000000000000001 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 0.16 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 0.25 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.1800000000000002 111.378 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.26000000000000001 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 0.45000000000000001 110.574 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.20999999999999999 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.17999999999999999 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.26 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 0.55000000000000004 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 0.25 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 0.23000000000000001 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.3400000000000001 109.851 177.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.344 -0.243 . . . . 0.45000000000000001 110.344 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 2.7400000000000002 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.6299999999999999 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 0.39000000000000001 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.26000000000000001 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.38 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.429 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.26000000000000001 109.188 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 0.42999999999999999 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.826 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 0.23000000000000001 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 0.33000000000000002 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 0.22 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.3300000000000001 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 1.48 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 2.7200000000000002 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 0.14999999999999999 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 0.19 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 0.16 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.1699999999999999 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.29 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 0.29999999999999999 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.61 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 0.26000000000000001 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.33000000000000002 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 0.98999999999999999 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.54000000000000004 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 0.5 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.3200000000000001 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.5 109.271 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.34999999999999998 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.637 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 0.16 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.3500000000000001 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 0.22 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.2200000000000002 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 0.13 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 87' ' ' THR . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 0.81999999999999995 109.66 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.34000000000000002 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.40999999999999998 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.42999999999999999 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 0.23999999999999999 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 0.25 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.571 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 0.14000000000000001 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 1.8799999999999999 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.96999999999999997 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.609 ' C ' HG21 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 1.8700000000000001 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.637 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 0.17000000000000001 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.1299999999999999 108.931 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.40000000000000002 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.4199999999999999 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 0.31 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 75' ' ' TYR . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 0.64000000000000001 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.783 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.3999999999999999 110.654 -171.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.7 t . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.987 -0.375 . . . . 0.14999999999999999 109.987 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 15.5 mm100 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.0299999999999998 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.29999999999999999 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.8700000000000001 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 0.33000000000000002 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.0099999999999998 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 0.17000000000000001 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 0.22 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 0.33000000000000002 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.22 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.60999999999999999 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.47999999999999998 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 1.8500000000000001 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 0.23000000000000001 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.404 ' OG1' HG22 ' A' ' 66' ' ' VAL . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 0.23999999999999999 109.381 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 0.17000000000000001 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 9.5 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 1.77 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.19 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 0.45000000000000001 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 0.14000000000000001 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.20000000000000001 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 0.16 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 0.25 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.1800000000000002 111.3 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.26000000000000001 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 0.45000000000000001 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.20999999999999999 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.23000000000000001 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.17999999999999999 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.622 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.26 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 0.55000000000000004 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 0.25 109.967 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 0.23000000000000001 110.224 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.3400000000000001 110.9 -175.021 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.29 -0.633 . . . . 0.45000000000000001 109.29 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 2.7400000000000002 111.851 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.6299999999999999 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 0.39000000000000001 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.26000000000000001 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 0.38 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.26000000000000001 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 0.42999999999999999 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 0.23000000000000001 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.33000000000000002 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 0.22 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.3300000000000001 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 1.48 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 2.7200000000000002 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 0.14999999999999999 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 HG12 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 0.16 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28000000000000003 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.1699999999999999 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 46' ' ' ILE . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.29 109.174 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 0.29999999999999999 111.151 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 0.26000000000000001 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.33000000000000002 112.299 -170.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 0.98999999999999999 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 0.5 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.3200000000000001 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.5 109.761 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' HB2' HG21 ' A' ' 97' ' ' VAL . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.34999999999999998 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 0.16 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.642 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 0.16 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.3500000000000001 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 0.22 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.622 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.2200000000000002 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 0.13 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.548 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 0.81999999999999995 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.34000000000000002 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.40999999999999998 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.42999999999999999 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 0.23999999999999999 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 0.25 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.573 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 0.14000000000000001 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 1.8799999999999999 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.96999999999999997 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 1.8700000000000001 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.642 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 0.17000000000000001 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' HG23 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.1299999999999999 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.40000000000000002 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.4199999999999999 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.31 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 75' ' ' TYR . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 0.64000000000000001 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.3999999999999999 111.607 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.613 ' CG1' HG23 ' A' ' 21' ' ' ILE . 44.1 t . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 109.999 -0.371 . . . . 0.14999999999999999 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.0299999999999998 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.29999999999999999 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.8700000000000001 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.602 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 0.33000000000000002 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 0.17000000000000001 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 0.22 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 0.33000000000000002 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.22 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.60999999999999999 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.47999999999999998 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 1.8500000000000001 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 0.23000000000000001 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 66' ' ' VAL . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 0.23999999999999999 109.239 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.625 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 0.17000000000000001 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 1.77 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.19 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 0.45000000000000001 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.613 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 0.14000000000000001 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.20000000000000001 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 0.16 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 0.25 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.1800000000000002 111.513 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.26000000000000001 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 0.45000000000000001 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.20999999999999999 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.23000000000000001 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.577 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.17999999999999999 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.26 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 0.25 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 0.23000000000000001 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 19.6 ttpt . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.3400000000000001 110.238 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.984 -0.376 . . . . 0.45000000000000001 109.984 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 2.7400000000000002 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.6299999999999999 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 0.39000000000000001 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.26000000000000001 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 0.38 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.26000000000000001 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 0.42999999999999999 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 0.23000000000000001 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 0.33000000000000002 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 0.22 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 1.48 109.696 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 2.7200000000000002 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 0.14999999999999999 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 0.19 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 0.16 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.1699999999999999 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.29 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 0.29999999999999999 110.792 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 0.26000000000000001 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.33000000000000002 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 0.98999999999999999 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.54000000000000004 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 0.5 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.3200000000000001 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.5 109.56 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.34999999999999998 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 0.16 109.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.685 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 0.16 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.3500000000000001 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 0.22 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.704 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.2200000000000002 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 0.13 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 0.81999999999999995 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.34000000000000002 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.40999999999999998 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.42999999999999999 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 0.23999999999999999 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 0.25 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.61 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 0.14000000000000001 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 1.8799999999999999 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.96999999999999997 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 1.8700000000000001 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 92' ' ' LEU . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.1299999999999999 109.625 170.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.40000000000000002 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.4199999999999999 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 0.31 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 0.64000000000000001 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.687 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.3999999999999999 111.854 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.6 t . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.14999999999999999 110.441 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.0299999999999998 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.29999999999999999 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.8700000000000001 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.674 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 0.33000000000000002 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.0099999999999998 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 0.17000000000000001 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 0.22 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 0.33000000000000002 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.22 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.60999999999999999 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.47999999999999998 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 1.8500000000000001 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 0.23000000000000001 110.259 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.403 ' OG1' HG22 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 0.23999999999999999 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.579 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 0.17000000000000001 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.637 ' CB ' HG22 ' A' ' 61' ' ' THR . 48.1 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 1.77 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.19 111.026 171.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.719 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 0.45000000000000001 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 0.14000000000000001 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.20000000000000001 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 0.16 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 0.25 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.1800000000000002 111.6 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.26000000000000001 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 0.45000000000000001 110.65 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.20999999999999999 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.23000000000000001 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.17999999999999999 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.26 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.55000000000000004 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 0.25 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 0.23000000000000001 110.296 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.6699999999999999 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.3400000000000001 110.536 -176.853 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 109.966 -0.383 . . . . 0.45000000000000001 109.966 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 2.7400000000000002 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.6299999999999999 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 0.39000000000000001 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.26000000000000001 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 0.38 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.26000000000000001 109.245 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 0.23000000000000001 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.33000000000000002 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.3300000000000001 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 1.48 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.719 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 2.7200000000000002 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.763 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 0.14999999999999999 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 0.19 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 0.16 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28000000000000003 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.1699999999999999 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.29 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 0.29999999999999999 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 0.26000000000000001 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.33000000000000002 112.075 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 0.98999999999999999 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.54000000000000004 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.5 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.3200000000000001 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.34999999999999998 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 0.16 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 0.16 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.3500000000000001 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 0.22 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.2200000000000002 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 0.13 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 87' ' ' THR . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 0.81999999999999995 109.653 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG12 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.34000000000000002 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.40999999999999998 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.42999999999999999 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 0.23999999999999999 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 0.25 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 0.14000000000000001 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.674 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 1.8700000000000001 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 0.17000000000000001 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.1299999999999999 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.40000000000000002 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 0.31 111.165 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 75' ' ' TYR . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 0.64000000000000001 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.3999999999999999 111.669 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 21' ' ' ILE . 21.5 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 0.14999999999999999 111.661 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.0299999999999998 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.29999999999999999 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.8700000000000001 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 0.33000000000000002 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.0099999999999998 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 0.17000000000000001 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 0.22 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 0.33000000000000002 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.22 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.60999999999999999 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.47999999999999998 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 1.8500000000000001 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.23000000000000001 109.739 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 0.23999999999999999 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 0.17000000000000001 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 1.77 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.19 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 0.45000000000000001 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.619 HG23 ' CG1' ' A' ' 2' ' ' VAL . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 0.14000000000000001 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.20000000000000001 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.716 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 0.16 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 0.25 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.1800000000000002 111.563 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.26000000000000001 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 0.45000000000000001 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.20999999999999999 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.23000000000000001 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.17999999999999999 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.26 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 0.55000000000000004 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 0.25 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 0.23000000000000001 110.143 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.6699999999999999 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.453 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.3400000000000001 110.236 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.626 -0.509 . . . . 0.45000000000000001 109.626 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 2.7400000000000002 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.6299999999999999 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 0.39000000000000001 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.26000000000000001 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 0.38 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.486 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.26000000000000001 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 0.42999999999999999 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 0.23000000000000001 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 0.33000000000000002 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 0.22 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.3300000000000001 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 1.48 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 2.7200000000000002 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 0.19 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 0.16 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28000000000000003 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.1699999999999999 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 46' ' ' ILE . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.29 109.661 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 0.29999999999999999 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 0.26000000000000001 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.33000000000000002 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 0.98999999999999999 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.54000000000000004 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.5 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.3200000000000001 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.5 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 97' ' ' VAL . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.34999999999999998 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 0.16 109.661 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 0.16 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.3500000000000001 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 0.22 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.2200000000000002 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.726 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 0.13 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 0.81999999999999995 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.536 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.40999999999999998 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.42999999999999999 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 0.23999999999999999 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.25 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 0.14000000000000001 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 1.8799999999999999 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.96999999999999997 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 1.8700000000000001 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 0.17000000000000001 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.1299999999999999 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.40000000000000002 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.4199999999999999 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 0.31 111.654 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 0.64000000000000001 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.73 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.3999999999999999 111.598 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.647 ' CG1' HG23 ' A' ' 21' ' ' ILE . 41.1 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.744 0.306 . . . . 0.14999999999999999 110.525 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.0299999999999998 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.29999999999999999 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.8700000000000001 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 0.33000000000000002 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.0099999999999998 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 0.17000000000000001 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 0.22 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 0.33000000000000002 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.22 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.60999999999999999 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.47999999999999998 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 1.8500000000000001 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 0.23000000000000001 110.267 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 0.23999999999999999 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 0.17000000000000001 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 1.77 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.19 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 0.45000000000000001 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.647 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 0.14000000000000001 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.20000000000000001 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 0.16 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 24' ' ' VAL . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 0.25 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.1800000000000002 111.7 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.26000000000000001 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 0.45000000000000001 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.20999999999999999 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.23000000000000001 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.17999999999999999 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 0.55000000000000004 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 0.25 110.622 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 0.23000000000000001 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.6699999999999999 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.3400000000000001 110.255 -179.08 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.497 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.496 -0.557 . . . . 0.45000000000000001 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 2.7400000000000002 112.521 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.6299999999999999 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.39000000000000001 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.26000000000000001 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.26000000000000001 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 0.42999999999999999 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 0.23000000000000001 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 0.33000000000000002 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 0.22 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.3300000000000001 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 1.48 109.699 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 2.7200000000000002 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 0.14999999999999999 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 0.19 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 0.16 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28000000000000003 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.1699999999999999 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.29 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG22 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 0.29999999999999999 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 0.26000000000000001 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.33000000000000002 111.691 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 0.98999999999999999 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.54000000000000004 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 0.5 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.5 110.042 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.34999999999999998 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 0.16 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 0.16 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.3500000000000001 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 0.22 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.2200000000000002 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 0.13 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 0.81999999999999995 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.34000000000000002 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.40999999999999998 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.42999999999999999 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 0.23999999999999999 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 0.25 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 0.14000000000000001 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.7 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 1.8799999999999999 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.6 p30 -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 1.8700000000000001 112.17 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.668 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 0.17000000000000001 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.1299999999999999 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.40000000000000002 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.4199999999999999 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 0.31 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 0.64000000000000001 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.429 ' H ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.3999999999999999 110.572 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG11 ' A' ' 81' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.14999999999999999 110.145 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.0299999999999998 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.29999999999999999 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 107.403 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.665 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 0.33000000000000002 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.0099999999999998 112.598 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 0.17000000000000001 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 0.22 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 0.33000000000000002 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.22 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.60999999999999999 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.47999999999999998 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 1.8500000000000001 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 0.23000000000000001 110.116 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 0.23999999999999999 109.114 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 0.17000000000000001 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.417 ' HB2' HG22 ' A' ' 61' ' ' THR . 2.2 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.19 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 0.45000000000000001 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.582 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 0.14000000000000001 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 59' ' ' ARG . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.20000000000000001 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 0.16 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 0.25 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.1800000000000002 110.964 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.26000000000000001 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 0.45000000000000001 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.20999999999999999 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.23000000000000001 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.17999999999999999 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.26 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 0.55000000000000004 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 0.25 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 0.23000000000000001 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.6699999999999999 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt . . . . . 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.3400000000000001 110.494 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 109.422 -0.584 . . . . 0.45000000000000001 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 2.7400000000000002 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.6299999999999999 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 0.39000000000000001 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.26000000000000001 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 0.38 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.26000000000000001 109.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 0.42999999999999999 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.23000000000000001 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 0.33000000000000002 110.72 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.22 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.3300000000000001 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 1.48 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 2.7200000000000002 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 0.14999999999999999 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 0.19 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 0.16 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28000000000000003 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.1699999999999999 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.29 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 0.29999999999999999 111.258 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.33000000000000002 112.362 -171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 0.98999999999999999 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.54000000000000004 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 0.5 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.3200000000000001 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.5 109.627 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.34999999999999998 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 0.16 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 0.16 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.3500000000000001 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 0.22 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.2200000000000002 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 0.13 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 0.81999999999999995 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.34000000000000002 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.40999999999999998 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.42999999999999999 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 0.23999999999999999 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 0.25 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.617 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 0.14000000000000001 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 1.8799999999999999 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.665 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 1.8700000000000001 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.62 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 0.17000000000000001 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.1299999999999999 109.182 170.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.40000000000000002 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.715 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.4199999999999999 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 0.31 111.922 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 0.64000000000000001 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.715 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.3999999999999999 110.162 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.1 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 0.14999999999999999 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.0299999999999998 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.29999999999999999 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.8700000000000001 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 0.33000000000000002 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.0099999999999998 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 0.17000000000000001 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 0.22 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 0.33000000000000002 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.22 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.60999999999999999 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.47999999999999998 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 1.8500000000000001 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 0.23000000000000001 110.454 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 0.23999999999999999 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 0.17000000000000001 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.788 HE21 HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 1.77 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.19 111.592 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.569 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 0.45000000000000001 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.588 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 0.14000000000000001 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.20000000000000001 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 0.16 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 0.25 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.1800000000000002 111.706 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.26000000000000001 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 0.45000000000000001 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.20999999999999999 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.23000000000000001 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.17999999999999999 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.26 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.55000000000000004 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 0.25 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.594 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 0.23000000000000001 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.6699999999999999 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt . . . . . 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.3400000000000001 110.431 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.8 -0.815 . . . . 0.45000000000000001 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 2.7400000000000002 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.6299999999999999 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 0.39000000000000001 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.26000000000000001 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 0.38 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.26000000000000001 109.145 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 0.42999999999999999 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 0.23000000000000001 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 0.33000000000000002 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.22 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.3300000000000001 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 1.48 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 2.7200000000000002 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 0.14999999999999999 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.788 HG21 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 0.19 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 0.16 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28000000000000003 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.1699999999999999 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.29 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 0.29999999999999999 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 0.26000000000000001 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.33000000000000002 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 0.98999999999999999 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.54000000000000004 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.5 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.5 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.486 ' HB2' HG21 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.34999999999999998 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 0.16 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 0.16 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.3500000000000001 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 0.22 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.2200000000000002 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 0.13 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 0.81999999999999995 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.34000000000000002 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.40999999999999998 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.42999999999999999 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.23999999999999999 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.608 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 0.14000000000000001 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.729 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 44.1 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.686 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 1.8700000000000001 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 0.17000000000000001 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.40000000000000002 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.818 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.4199999999999999 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 0.31 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 0.64000000000000001 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.3999999999999999 111.839 -170.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG23 ' A' ' 21' ' ' ILE . 20.3 t . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.999 0.428 . . . . 0.14999999999999999 111.068 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.0299999999999998 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.29999999999999999 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.8700000000000001 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.718 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 0.33000000000000002 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.0099999999999998 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 0.17000000000000001 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 0.22 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 0.33000000000000002 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.22 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.60999999999999999 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.47999999999999998 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 1.8500000000000001 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 0.23999999999999999 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 0.17000000000000001 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 61' ' ' THR . 1.2 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 1.77 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.19 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 0.45000000000000001 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 0.14000000000000001 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.20000000000000001 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 0.16 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 0.25 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.1800000000000002 111.199 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.26000000000000001 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 0.45000000000000001 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.20999999999999999 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.23000000000000001 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.17999999999999999 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.26 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 0.55000000000000004 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 0.25 110.245 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.23000000000000001 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.6699999999999999 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.3400000000000001 110.317 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.974 -0.38 . . . . 0.45000000000000001 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 2.7400000000000002 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.6299999999999999 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 0.39000000000000001 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.26000000000000001 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 0.38 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.26000000000000001 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 0.42999999999999999 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 0.33000000000000002 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.22 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.3300000000000001 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 1.48 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 2.7200000000000002 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.697 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.14999999999999999 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 0.19 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 0.16 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28000000000000003 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.1699999999999999 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG21 HG21 ' A' ' 46' ' ' ILE . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.29 109.603 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 0.29999999999999999 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 0.26000000000000001 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.33000000000000002 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.453 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 0.98999999999999999 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 0.5 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.3200000000000001 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.5 109.712 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.34999999999999998 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 0.16 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.657 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 0.16 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.3500000000000001 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 0.22 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.2200000000000002 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 0.13 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 0.81999999999999995 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.539 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.34000000000000002 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.40999999999999998 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.42999999999999999 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 0.23999999999999999 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 0.25 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.14000000000000001 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 1.8799999999999999 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.96999999999999997 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.718 ' C ' HG21 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 1.8700000000000001 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 0.17000000000000001 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.1299999999999999 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.40000000000000002 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.839 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.4199999999999999 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 0.31 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' TYR . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 0.64000000000000001 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.839 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.3999999999999999 110.986 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.9 t . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 0.14999999999999999 109.923 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.586 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.0299999999999998 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.29999999999999999 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.8700000000000001 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 0.33000000000000002 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.0099999999999998 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 0.17000000000000001 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.22 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.22 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.60999999999999999 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.47999999999999998 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 1.8500000000000001 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 0.23000000000000001 109.643 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 0.23999999999999999 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 0.17000000000000001 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' CB ' HG22 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 1.77 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.19 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 0.45000000000000001 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 0.14000000000000001 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.20000000000000001 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 0.16 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 0.25 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.1800000000000002 112.657 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.26000000000000001 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 0.45000000000000001 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.20999999999999999 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.23000000000000001 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.63 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.17999999999999999 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.26 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 0.55000000000000004 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 0.25 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 0.23000000000000001 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.3400000000000001 110.645 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.501 -0.185 . . . . 0.45000000000000001 110.501 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 2.7400000000000002 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.6299999999999999 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 0.39000000000000001 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.26000000000000001 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 0.38 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.26000000000000001 109.476 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 0.42999999999999999 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 0.23000000000000001 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.33000000000000002 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 0.22 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.3300000000000001 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 1.48 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 2.7200000000000002 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 0.19 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 0.16 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28000000000000003 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.1699999999999999 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.29 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 0.29999999999999999 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 0.26000000000000001 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.33000000000000002 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 0.98999999999999999 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.54000000000000004 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.5 t-20 -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.3200000000000001 110.492 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.5 109.984 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.34999999999999998 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 0.16 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 0.16 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.3500000000000001 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 0.22 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.2200000000000002 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 0.13 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 0.81999999999999995 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.34000000000000002 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.40999999999999998 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.42999999999999999 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 0.23999999999999999 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 0.25 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.585 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 0.14000000000000001 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 1.8799999999999999 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 1.8700000000000001 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 0.17000000000000001 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.1299999999999999 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.40000000000000002 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.112 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 0.31 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 0.64000000000000001 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' N ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.3999999999999999 111.469 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 109.767 -0.457 . . . . 0.14999999999999999 109.767 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.0299999999999998 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.29999999999999999 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.8700000000000001 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 0.33000000000000002 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.0099999999999998 111.971 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 0.17000000000000001 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 0.22 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.33000000000000002 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.22 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.60999999999999999 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.47999999999999998 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 1.8500000000000001 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 0.23000000000000001 109.956 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 0.23999999999999999 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.588 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 0.17000000000000001 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HB2' HG22 ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 1.77 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.19 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 61' ' ' THR . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 0.45000000000000001 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 0.14000000000000001 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.20000000000000001 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 0.16 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 0.25 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.1800000000000002 112.731 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.26000000000000001 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 0.45000000000000001 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.20999999999999999 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.23000000000000001 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.17999999999999999 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.26 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 0.55000000000000004 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 0.23000000000000001 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.6699999999999999 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.3400000000000001 110.896 -177.28 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.641 HG21 HG11 ' A' ' 65' ' ' VAL . 5.4 mp . . . . . 0 C--O 1.227 -0.089 0 N-CA-C 110.722 -0.103 . . . . 0.45000000000000001 110.722 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 2.7400000000000002 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.43 ' NE2' HG12 ' A' ' 65' ' ' VAL . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.6299999999999999 109.758 172.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 0.39000000000000001 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.26000000000000001 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 0.38 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.417 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.26000000000000001 109.018 -176.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 0.42999999999999999 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 0.23000000000000001 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 0.33000000000000002 110.147 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 0.22 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.3300000000000001 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 1.48 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 2.7200000000000002 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 0.14999999999999999 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 0.19 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 0.16 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28000000000000003 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.1699999999999999 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.29 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 0.29999999999999999 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 0.26000000000000001 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.33000000000000002 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.98999999999999999 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.54000000000000004 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.5 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.3200000000000001 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.5 110.22 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.34999999999999998 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 0.16 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 0.16 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.3500000000000001 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 0.22 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.2200000000000002 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 0.13 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 0.81999999999999995 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.588 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.34000000000000002 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.40999999999999998 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.42999999999999999 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 0.23999999999999999 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.14000000000000001 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 1.8799999999999999 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.96999999999999997 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.0 t-20 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 1.8700000000000001 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.17000000000000001 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.1299999999999999 109.387 170.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.40000000000000002 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.4199999999999999 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 0.31 111.653 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 0.64000000000000001 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.489 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.3999999999999999 112.862 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.948 -0.39 . . . . 0.14999999999999999 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.0299999999999998 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.29999999999999999 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 0.33000000000000002 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.0099999999999998 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 0.17000000000000001 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 0.22 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 0.33000000000000002 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.22 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.60999999999999999 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.47999999999999998 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 1.8500000000000001 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 0.23000000000000001 110.124 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.23999999999999999 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 0.17000000000000001 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.3 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 1.77 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.19 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.56 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 0.45000000000000001 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 0.14000000000000001 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.20000000000000001 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 0.16 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.25 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.1800000000000002 111.662 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.26000000000000001 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 0.45000000000000001 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.20999999999999999 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.17999999999999999 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 0.55000000000000004 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 0.25 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 0.23000000000000001 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.6699999999999999 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HD3' HD12 ' A' ' 67' ' ' LEU . 32.9 mtmt . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.3400000000000001 111.226 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 110.203 -0.295 . . . . 0.45000000000000001 110.203 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 2.7400000000000002 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.518 ' NE2' HG22 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.6299999999999999 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 0.39000000000000001 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.26000000000000001 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 0.38 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.26000000000000001 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 0.42999999999999999 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 0.33000000000000002 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 0.22 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.3300000000000001 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 1.48 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 2.7200000000000002 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 0.14999999999999999 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 0.19 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 0.16 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28000000000000003 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.1699999999999999 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG22 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.29 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 0.29999999999999999 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 0.26000000000000001 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.33000000000000002 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 0.98999999999999999 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.54000000000000004 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 0.5 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.3200000000000001 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.5 109.078 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.34999999999999998 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 0.16 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.3500000000000001 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 0.22 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.2200000000000002 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 0.13 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 0.81999999999999995 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.34000000000000002 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.40999999999999998 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.42999999999999999 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 0.23999999999999999 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 0.25 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 0.14000000000000001 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 1.8799999999999999 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.658 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 1.8700000000000001 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.647 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 0.17000000000000001 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.1299999999999999 109.085 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.40000000000000002 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.4199999999999999 111.547 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 0.31 111.146 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 0.64000000000000001 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.622 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.3999999999999999 111.303 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.608 ' CG1' HG23 ' A' ' 21' ' ' ILE . 38.4 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.801 0.334 . . . . 0.14999999999999999 110.12 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.0299999999999998 108.098 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.29999999999999999 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.8700000000000001 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 0.33000000000000002 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.0099999999999998 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 0.17000000000000001 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 0.22 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.33000000000000002 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.22 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.60999999999999999 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.47999999999999998 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 1.8500000000000001 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 0.23000000000000001 109.865 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 0.23999999999999999 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.59 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 0.17000000000000001 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 1.77 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.19 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 0.45000000000000001 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.608 HG23 ' CG1' ' A' ' 2' ' ' VAL . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 59' ' ' ARG . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.20000000000000001 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 0.16 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 0.25 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.1800000000000002 111.073 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.26000000000000001 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 0.45000000000000001 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.20999999999999999 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.17999999999999999 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.26 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 0.55000000000000004 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.25 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 0.23000000000000001 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.6699999999999999 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 tttm . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.3400000000000001 111.097 -171.612 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 65' ' ' VAL . 5.2 mp . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.621 0.248 . . . . 0.45000000000000001 110.38 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 2.7400000000000002 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.6299999999999999 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 0.39000000000000001 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.26000000000000001 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 0.38 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.26000000000000001 108.924 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 0.42999999999999999 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 0.23000000000000001 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 0.33000000000000002 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 0.22 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.3300000000000001 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.566 ' HA ' ' NE2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 1.48 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 2.7200000000000002 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.82 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 0.14999999999999999 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 79' ' ' LEU . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 0.16 112.192 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.1699999999999999 109.503 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 46' ' ' ILE . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.29 109.842 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 0.29999999999999999 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 0.26000000000000001 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 0.98999999999999999 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.54000000000000004 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.5 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.3200000000000001 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.5 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' HB2' HG21 ' A' ' 97' ' ' VAL . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.34999999999999998 109.223 173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 0.16 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.3500000000000001 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 0.22 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.68 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.2200000000000002 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 0.13 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 87' ' ' THR . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 0.81999999999999995 109.445 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.541 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.42999999999999999 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 0.23999999999999999 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 0.25 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 0.14000000000000001 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 1.8799999999999999 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.96999999999999997 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.639 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 1.8700000000000001 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 0.17000000000000001 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.1299999999999999 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.40000000000000002 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.4199999999999999 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 0.31 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 0.64000000000000001 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? . . . . . 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.3999999999999999 111.499 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.0 t . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.14999999999999999 110.453 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.0299999999999998 108.364 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.29999999999999999 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.8700000000000001 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 0.33000000000000002 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.0099999999999998 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 0.17000000000000001 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 0.22 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 0.33000000000000002 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.22 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.60999999999999999 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.47999999999999998 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 1.8500000000000001 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 0.23000000000000001 110.245 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 0.23999999999999999 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 0.17000000000000001 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 1.77 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.19 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' THR . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 0.45000000000000001 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 0.14000000000000001 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.20000000000000001 107.221 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 0.25 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.1800000000000002 112.078 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.26000000000000001 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 0.45000000000000001 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.20999999999999999 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.23000000000000001 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.17999999999999999 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.26 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 0.55000000000000004 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 0.25 109.963 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 0.23000000000000001 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.6699999999999999 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD3' HD12 ' A' ' 67' ' ' LEU . 7.5 mtmp? . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 110.557 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 HG11 ' A' ' 65' ' ' VAL . 4.8 mp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.203 -0.666 . . . . 0.45000000000000001 109.203 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 2.7400000000000002 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.6299999999999999 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 0.39000000000000001 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.26000000000000001 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 0.38 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.26000000000000001 109.766 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 0.42999999999999999 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 0.23000000000000001 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 0.33000000000000002 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 0.22 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.3300000000000001 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.559 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 1.48 109.859 177.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 2.7200000000000002 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 0.14999999999999999 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 0.19 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 0.16 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28000000000000003 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.1699999999999999 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.29 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 0.29999999999999999 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 ' HD3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 0.26000000000000001 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.33000000000000002 111.96 -173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 0.98999999999999999 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.54000000000000004 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 0.5 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 3.5 t-20 -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.3200000000000001 110.106 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.5 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.34999999999999998 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 0.16 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.63 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 0.16 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.3500000000000001 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.583 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 0.22 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.2200000000000002 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 0.13 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 0.81999999999999995 109.247 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' O ' HG12 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.34000000000000002 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.40999999999999998 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.42999999999999999 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 0.23999999999999999 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 0.25 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.582 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.14000000000000001 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.9 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 1.8799999999999999 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.96999999999999997 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.73 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 1.8700000000000001 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.63 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.17000000000000001 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.1299999999999999 109.012 168.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.40000000000000002 112.173 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.769 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 0.31 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 0.64000000000000001 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.3999999999999999 111.746 -168.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG1' HG23 ' A' ' 21' ' ' ILE . 34.9 t . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.912 0.387 . . . . 0.14999999999999999 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.0299999999999998 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.29999999999999999 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.8700000000000001 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 0.33000000000000002 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.0099999999999998 112.33 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 0.17000000000000001 107.206 168.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 0.22 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 0.33000000000000002 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.22 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.60999999999999999 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.47999999999999998 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 1.8500000000000001 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 0.23000000000000001 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 0.23999999999999999 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 0.17000000000000001 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 1.77 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.19 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 61' ' ' THR . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 0.45000000000000001 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 0.14000000000000001 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.20000000000000001 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 0.16 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 0.25 112.601 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.1800000000000002 112.09 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.26000000000000001 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 0.45000000000000001 110.457 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.20999999999999999 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.17999999999999999 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.26 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.556 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 0.55000000000000004 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 0.23000000000000001 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.306 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.3400000000000001 111.13 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.569 -0.53 . . . . 0.45000000000000001 109.569 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 2.7400000000000002 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' OE1' HG22 ' A' ' 65' ' ' VAL . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.6299999999999999 109.737 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.39000000000000001 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.26000000000000001 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.26000000000000001 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.42999999999999999 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 0.33000000000000002 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 0.22 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.3300000000000001 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 1.48 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 2.7200000000000002 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 0.14999999999999999 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 0.19 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 0.16 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28000000000000003 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.1699999999999999 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 HG21 ' A' ' 46' ' ' ILE . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.29 109.962 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 0.29999999999999999 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.639 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 0.26000000000000001 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.33000000000000002 112.163 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.98999999999999999 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.54000000000000004 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.5 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.3200000000000001 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.5 109.392 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.34999999999999998 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 0.16 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.624 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 0.16 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.3500000000000001 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 0.22 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.2200000000000002 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 0.13 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 0.81999999999999995 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.534 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.34000000000000002 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.40999999999999998 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.42999999999999999 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 0.23999999999999999 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 0.25 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.14000000000000001 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.96999999999999997 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 1.8700000000000001 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 0.17000000000000001 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.1299999999999999 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.40000000000000002 113.164 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.4199999999999999 110.595 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 0.31 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 75' ' ' TYR . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 0.64000000000000001 111.631 170.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' N ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.3999999999999999 111.991 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 tpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.752 0.311 . . . . 3.75 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 40.6 t -90.86 152.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.3 0.571 . . . . 0.14999999999999999 109.788 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 22' ' ' THR . 49.4 tp60 -126.57 153.02 45.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.275 -1.38 . . . . 2.0299999999999998 107.275 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -138.48 150.0 45.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.394 -0.922 . . . . 0.29999999999999999 111.503 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -143.72 175.07 10.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.301 -1.318 . . . . 1.8700000000000001 108.001 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -136.92 112.6 11.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.402 0.62 . . . . 0.33000000000000002 112.067 -176.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -112.47 160.22 17.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 2.0099999999999998 111.823 -174.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.81 125.74 22.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.992 -1.458 . . . . 0.17000000000000001 107.584 171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.97 104.84 12.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.22 111.27 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 97' ' ' VAL . 85.6 t -85.38 122.88 38.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.398 0.618 . . . . 0.33000000000000002 111.81 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -114.23 177.56 4.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.122 -0.945 . . . . 1.22 108.483 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.7 97.73 0.07 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.982 -0.627 . . . . 0.60999999999999999 113.369 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.83 -15.26 59.6 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.198 -0.525 . . . . 0.47999999999999998 113.536 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -135.28 135.08 40.59 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.019 -0.695 . . . . 1.8500000000000001 110.956 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.2 p -109.04 118.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.299 0.571 . . . . 0.23000000000000001 109.994 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 66' ' ' VAL . 73.2 m -95.48 116.97 29.55 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.23999999999999999 109.342 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.31 135.28 52.08 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.664 -0.415 . . . . 0.17000000000000001 111.164 -171.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.4 pt20 -164.21 147.65 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.763 0.664 . . . . 1.77 110.132 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.87 130.05 10.13 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.719 -0.753 . . . . 0.19 112.531 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.587 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 11.4 t -84.98 109.38 17.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-O 122.489 1.137 . . . . 0.45000000000000001 112.614 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.7 mt -91.18 106.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 114.17 -1.377 . . . . 0.14000000000000001 110.388 175.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 4.4 m -84.04 131.46 34.81 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.547 -1.279 . . . . 0.20000000000000001 107.547 169.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.57 122.66 39.4 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.609 -0.836 . . . . 0.16 109.538 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -71.07 -10.93 14.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.211 0.449 . . . . 0.25 112.211 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -131.25 140.73 49.89 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.722 -0.611 . . . . 2.1800000000000002 111.61 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 6.2 p-10 -83.9 132.29 34.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.207 0.527 . . . . 1.54 110.193 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 53' ' ' THR . . . 161.78 -133.96 3.34 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.205 -1.158 . . . . 0.26000000000000001 110.205 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.45 139.7 27.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.137 0.468 . . . . 0.45000000000000001 110.433 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -173.16 13.13 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.858 -0.897 . . . . 0.20999999999999999 110.858 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.2 p -127.93 138.01 52.49 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.121 0.486 . . . . 0.23000000000000001 110.783 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.02 159.59 38.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.376 -0.829 . . . . 0.17999999999999999 110.583 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.615 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.39 111.75 13.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.61 . . . . 1.26 111.296 -173.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -104.49 126.55 51.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.45 0.643 . . . . 0.55000000000000004 110.056 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -123.0 139.89 53.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.305 -0.861 . . . . 0.25 109.993 174.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 37.2 t -116.36 143.66 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.951 -0.388 . . . . 0.23000000000000001 109.951 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 12.3 t70 -120.23 114.5 22.0 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.575 -0.528 . . . . 1.6699999999999999 109.575 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -112.56 121.99 46.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.086 0.47 . . . . 1.3400000000000001 110.649 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -130.21 108.41 10.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 0.59999999999999998 110.437 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.08 -163.44 9.91 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.875 -0.679 . . . . 0.95999999999999996 111.647 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.76 -17.66 64.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.75 0.309 . . . . 1.5700000000000001 111.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.2 -7.85 57.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 1.72 111.396 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.24 -170.42 14.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.629 -0.796 . . . . 1.21 112.637 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -108.49 114.98 29.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.661 0.267 . . . . 1.1399999999999999 110.761 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 m -106.21 143.39 34.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.741 0.305 . . . . 1.1499999999999999 110.201 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -112.06 112.42 24.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.288 -0.415 . . . . 3.0800000000000001 110.645 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp -99.12 134.48 37.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.562 -0.532 . . . . 0.45000000000000001 109.562 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -145.97 120.72 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.103 -0.239 . . . . 2.7400000000000002 111.082 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.49 117.42 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 1.6299999999999999 110.268 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -126.26 138.3 53.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.458 -0.337 . . . . 0.39000000000000001 110.748 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.67 -142.35 5.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.861 -0.685 . . . . 0.26000000000000001 111.701 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.5 152.71 47.17 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.896 -0.409 . . . . 0.38 109.896 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.1 t80 -156.23 171.19 20.62 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.27 -0.641 . . . . 0.26000000000000001 109.27 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -88.92 138.73 31.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.749 0.309 . . . . 0.42999999999999999 110.868 -176.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -132.83 139.27 47.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.29 -0.414 . . . . 0.23000000000000001 110.803 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.8 142.08 16.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.333 -0.394 . . . . 0.33000000000000002 110.862 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.71 123.32 15.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.261 -0.881 . . . . 0.22 112.264 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.81 26.6 16.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.864 -1.062 . . . . 1.3300000000000001 110.008 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -116.47 149.29 39.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.281 -1.327 . . . . 1.48 109.328 176.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mpt_? -87.0 122.22 30.55 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.753 -1.112 . . . . 2.7200000000000002 110.188 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 54' ' ' ALA . 54.1 t -115.99 109.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.214 -0.661 . . . . 0.14999999999999999 109.214 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -90.81 128.05 36.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.593 -0.843 . . . . 0.19 110.382 -174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.11 136.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.28 -0.873 . . . . 0.16 113.104 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 77.14 62.57 2.43 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.153 -0.93 . . . . 0.28000000000000003 112.669 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 4.9 p-10 -80.09 108.15 13.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.823 0.82 . . . . 2.1699999999999999 110.266 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.64 138.55 54.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.987 -1.006 . . . . 1.29 109.187 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' OG1' ' A' ' 16' ' ' THR . 42.5 t -105.51 123.5 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.382 0.61 . . . . 0.29999999999999999 111.718 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.77 162.79 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.375 -0.972 . . . . 0.26000000000000001 108.375 177.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -74.41 127.8 33.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.062 -1.088 . . . . 1.25 108.062 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.63 125.65 29.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.165 0.432 . . . . 0.33000000000000002 112.165 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.11 124.17 13.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.062 -0.718 . . . . 0.98999999999999999 109.062 169.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 p -67.51 -21.78 65.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.797 0.332 . . . . 0.54000000000000004 111.189 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.38 -4.82 47.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.486 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -86.38 147.84 25.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.86 0.362 . . . . 1.3200000000000001 110.811 -176.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.3 mmt180 -89.41 109.07 20.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.112 0.482 . . . . 2.5 109.948 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 33.7 m-85 -122.38 112.85 18.6 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.094 -0.706 . . . . 0.34999999999999998 109.094 174.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.86 168.73 13.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.031 -0.532 . . . . 0.16 110.139 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.38 163.52 35.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.449 -0.342 . . . . 0.16 110.333 -175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.11 120.76 6.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.724 -0.671 . . . . 3.3500000000000001 109.373 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -120.98 118.11 29.01 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.114 -0.635 . . . . 0.22 110.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.615 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 8.6 t70 -97.75 120.86 38.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.119 -0.946 . . . . 2.2200000000000002 109.182 174.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.0 t -106.41 105.76 19.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.923 -0.769 . . . . 0.13 108.923 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' THR . 2.0 p -124.77 104.2 8.51 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.849 -0.614 . . . . 0.81999999999999995 109.844 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 86' ' ' VAL . 53.8 t80 -150.28 94.18 2.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 0.34000000000000002 110.583 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.59 -103.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.847 -0.692 . . . . 0.40999999999999998 112.514 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -90.74 -13.23 34.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.976 0.361 . . . . 0.42999999999999999 111.976 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 83' ' ' PHE . 13.8 p -101.71 132.86 46.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.977 0.418 . . . . 0.23999999999999999 111.296 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 19.8 m -150.63 116.99 5.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.111 -0.495 . . . . 0.25 109.68 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -148.97 166.73 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 0.14000000000000001 109.862 -173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 10.2 pt20 -151.87 149.34 28.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 1.8799999999999999 111.297 173.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.57 165.3 25.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.67 -0.695 . . . . 0.96999999999999997 110.067 178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.664 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.8 t-20 -143.86 130.78 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 1.8700000000000001 111.42 -175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 14.5 tp -77.26 136.3 38.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.17000000000000001 111.505 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.577 ' HB3' HG23 ' A' ' 96' ' ' THR . 22.4 t70 -84.72 111.74 37.35 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.09 -0.707 . . . . 2.1299999999999999 109.09 169.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.7 Cg_endo -61.33 -17.03 50.75 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.473 2.115 . . . . 0.40000000000000002 113.16 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 98' ' ' LYS . 39.8 mt-10 -82.98 3.03 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 110.782 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' ASP . 44.9 p -97.84 -20.21 17.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.258 0.466 . . . . 0.31 112.258 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 97' ' ' VAL . 0.8 OUTLIER -62.23 5.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.213 0.53 . . . . 0.64000000000000001 112.194 176.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -65.44 81.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.063 -0.398 . . . . 2.3999999999999999 111.061 175.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.65 18.18 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.236 -0.893 . . . . 1.3300000000000001 111.967 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.27 132.29 35.33 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.122 -0.696 . . . . 4.1299999999999999 109.122 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.965 -0.541 . . . . 6.6900000000000004 110.843 -176.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' H3 ' ' HB ' ' A' ' 86' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 111.56 0.207 . . . . 3.75 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' HG11 ' A' ' 81' ' ' VAL . 21.5 t -93.15 150.03 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.513 -0.475 . . . . 0.14999999999999999 110.563 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 10.5 mm-40 -122.13 167.17 13.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.748 -1.204 . . . . 2.0299999999999998 107.748 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -150.55 144.79 25.54 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.135 -1.026 . . . . 0.29999999999999999 112.179 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -139.37 175.79 9.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.074 -1.421 . . . . 1.8700000000000001 107.594 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -137.65 127.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.237 0.541 . . . . 0.33000000000000002 111.542 -177.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -130.67 158.65 39.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.819 0.819 . . . . 2.0099999999999998 112.058 -175.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.79 125.21 37.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.435 -1.257 . . . . 0.17000000000000001 108.038 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.25 105.76 15.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.22 110.56 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 71.0 t -85.82 135.87 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.558 0.694 . . . . 0.33000000000000002 112.141 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.3 t -119.12 177.64 4.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.661 -1.154 . . . . 1.22 108.672 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.15 86.33 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.874 -0.679 . . . . 0.60999999999999999 112.863 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.13 -14.37 51.88 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.282 -0.485 . . . . 0.47999999999999998 112.865 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -130.35 156.64 44.36 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.495 -0.415 . . . . 1.8500000000000001 109.947 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.2 p -129.63 118.4 45.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.116 0.484 . . . . 0.23000000000000001 109.857 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 78.9 m -95.59 116.02 28.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.114 -0.699 . . . . 0.23999999999999999 109.114 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -103.51 141.38 36.09 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.367 -175.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB2' HG22 ' A' ' 61' ' ' THR . 9.8 pt20 -163.46 139.8 6.94 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.66 0.6 . . . . 1.77 110.334 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.01 127.89 9.36 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.63 -0.795 . . . . 0.19 112.273 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.6 t -86.9 114.25 25.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 122.133 0.968 . . . . 0.45000000000000001 112.152 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.59 HD13 ' CD2' ' A' ' 31' ' ' TYR . 9.4 mt -96.99 106.31 18.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.481 -1.236 . . . . 0.14000000000000001 110.327 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 133.99 36.06 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.074 -1.454 . . . . 0.20000000000000001 107.074 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.66 34.64 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.133 -1.027 . . . . 0.16 109.298 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.7 t -71.65 -6.41 7.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.082 0.467 . . . . 0.25 111.928 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 80.3 mmt-85 -133.39 136.13 45.09 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.526 -0.734 . . . . 2.1800000000000002 111.363 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 3.6 p-10 -83.22 146.72 28.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.779 -0.646 . . . . 1.54 110.834 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 53' ' ' THR . . . 143.07 -129.61 3.83 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.969 -1.252 . . . . 0.26000000000000001 109.969 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -140.62 134.63 30.76 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.217 -0.29 . . . . 0.45000000000000001 110.217 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.53 178.64 17.28 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.902 -0.879 . . . . 0.20999999999999999 110.902 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.1 p -125.41 136.86 53.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.12 0.486 . . . . 0.23000000000000001 110.792 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.594 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.0 162.17 39.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.917 -175.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -133.79 111.72 10.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.98 -0.555 . . . . 1.26 111.429 -175.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -102.97 127.74 50.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.433 0.635 . . . . 0.55000000000000004 110.072 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -120.95 142.57 49.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.469 -0.787 . . . . 0.25 109.996 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -117.16 139.02 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.23000000000000001 110.256 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 14.7 t70 -112.99 114.8 27.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 1.6699999999999999 109.074 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -119.25 134.55 55.14 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.757 0.313 . . . . 1.3400000000000001 110.884 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -148.36 113.33 5.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.59999999999999998 110.871 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.61 -161.97 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.828 -0.909 . . . . 0.95999999999999996 110.828 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.95 67.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.095 0.448 . . . . 1.5700000000000001 110.784 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.67 -1.14 41.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 1.72 111.36 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.37 -164.09 13.58 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.878 -0.677 . . . . 1.21 112.419 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 p -107.85 141.35 39.57 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.886 0.374 . . . . 1.1399999999999999 110.906 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -128.18 144.33 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.273 -0.421 . . . . 1.1499999999999999 110.041 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -117.19 112.42 20.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.21 -0.292 . . . . 3.0800000000000001 110.21 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.645 HG21 HG21 ' A' ' 65' ' ' VAL . 5.1 mp -107.36 140.09 26.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.542 -0.299 . . . . 0.45000000000000001 110.541 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -145.1 113.31 6.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.622 0.248 . . . . 2.7400000000000002 111.523 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -126.33 117.42 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.96 -0.385 . . . . 1.6299999999999999 109.96 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.55 149.81 52.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.39000000000000001 111.518 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 -143.05 8.41 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.836 -0.62 . . . . 0.26000000000000001 111.815 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.31 154.77 50.01 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.664 -0.495 . . . . 0.38 109.664 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.8 t80 -155.38 172.41 18.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.338 -0.616 . . . . 0.26000000000000001 109.338 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.61 126.6 35.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.912 0.386 . . . . 0.42999999999999999 111.105 -176.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -122.81 145.1 48.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.617 . . . . 0.23000000000000001 110.467 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -109.6 142.44 22.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.695 0.283 . . . . 0.33000000000000002 110.49 178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.93 124.32 20.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.321 -0.854 . . . . 0.22 111.423 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 61.89 33.3 17.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 122.113 0.959 . . . . 1.3300000000000001 109.646 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -125.65 142.62 51.42 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.03 -1.441 . . . . 1.48 109.822 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -81.51 127.89 33.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.959 -1.019 . . . . 2.7200000000000002 110.707 176.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.6 t -122.76 109.64 24.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.008 -0.738 . . . . 0.14999999999999999 109.008 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -89.19 128.18 35.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.406 -0.918 . . . . 0.19 110.815 -175.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.8 t -123.61 137.98 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 114.707 -1.133 . . . . 0.16 112.139 -168.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.79 76.61 1.03 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 112.157 176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.59 108.25 18.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.43 . . . . 2.1699999999999999 109.917 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 46' ' ' ILE . 21.6 t -122.37 119.27 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.635 -0.711 . . . . 1.29 110.077 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 45.5 t -99.31 117.83 45.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.355 0.597 . . . . 0.29999999999999999 111.434 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 169.15 8.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.103 -0.953 . . . . 0.26000000000000001 108.756 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.52 136.82 40.59 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.254 -1.017 . . . . 1.25 108.254 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -81.66 124.21 29.37 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.986 0.736 . . . . 0.33000000000000002 112.986 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -144.59 120.3 10.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.433 -0.803 . . . . 0.98999999999999999 109.388 166.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 15.8 p -61.9 -21.71 64.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.932 0.396 . . . . 0.54000000000000004 111.187 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.13 1.23 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.5 111.583 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.7 t-20 -80.34 153.64 28.25 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.37 -0.604 . . . . 1.3200000000000001 109.37 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 24.9 mmm180 -93.12 107.35 19.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.207 -0.664 . . . . 2.5 109.207 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' HB2' HG21 ' A' ' 97' ' ' VAL . 41.1 m-85 -125.7 118.88 26.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.372 -0.831 . . . . 0.34999999999999998 108.868 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -126.67 168.47 14.3 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.627 -0.715 . . . . 0.16 109.468 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -145.58 162.26 37.88 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.787 -0.449 . . . . 0.16 109.787 -177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -151.8 116.93 5.24 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.656 0.598 . . . . 3.3500000000000001 109.451 175.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -114.24 117.22 30.55 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.89 -0.724 . . . . 0.22 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.663 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.4 m-20 -93.92 115.42 27.78 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.953 -1.021 . . . . 2.2200000000000002 108.871 173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -103.21 106.64 20.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 119.527 -0.869 . . . . 0.13 109.282 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 87' ' ' THR . 4.3 p -121.76 103.79 9.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.751 -0.658 . . . . 0.81999999999999995 109.785 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' O ' HG12 ' A' ' 86' ' ' VAL . 27.2 t80 -143.06 93.55 2.52 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.85 -0.613 . . . . 0.34000000000000002 110.038 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.9 -103.46 0.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.85 -0.69 . . . . 0.40999999999999998 112.27 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.6 p -86.12 -13.22 47.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.094 0.405 . . . . 0.42999999999999999 112.094 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 83' ' ' PHE . 9.6 p -100.67 135.28 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.11 0.481 . . . . 0.23999999999999999 111.489 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 18.3 m -149.71 117.02 6.06 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.9 -0.778 . . . . 0.25 108.9 167.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.1 pt -147.03 168.24 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.14000000000000001 109.994 -172.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 20.7 pt20 -151.47 147.79 27.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.79 0.328 . . . . 1.8799999999999999 110.63 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.68 158.29 44.67 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.565 -0.531 . . . . 0.96999999999999997 109.565 176.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 8.5 p30 -138.17 132.76 32.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.19 0.519 . . . . 1.8700000000000001 111.522 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.636 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -74.98 139.05 42.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.654 -0.703 . . . . 0.17000000000000001 111.502 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' HG23 ' A' ' 96' ' ' THR . 30.3 t70 -88.7 110.59 38.35 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 2.1299999999999999 109.372 170.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 50.3 Cg_exo -55.52 -24.73 45.76 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.737 2.292 . . . . 0.40000000000000002 113.223 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.707 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 15.3 mt-10 -81.43 8.22 9.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 111.756 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.4 p -96.26 -17.23 20.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.813 0.34 . . . . 0.31 110.671 169.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' SER . 40.9 t -69.64 66.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.791 0.805 . . . . 0.64000000000000001 112.391 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.707 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -125.89 83.42 2.16 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.89 -0.781 . . . . 2.3999999999999999 108.89 167.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 mm? 76.83 -58.82 0.5 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.001 -1.0 . . . . 1.3300000000000001 112.272 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -129.18 169.38 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.531 0.205 . . . . 4.1299999999999999 110.585 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.481 -0.771 . . . . 6.6900000000000004 109.829 177.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.84 0.352 . . . . 3.75 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.589 ' CG1' HG23 ' A' ' 21' ' ' ILE . 43.6 t -108.9 153.74 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.649 -0.5 . . . . 0.14999999999999999 109.649 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 83.0 mm-40 -122.87 167.14 13.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.153 -1.054 . . . . 2.0299999999999998 108.153 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -152.8 151.57 30.61 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.452 -0.899 . . . . 0.29999999999999999 112.426 -178.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.71 175.3 14.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.921 -1.491 . . . . 1.8700000000000001 107.539 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -131.55 139.62 50.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.48 0.657 . . . . 0.33000000000000002 111.71 -173.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 20' ' ' VAL . 3.9 mm-40 -133.61 158.85 42.15 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.653 -1.158 . . . . 2.0099999999999998 112.041 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.15 124.89 25.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.447 -1.251 . . . . 0.17000000000000001 107.931 170.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 104.86 13.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.983 0.42 . . . . 0.22 110.877 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.97 131.3 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.295 0.569 . . . . 0.33000000000000002 111.443 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -118.0 177.94 4.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.184 -0.916 . . . . 1.22 109.03 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.02 96.53 0.11 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.742 -0.742 . . . . 0.60999999999999999 112.851 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.12 63.4 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.357 -0.449 . . . . 0.47999999999999998 113.326 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -131.66 162.5 30.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.408 -0.466 . . . . 1.8500000000000001 110.257 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' A' ' 67' ' ' LEU . 6.5 p -135.01 118.64 24.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.386 0.612 . . . . 0.23000000000000001 110.489 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.8 m -96.31 117.99 31.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.892 -0.595 . . . . 0.23999999999999999 109.486 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -110.65 136.19 50.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.666 -0.413 . . . . 0.17000000000000001 110.753 -173.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG22 ' A' ' 61' ' ' THR . 5.1 pt20 -164.29 148.13 9.57 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.511 0.507 . . . . 1.77 110.185 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.18 136.55 12.82 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.317 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 7' ' ' GLU . 3.3 t -89.01 125.84 42.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 122.064 0.935 . . . . 0.45000000000000001 111.507 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.589 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.6 mt -107.34 105.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.647 -1.16 . . . . 0.14000000000000001 109.866 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.8 m -78.82 132.54 36.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.019 -1.474 . . . . 0.20000000000000001 107.019 168.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.05 121.7 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.553 -0.859 . . . . 0.16 109.081 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 24' ' ' VAL . 47.6 t -74.39 -2.71 3.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.341 0.497 . . . . 0.25 112.341 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 69.4 mmt-85 -134.78 137.55 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.045 -1.034 . . . . 2.1800000000000002 112.563 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 9.6 m-20 -71.67 137.5 47.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.534 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.93 -129.38 3.76 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 111.129 -0.788 . . . . 0.26000000000000001 111.129 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.07 157.82 45.03 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.12 -0.326 . . . . 0.45000000000000001 110.12 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.19 176.35 30.51 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.562 -1.015 . . . . 0.20999999999999999 110.562 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.7 p -123.48 137.19 54.84 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.121 0.486 . . . . 0.23000000000000001 110.673 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.604 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.98 154.01 28.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.17999999999999999 110.742 -174.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -122.88 112.07 17.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.175 -174.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.629 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.3 tm? -104.93 127.82 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 0.55000000000000004 110.6 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.74 143.27 49.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.255 -0.884 . . . . 0.25 109.917 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 23.3 t -122.28 143.67 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.15 0.5 . . . . 0.23000000000000001 110.005 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -118.61 139.46 51.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.819 -0.628 . . . . 1.6699999999999999 109.876 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -136.1 138.51 42.13 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 120.754 0.311 . . . . 1.3400000000000001 110.53 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 74' ' ' ARG . . . -149.71 114.93 5.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 0.59999999999999998 110.693 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.8 -162.01 9.83 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.737 -0.744 . . . . 0.95999999999999996 112.342 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.9 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 1.5700000000000001 111.564 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.05 12.8 16.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.989 0.423 . . . . 1.72 110.853 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 -168.93 28.95 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 1.21 111.98 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 p -96.51 153.53 17.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.854 0.359 . . . . 1.1399999999999999 110.478 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.4 m -149.47 149.14 30.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 1.1499999999999999 110.11 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -124.31 133.7 53.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 3.0800000000000001 111.144 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp -122.65 134.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.45000000000000001 108.966 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -146.73 126.5 13.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.524 -0.471 . . . . 2.7400000000000002 111.181 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -128.93 167.86 16.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.423 -0.584 . . . . 1.6299999999999999 109.423 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -168.02 148.04 4.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.39000000000000001 110.43 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.03 -147.3 12.02 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.755 -0.736 . . . . 0.26000000000000001 112.198 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.16 139.66 35.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.732 0.301 . . . . 0.38 110.306 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 58.3 t80 -140.38 176.32 8.87 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.921 -0.77 . . . . 0.26000000000000001 108.921 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -87.85 140.45 29.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.846 0.355 . . . . 0.42999999999999999 111.168 -178.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.67 130.91 32.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.128 -0.487 . . . . 0.23000000000000001 110.855 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -99.27 145.2 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.008 -0.542 . . . . 0.33000000000000002 110.261 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -64.19 126.88 29.17 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.781 0.676 . . . . 0.22 111.362 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 62.02 27.88 16.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.329 -0.851 . . . . 1.3300000000000001 109.541 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -118.94 137.53 53.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.46 -1.245 . . . . 1.48 109.647 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -81.53 127.12 32.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.124 -0.943 . . . . 2.7200000000000002 110.957 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 54' ' ' ALA . 52.2 t -120.0 109.87 27.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.023 -0.99 . . . . 0.14999999999999999 109.147 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -89.14 126.56 35.52 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.645 -175.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.92 140.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.563 -1.199 . . . . 0.16 112.062 -167.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.629 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 88.75 60.1 1.55 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.55 -0.75 . . . . 0.28000000000000003 112.096 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -74.87 106.86 6.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.161 0.505 . . . . 2.1699999999999999 109.723 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 46' ' ' ILE . 4.6 m -129.71 140.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.591 -0.732 . . . . 1.29 109.19 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.11 119.33 61.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.483 0.659 . . . . 0.29999999999999999 111.502 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -106.1 166.25 10.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.864 -1.062 . . . . 0.26000000000000001 108.847 178.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.1 141.09 43.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.081 -1.081 . . . . 1.25 108.081 166.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -80.6 122.23 26.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.33000000000000002 112.022 -173.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.35 117.53 10.1 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.98999999999999999 109.422 170.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 p -65.34 -23.49 67.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.54000000000000004 111.128 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.24 54.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.68 -0.691 . . . . 0.5 111.263 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.8 t-20 -85.42 150.55 24.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.993 -0.373 . . . . 1.3200000000000001 109.993 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.2 tmt_? -95.09 105.48 17.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.202 -1.036 . . . . 2.5 108.202 173.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' HG21 ' A' ' 97' ' ' VAL . 36.6 m-85 -119.15 119.33 33.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.362 -0.977 . . . . 0.34999999999999998 108.362 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.9 168.82 16.67 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.85 -0.613 . . . . 0.16 109.882 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.54 163.25 36.34 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.943 -0.571 . . . . 0.16 109.739 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -155.64 120.79 4.83 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.01 -0.737 . . . . 3.3500000000000001 109.01 176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -119.5 121.77 40.18 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.253 -0.579 . . . . 0.22 110.394 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.4 t70 -101.15 119.45 38.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.235 -0.893 . . . . 2.2200000000000002 109.207 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.6 t -104.6 105.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 C-N-CA 119.653 -0.819 . . . . 0.13 109.3 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.21 107.46 11.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.72 -0.673 . . . . 0.81999999999999995 109.78 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 69.1 t80 -153.67 110.26 3.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.193 -0.458 . . . . 0.34000000000000002 110.618 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.2 -102.18 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.648 -0.787 . . . . 0.40999999999999998 112.275 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.8 p -100.47 -6.62 25.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.143 0.423 . . . . 0.42999999999999999 112.143 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.8 p -101.15 137.17 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.5 -0.48 . . . . 0.23999999999999999 111.495 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 15.2 m -150.79 117.3 5.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.7 pt -147.52 167.12 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.954 -0.567 . . . . 0.14000000000000001 109.88 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 8.9 tt0 -152.38 150.44 29.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.866 0.365 . . . . 1.8799999999999999 111.109 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -143.05 166.28 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 109.918 175.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.624 ' C ' HG21 ' A' ' 6' ' ' VAL . 28.2 p-10 -143.3 138.48 29.56 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.948 0.404 . . . . 1.8700000000000001 111.64 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.4 tp -80.32 139.67 36.49 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.109 -0.496 . . . . 0.17000000000000001 111.935 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 95' ' ' GLU . 9.9 t70 -90.42 115.97 65.33 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 2.1299999999999999 109.269 170.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.426 ' HG3' ' HG2' ' A' ' 74' ' ' ARG . 30.3 Cg_endo -64.74 -15.07 48.31 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 121.801 1.667 . . . . 0.40000000000000002 113.331 -175.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HB2' ' OD1' ' A' ' 93' ' ' ASP . 33.7 mt-10 -79.26 1.12 25.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.949 0.404 . . . . 1.4199999999999999 110.772 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 93' ' ' ASP . 23.9 p -99.86 -15.71 18.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.83 -0.623 . . . . 0.31 110.734 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 75' ' ' TYR . 94.5 t -52.86 -8.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.179 -0.918 . . . . 0.64000000000000001 112.135 172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.81 69.99 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.956 -0.465 . . . . 2.3999999999999999 110.638 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.7 mm? 73.28 -64.08 0.41 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.999 -1.001 . . . . 1.3300000000000001 110.807 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.08 -43.85 0.34 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.345 -0.389 . . . . 4.1299999999999999 110.246 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.412 -0.804 . . . . 6.6900000000000004 110.512 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 86' ' ' VAL . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.797 0.332 . . . . 3.75 110.531 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.1 t -95.16 151.37 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.201 -0.454 . . . . 0.14999999999999999 110.407 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 22' ' ' THR . 63.0 mm-40 -119.79 167.17 12.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.076 0.95 . . . . 2.0299999999999998 108.474 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.64 144.68 23.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.346 -0.942 . . . . 0.29999999999999999 112.185 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' VAL . 58.3 mm-40 -140.87 176.31 8.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.552 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.28 123.89 24.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.214 0.531 . . . . 0.33000000000000002 111.461 -177.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.8 mt-10 -126.88 158.31 37.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.67 0.748 . . . . 2.0099999999999998 111.969 -175.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.6 125.41 38.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.698 -1.137 . . . . 0.17000000000000001 108.255 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.77 105.01 13.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.068 0.461 . . . . 0.22 110.656 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.72 127.96 39.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.285 0.564 . . . . 0.33000000000000002 111.57 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -116.88 176.6 5.05 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.175 -0.921 . . . . 1.22 108.934 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.73 92.83 0.11 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.886 -0.673 . . . . 0.60999999999999999 113.155 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.85 -14.77 62.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.17 -0.538 . . . . 0.47999999999999998 113.178 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -138.05 135.72 36.14 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.414 -0.462 . . . . 1.8500000000000001 110.559 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.3 p -108.24 118.94 56.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.096 0.475 . . . . 0.23000000000000001 110.094 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -96.51 118.53 33.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.536 -0.542 . . . . 0.23999999999999999 109.536 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.638 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.36 128.51 56.38 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.749 -0.38 . . . . 0.17000000000000001 111.138 -171.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.632 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 23.0 mt-30 -148.21 155.54 41.49 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.383 0.427 . . . . 1.77 110.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -100.78 128.08 9.46 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.19 111.931 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.572 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.7 t -86.4 114.56 26.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 121.983 0.897 . . . . 0.45000000000000001 112.122 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -97.48 105.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.553 -1.203 . . . . 0.14000000000000001 110.239 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.553 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -80.02 131.35 35.77 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.291 -1.374 . . . . 0.20000000000000001 107.291 168.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.95 120.78 35.45 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.122 -1.031 . . . . 0.16 109.17 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' VAL . 60.7 t -72.86 -5.52 6.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.046 0.451 . . . . 0.25 111.934 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 mmt180 -132.36 136.1 46.61 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.616 -0.677 . . . . 2.1800000000000002 111.436 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 7.1 p-10 -77.89 141.17 39.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.398 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.03 -131.44 3.95 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.667 -0.973 . . . . 0.26000000000000001 110.667 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.69 137.5 25.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.835 0.318 . . . . 0.45000000000000001 110.566 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.9 -174.28 13.25 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.781 -0.928 . . . . 0.20999999999999999 110.781 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 53.3 p -129.46 138.48 51.45 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.251 0.548 . . . . 0.23000000000000001 110.355 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.93 156.91 35.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.276 -0.874 . . . . 0.17999999999999999 110.662 -175.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -128.44 111.39 13.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.469 -0.787 . . . . 1.26 111.257 -169.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -104.9 131.49 52.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.398 0.618 . . . . 0.55000000000000004 110.432 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -122.39 140.81 52.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.617 -0.719 . . . . 0.25 110.178 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 33.0 t -121.64 137.92 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.44 -0.578 . . . . 0.23000000000000001 109.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.67 115.85 17.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.054 -0.521 . . . . 1.6699999999999999 110.371 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HE2' HD12 ' A' ' 67' ' ' LEU . 21.8 mttt -90.99 156.98 17.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.053 0.454 . . . . 1.3400000000000001 110.081 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.45 104.69 3.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.068 -0.969 . . . . 0.59999999999999998 110.013 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.5 -161.63 12.58 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.303 -0.862 . . . . 0.95999999999999996 111.385 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.32 -29.88 66.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.795 0.331 . . . . 1.5700000000000001 111.106 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.57 -26.02 32.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 1.72 111.559 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.61 -164.87 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.558 -0.829 . . . . 1.21 112.618 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 72.3 p -97.35 153.72 17.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.474 0.178 . . . . 1.1399999999999999 110.883 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -138.38 123.24 18.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.489 0.185 . . . . 1.1499999999999999 110.859 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -93.91 135.66 35.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 3.0800000000000001 112.065 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.428 HD11 ' HE3' ' A' ' 37' ' ' LYS . 5.2 mp -129.33 139.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.2 -0.909 . . . . 0.45000000000000001 109.172 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.03 124.77 19.63 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.064 -0.398 . . . . 2.7400000000000002 111.907 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.91 115.92 17.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 1.6299999999999999 109.701 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.02 137.94 50.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.39000000000000001 110.968 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.68 -148.41 10.14 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 111.729 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.21 150.42 51.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.81 0.338 . . . . 0.38 110.325 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.5 t80 -150.62 174.71 12.67 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.161 -0.681 . . . . 0.26000000000000001 109.161 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.78 132.41 36.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.749 0.309 . . . . 0.42999999999999999 110.906 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -125.26 142.2 51.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.205 -0.452 . . . . 0.23000000000000001 110.716 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -108.97 139.7 30.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.162 -0.472 . . . . 0.33000000000000002 110.6 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.16 123.4 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.232 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 62.39 26.4 15.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.787 -1.097 . . . . 1.3300000000000001 110.083 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -116.43 146.84 42.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.225 -1.352 . . . . 1.48 109.275 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.9 mpt_? -84.85 128.22 34.51 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.81 -1.086 . . . . 2.7200000000000002 110.249 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.0 t -120.43 109.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.498 -0.773 . . . . 0.14999999999999999 109.193 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.5 m -90.6 127.59 36.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.531 -0.868 . . . . 0.19 110.65 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -125.64 140.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.362 -167.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.99 69.42 1.22 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.581 -0.736 . . . . 0.28000000000000003 112.218 177.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.6 p30 -76.63 106.7 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.678 0.751 . . . . 2.1699999999999999 110.598 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 46' ' ' ILE . 4.3 m -127.69 138.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.008 -0.996 . . . . 1.29 108.833 173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.9 t -120.09 117.07 52.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 110.517 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.11 163.69 12.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.123 -0.944 . . . . 0.26000000000000001 109.162 -177.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.22 129.94 38.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.933 -1.136 . . . . 1.25 107.933 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 71' ' ' SER . 16.6 t80 -79.36 128.66 33.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.39 0.614 . . . . 0.33000000000000002 112.503 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -141.96 123.23 14.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.902 -1.044 . . . . 0.98999999999999999 109.057 169.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.454 ' HB3' ' OH ' ' A' ' 69' ' ' TYR . 14.2 p -68.68 -23.76 64.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.484 -0.326 . . . . 0.54000000000000004 111.184 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.03 -1.22 57.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.201 -0.454 . . . . 0.5 111.123 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -81.54 152.7 27.14 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.205 0.526 . . . . 1.3200000000000001 110.998 -177.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.4 mmm180 -102.52 110.95 23.05 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.409 -0.814 . . . . 2.5 109.237 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 97' ' ' VAL . 43.3 m-85 -120.97 131.16 54.15 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.847 -0.798 . . . . 0.34999999999999998 108.847 173.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.99 15.47 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.858 0.361 . . . . 0.16 111.305 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -150.8 163.21 39.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.822 -0.627 . . . . 0.16 109.816 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -157.99 121.09 3.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.944 -0.391 . . . . 3.3500000000000001 109.944 175.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.3 tt -115.05 122.01 44.86 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.153 -0.619 . . . . 0.22 110.386 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 8.9 t70 -99.08 121.62 41.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.976 -1.011 . . . . 2.2200000000000002 108.743 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 87' ' ' THR . 7.4 t -108.89 105.69 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.812 -0.81 . . . . 0.13 108.812 175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -128.17 101.96 6.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.929 -0.578 . . . . 0.81999999999999995 109.784 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' O ' HG12 ' A' ' 86' ' ' VAL . 48.3 t80 -145.8 100.42 3.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.34000000000000002 110.307 -174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.46 -103.5 0.96 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 112.075 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 p -92.24 -14.33 29.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.806 0.299 . . . . 0.42999999999999999 111.806 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.9 p -96.88 135.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.908 0.385 . . . . 0.23999999999999999 111.17 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 23.7 m -151.54 118.35 5.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.25 109.834 169.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.572 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.7 pt -150.15 167.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.395 -0.82 . . . . 0.14000000000000001 109.863 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 14.5 pt20 -150.97 156.81 41.94 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.091 0.472 . . . . 1.8799999999999999 111.004 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.58 165.88 26.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.96999999999999997 109.187 176.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.638 ' C ' HG21 ' A' ' 6' ' ' VAL . 5.5 p-10 -146.03 133.95 21.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.959 0.409 . . . . 1.8700000000000001 111.28 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -75.31 133.64 41.24 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.839 -0.619 . . . . 0.17000000000000001 111.664 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.88 110.34 17.05 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.386 -0.825 . . . . 2.1299999999999999 109.242 168.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.6 Cg_endo -59.47 -11.8 15.01 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.576 2.184 . . . . 0.40000000000000002 112.498 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -79.77 0.2 31.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.43 -0.804 . . . . 1.4199999999999999 110.965 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -104.07 -13.44 16.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 111.914 0.339 . . . . 0.31 111.914 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.7 t -54.14 -15.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.03 -0.532 . . . . 0.64000000000000001 111.856 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.67 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -75.13 60.54 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.193 -0.317 . . . . 2.3999999999999999 110.794 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.4 mm? 71.69 -59.38 0.55 Allowed 'General case' 0 C--O 1.231 0.126 0 O-C-N 123.898 0.749 . . . . 1.3300000000000001 111.629 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -138.53 -65.18 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.124 -0.325 . . . . 4.1299999999999999 110.124 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.626 -0.702 . . . . 6.6900000000000004 110.325 -178.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.852 0.358 . . . . 3.75 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' CG1' HG23 ' A' ' 21' ' ' ILE . 27.5 t -93.22 156.73 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.14999999999999999 109.797 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 22' ' ' THR . 38.5 tp60 -129.46 155.7 45.3 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.452 -1.314 . . . . 2.0299999999999998 107.452 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 p -143.71 153.04 42.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.223 -0.991 . . . . 0.29999999999999999 112.21 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -146.9 175.88 10.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.926 -1.488 . . . . 1.8700000000000001 107.818 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -135.37 124.35 40.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 120.816 0.341 . . . . 0.33000000000000002 110.671 -178.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.16 153.69 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.879 0.847 . . . . 2.0099999999999998 112.272 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.25 125.08 44.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.35 -1.295 . . . . 0.17000000000000001 107.89 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.5 104.72 14.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.0 0.428 . . . . 0.22 110.576 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.24 119.85 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.089 0.471 . . . . 0.33000000000000002 111.822 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.1 p -108.45 177.75 4.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.808 -0.812 . . . . 1.22 108.808 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.48 98.31 0.32 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.564 -0.827 . . . . 0.60999999999999999 112.655 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.67 59.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.026 -0.607 . . . . 0.47999999999999998 113.485 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -141.32 153.9 45.4 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.357 -0.496 . . . . 1.8500000000000001 110.431 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.8 p -123.63 117.71 52.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.312 0.577 . . . . 0.23000000000000001 109.897 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.427 ' OG1' HG22 ' A' ' 66' ' ' VAL . 83.4 m -96.14 116.93 29.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.103 -0.703 . . . . 0.23999999999999999 109.103 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -107.06 133.69 51.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.177 -0.609 . . . . 0.17000000000000001 110.92 -173.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 61' ' ' THR . 60.5 mt-30 -150.87 143.47 24.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.682 0.614 . . . . 1.77 109.939 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -95.16 127.8 9.27 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.189 -1.005 . . . . 0.19 111.423 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.3 t -83.85 142.64 13.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 121.609 0.719 . . . . 0.45000000000000001 111.162 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.646 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.2 mt -129.93 105.6 12.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.057 -0.974 . . . . 0.14000000000000001 109.973 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 2.9 m -84.28 128.03 34.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.124 -1.065 . . . . 0.20000000000000001 108.124 172.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.96 121.83 37.97 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.736 -0.786 . . . . 0.16 109.079 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.7 t -68.54 -13.42 17.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 112.162 0.43 . . . . 0.25 112.162 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.73 138.62 54.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.883 -0.511 . . . . 2.1800000000000002 111.975 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -78.55 138.14 38.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.044 -0.525 . . . . 1.54 109.896 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 53' ' ' THR . . . 147.89 -127.67 2.67 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.53 -1.028 . . . . 0.26000000000000001 110.53 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.77 145.31 34.64 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.959 0.38 . . . . 0.45000000000000001 110.798 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.09 177.41 20.63 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.569 -1.012 . . . . 0.20999999999999999 110.569 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 21.9 p -124.9 137.93 54.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.11 0.481 . . . . 0.23000000000000001 111.166 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.82 166.77 32.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.121 -174.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.09 111.93 9.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.26 111.351 -175.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.9 tm? -106.58 129.34 54.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.42 0.628 . . . . 0.55000000000000004 110.583 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -124.82 132.58 53.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.292 -0.867 . . . . 0.25 110.29 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 43.6 t -113.3 137.73 45.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.238 0.542 . . . . 0.23000000000000001 109.858 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.7 113.5 23.58 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.126 -0.943 . . . . 1.6699999999999999 109.915 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' THR . 28.7 tttt -108.23 137.88 45.46 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 110.008 -0.367 . . . . 1.3400000000000001 110.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.57 106.69 3.59 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.996 -0.547 . . . . 0.59999999999999998 110.655 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.72 -167.27 11.55 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.618 -0.801 . . . . 0.95999999999999996 111.689 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.86 -23.26 67.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.106 0.479 . . . . 1.5700000000000001 110.97 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.64 -9.93 56.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 1.72 111.546 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.93 -174.18 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 1.21 112.78 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 27.4 p -102.95 132.36 49.24 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.263 0.225 . . . . 1.1399999999999999 110.62 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 m -111.31 146.51 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.713 0.292 . . . . 1.1499999999999999 110.608 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -109.12 120.81 43.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.717 0.77 . . . . 3.0800000000000001 112.332 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mp -121.13 120.46 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.193 -1.367 . . . . 0.45000000000000001 109.535 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -147.36 113.26 5.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.717 0.294 . . . . 2.7400000000000002 110.364 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -133.92 123.69 25.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.363 -0.381 . . . . 1.6299999999999999 110.377 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.22 145.79 51.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.943 0.401 . . . . 0.39000000000000001 111.348 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.58 -138.94 5.47 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.733 -0.667 . . . . 0.26000000000000001 111.704 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -140.18 152.48 46.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 110.071 -0.344 . . . . 0.38 110.071 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 59.2 t80 -151.72 173.94 14.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.178 -0.675 . . . . 0.26000000000000001 109.178 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.58 134.48 34.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.769 0.319 . . . . 0.42999999999999999 110.833 -177.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.54 139.93 51.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.468 -0.333 . . . . 0.23000000000000001 111.014 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -101.3 141.15 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.944 0.402 . . . . 0.33000000000000002 110.737 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.67 124.9 21.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.019 -0.991 . . . . 0.22 111.575 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 60.08 28.14 17.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.252 -0.885 . . . . 1.3300000000000001 110.33 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 2.7 mm-40 -117.55 153.98 32.29 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.673 -1.148 . . . . 1.48 109.399 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mpt_? -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.645 -1.162 . . . . 2.7200000000000002 109.858 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 46.9 t -114.72 109.5 28.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.14999999999999999 108.692 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.2 m -92.99 127.06 38.37 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.78 -172.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.2 136.41 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.361 -1.291 . . . . 0.16 112.271 -165.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.32 68.1 1.24 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.582 -0.736 . . . . 0.28000000000000003 112.178 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.596 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 47.6 t-20 -77.42 107.19 9.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.944 0.402 . . . . 2.1699999999999999 110.035 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 46' ' ' ILE . 19.4 m -134.02 139.14 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.708 -0.678 . . . . 1.29 109.519 174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' OG1' ' A' ' 16' ' ' THR . 57.5 t -113.71 123.9 69.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.377 0.608 . . . . 0.29999999999999999 111.392 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -107.72 162.08 14.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.055 -0.975 . . . . 0.26000000000000001 108.652 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.62 128.43 35.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 170.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -70.05 123.94 22.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.213 0.53 . . . . 0.33000000000000002 112.322 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 4.6 m -143.61 121.16 11.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.907 -0.588 . . . . 0.98999999999999999 110.342 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.8 p -67.27 -26.18 66.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.181 0.515 . . . . 0.54000000000000004 110.958 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 14.12 23.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.528 -0.76 . . . . 0.5 110.742 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -97.36 154.7 17.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.023 -0.535 . . . . 1.3200000000000001 110.287 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 25.7 mmt180 -101.3 108.3 19.89 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.689 -0.486 . . . . 2.5 109.689 175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.401 ' HB2' HG21 ' A' ' 97' ' ' VAL . 32.5 m-85 -122.05 115.43 22.47 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.026 -0.731 . . . . 0.34999999999999998 109.026 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.22 167.81 14.34 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.169 -0.469 . . . . 0.16 110.272 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.9 163.08 37.29 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.283 -0.417 . . . . 0.16 110.296 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -152.93 118.72 5.37 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 123.631 0.582 . . . . 3.3500000000000001 109.787 173.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.2 tt -116.95 117.22 29.09 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.301 -0.56 . . . . 0.22 110.297 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.641 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 4.5 m-20 -96.56 121.26 38.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 108.947 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 87' ' ' THR . 12.6 t -107.76 107.16 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 C-N-CA 119.89 -0.724 . . . . 0.13 109.581 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -121.58 108.04 13.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.784 -0.644 . . . . 0.81999999999999995 109.489 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.0 t80 -150.22 102.91 3.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.34000000000000002 110.487 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.66 -102.37 0.49 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 0.40999999999999998 112.674 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -92.78 -7.54 46.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.369 0.507 . . . . 0.42999999999999999 112.369 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -105.25 137.89 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.555 -0.458 . . . . 0.23999999999999999 111.474 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.8 m -151.6 117.72 5.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.908 -0.775 . . . . 0.25 108.908 167.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.589 HG12 ' HB ' ' A' ' 81' ' ' VAL . 14.9 pt -147.4 167.53 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.793 -0.639 . . . . 0.14000000000000001 109.893 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -151.1 153.67 35.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.133 0.492 . . . . 1.8799999999999999 111.227 173.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -142.8 158.05 44.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.533 -0.758 . . . . 0.96999999999999997 109.546 175.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.6 p-10 -139.4 131.56 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.8700000000000001 111.33 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 tp -75.65 133.19 40.91 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.957 -0.565 . . . . 0.17000000000000001 111.264 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.75 110.7 32.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 2.1299999999999999 109.189 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 17.6 Cg_endo -59.32 -16.06 32.65 Favored 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.752 2.301 . . . . 0.40000000000000002 112.873 -175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.796 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 2.1 mt-10 -80.92 7.2 11.14 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.457 -0.792 . . . . 1.4199999999999999 111.276 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.9 p -106.89 -16.7 14.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.865 0.32 . . . . 0.31 111.865 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 75' ' ' TYR . 53.3 t -42.54 -39.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 113.865 1.061 . . . . 0.64000000000000001 113.865 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.796 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -51.59 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.348 0.405 . . . . 2.3999999999999999 111.703 -171.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.55 34.06 20.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.026 -0.988 . . . . 1.3300000000000001 111.631 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.73 138.8 44.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 4.1299999999999999 110.188 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.826 -0.606 . . . . 6.6900000000000004 109.861 177.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' HG3' ' A' ' 25' ' ' ARG . 61.9 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.682 0.253 . . . . 3.75 111.682 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 ' CG1' HG11 ' A' ' 81' ' ' VAL . 18.2 t -97.31 146.05 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.342 -0.543 . . . . 0.14999999999999999 111.028 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -122.67 167.25 13.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.722 -1.214 . . . . 2.0299999999999998 107.722 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.1 p -148.23 154.5 40.15 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.147 -1.021 . . . . 0.29999999999999999 112.931 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -148.01 176.61 10.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.771 -1.559 . . . . 1.8700000000000001 107.857 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.67 128.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.02 0.438 . . . . 0.33000000000000002 111.373 -176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.77 159.8 36.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.546 -0.752 . . . . 2.0099999999999998 112.04 -173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.43 124.45 27.12 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.037 -0.983 . . . . 0.17000000000000001 108.647 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.64 116.37 32.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.19 -0.3 . . . . 0.22 110.19 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 97' ' ' VAL . 68.7 t -109.02 122.79 64.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.427 0.632 . . . . 0.33000000000000002 112.417 -171.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -110.36 178.06 4.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.763 -1.108 . . . . 1.22 109.128 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 89.24 0.2 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.956 -0.64 . . . . 0.60999999999999999 113.181 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.57 53.64 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.15 -0.548 . . . . 0.47999999999999998 113.431 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -136.38 143.38 43.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.34 -0.506 . . . . 1.8500000000000001 110.298 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.3 p -124.75 117.41 50.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.368 0.604 . . . . 0.23000000000000001 110.417 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 m -97.15 117.98 32.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.838 -0.619 . . . . 0.23999999999999999 109.647 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.95 127.33 53.97 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.857 -0.337 . . . . 0.17000000000000001 111.261 -172.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.527 ' CB ' HG22 ' A' ' 61' ' ' THR . 63.5 mt-30 -141.24 150.47 42.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 123.459 0.474 . . . . 1.77 109.971 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' H ' HD22 ' A' ' 33' ' ' LEU . . . -100.68 129.09 9.78 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.272 -0.731 . . . . 0.19 111.272 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.694 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 2.3 t -84.74 148.65 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.461 0.648 . . . . 0.45000000000000001 111.358 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.591 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.7 mt -135.12 106.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.291 -0.868 . . . . 0.14000000000000001 110.319 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 5.1 m -82.49 126.92 32.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.051 -1.092 . . . . 0.20000000000000001 108.051 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.31 119.87 33.45 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.563 -0.855 . . . . 0.16 108.825 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 24' ' ' VAL . 53.9 t -66.99 -12.43 15.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.678 0.622 . . . . 0.25 112.678 -173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 33.6 mmt180 -135.68 131.53 35.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.363 -0.535 . . . . 2.1800000000000002 111.378 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.0 p-10 -72.83 151.02 42.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 1.54 110.786 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.15 -129.88 4.42 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.205 -1.158 . . . . 0.26000000000000001 110.205 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -143.07 144.38 32.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.731 0.3 . . . . 0.45000000000000001 110.574 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.94 -179.73 20.68 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.406 -1.078 . . . . 0.20999999999999999 110.406 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 29.4 p -127.02 138.52 53.26 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.041 -176.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.4 161.72 40.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.44 -0.8 . . . . 0.17999999999999999 110.679 -174.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.81 112.73 10.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 1.26 111.692 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.577 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 28.1 tp -98.69 124.67 43.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.364 0.602 . . . . 0.55000000000000004 110.869 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -116.13 118.28 32.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.421 -0.809 . . . . 0.25 109.68 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 48.7 t -105.81 143.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.028 -0.533 . . . . 0.23000000000000001 109.837 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.98 114.51 18.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.634 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.5 ttpt -103.64 136.7 42.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.102 -0.499 . . . . 1.3400000000000001 109.851 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 43' ' ' THR . . . -141.14 122.57 14.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.353 0.597 . . . . 0.59999999999999998 111.228 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.93 -165.15 11.52 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.227 -1.149 . . . . 0.95999999999999996 110.227 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -17.98 63.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.346 0.573 . . . . 1.5700000000000001 110.657 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.64 -7.44 59.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.589 . . . . 1.72 110.929 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.24 -173.91 15.2 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.904 -0.665 . . . . 1.21 112.322 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 36.1 p -100.67 137.41 39.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.662 0.267 . . . . 1.1399999999999999 110.487 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m -120.58 122.68 41.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.802 -0.444 . . . . 1.1499999999999999 109.802 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -96.73 133.21 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.262 0.553 . . . . 3.0800000000000001 110.361 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 4.9 mp -122.64 129.88 74.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.356 -0.838 . . . . 0.45000000000000001 110.344 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -122.14 116.68 24.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.694 0.283 . . . . 2.7400000000000002 111.479 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -125.27 115.71 20.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.86 -0.422 . . . . 1.6299999999999999 109.86 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.23 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.852 0.358 . . . . 0.39000000000000001 111.411 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.88 -158.18 30.16 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 0.26000000000000001 112.11 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -130.31 135.94 48.61 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.38 110.282 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.429 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 68.6 t80 -137.58 176.16 8.95 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.188 -0.671 . . . . 0.26000000000000001 109.188 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -89.48 125.8 35.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.93 0.395 . . . . 0.42999999999999999 111.082 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.826 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -118.44 132.97 56.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.969 -0.56 . . . . 0.23000000000000001 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.05 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.188 -0.46 . . . . 0.33000000000000002 111.266 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.56 124.83 21.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.072 -0.967 . . . . 0.22 112.18 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 65.22 16.78 10.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.086 -0.961 . . . . 1.3300000000000001 110.712 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -111.9 151.62 28.95 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.563 -1.199 . . . . 1.48 109.518 176.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -89.66 127.67 35.95 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.364 -0.835 . . . . 2.7200000000000002 110.675 177.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.3 t -119.33 111.25 32.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.192 -0.458 . . . . 0.14999999999999999 109.817 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.2 m -86.45 128.06 34.91 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.466 0.651 . . . . 0.19 110.782 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -126.7 140.44 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.934 -1.03 . . . . 0.16 112.475 -167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 33' ' ' LEU . . . 87.67 93.62 0.98 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 112.578 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -86.6 107.37 18.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.358 . . . . 2.1699999999999999 110.04 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' ILE . 23.5 t -129.39 114.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.831 -0.433 . . . . 1.29 109.831 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.51 119.24 53.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.409 0.624 . . . . 0.29999999999999999 111.516 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.61 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.8 165.6 11.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.933 -1.03 . . . . 0.26000000000000001 108.827 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.93 137.07 41.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.918 -1.142 . . . . 1.25 107.918 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -82.56 125.52 31.23 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.476 -0.489 . . . . 0.33000000000000002 112.177 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 73' ' ' ASN . 11.7 t -143.98 128.21 17.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.159 -0.682 . . . . 0.98999999999999999 109.159 166.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 p -70.82 -10.61 59.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.478 0.656 . . . . 0.54000000000000004 110.146 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.16 -2.36 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.938 -1.028 . . . . 0.5 111.138 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 70' ' ' SER . 0.5 OUTLIER -96.99 150.37 20.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.139 -0.482 . . . . 1.3200000000000001 110.803 -176.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 28.9 mmt180 -94.75 109.84 21.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.271 -0.64 . . . . 2.5 109.271 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.5 m-85 -117.72 117.7 30.08 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.977 -0.749 . . . . 0.34999999999999998 108.977 173.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.65 168.3 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.467 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.637 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.55 163.46 36.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.121 -0.491 . . . . 0.16 110.551 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -154.15 117.57 4.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.408 -0.96 . . . . 3.3500000000000001 108.408 173.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.9 tt -113.53 117.36 31.45 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.79 -0.764 . . . . 0.22 110.019 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 34.2 t70 -94.25 118.13 31.12 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.871 -1.058 . . . . 2.2200000000000002 109.152 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.5 t -103.99 107.24 21.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 121.467 -0.77 . . . . 0.13 109.433 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 87' ' ' THR . 33.2 p -123.01 103.61 8.7 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.66 -0.496 . . . . 0.81999999999999995 109.66 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 86' ' ' VAL . 26.1 t80 -140.95 97.04 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.34000000000000002 110.324 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.19 -102.54 0.74 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.638 -0.792 . . . . 0.40999999999999998 112.295 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 p -90.38 -13.41 35.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.102 0.408 . . . . 0.42999999999999999 112.102 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.0 p -100.9 136.41 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.827 -0.349 . . . . 0.23999999999999999 111.133 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -152.82 117.48 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.727 -0.472 . . . . 0.25 109.727 169.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.571 HG12 ' HB ' ' A' ' 81' ' ' VAL . 29.0 pt -149.45 167.35 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.684 -0.689 . . . . 0.14000000000000001 109.853 -172.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.9 pt20 -152.49 153.63 33.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.028 0.442 . . . . 1.8799999999999999 110.847 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -135.47 164.1 28.57 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.705 . . . . 0.96999999999999997 109.098 176.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.609 ' C ' HG21 ' A' ' 6' ' ' VAL . 3.2 p-10 -137.24 135.49 37.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.755 -0.378 . . . . 1.8700000000000001 111.34 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.637 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.5 tp -78.24 136.57 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.932 -0.576 . . . . 0.17000000000000001 111.24 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 11.9 m-20 -85.61 109.9 25.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.495 -0.775 . . . . 2.1299999999999999 108.931 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 13.9 Cg_endo -58.78 -17.21 35.09 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.292 1.995 . . . . 0.40000000000000002 112.108 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.783 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -76.79 6.29 6.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.244 -0.889 . . . . 1.4199999999999999 111.743 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p -109.79 -12.78 14.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 111.951 0.352 . . . . 0.31 111.951 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG21 ' HB2' ' A' ' 75' ' ' TYR . 57.0 t -48.2 -27.55 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.525 -0.762 . . . . 0.64000000000000001 113.015 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.783 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -74.5 82.73 1.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.246 0.545 . . . . 2.3999999999999999 110.654 -171.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 64.92 56.01 1.12 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.646 -1.161 . . . . 1.3300000000000001 111.444 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -77.39 -71.73 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 4.1299999999999999 109.949 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.66 -0.686 . . . . 6.6900000000000004 109.461 176.704 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.914 0.388 . . . . 3.75 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.7 t -98.66 152.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.14999999999999999 109.987 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 15.5 mm100 -119.75 166.5 13.16 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.762 -1.199 . . . . 2.0299999999999998 107.762 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -151.02 144.55 24.95 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.234 -0.986 . . . . 0.29999999999999999 112.073 -179.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.96 175.88 9.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.965 -1.47 . . . . 1.8700000000000001 107.711 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -138.11 124.18 25.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.985 0.422 . . . . 0.33000000000000002 111.34 -175.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.32 158.52 35.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.839 0.828 . . . . 2.0099999999999998 111.811 -176.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.02 123.93 33.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.537 -1.211 . . . . 0.17000000000000001 107.855 170.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.14 103.96 13.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.139 0.495 . . . . 0.22 110.659 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -88.91 128.35 41.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.106 0.479 . . . . 0.33000000000000002 111.441 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.9 m -123.78 178.26 5.33 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.845 -0.798 . . . . 1.22 108.845 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.3 110.26 2.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.755 -0.736 . . . . 0.60999999999999999 112.752 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.95 -16.22 38.7 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.425 -0.417 . . . . 0.47999999999999998 114.018 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -142.76 141.86 31.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.728 0.764 . . . . 1.8500000000000001 111.224 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.4 p -114.19 117.46 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.736 -0.665 . . . . 0.23000000000000001 109.665 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.404 ' OG1' HG22 ' A' ' 66' ' ' VAL . 87.8 m -97.04 118.0 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.686 -0.688 . . . . 0.23999999999999999 109.381 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.77 127.45 55.8 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.789 -0.365 . . . . 0.17000000000000001 111.262 -169.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 9.5 mt-30 -147.41 151.29 36.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.268 -0.424 . . . . 1.77 110.331 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -97.64 128.16 9.46 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.6 -0.809 . . . . 0.19 111.719 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.1 t -89.86 112.6 24.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 122.381 1.086 . . . . 0.45000000000000001 112.246 -175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.8 mt -95.23 106.28 18.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.186 -1.37 . . . . 0.14000000000000001 110.332 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' HD2' ' A' ' 59' ' ' ARG . 2.5 m -80.55 135.02 36.01 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.114 -1.439 . . . . 0.20000000000000001 107.114 168.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.95 120.81 34.49 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.996 -1.082 . . . . 0.16 109.002 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' VAL . 44.9 t -71.22 -7.84 9.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.098 0.475 . . . . 0.25 112.043 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 23.1 mmt180 -132.84 139.79 47.63 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.587 -0.696 . . . . 2.1800000000000002 111.3 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 4.6 p-10 -79.76 142.26 35.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.733 -0.667 . . . . 1.54 110.354 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' THR . . . 144.99 -133.21 5.04 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.457 -1.057 . . . . 0.26000000000000001 110.457 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.09 35.77 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.809 0.337 . . . . 0.45000000000000001 110.604 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.75 21.74 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.014 -1.234 . . . . 0.20999999999999999 110.014 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 10.7 p -126.88 138.56 53.33 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.437 0.637 . . . . 0.23000000000000001 110.855 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.26 160.55 39.88 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.135 -0.939 . . . . 0.17999999999999999 110.77 -174.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.622 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.35 111.68 12.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.76 -0.655 . . . . 1.26 111.221 -172.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -105.26 122.23 45.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.426 0.631 . . . . 0.55000000000000004 110.284 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -118.35 140.92 49.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.517 -0.765 . . . . 0.25 109.967 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 37.7 t -119.62 131.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.249 0.547 . . . . 0.23000000000000001 110.224 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.82 115.08 29.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 109.999 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -116.19 134.38 54.99 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.968 -0.56 . . . . 1.3400000000000001 110.9 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -144.75 138.58 27.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.747 -0.66 . . . . 0.59999999999999998 110.349 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.1 16.86 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.463 -0.875 . . . . 0.95999999999999996 111.743 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.62 -17.0 63.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.885 0.374 . . . . 1.5700000000000001 110.592 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.74 13.2 25.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.016 -0.538 . . . . 1.72 111.364 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.24 -171.82 15.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.641 -0.79 . . . . 1.21 112.797 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.31 152.55 26.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.643 0.259 . . . . 1.1399999999999999 110.964 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 m -140.92 157.14 45.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.321 -0.4 . . . . 1.1499999999999999 110.496 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -127.46 111.63 14.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.945 0.402 . . . . 3.0800000000000001 110.731 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp -108.01 131.28 58.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.29 -0.633 . . . . 0.45000000000000001 109.29 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 14.7 tmtt? -146.5 128.08 15.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.187 -0.605 . . . . 2.7400000000000002 111.851 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -127.39 159.18 35.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 1.6299999999999999 109.521 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -166.54 139.33 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.954 0.406 . . . . 0.39000000000000001 111.191 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.36 -139.43 5.11 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.852 -0.69 . . . . 0.26000000000000001 111.713 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -141.92 151.0 42.21 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.17 -0.307 . . . . 0.38 110.17 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -153.44 169.52 22.96 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.382 -0.599 . . . . 0.26000000000000001 109.382 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.993 0.425 . . . . 0.42999999999999999 111.005 -175.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.93 134.13 49.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.596 . . . . 0.23000000000000001 111.04 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -95.7 145.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.33000000000000002 110.749 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.58 125.64 24.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.362 -0.835 . . . . 0.22 111.799 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.73 25.12 14.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.178 -0.919 . . . . 1.3300000000000001 109.891 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.48 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 mm-40 -115.89 138.6 51.02 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.683 -1.144 . . . . 1.48 109.864 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.5 mpt_? -80.49 119.82 23.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.705 -1.134 . . . . 2.7200000000000002 110.368 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.1 t -113.31 109.77 29.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.741 -0.663 . . . . 0.14999999999999999 109.48 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.585 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.1 m -88.7 124.39 34.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.425 -0.91 . . . . 0.19 110.643 -175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 HG12 ' A' ' 60' ' ' VAL . 3.2 t -121.29 140.32 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.483 -1.235 . . . . 0.16 112.163 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.36 77.35 1.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.28000000000000003 112.318 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.594 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 14.0 p-10 -82.45 106.55 14.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.394 0.616 . . . . 2.1699999999999999 110.443 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 46' ' ' ILE . 5.6 m -129.44 140.78 48.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.663 -0.699 . . . . 1.29 109.174 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.4 t -118.49 118.82 59.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.404 0.621 . . . . 0.29999999999999999 111.151 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.593 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -104.55 158.51 16.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.179 -0.918 . . . . 0.26000000000000001 108.661 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -73.95 129.07 37.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.091 -1.077 . . . . 1.25 108.091 171.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.624 ' OH ' HD11 ' A' ' 99' ' ' LEU . 15.5 t80 -72.04 125.49 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.427 0.632 . . . . 0.33000000000000002 112.299 -170.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.2 119.49 10.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.12 -0.946 . . . . 0.98999999999999999 108.721 167.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 p -62.25 -26.04 68.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 111.172 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.46 -2.46 54.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.696 -0.684 . . . . 0.5 111.73 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.5 t30 -83.36 155.02 23.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.123 0.487 . . . . 1.3200000000000001 111.185 -175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 27.9 mmt180 -95.58 108.82 21.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.706 -0.679 . . . . 2.5 109.761 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' HB2' HG21 ' A' ' 97' ' ' VAL . 42.4 m-85 -127.08 121.59 31.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.252 -0.647 . . . . 0.34999999999999998 109.252 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.62 168.0 16.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.719 -0.673 . . . . 0.16 110.125 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.642 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.79 163.38 36.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.848 -0.615 . . . . 0.16 109.766 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ptm180 -152.79 122.26 6.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.861 -0.608 . . . . 3.3500000000000001 109.535 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -118.89 122.3 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 119.784 -0.767 . . . . 0.22 110.245 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.622 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 12.1 t70 -102.69 119.49 38.91 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.883 -1.053 . . . . 2.2200000000000002 108.981 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.2 t -106.94 106.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.848 -0.797 . . . . 0.13 108.848 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.548 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.4 p -127.27 102.72 7.04 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.589 -0.732 . . . . 0.81999999999999995 109.914 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.5 t80 -148.38 96.28 2.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.34000000000000002 110.43 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.03 -104.24 1.07 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.898 -0.668 . . . . 0.40999999999999998 112.758 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -88.12 -13.78 40.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.139 0.422 . . . . 0.42999999999999999 112.139 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 2' ' ' VAL . 10.5 p -102.56 136.2 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.024 0.44 . . . . 0.23999999999999999 111.373 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.5 m -153.74 117.32 4.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.523 -0.547 . . . . 0.25 109.523 169.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.573 HG12 ' HB ' ' A' ' 81' ' ' VAL . 15.9 pt -149.6 167.64 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.832 -0.622 . . . . 0.14000000000000001 109.98 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 18.4 pt20 -151.2 155.88 39.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.987 0.423 . . . . 1.8799999999999999 110.996 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -147.51 162.81 38.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.842 -0.617 . . . . 0.96999999999999997 109.754 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.2 p30 -143.03 134.93 26.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 1.8700000000000001 111.326 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.642 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.6 tp -75.37 138.7 41.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.967 -0.56 . . . . 0.17000000000000001 111.556 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' HB3' HG23 ' A' ' 96' ' ' THR . 12.2 t70 -87.73 111.07 39.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.611 -0.722 . . . . 2.1299999999999999 109.502 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.68 -16.76 32.21 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.254 1.969 . . . . 0.40000000000000002 113.729 -175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 4.3 mt-10 -82.05 0.32 40.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 122.141 -0.349 . . . . 1.4199999999999999 110.989 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.6 p -98.03 -12.19 22.18 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.31 111.122 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 75' ' ' TYR . 90.7 t -52.84 -11.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 0.64000000000000001 111.248 170.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -74.57 49.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.458 -0.337 . . . . 2.3999999999999999 111.607 -178.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.624 HD11 ' OH ' ' A' ' 69' ' ' TYR . 1.3 mt 63.97 34.76 11.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.758 -0.656 . . . . 1.3300000000000001 112.404 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -82.19 112.5 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.751 -0.659 . . . . 4.1299999999999999 109.955 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.726 -0.654 . . . . 6.6900000000000004 109.837 -177.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 18.8 ptm . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.331 0.586 . . . . 3.75 110.815 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.734 ' H ' HG21 ' A' ' 86' ' ' VAL . 44.1 t -128.13 157.63 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.72 -0.673 . . . . 0.14999999999999999 109.999 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 19.9 mm-40 -122.33 167.04 13.75 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.0299999999999998 108.245 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.81 144.93 23.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.361 -0.936 . . . . 0.29999999999999999 112.39 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -141.06 176.76 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.012 -1.449 . . . . 1.8700000000000001 107.616 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.602 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.6 OUTLIER -136.93 135.65 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.929 0.395 . . . . 0.33000000000000002 110.884 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 20' ' ' VAL . 1.1 mt-10 -137.38 157.84 45.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 111.937 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.03 124.68 31.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.141 -0.936 . . . . 0.17000000000000001 108.776 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.57 107.24 17.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.841 0.353 . . . . 0.22 110.881 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.49 130.08 39.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.22 0.533 . . . . 0.33000000000000002 111.918 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -122.94 177.02 5.68 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.489 -0.93 . . . . 1.22 108.489 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.21 96.86 0.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.068 -0.586 . . . . 0.60999999999999999 113.006 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.13 -15.48 62.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.241 -0.504 . . . . 0.47999999999999998 113.5 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -137.61 141.6 41.25 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.238 -0.566 . . . . 1.8500000000000001 110.773 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.8 p -116.36 117.91 57.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.503 -0.554 . . . . 0.23000000000000001 109.503 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 66' ' ' VAL . 52.2 m -95.96 117.84 31.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.239 -0.652 . . . . 0.23999999999999999 109.239 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.625 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -113.09 133.36 55.04 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.616 -0.433 . . . . 0.17000000000000001 111.222 -171.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 78.0 mt-30 -148.84 172.98 13.77 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.63 0.581 . . . . 1.77 110.07 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.02 127.79 7.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.19 111.931 175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 4.9 t -85.6 113.53 24.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 122.286 1.041 . . . . 0.45000000000000001 112.131 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.613 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -97.02 105.93 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 114.166 -1.379 . . . . 0.14000000000000001 110.423 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.1 m -78.97 132.61 36.75 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.32 -1.363 . . . . 0.20000000000000001 107.32 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.39 120.91 35.36 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.318 -0.953 . . . . 0.16 108.763 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 24' ' ' VAL . 51.1 t -73.58 -5.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.236 0.541 . . . . 0.25 111.708 -175.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 25.2 mmt180 -133.68 135.86 44.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.495 -0.753 . . . . 2.1800000000000002 111.513 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.1 p-10 -80.92 139.19 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.8 -0.636 . . . . 1.54 110.762 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.68 -136.34 5.45 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.379 -1.088 . . . . 0.26000000000000001 110.379 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 136.09 39.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.073 0.436 . . . . 0.45000000000000001 110.087 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.33 177.64 19.23 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.887 -0.885 . . . . 0.20999999999999999 110.887 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 23.6 p -124.7 137.69 54.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.111 0.481 . . . . 0.23000000000000001 111.005 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.577 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.29 166.58 32.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.437 -0.801 . . . . 0.17999999999999999 110.608 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -135.55 111.6 9.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 1.26 111.445 -175.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 79' ' ' LEU . 3.1 tm? -101.35 119.75 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.396 0.617 . . . . 0.55000000000000004 109.946 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.47 142.85 39.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.401 -0.818 . . . . 0.25 109.829 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 14.0 t -119.85 136.33 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.019 0.438 . . . . 0.23000000000000001 110.02 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.02 113.55 23.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.668 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 43' ' ' THR . 19.6 ttpt -114.1 132.57 56.0 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.34 -0.391 . . . . 1.3400000000000001 110.238 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -137.34 104.81 5.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.052 0.454 . . . . 0.59999999999999998 110.376 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.13 -161.41 9.37 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.702 -0.681 . . . . 0.95999999999999996 111.561 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.99 -19.97 66.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.42 . . . . 1.5700000000000001 110.657 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.32 9.48 23.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.919 -0.582 . . . . 1.72 111.247 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 -167.46 31.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.886 -0.673 . . . . 1.21 112.289 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 41.5 p -97.17 133.78 41.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.783 0.325 . . . . 1.1399999999999999 110.339 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -125.4 137.01 54.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.45 -0.341 . . . . 1.1499999999999999 110.363 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -106.36 112.62 25.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 3.0800000000000001 110.985 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -112.36 135.33 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.72 -0.673 . . . . 0.45000000000000001 109.984 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -142.3 125.45 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 2.7400000000000002 111.773 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -124.02 116.24 22.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.731 -0.47 . . . . 1.6299999999999999 109.731 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.06 153.07 47.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.267 -0.424 . . . . 0.39000000000000001 110.955 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.81 -142.9 8.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.508 -0.637 . . . . 0.26000000000000001 111.508 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.3 148.63 46.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.035 -0.357 . . . . 0.38 110.035 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 56.3 t80 -148.77 171.58 16.01 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.281 -0.637 . . . . 0.26000000000000001 109.281 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 123.79 33.58 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.499 -0.319 . . . . 0.42999999999999999 110.798 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -119.88 144.96 47.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.019 0.438 . . . . 0.23000000000000001 111.023 -176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -113.62 140.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.445 . . . . 0.33000000000000002 110.885 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.98 123.81 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.139 -0.937 . . . . 0.22 111.98 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 64.43 24.92 13.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 110.171 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.11 150.07 39.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.421 -1.263 . . . . 1.48 109.696 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.09 127.24 36.04 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.897 -1.047 . . . . 2.7200000000000002 110.679 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.7 t -119.59 109.53 26.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.468 -0.787 . . . . 0.14999999999999999 109.475 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 18' ' ' GLN . 1.4 m -87.71 129.0 35.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.411 -0.916 . . . . 0.19 110.709 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.9 142.55 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.942 -1.026 . . . . 0.16 112.477 -167.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.4 76.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 112.519 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 2.8 p30 -80.82 106.66 12.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.787 0.803 . . . . 2.1699999999999999 110.722 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.69 119.63 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.025 -0.989 . . . . 1.29 109.589 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 16' ' ' THR . 61.5 t -102.64 119.19 50.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.358 0.599 . . . . 0.29999999999999999 110.792 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -104.76 162.76 13.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.14 -0.936 . . . . 0.26000000000000001 108.918 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.05 128.91 36.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.991 -1.114 . . . . 1.25 107.991 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -76.66 127.82 33.52 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.081 0.467 . . . . 0.33000000000000002 112.188 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -142.56 123.99 14.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.648 -0.705 . . . . 0.98999999999999999 109.282 169.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 p -63.16 -24.38 67.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.54000000000000004 111.668 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.13 0.21 43.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.045 -0.525 . . . . 0.5 111.499 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 4.8 t-20 -79.5 153.9 29.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.972 0.415 . . . . 1.3200000000000001 110.624 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 22.7 mmm180 -97.75 108.77 21.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.56 -0.533 . . . . 2.5 109.56 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 30.6 m-85 -124.37 120.6 32.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.34999999999999998 109.329 175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.27 168.89 14.86 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.773 -0.649 . . . . 0.16 109.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.685 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.09 163.22 36.97 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.377 -0.601 . . . . 0.16 109.377 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 4.3 tmt_? -155.85 115.02 3.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.304 -0.628 . . . . 3.3500000000000001 109.304 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.0 tt -113.03 123.53 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.482 -0.487 . . . . 0.22 110.074 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.704 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 19.5 t70 -103.8 116.21 31.89 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.249 -0.887 . . . . 2.2200000000000002 109.047 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.7 t -102.36 106.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.495 -0.753 . . . . 0.13 109.068 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 p -123.99 106.24 10.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.54 -0.755 . . . . 0.81999999999999995 109.442 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' HG12 ' A' ' 86' ' ' VAL . 24.0 t80 -148.44 100.87 3.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.194 -0.457 . . . . 0.34000000000000002 110.564 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.26 -103.1 0.74 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.838 -0.696 . . . . 0.40999999999999998 112.223 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.6 p -94.1 -12.95 27.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.03 0.381 . . . . 0.42999999999999999 112.03 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.734 HG21 ' H ' ' A' ' 2' ' ' VAL . 10.2 p -95.65 137.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.516 -0.473 . . . . 0.23999999999999999 111.141 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 9.0 m -154.38 117.83 4.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.382 -0.599 . . . . 0.25 109.382 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.61 HG12 ' HB ' ' A' ' 81' ' ' VAL . 26.6 pt -149.96 166.2 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.548 . . . . 0.14000000000000001 109.759 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.3 pt20 -152.62 152.65 32.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.218 0.532 . . . . 1.8799999999999999 111.475 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.2 168.76 18.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.96999999999999997 109.749 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.9 t-20 -147.39 133.1 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.674 0.273 . . . . 1.8700000000000001 111.2 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.685 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.3 tp -76.01 136.84 39.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.961 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 92' ' ' LEU . 3.2 m-20 -86.76 108.99 20.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.312 -0.858 . . . . 2.1299999999999999 109.625 170.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 51.7 Cg_exo -55.19 -23.63 37.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.789 2.326 . . . . 0.40000000000000002 113.295 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -74.61 2.72 9.15 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 120.819 0.342 . . . . 1.4199999999999999 111.873 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.8 p -97.44 -18.54 18.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.751 0.31 . . . . 0.31 111.367 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 99.2 t -51.77 -13.58 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.384 0.674 . . . . 0.64000000000000001 112.478 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.687 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.78 77.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.05 -0.406 . . . . 2.3999999999999999 111.854 -175.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 61.88 42.1 10.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.486 -0.779 . . . . 1.3300000000000001 111.926 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.55 114.64 17.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 4.1299999999999999 110.086 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.593 -0.718 . . . . 6.6900000000000004 109.682 179.165 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.802 0.334 . . . . 3.75 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.6 t -97.31 148.6 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.14999999999999999 110.441 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -119.45 166.66 12.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.606 -1.257 . . . . 2.0299999999999998 107.606 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -149.61 152.32 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.364 -0.934 . . . . 0.29999999999999999 112.301 -178.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -144.57 175.49 10.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.066 -1.424 . . . . 1.8700000000000001 107.648 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.674 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -138.69 116.24 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.701 0.762 . . . . 0.33000000000000002 112.224 -177.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 1.9 mp0 -116.79 161.25 19.57 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.482 -1.235 . . . . 2.0099999999999998 111.991 -171.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.97 124.35 17.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.221 -1.354 . . . . 0.17000000000000001 107.914 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.49 104.71 12.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.965 0.412 . . . . 0.22 110.76 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.0 t -78.09 132.87 31.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.343 -0.39 . . . . 0.33000000000000002 111.046 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -123.32 177.89 5.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.779 -0.822 . . . . 1.22 108.779 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.34 99.37 0.14 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.254 -0.498 . . . . 0.60999999999999999 113.171 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.14 -14.94 51.9 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.295 -0.478 . . . . 0.47999999999999998 113.347 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -140.07 136.67 33.87 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.307 -0.525 . . . . 1.8500000000000001 110.321 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -107.17 121.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.281 0.562 . . . . 0.23000000000000001 110.259 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.403 ' OG1' HG22 ' A' ' 66' ' ' VAL . 89.1 m -96.45 118.49 33.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.868 -0.605 . . . . 0.23999999999999999 109.587 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.579 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.76 139.44 49.7 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.676 -0.41 . . . . 0.17000000000000001 111.426 -171.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.637 ' CB ' HG22 ' A' ' 61' ' ' THR . 48.1 mt-30 -153.26 173.92 14.94 Favored 'General case' 0 C--O 1.225 -0.216 0 O-C-N 123.415 0.447 . . . . 1.77 110.796 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -118.66 124.14 5.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.026 -0.829 . . . . 0.19 111.026 171.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.719 ' CG1' ' HG2' ' A' ' 59' ' ' ARG . 11.7 t -85.13 116.2 28.17 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-O 122.416 1.103 . . . . 0.45000000000000001 112.629 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 ' CD2' ' A' ' 31' ' ' TYR . 8.1 mt -100.15 110.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.304 -1.317 . . . . 0.14000000000000001 111.006 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -84.33 127.36 33.93 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.263 -1.014 . . . . 0.20000000000000001 108.263 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.45 120.04 33.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.528 -0.869 . . . . 0.16 109.701 -176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 64.4 t -66.37 -12.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.823 0.675 . . . . 0.25 112.823 -171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.6 mmt180 -133.73 137.73 45.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.6 -0.687 . . . . 2.1800000000000002 111.6 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 6.1 p-10 -75.74 147.56 39.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.719 -0.673 . . . . 1.54 110.615 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.27 -128.72 3.94 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.29 -1.124 . . . . 0.26000000000000001 110.29 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.07 153.06 45.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.875 0.369 . . . . 0.45000000000000001 110.65 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.29 177.77 27.26 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.0 -1.24 . . . . 0.20999999999999999 110.0 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.9 p -125.9 137.26 53.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.436 0.636 . . . . 0.23000000000000001 110.564 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.62 155.0 31.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.217 -0.901 . . . . 0.17999999999999999 110.671 -174.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.89 111.23 16.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.08 -0.509 . . . . 1.26 111.491 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.564 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.65 122.41 44.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.55000000000000004 109.867 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -120.11 143.06 48.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.304 -0.862 . . . . 0.25 110.119 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 43.1 t -119.04 134.11 63.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.163 0.506 . . . . 0.23000000000000001 110.296 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.48 114.05 27.36 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.672 -0.695 . . . . 1.6699999999999999 109.997 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -112.23 139.51 47.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.251 -0.431 . . . . 1.3400000000000001 110.536 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.07 105.48 3.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.115 -0.493 . . . . 0.59999999999999998 110.41 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.74 -162.49 9.84 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.954 -0.641 . . . . 0.95999999999999996 111.951 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.23 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 1.5700000000000001 111.11 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.14 -1.01 47.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 1.72 110.883 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.69 -166.7 12.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.848 -0.692 . . . . 1.21 112.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.1 p -99.52 135.7 40.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.881 0.372 . . . . 1.1399999999999999 110.65 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.8 m -128.16 138.21 52.4 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.133 -0.485 . . . . 1.1499999999999999 110.378 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -111.71 118.0 34.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 3.0800000000000001 110.362 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.79 133.84 62.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.921 -0.582 . . . . 0.45000000000000001 109.966 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 33.0 ttpt -146.75 131.51 17.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.542 -0.463 . . . . 2.7400000000000002 112.042 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -129.79 116.15 18.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.834 -0.621 . . . . 1.6299999999999999 109.63 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.04 145.22 48.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.002 -0.545 . . . . 0.39000000000000001 110.647 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.08 -146.14 10.51 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.75 -0.738 . . . . 0.26000000000000001 111.94 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.99 150.24 50.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.838 0.351 . . . . 0.38 110.308 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.2 t80 -148.35 175.42 11.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.245 -0.65 . . . . 0.26000000000000001 109.245 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -93.86 127.88 39.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 110.713 -178.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -124.32 126.74 46.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.079 -0.51 . . . . 0.23000000000000001 110.973 -175.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.21 143.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.33000000000000002 111.04 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -59.35 121.67 12.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.343 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 60.04 28.46 18.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.256 1.027 . . . . 1.3300000000000001 110.054 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.53 147.34 40.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.739 -1.573 . . . . 1.48 108.491 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.719 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 1.1 mtt180 -88.73 120.16 29.87 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.05 -0.977 . . . . 2.7200000000000002 111.526 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.763 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.7 t -113.32 110.65 32.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.599 -0.728 . . . . 0.14999999999999999 110.242 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -85.29 127.5 34.35 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.849 -0.74 . . . . 0.19 110.515 -176.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.03 141.62 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 115.436 -0.802 . . . . 0.16 113.126 -167.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 76.36 66.93 1.77 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.286 -0.87 . . . . 0.28000000000000003 112.292 176.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 5.4 p30 -79.89 107.49 12.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.917 0.865 . . . . 2.1699999999999999 110.478 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -124.19 138.1 54.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.332 -1.304 . . . . 1.29 108.644 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' OG1' ' A' ' 16' ' ' THR . 60.9 t -110.21 124.55 67.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.452 0.644 . . . . 0.29999999999999999 111.088 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.1 mm? -105.03 164.82 11.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.875 -1.057 . . . . 0.26000000000000001 108.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.86 128.86 36.64 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.18 -1.044 . . . . 1.25 108.18 168.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -73.59 123.15 23.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.176 0.513 . . . . 0.33000000000000002 112.075 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 9.0 m -142.7 116.88 9.5 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.572 -0.74 . . . . 0.98999999999999999 109.194 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 p -65.46 -29.81 70.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.979 0.419 . . . . 0.54000000000000004 111.087 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.71 4.39 47.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.5 111.168 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 2.0 t-20 -82.43 167.96 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.318 -0.401 . . . . 1.3200000000000001 110.109 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -110.69 107.41 16.97 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.7 m-85 -122.51 115.98 23.13 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.522 -0.763 . . . . 0.34999999999999998 109.083 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -123.84 168.21 13.05 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.8 -0.637 . . . . 0.16 109.708 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.0 163.47 33.4 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.754 0.312 . . . . 0.16 110.294 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ppt_? -154.26 119.82 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.766 -0.827 . . . . 3.3500000000000001 108.766 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -118.58 122.42 42.58 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.983 -0.687 . . . . 0.22 110.004 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.4 m-20 -101.13 115.67 31.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.22 -0.9 . . . . 2.2200000000000002 108.938 172.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 87' ' ' THR . 21.4 t -101.87 106.7 20.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.827 -0.805 . . . . 0.13 108.827 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 87' ' ' THR . 23.2 p -126.53 102.95 7.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.013 -0.54 . . . . 0.81999999999999995 109.653 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.549 ' O ' HG12 ' A' ' 86' ' ' VAL . 45.5 t80 -145.39 96.78 2.89 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.305 0.574 . . . . 0.34000000000000002 110.206 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.61 -107.94 2.27 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.647 -0.706 . . . . 0.40999999999999998 112.087 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.4 p -88.93 -12.72 40.86 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.967 0.358 . . . . 0.42999999999999999 111.967 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.5 p -96.45 133.76 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.494 -0.482 . . . . 0.23999999999999999 111.009 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.2 m -151.76 118.11 5.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.506 -0.553 . . . . 0.25 109.506 169.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 81' ' ' VAL . 34.5 pt -148.28 167.62 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.597 -0.729 . . . . 0.14000000000000001 110.219 -173.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 13.0 pt20 -146.67 159.56 43.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 111.089 177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.11 157.95 42.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 109.577 177.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.674 ' C ' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -140.29 129.28 23.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.518 0.562 . . . . 1.8700000000000001 112.518 -174.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.3 tp -74.85 142.98 44.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.061 -0.518 . . . . 0.17000000000000001 111.36 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -96.21 111.45 56.59 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 2.1299999999999999 109.611 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.0 Cg_exo -55.24 -21.57 29.17 Favored 'Trans proline' 0 N--CA 1.472 0.247 0 C-N-CA 122.597 2.198 . . . . 0.40000000000000002 113.512 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.38 0.36 19.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 111.71 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.8 p -99.38 -14.55 19.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.909 0.385 . . . . 0.31 111.165 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 75' ' ' TYR . 86.3 t -52.05 -10.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.563 -0.744 . . . . 0.64000000000000001 112.034 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.68 75.6 0.28 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.054 0.454 . . . . 2.3999999999999999 111.669 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 65.53 42.79 3.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.051 -0.977 . . . . 1.3300000000000001 112.485 170.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -91.77 147.23 23.14 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.217 -0.661 . . . . 4.1299999999999999 109.217 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.77 -0.633 . . . . 6.6900000000000004 109.542 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 tmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.525 -0.546 . . . . 3.75 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 21' ' ' ILE . 21.5 t -102.11 151.27 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.202 0.525 . . . . 0.14999999999999999 111.661 -173.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' THR . 24.1 mm-40 -117.45 167.72 11.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.498 1.119 . . . . 2.0299999999999998 108.192 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -151.79 144.88 24.57 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.655 -0.818 . . . . 0.29999999999999999 111.534 178.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -135.99 176.21 8.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.124 -1.398 . . . . 1.8700000000000001 108.202 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.48 113.86 11.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.621 0.724 . . . . 0.33000000000000002 112.344 -178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -111.33 160.5 16.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.606 -1.179 . . . . 2.0099999999999998 111.875 -173.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.49 123.6 16.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.963 -1.471 . . . . 0.17000000000000001 107.544 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.91 105.6 13.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.828 0.347 . . . . 0.22 111.096 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.13 124.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.291 0.567 . . . . 0.33000000000000002 111.58 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 m -116.78 177.96 4.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.29 -0.868 . . . . 1.22 108.829 172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.27 98.79 0.08 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.139 -0.553 . . . . 0.60999999999999999 113.293 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.85 57.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.303 -0.475 . . . . 0.47999999999999998 113.514 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -135.94 132.52 36.53 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.394 -0.474 . . . . 1.8500000000000001 110.253 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.8 p -107.07 118.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.23000000000000001 109.739 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 99.2 m -96.14 117.11 30.07 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.933 -0.576 . . . . 0.23999999999999999 109.691 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -110.99 135.24 51.79 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.663 -0.415 . . . . 0.17000000000000001 111.004 -172.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.6 pt20 -163.66 152.96 14.45 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.501 0.5 . . . . 1.77 109.842 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -103.38 131.14 10.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.727 -0.749 . . . . 0.19 112.543 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 4.4 t -84.29 109.86 18.13 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 122.707 1.242 . . . . 0.45000000000000001 112.52 -177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.619 HG23 ' CG1' ' A' ' 2' ' ' VAL . 10.3 mt -91.25 105.82 16.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.769 -1.56 . . . . 0.14000000000000001 110.129 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -82.86 135.13 35.03 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.307 -1.368 . . . . 0.20000000000000001 107.307 168.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.716 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -123.32 120.92 34.48 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.265 -0.974 . . . . 0.16 109.4 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.3 t -67.45 -16.12 20.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 112.631 0.604 . . . . 0.25 112.631 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 36.9 mmt180 -133.83 135.03 43.5 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.396 -0.522 . . . . 2.1800000000000002 111.563 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.8 p-10 -72.37 141.11 48.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.434 -0.803 . . . . 1.54 110.34 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.52 -137.92 5.81 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.177 -1.169 . . . . 0.26000000000000001 110.177 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.21 136.51 26.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.999 0.4 . . . . 0.45000000000000001 110.296 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.94 -171.45 12.19 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.801 -0.714 . . . . 0.20999999999999999 111.527 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 17.8 p -130.71 138.49 50.03 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.173 0.511 . . . . 0.23000000000000001 110.853 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.77 156.75 33.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.334 -0.848 . . . . 0.17999999999999999 110.631 -176.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -125.96 112.32 15.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 1.26 111.688 -174.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.3 tm? -104.15 118.69 37.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.651 . . . . 0.55000000000000004 110.067 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.76 136.89 52.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.5 -0.773 . . . . 0.25 109.586 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.2 t -107.08 137.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.061 0.458 . . . . 0.23000000000000001 110.143 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.23 112.84 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.608 -0.724 . . . . 1.6699999999999999 109.324 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.453 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 20.3 ttpt -117.98 129.48 55.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.816 0.341 . . . . 1.3400000000000001 110.236 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.54 105.28 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 0.59999999999999998 110.13 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.13 -162.28 11.54 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.95999999999999996 112.037 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.6 70.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 1.5700000000000001 111.195 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.57 13.09 10.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 1.72 111.253 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.48 -160.91 23.82 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.701 -0.762 . . . . 1.21 112.369 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -94.43 150.89 19.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.791 0.329 . . . . 1.1399999999999999 111.025 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . 22.4 m -130.16 157.75 41.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.085 -0.507 . . . . 1.1499999999999999 110.085 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 45' ' ' ARG . 16.9 mmt180 -120.54 112.19 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.162 0.506 . . . . 3.0800000000000001 111.798 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 65' ' ' VAL . 5.3 mp -119.04 130.32 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.559 -0.746 . . . . 0.45000000000000001 109.626 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -146.26 113.4 6.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.767 0.318 . . . . 2.7400000000000002 111.195 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.86 115.92 23.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.761 -0.459 . . . . 1.6299999999999999 109.761 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.99 48.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.259 -0.428 . . . . 0.39000000000000001 110.798 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.67 -138.95 5.54 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.897 -0.668 . . . . 0.26000000000000001 111.623 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.18 156.96 44.89 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 110.206 -0.294 . . . . 0.38 110.206 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.486 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 45.8 t80 -155.37 176.53 12.46 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.34 -0.615 . . . . 0.26000000000000001 109.34 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.42 132.3 42.09 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.537 0.208 . . . . 0.42999999999999999 110.465 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -127.16 143.45 51.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.979 0.418 . . . . 0.23000000000000001 111.164 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.45 143.36 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.209 -0.45 . . . . 0.33000000000000002 110.866 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.56 124.59 20.18 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.406 -0.815 . . . . 0.22 112.381 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 62.53 16.23 8.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.034 -0.984 . . . . 1.3300000000000001 110.82 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' THR . 1.1 mm100 -104.32 150.83 24.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.271 -1.331 . . . . 1.48 109.629 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 10.4 mpt_? -90.88 120.29 31.77 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.525 -1.216 . . . . 2.7200000000000002 110.204 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.2 t -115.25 108.79 26.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 109.238 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.1 m -90.79 128.22 36.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 119.369 -0.932 . . . . 0.19 110.621 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.66 139.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.036 -0.984 . . . . 0.16 112.58 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 85.26 58.56 2.06 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.351 -0.84 . . . . 0.28000000000000003 112.355 175.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -73.54 107.82 6.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.912 0.863 . . . . 2.1699999999999999 110.488 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 46' ' ' ILE . 58.6 t -126.51 116.87 46.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.751 -1.113 . . . . 1.29 109.661 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.3 t -94.13 122.26 45.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.205 0.526 . . . . 0.29999999999999999 111.295 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -104.86 164.63 11.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.178 -0.919 . . . . 0.26000000000000001 108.594 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.42 129.21 37.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.95 -1.13 . . . . 1.25 107.95 168.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -76.04 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.351 0.501 . . . . 0.33000000000000002 112.351 -170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -142.95 123.2 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.559 -0.904 . . . . 0.98999999999999999 108.559 167.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 p -65.48 -15.64 62.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.46 -0.336 . . . . 0.54000000000000004 111.768 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.49 -5.01 24.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.5 111.52 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.0 OUTLIER -84.18 132.02 34.71 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.927 -0.309 . . . . 1.3200000000000001 110.597 -176.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -75.53 109.25 8.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.235 0.54 . . . . 2.5 110.18 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 97' ' ' VAL . 27.9 m-85 -122.03 119.84 32.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.429 -0.805 . . . . 0.34999999999999998 109.457 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -128.5 169.76 13.98 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.441 -0.799 . . . . 0.16 109.661 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -146.21 163.19 36.19 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.121 -0.491 . . . . 0.16 109.69 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -151.78 117.23 5.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.181 -0.674 . . . . 3.3500000000000001 109.181 177.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.3 tt -117.13 118.52 32.58 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.006 -0.677 . . . . 0.22 110.175 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.9 m-20 -99.64 115.26 29.01 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.964 -1.017 . . . . 2.2200000000000002 109.073 175.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.726 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.6 t -102.3 106.77 20.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.832 -0.747 . . . . 0.13 109.266 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 t -125.52 115.58 20.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.942 -0.762 . . . . 0.81999999999999995 108.942 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.536 ' O ' HG12 ' A' ' 86' ' ' VAL . 41.2 t80 -156.77 102.59 2.03 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 110.146 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.57 -103.39 0.74 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.849 -0.691 . . . . 0.40999999999999998 112.693 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -95.85 -9.55 31.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.087 0.402 . . . . 0.42999999999999999 112.087 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 83' ' ' PHE . 8.5 p -100.2 136.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.571 -0.452 . . . . 0.23999999999999999 111.089 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 27.8 m -153.77 117.98 4.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.25 109.634 169.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 81' ' ' VAL . 18.1 pt -147.34 168.4 4.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.519 -0.764 . . . . 0.14000000000000001 109.972 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 4.2 pt20 -151.12 153.66 35.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.069 0.461 . . . . 1.8799999999999999 110.966 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.46 160.6 39.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.96999999999999997 109.473 177.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.2 p-10 -141.38 130.33 23.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.934 0.397 . . . . 1.8700000000000001 111.164 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.0 tp -74.69 129.72 38.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.091 -0.504 . . . . 0.17000000000000001 111.681 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.44 111.42 18.84 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.356 -0.609 . . . . 2.1299999999999999 109.356 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 32.3 Cg_exo -57.93 -20.79 46.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.399 2.066 . . . . 0.40000000000000002 112.454 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' C ' ' HE3' ' A' ' 98' ' ' LYS . 43.8 mt-10 -71.12 1.35 5.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.033 -0.53 . . . . 1.4199999999999999 111.588 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 101' ' ' HIS . 31.2 p -101.27 -18.17 16.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.747 0.308 . . . . 0.31 111.654 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 75' ' ' TYR . 87.4 t -52.17 -14.51 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.956 -0.566 . . . . 0.64000000000000001 112.233 174.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.73 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.49 70.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 2.3999999999999999 111.598 -176.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.45 56.45 3.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.495 -0.775 . . . . 1.3300000000000001 111.564 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 62.79 72.91 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.503 -0.771 . . . . 4.1299999999999999 111.351 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 72.5 t60 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.688 -0.672 . . . . 6.6900000000000004 109.829 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.909 0.385 . . . . 3.75 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.647 ' CG1' HG23 ' A' ' 21' ' ' ILE . 41.1 t -104.25 152.75 6.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.14999999999999999 110.525 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' THR . 14.4 mm100 -117.45 166.69 12.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.273 -1.01 . . . . 2.0299999999999998 108.273 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.54 144.07 23.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.329 -0.948 . . . . 0.29999999999999999 112.361 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -140.27 176.35 8.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.099 -1.41 . . . . 1.8700000000000001 107.615 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.648 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -135.75 130.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.496 0.665 . . . . 0.33000000000000002 111.884 -177.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 20' ' ' VAL . 4.1 mm-40 -127.08 158.7 36.31 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.671 -1.149 . . . . 2.0099999999999998 111.992 -174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.62 123.64 22.82 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.622 -1.251 . . . . 0.17000000000000001 107.622 169.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.09 104.65 12.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.028 0.442 . . . . 0.22 110.901 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.29 133.69 28.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.6 . . . . 0.33000000000000002 111.336 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.7 t -123.0 176.89 5.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.097 -0.956 . . . . 1.22 108.725 174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.13 90.52 0.09 OUTLIER Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.193 -0.527 . . . . 0.60999999999999999 113.419 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.14 -15.79 56.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.324 -0.465 . . . . 0.47999999999999998 113.103 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -140.57 147.87 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.38 -0.482 . . . . 1.8500000000000001 110.246 -177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -116.08 120.17 64.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.061 0.457 . . . . 0.23000000000000001 110.267 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 66' ' ' VAL . 51.6 m -96.21 118.4 32.7 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.626 -0.509 . . . . 0.23999999999999999 109.626 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -114.29 136.99 52.37 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.769 -0.372 . . . . 0.17000000000000001 111.342 -171.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' ASN . 8.5 pt20 -164.27 163.08 22.76 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.489 0.493 . . . . 1.77 110.645 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -107.45 133.28 11.57 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.19 112.552 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 3.3 t -87.54 115.28 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.102 0.953 . . . . 0.45000000000000001 112.226 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.647 HG23 ' CG1' ' A' ' 2' ' ' VAL . 7.6 mt -99.03 106.06 18.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.307 -1.315 . . . . 0.14000000000000001 110.143 176.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 5.4 m -83.05 129.45 35.03 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.466 -1.309 . . . . 0.20000000000000001 107.466 170.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 119.83 33.28 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.181 -1.008 . . . . 0.16 109.227 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 24' ' ' VAL . 80.0 t -68.79 -9.97 12.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 112.118 0.414 . . . . 0.25 112.118 -174.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 38.7 mmt180 -132.86 134.81 45.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.668 -0.645 . . . . 2.1800000000000002 111.7 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -73.93 155.04 39.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.826 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.57 -126.88 4.65 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.498 -1.041 . . . . 0.26000000000000001 110.498 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.54 141.69 28.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.672 0.272 . . . . 0.45000000000000001 110.427 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.43 178.86 18.7 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.531 -1.028 . . . . 0.20999999999999999 110.531 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 33.2 p -122.71 136.32 54.84 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.476 -0.49 . . . . 0.23000000000000001 110.64 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -158.01 167.98 28.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.363 -0.835 . . . . 0.17999999999999999 110.662 -175.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -140.22 111.18 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.691 -175.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -103.27 118.08 35.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.223 0.535 . . . . 0.55000000000000004 109.721 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . . . -114.53 128.98 56.61 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.593 -0.731 . . . . 0.25 110.622 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.1 t -107.35 139.21 29.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.309 0.576 . . . . 0.23000000000000001 110.192 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.66 114.16 22.33 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.214 -0.903 . . . . 1.6699999999999999 109.689 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.6 ttpt -108.19 132.21 53.87 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.186 -0.461 . . . . 1.3400000000000001 110.255 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -137.17 105.61 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.778 -0.646 . . . . 0.59999999999999998 109.81 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.86 -161.53 9.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.785 -0.721 . . . . 0.95999999999999996 112.313 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.66 -17.46 64.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.055 0.455 . . . . 1.5700000000000001 110.811 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.41 12.94 25.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 1.72 110.772 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.04 -168.58 34.15 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.88 -0.676 . . . . 1.21 112.594 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 40.8 p -94.09 154.21 17.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.616 0.246 . . . . 1.1399999999999999 110.387 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -148.47 137.23 21.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.199 -0.297 . . . . 1.1499999999999999 110.199 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -99.74 114.3 27.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.305 -0.407 . . . . 3.0800000000000001 110.788 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG21 HG11 ' A' ' 65' ' ' VAL . 5.2 mp -112.42 133.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.45000000000000001 109.496 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 83.1 tttt -146.42 120.42 9.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.521 0.563 . . . . 2.7400000000000002 112.521 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 63' ' ' GLY . 64.0 mt-30 -115.88 116.57 28.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.408 -0.59 . . . . 1.6299999999999999 109.408 170.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.49 145.65 49.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.39000000000000001 111.003 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.22 -139.17 6.15 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.966 -0.635 . . . . 0.26000000000000001 111.774 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -137.26 142.45 41.99 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 65.1 t80 -145.25 175.4 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.822 -0.807 . . . . 0.26000000000000001 108.822 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -86.88 136.97 32.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.984 0.421 . . . . 0.42999999999999999 111.257 -178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -129.69 140.1 51.2 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.932 -0.576 . . . . 0.23000000000000001 110.241 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.69 138.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.449 -0.341 . . . . 0.33000000000000002 110.63 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -58.55 121.68 11.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.17 -0.923 . . . . 0.22 112.319 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 65.84 18.3 11.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.747 -1.115 . . . . 1.3300000000000001 110.736 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.76 153.01 24.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.603 -1.18 . . . . 1.48 109.699 173.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.12 126.56 35.83 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.563 -1.198 . . . . 2.7200000000000002 110.543 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.6 t -118.39 110.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.26 -0.882 . . . . 0.14999999999999999 108.813 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.4 m -90.39 127.63 36.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.716 -0.794 . . . . 0.19 110.326 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -121.87 138.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 114.913 -1.04 . . . . 0.16 112.471 -166.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 81.94 52.4 4.11 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.28000000000000003 112.538 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 2.9 p30 -73.92 108.11 6.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.683 0.754 . . . . 2.1699999999999999 110.493 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 46' ' ' ILE . 12.5 m -127.59 141.06 47.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.749 -1.114 . . . . 1.29 109.359 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG22 ' OG1' ' A' ' 16' ' ' THR . 46.4 t -110.13 122.65 65.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.669 . . . . 0.29999999999999999 111.761 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -106.04 168.06 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.896 -1.047 . . . . 0.26000000000000001 108.882 178.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.43 132.74 42.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 168.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -75.64 118.61 18.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.204 0.526 . . . . 0.33000000000000002 111.691 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 25.9 m -142.97 120.49 11.72 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.77 -0.65 . . . . 0.98999999999999999 109.492 172.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.7 p -64.71 -29.75 70.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.309 -0.405 . . . . 0.54000000000000004 111.237 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.47 1.04 56.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.644 . . . . 0.5 111.223 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 0.9 OUTLIER -91.04 132.98 35.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.717 -177.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.4 mmt180 -77.64 109.7 11.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.241 -0.436 . . . . 2.5 110.042 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' HB2' HG21 ' A' ' 97' ' ' VAL . 31.4 m-85 -121.85 114.19 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.018 -0.734 . . . . 0.34999999999999998 109.018 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.05 167.25 13.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.133 -0.485 . . . . 0.16 110.166 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.66 164.5 32.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.155 -0.475 . . . . 0.16 109.995 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 1.4 ppt_? -157.63 119.2 3.65 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.457 -0.572 . . . . 3.3500000000000001 109.457 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -115.3 125.89 53.81 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.214 -0.594 . . . . 0.22 110.266 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 4.9 m-20 -106.23 115.31 30.0 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.053 -0.976 . . . . 2.2200000000000002 109.378 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 87' ' ' THR . 11.6 t -105.65 107.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 O-C-N 121.659 -0.651 . . . . 0.13 109.435 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 p -124.81 109.63 13.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.467 -0.568 . . . . 0.81999999999999995 109.467 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 86' ' ' VAL . 29.4 t80 -153.36 89.83 1.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.413 0.625 . . . . 0.34000000000000002 110.46 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.44 -105.78 1.74 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.623 -0.717 . . . . 0.40999999999999998 112.439 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 p -85.4 -13.32 49.72 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.787 0.292 . . . . 0.42999999999999999 111.787 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.0 p -100.14 132.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 0.23999999999999999 111.513 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 10.6 m -150.4 117.3 5.89 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.926 -0.768 . . . . 0.25 108.926 167.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG12 ' HB ' ' A' ' 81' ' ' VAL . 20.7 pt -148.8 167.31 3.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.04 -0.527 . . . . 0.14000000000000001 110.232 -172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.7 OUTLIER -151.8 150.81 30.56 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 1.8799999999999999 110.684 175.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.98 162.49 35.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 109.51 177.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.648 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.6 p30 -140.53 132.55 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.249 0.547 . . . . 1.8700000000000001 112.17 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.668 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.9 tp -76.08 134.3 40.08 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.823 -0.626 . . . . 0.17000000000000001 111.223 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.64 112.66 50.08 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.028 -0.73 . . . . 2.1299999999999999 109.028 169.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.49 -16.83 31.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.675 2.25 . . . . 0.40000000000000002 112.012 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.03 -7.68 43.02 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.37 -0.832 . . . . 1.4199999999999999 110.7 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 p -100.59 -12.24 19.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.399 -0.364 . . . . 0.31 111.902 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 75' ' ' TYR . 82.7 t -51.29 -14.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.207 0.527 . . . . 0.64000000000000001 111.096 170.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' H ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.34 63.11 0.24 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.136 -0.484 . . . . 2.3999999999999999 110.572 176.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 60.39 45.52 10.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.6 -0.727 . . . . 1.3300000000000001 111.466 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 58.78 58.07 3.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.719 -0.673 . . . . 4.1299999999999999 111.773 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.162 -0.923 . . . . 6.6900000000000004 110.823 178.468 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' HB ' ' A' ' 86' ' ' VAL . 24.6 mmt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.533 0.197 . . . . 3.75 111.533 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG11 ' A' ' 81' ' ' VAL . 22.0 t -109.79 148.46 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.14999999999999999 110.145 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 14.7 mm100 -122.37 168.31 12.23 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 107.916 -1.142 . . . . 2.0299999999999998 107.916 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 29.8 p -142.12 158.02 44.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 118.696 -1.201 . . . . 0.29999999999999999 113.469 -177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 50.4 mt-10 -153.58 176.18 12.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 107.403 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.665 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -142.97 132.5 21.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.983 0.421 . . . . 0.33000000000000002 110.778 -177.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -130.32 157.77 41.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.976 0.893 . . . . 2.0099999999999998 112.598 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.09 125.05 25.66 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.782 -1.554 . . . . 0.17000000000000001 107.715 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.23 104.96 12.61 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.117 0.484 . . . . 0.22 110.605 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.3 t -85.7 129.77 37.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.189 0.519 . . . . 0.33000000000000002 111.592 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.5 p -123.25 177.84 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.331 -0.849 . . . . 1.22 108.929 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.22 102.3 0.1 OUTLIER Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.255 -0.498 . . . . 0.60999999999999999 113.477 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.57 -14.72 28.54 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.417 -0.42 . . . . 0.47999999999999998 113.583 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -133.51 136.0 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.275 -0.544 . . . . 1.8500000000000001 110.652 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -107.51 118.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 0.23000000000000001 110.116 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.5 m -95.2 117.04 29.56 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.114 -0.699 . . . . 0.23999999999999999 109.114 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -111.81 138.76 47.98 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.809 -0.357 . . . . 0.17000000000000001 110.578 -173.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.417 ' HB2' HG22 ' A' ' 61' ' ' THR . 2.2 pt20 -162.65 141.41 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.143 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -93.53 133.38 11.64 Favored Glycine 0 C--O 1.221 -0.659 0 C-N-CA 120.71 -0.757 . . . . 0.19 112.064 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.5 t -84.76 147.05 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.689 0.757 . . . . 0.45000000000000001 110.935 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.582 HD13 ' CD2' ' A' ' 31' ' ' TYR . 4.8 mt -130.36 106.84 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.134 -0.939 . . . . 0.14000000000000001 109.061 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 59' ' ' ARG . 1.8 m -78.87 133.74 36.96 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.204 -1.406 . . . . 0.20000000000000001 107.204 169.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.36 121.03 35.73 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.988 -1.085 . . . . 0.16 108.948 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.7 t -72.48 -7.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.122 0.487 . . . . 0.25 111.543 -174.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.0 mmt180 -133.09 135.05 45.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.012 -0.43 . . . . 2.1800000000000002 110.964 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.2 p-10 -81.23 143.7 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.54 110.521 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.28 -128.76 3.14 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 110.243 -1.143 . . . . 0.26000000000000001 110.243 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.56 34.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.959 -0.385 . . . . 0.45000000000000001 109.959 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.33 -179.58 19.35 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.948 -0.861 . . . . 0.20999999999999999 110.948 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 15.3 p -127.26 137.73 52.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.149 0.499 . . . . 0.23000000000000001 111.001 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -157.47 159.63 37.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.17999999999999999 111.007 -174.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.55 112.06 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.26 111.509 -175.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.7 tm? -100.27 120.53 40.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.583 0.706 . . . . 0.55000000000000004 110.214 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.7 132.53 56.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.108 -0.951 . . . . 0.25 109.974 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 31.0 t -107.88 143.18 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.66 -0.496 . . . . 0.23000000000000001 109.66 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -123.64 113.99 19.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.156 -0.475 . . . . 1.6699999999999999 110.083 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HE2' HD11 ' A' ' 46' ' ' ILE . 28.0 mtmt -108.5 147.15 32.12 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.152 -0.619 . . . . 1.3400000000000001 110.494 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -151.34 123.61 8.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.138 -0.937 . . . . 0.59999999999999998 111.031 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.88 -163.45 10.7 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.967 -0.853 . . . . 0.95999999999999996 110.967 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.41 -25.09 66.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.021 0.439 . . . . 1.5700000000000001 110.803 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.72 -6.96 58.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 1.72 111.333 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.59 -163.76 12.25 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 1.21 112.238 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -105.55 160.47 15.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.385 -0.228 . . . . 1.1399999999999999 110.385 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -144.38 138.07 27.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.513 0.197 . . . . 1.1499999999999999 110.831 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -101.96 117.76 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 3.0800000000000001 111.563 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -113.48 130.25 67.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.422 -0.584 . . . . 0.45000000000000001 109.422 174.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.73 116.35 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.89 0.376 . . . . 2.7400000000000002 111.677 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.47 117.1 21.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 1.6299999999999999 110.016 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -119.05 156.89 28.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.285 -0.416 . . . . 0.39000000000000001 111.08 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.76 -140.67 6.61 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.83 -0.7 . . . . 0.26000000000000001 112.058 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -143.24 157.14 44.75 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.823 -0.436 . . . . 0.38 109.823 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.419 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 52.2 t80 -158.56 172.7 17.83 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.478 -0.564 . . . . 0.26000000000000001 109.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -87.56 139.91 30.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.483 -0.326 . . . . 0.42999999999999999 110.429 -176.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -135.61 145.55 47.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.23000000000000001 111.017 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.19 141.94 25.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.29 -0.414 . . . . 0.33000000000000002 110.72 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.9 125.05 22.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.22 111.826 -178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 62.68 30.8 16.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.043 -0.98 . . . . 1.3300000000000001 109.879 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -123.92 148.03 47.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.388 -1.278 . . . . 1.48 109.287 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 6.8 mpt_? -87.33 129.88 34.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.131 -0.941 . . . . 2.7200000000000002 110.006 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 54' ' ' ALA . 42.2 t -122.76 110.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 0.14999999999999999 109.149 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -90.39 129.33 36.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.735 0.778 . . . . 0.19 110.953 -174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.5 t -125.91 137.1 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.612 -1.176 . . . . 0.16 112.353 -166.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 82.82 72.17 1.28 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.807 -0.633 . . . . 0.28000000000000003 112.512 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -81.6 107.6 14.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.398 -0.593 . . . . 2.1699999999999999 109.398 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.01 138.39 54.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 1.29 109.03 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.3 117.21 54.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.467 0.651 . . . . 0.29999999999999999 111.258 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -104.43 167.07 9.98 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.421 -177.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.34 128.88 36.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.461 -0.94 . . . . 1.25 108.461 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.13 129.27 34.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.362 0.504 . . . . 0.33000000000000002 112.362 -171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 0.7 OUTLIER -142.85 126.96 17.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.839 -0.8 . . . . 0.98999999999999999 108.839 165.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.5 p -67.7 -14.52 63.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.312 0.577 . . . . 0.54000000000000004 110.428 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.91 4.6 40.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.443 -0.798 . . . . 0.5 111.728 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 17.3 t-20 -98.08 151.53 20.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.867 0.365 . . . . 1.3200000000000001 110.295 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 23.4 mmm180 -94.35 108.31 20.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.305 0.574 . . . . 2.5 109.627 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 97' ' ' VAL . 29.9 m-85 -120.7 121.62 38.67 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.943 -0.762 . . . . 0.34999999999999998 108.943 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.18 168.74 14.27 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.192 0.52 . . . . 0.16 110.152 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.54 163.14 35.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.505 -0.77 . . . . 0.16 109.229 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -157.85 117.36 3.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.448 0.642 . . . . 3.3500000000000001 109.53 177.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -113.14 116.59 30.08 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.077 -0.649 . . . . 0.22 110.292 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.668 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 2.6 m-20 -93.24 115.88 28.47 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.644 -1.162 . . . . 2.2200000000000002 108.738 174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 87' ' ' THR . 13.4 t -101.72 107.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 119.609 -0.836 . . . . 0.13 109.459 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 p -120.48 103.09 8.9 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.702 -0.681 . . . . 0.81999999999999995 109.399 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.566 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.3 t80 -141.22 97.01 3.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.209 -0.451 . . . . 0.34000000000000002 109.829 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.51 -102.94 0.6 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.745 -0.741 . . . . 0.40999999999999998 112.318 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.0 p -91.19 -12.92 33.94 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.014 0.376 . . . . 0.42999999999999999 112.014 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.2 p -96.56 133.27 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.898 0.38 . . . . 0.23999999999999999 111.015 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 14.6 m -148.89 117.88 6.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.965 -0.754 . . . . 0.25 108.965 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.617 HG12 ' HB ' ' A' ' 81' ' ' VAL . 11.0 pt -148.02 169.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.985 -0.552 . . . . 0.14000000000000001 110.182 -172.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 26.7 pt20 -150.55 143.87 24.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 1.8799999999999999 111.218 173.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 85.7 m -133.42 153.58 51.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 173.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.665 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.3 p30 -135.9 134.59 38.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.121 0.486 . . . . 1.8700000000000001 111.972 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.62 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 9.0 tp -74.96 134.33 41.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.47 -0.786 . . . . 0.17000000000000001 111.581 -175.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -82.88 111.85 33.13 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.547 -0.752 . . . . 2.1299999999999999 109.182 170.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 31.5 Cg_exo -58.6 -17.85 37.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.197 1.932 . . . . 0.40000000000000002 111.824 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.715 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -76.11 6.9 4.68 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.191 -0.913 . . . . 1.4199999999999999 112.01 176.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.3 p -110.06 -10.77 14.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.012 0.434 . . . . 0.31 111.922 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 75' ' ' TYR . 88.5 t -56.93 -14.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 115.726 -0.67 . . . . 0.64000000000000001 112.706 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.715 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -77.67 78.0 4.19 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.523 -0.736 . . . . 2.3999999999999999 110.162 -176.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 3.4 mm? 77.93 122.21 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.068 -1.424 . . . . 1.3300000000000001 111.054 172.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -51.34 126.43 16.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.166 -1.379 . . . . 4.1299999999999999 112.843 -171.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.086 -0.961 . . . . 6.6900000000000004 111.704 173.58 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.78 0.324 . . . . 3.75 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.1 t -97.19 155.66 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 0.14999999999999999 110.967 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' THR . 78.4 mm-40 -123.73 167.04 14.53 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.576 -1.268 . . . . 2.0299999999999998 107.576 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.9 OUTLIER -149.1 151.41 34.38 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.025 -1.07 . . . . 0.29999999999999999 112.313 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -144.67 175.58 10.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.063 -1.426 . . . . 1.8700000000000001 108.466 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -139.95 117.25 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.898 0.856 . . . . 0.33000000000000002 112.012 -177.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -114.64 162.05 17.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.319 -1.309 . . . . 2.0099999999999998 111.804 -171.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.77 124.93 16.35 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.261 -1.336 . . . . 0.17000000000000001 107.949 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.19 104.85 11.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.07 0.462 . . . . 0.22 111.392 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.07 111.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.343 -0.39 . . . . 0.33000000000000002 111.075 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -126.34 119.07 26.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.22 111.482 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.77 52.71 32.95 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 114.537 0.575 . . . . 0.60999999999999999 114.537 171.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 69' ' ' TYR . . . 79.44 -7.06 55.61 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.538 -0.839 . . . . 0.47999999999999998 113.055 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -116.08 164.83 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.201 -1.037 . . . . 1.8500000000000001 108.201 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.1 p -130.71 118.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.213 0.53 . . . . 0.23000000000000001 110.454 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 62.4 m -94.84 116.64 28.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.488 -0.93 . . . . 0.23999999999999999 108.488 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.16 135.78 53.44 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.646 -0.421 . . . . 0.17000000000000001 110.73 -171.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.788 HE21 HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -156.21 166.0 34.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.84 . . . . 1.77 110.535 -172.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -116.7 124.32 6.14 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.444 -0.884 . . . . 0.19 111.592 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.569 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 3.8 t -86.23 116.59 29.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 122.432 1.11 . . . . 0.45000000000000001 112.375 -176.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.588 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -97.73 106.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.228 -1.351 . . . . 0.14000000000000001 110.638 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 59' ' ' ARG . 3.4 m -79.17 132.05 36.41 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.28 -1.378 . . . . 0.20000000000000001 107.28 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 121.14 35.6 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 119.241 -0.984 . . . . 0.16 109.384 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 24' ' ' VAL . 50.4 t -71.92 -7.27 9.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.201 0.445 . . . . 0.25 112.201 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 83.0 mmt-85 -133.89 133.56 41.64 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.467 -0.771 . . . . 2.1800000000000002 111.706 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.0 p30 -73.98 150.85 40.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.805 -0.634 . . . . 1.54 110.802 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.39 -125.2 4.13 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.114 -1.194 . . . . 0.26000000000000001 110.114 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -139.15 163.49 32.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.886 0.343 . . . . 0.45000000000000001 110.367 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.88 168.93 34.55 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.289 -1.124 . . . . 0.20999999999999999 110.289 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 32.4 p -119.33 136.93 54.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.204 0.502 . . . . 0.23000000000000001 110.807 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -158.05 162.39 38.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.17999999999999999 110.929 -174.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.73 110.84 10.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 1.26 111.36 -175.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.55 126.93 48.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.55000000000000004 110.335 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 33' ' ' LEU . . . -124.93 132.13 53.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.21 -0.905 . . . . 0.25 109.797 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.594 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 51.6 t -107.2 144.81 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.828 0.347 . . . . 0.23000000000000001 110.259 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -123.9 115.91 22.05 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.33 -0.395 . . . . 1.6699999999999999 110.134 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 67' ' ' LEU . 32.8 mtmt -108.19 150.64 26.98 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.247 -0.581 . . . . 1.3400000000000001 110.431 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.18 104.85 3.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.223 -0.899 . . . . 0.59999999999999998 110.616 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.51 -164.45 13.29 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.098 -0.801 . . . . 0.95999999999999996 111.098 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -18.82 61.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 1.5700000000000001 111.249 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.9 -8.33 54.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 1.72 111.228 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.62 -175.21 19.12 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.442 -0.885 . . . . 1.21 113.306 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.4 p -97.92 137.94 36.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.656 0.265 . . . . 1.1399999999999999 111.039 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.5 m -127.94 137.91 52.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.251 -0.431 . . . . 1.1499999999999999 110.166 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -113.45 122.3 46.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.474 0.654 . . . . 3.0800000000000001 112.181 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.4 mp -105.99 137.68 34.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 108.8 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -146.2 122.72 11.07 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.59 -0.444 . . . . 2.7400000000000002 111.337 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -130.16 166.24 20.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.782 -0.645 . . . . 1.6299999999999999 109.819 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' LYS . . . -168.98 155.61 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.605 -0.27 . . . . 0.39000000000000001 110.67 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.21 -154.33 25.43 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.001 -0.619 . . . . 0.26000000000000001 111.729 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -133.47 136.33 45.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.81 -0.441 . . . . 0.38 109.81 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 60.0 t80 -137.93 171.61 14.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.145 -0.687 . . . . 0.26000000000000001 109.145 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -86.95 133.67 33.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.832 0.349 . . . . 0.42999999999999999 111.117 -176.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.92 129.33 42.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.291 -0.413 . . . . 0.23000000000000001 111.121 -175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.39 141.46 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.207 -0.451 . . . . 0.33000000000000002 110.817 178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -62.28 125.36 23.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.22 112.033 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 60.96 33.53 19.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.037 -0.983 . . . . 1.3300000000000001 109.856 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.61 145.91 50.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.3 -1.318 . . . . 1.48 109.136 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 4.8 mpt_? -84.42 122.53 29.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.98 -1.009 . . . . 2.7200000000000002 110.509 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 54' ' ' ALA . 49.1 t -116.15 110.77 32.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.696 -0.483 . . . . 0.14999999999999999 109.696 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.788 HG21 HE21 ' A' ' 18' ' ' GLN . 1.3 m -87.3 130.12 34.73 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.021 -1.071 . . . . 0.19 111.089 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.2 t -122.86 135.86 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.836 -1.075 . . . . 0.16 112.125 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 67.88 64.96 2.9 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.543 -0.753 . . . . 0.28000000000000003 112.823 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.97 108.47 19.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 2.1699999999999999 109.729 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 46' ' ' ILE . 12.2 m -118.33 139.83 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.432 -0.803 . . . . 1.29 109.391 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 40.1 t -103.7 124.04 57.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.576 0.703 . . . . 0.29999999999999999 111.818 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -112.27 168.68 9.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.716 -1.129 . . . . 0.26000000000000001 109.205 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.16 128.95 36.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.803 -0.814 . . . . 1.25 108.803 168.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 13.6 t80 -74.69 127.43 33.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.33000000000000002 111.746 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 10.7 m -143.66 126.25 15.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.611 -0.722 . . . . 0.98999999999999999 109.726 169.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.2 p -71.05 -25.66 62.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.54000000000000004 111.275 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.45 7.54 44.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.5 110.737 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 6.3 t-20 -87.63 163.42 16.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.105 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 74' ' ' ARG . 26.4 mmt180 -112.09 108.62 17.97 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.637 0.732 . . . . 2.5 109.548 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.486 ' HB2' HG21 ' A' ' 97' ' ' VAL . 22.7 m-85 -123.45 116.19 22.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.887 -1.052 . . . . 0.34999999999999998 109.04 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.07 168.82 12.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.897 0.38 . . . . 0.16 110.508 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 91' ' ' ASN . . . -144.22 160.62 40.65 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.99 -0.55 . . . . 0.16 109.785 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -152.47 122.44 7.04 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.116 -0.698 . . . . 3.3500000000000001 109.116 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 2.2 tt -123.18 126.94 47.93 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.484 -0.487 . . . . 0.22 110.243 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 12.4 t70 -104.19 115.72 30.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.639 -0.71 . . . . 2.2200000000000002 109.476 173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 18.3 t -102.67 106.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 119.795 -0.762 . . . . 0.13 109.261 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -123.93 103.66 8.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.522 -0.763 . . . . 0.81999999999999995 109.816 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 86' ' ' VAL . 34.5 t80 -144.34 92.85 2.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.761 -0.654 . . . . 0.34000000000000002 110.182 -175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.68 -105.04 1.04 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.68 -0.691 . . . . 0.40999999999999998 112.266 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.6 p -82.81 -13.72 55.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.012 0.375 . . . . 0.42999999999999999 112.012 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 83' ' ' PHE . 7.6 p -103.1 137.04 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.23999999999999999 111.343 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.8 m -152.99 117.67 5.02 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.19 -0.67 . . . . 0.25 109.19 168.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.608 HG12 ' HB ' ' A' ' 81' ' ' VAL . 27.1 pt -149.97 166.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.763 -0.653 . . . . 0.14000000000000001 110.147 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.729 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 44.1 tt0 -151.5 143.97 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 111.192 177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -133.8 164.19 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.862 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.686 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.4 t30 -146.78 129.7 16.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.613 0.244 . . . . 1.8700000000000001 111.083 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 tp -75.3 137.52 41.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.057 -0.519 . . . . 0.17000000000000001 111.301 -175.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' A' ' 96' ' ' THR . 17.8 t70 -86.88 110.99 37.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 109.487 170.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.03 -17.72 53.53 Favored 'Trans proline' 0 CA--C 1.527 0.153 0 C-N-CA 122.411 2.074 . . . . 0.40000000000000002 112.802 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.818 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 44.4 mt-10 -79.3 7.36 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 1.4199999999999999 111.417 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 93' ' ' ASP . 34.6 p -106.04 -17.17 14.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.08 0.466 . . . . 0.31 111.742 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 75' ' ' TYR . 75.2 t -47.85 -28.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.613 1.338 . . . . 0.64000000000000001 114.613 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.818 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -61.88 89.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.203 0.456 . . . . 2.3999999999999999 111.839 -170.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 71.28 -66.13 0.31 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.317 1.01 . . . . 1.3300000000000001 112.4 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -107.34 130.33 54.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.984 0.421 . . . . 4.1299999999999999 110.806 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.691 -0.671 . . . . 6.6900000000000004 109.851 -179.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.058 -0.349 . . . . 3.75 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' HG23 ' A' ' 21' ' ' ILE . 20.3 t -121.03 152.63 24.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 0.14999999999999999 111.068 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' THR . 29.4 mm-40 -120.25 167.55 12.16 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.491 -1.3 . . . . 2.0299999999999998 107.491 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -149.61 149.52 30.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.302 -0.959 . . . . 0.29999999999999999 112.175 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -145.46 176.02 9.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.396 -1.275 . . . . 1.8700000000000001 108.045 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.718 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -136.97 112.02 10.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.623 0.725 . . . . 0.33000000000000002 112.185 -176.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLN . 0.1 OUTLIER -114.55 160.45 19.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 114.978 -1.01 . . . . 2.0099999999999998 111.873 -173.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.5 123.75 23.14 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.842 -1.527 . . . . 0.17000000000000001 107.566 169.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.51 105.23 15.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.983 0.421 . . . . 0.22 110.551 -174.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 97' ' ' VAL . 98.3 t -90.38 126.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.354 0.597 . . . . 0.33000000000000002 111.774 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -113.41 177.84 4.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.872 -1.058 . . . . 1.22 109.066 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.68 91.15 0.21 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.059 -0.591 . . . . 0.60999999999999999 112.924 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.3 -15.22 54.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.228 -0.511 . . . . 0.47999999999999998 113.281 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -137.85 156.31 48.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.298 -0.531 . . . . 1.8500000000000001 110.776 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -127.25 118.94 51.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 110.08 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 92.8 m -95.61 117.4 30.38 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.182 -0.673 . . . . 0.23999999999999999 109.182 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -110.26 133.24 53.44 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.186 -0.606 . . . . 0.17000000000000001 111.135 -173.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 61' ' ' THR . 1.2 pt20 -164.24 147.68 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.575 -0.739 . . . . 1.77 109.758 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -94.82 132.62 11.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.96 -0.638 . . . . 0.19 112.474 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 59' ' ' ARG . 5.2 t -84.8 109.28 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 122.605 1.193 . . . . 0.45000000000000001 112.686 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.8 mt -92.56 105.93 17.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 113.715 -1.584 . . . . 0.14000000000000001 110.107 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 8.7 m -81.38 136.05 35.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.994 -1.484 . . . . 0.20000000000000001 106.994 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.4 120.14 33.1 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.992 -1.083 . . . . 0.16 109.41 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' VAL . 59.0 t -70.91 -8.79 11.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 120.952 0.406 . . . . 0.25 111.902 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 27.5 mmt180 -132.78 135.69 45.86 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.851 -0.531 . . . . 2.1800000000000002 111.199 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -74.97 156.59 36.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.54 110.574 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.18 -141.03 12.17 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.139 -1.184 . . . . 0.26000000000000001 110.139 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.91 138.57 47.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.84 -0.43 . . . . 0.45000000000000001 109.84 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.18 178.78 17.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.8 -0.92 . . . . 0.20999999999999999 110.8 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 25.7 p -126.23 138.09 53.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.197 0.522 . . . . 0.23000000000000001 111.244 -176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -157.03 164.73 37.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.249 -0.887 . . . . 0.17999999999999999 110.586 -174.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -136.05 111.77 9.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.918 -0.583 . . . . 1.26 111.167 -174.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.1 tm? -105.52 131.79 52.49 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.319 0.58 . . . . 0.55000000000000004 109.865 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -128.2 132.36 48.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.562 -0.744 . . . . 0.25 110.245 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 35.3 t -108.56 137.72 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.23000000000000001 110.247 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.44 113.92 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.6699999999999999 109.046 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.5 ttpt -118.21 135.58 54.17 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.684 0.278 . . . . 1.3400000000000001 110.317 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.16 105.89 3.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.59999999999999998 110.653 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.64 -167.62 12.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.565 -0.826 . . . . 0.95999999999999996 111.513 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.08 -22.13 66.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.435 . . . . 1.5700000000000001 110.675 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.66 -1.73 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.935 -0.575 . . . . 1.72 111.474 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -170.89 13.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.836 -0.697 . . . . 1.21 112.766 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.2 p -100.43 158.6 15.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 110.404 -0.221 . . . . 1.1399999999999999 110.404 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 m -148.76 147.83 29.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.633 0.254 . . . . 1.1499999999999999 110.317 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -110.87 113.06 25.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 3.0800000000000001 111.019 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.6 mp -105.08 116.22 48.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.298 -0.41 . . . . 0.45000000000000001 109.974 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 1.2 mptm? -129.84 116.44 18.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 2.7400000000000002 110.819 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -130.41 114.94 16.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.303 -0.408 . . . . 1.6299999999999999 110.306 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.48 144.89 51.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.828 0.347 . . . . 0.39000000000000001 111.026 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.72 -143.89 8.54 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.893 -0.67 . . . . 0.26000000000000001 111.886 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.78 142.3 38.77 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.055 -0.35 . . . . 0.38 110.055 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 49.0 t80 -140.93 175.07 9.92 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.976 -0.75 . . . . 0.26000000000000001 108.976 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 134.85 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.155 -0.313 . . . . 0.42999999999999999 110.155 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -136.82 120.33 17.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.184 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.78 144.68 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.473 -0.785 . . . . 0.33000000000000002 110.997 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -63.35 127.59 31.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.22 111.784 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' ALA . 31.7 mt-10 63.67 22.69 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.938 -1.028 . . . . 1.3300000000000001 110.189 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.02 142.68 46.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.329 -1.305 . . . . 1.48 109.986 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -79.26 130.57 35.59 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.366 -1.288 . . . . 2.7200000000000002 110.551 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.697 HG21 ' HA ' ' A' ' 54' ' ' ALA . 53.2 t -125.49 109.5 22.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.14999999999999999 108.8 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.2 m -89.76 128.52 36.14 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.361 -0.936 . . . . 0.19 110.296 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.9 t -125.24 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.353 -0.84 . . . . 0.16 112.604 -167.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 96.34 42.16 3.52 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.733 -0.667 . . . . 0.28000000000000003 112.011 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.55 107.08 1.59 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.211 -0.495 . . . . 2.1699999999999999 110.849 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG21 HG21 ' A' ' 46' ' ' ILE . 33.8 m -137.16 140.16 42.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.69 -0.686 . . . . 1.29 109.603 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 53.4 t -108.01 124.8 64.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.582 0.706 . . . . 0.29999999999999999 111.619 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.2 mm? -108.04 168.88 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.534 -1.212 . . . . 0.26000000000000001 108.966 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.47 139.92 44.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.137 -1.06 . . . . 1.25 108.137 167.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -82.98 121.33 26.86 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.171 -0.611 . . . . 0.33000000000000002 111.739 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.453 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.92 122.52 12.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 0.98999999999999999 109.271 170.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.0 p -67.21 -18.55 65.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 111.219 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.34 14.15 32.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.778 -0.646 . . . . 0.5 111.018 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.453 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 7.4 t-20 -93.27 139.42 30.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.94 -0.393 . . . . 1.3200000000000001 109.94 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 39.2 mmt180 -81.42 108.09 14.74 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.325 0.583 . . . . 2.5 109.712 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 24.7 m-85 -127.36 115.67 19.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.12 -0.945 . . . . 0.34999999999999998 109.198 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . . . -127.42 167.81 15.72 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.316 -0.624 . . . . 0.16 109.316 176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.657 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.34 163.33 34.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.854 -0.424 . . . . 0.16 109.854 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 3.0 ppt_? -151.94 127.15 9.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.265 -1.013 . . . . 3.3500000000000001 108.265 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.6 tt -126.81 123.33 37.12 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.892 -0.723 . . . . 0.22 110.294 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 7.3 t70 -101.85 120.25 40.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.114 -0.948 . . . . 2.2200000000000002 109.035 174.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' THR . 15.8 t -108.11 106.75 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 119.85 -0.74 . . . . 0.13 109.363 176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.49 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.5 p -124.67 103.63 8.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.414 -0.812 . . . . 0.81999999999999995 110.021 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.539 ' O ' HG12 ' A' ' 86' ' ' VAL . 21.0 t80 -143.32 93.99 2.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.34000000000000002 110.141 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.25 -103.46 0.87 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.721 . . . . 0.40999999999999998 112.405 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -87.7 -14.02 40.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.85 0.315 . . . . 0.42999999999999999 111.85 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -98.3 135.11 34.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 0.23999999999999999 111.31 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 8.9 m -152.59 117.32 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.129 -0.693 . . . . 0.25 109.129 171.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 81' ' ' VAL . 25.9 pt -151.76 167.98 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.14000000000000001 110.164 -171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -150.42 161.79 41.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.903 0.382 . . . . 1.8799999999999999 111.121 175.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -152.03 165.33 35.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.759 -0.655 . . . . 0.96999999999999997 109.802 178.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.718 ' C ' HG21 ' A' ' 6' ' ' VAL . 1.9 t30 -144.82 131.1 19.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.821 0.304 . . . . 1.8700000000000001 111.821 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 10.5 tp -75.43 136.22 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.972 0.415 . . . . 0.17000000000000001 111.141 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 96' ' ' THR . 9.9 t70 -88.51 110.82 39.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.476 -0.783 . . . . 2.1299999999999999 109.294 172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.9 Cg_exo -56.25 -25.03 53.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.378 2.052 . . . . 0.40000000000000002 112.778 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.839 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 7.8 mt-10 -74.28 8.63 2.07 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.11 -0.496 . . . . 1.4199999999999999 111.609 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 93' ' ' ASP . 30.5 p -108.99 -12.14 14.89 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 112.209 0.448 . . . . 0.31 112.209 175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' TYR . 72.5 t -51.86 -19.84 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.472 0.915 . . . . 0.64000000000000001 113.472 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.839 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -76.02 76.09 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.588 -0.695 . . . . 2.3999999999999999 110.986 -174.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 73.97 -55.07 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.913 -1.039 . . . . 1.3300000000000001 112.458 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.16 149.19 24.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.179 -0.304 . . . . 4.1299999999999999 110.179 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.518 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.9 t60 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.401 -0.809 . . . . 6.6900000000000004 109.606 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.666 0.27 . . . . 3.75 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG1' HG23 ' A' ' 21' ' ' ILE . 39.9 t -93.5 154.03 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.97 0.414 . . . . 0.14999999999999999 109.923 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.586 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 48.8 mt-30 -121.22 167.04 13.14 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.712 1.205 . . . . 2.0299999999999998 108.122 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.87 145.11 22.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.166 -1.014 . . . . 0.29999999999999999 112.354 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' VAL . 81.5 mm-40 -142.1 176.3 9.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.717 -1.583 . . . . 1.8700000000000001 107.287 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -135.42 138.55 48.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.023 0.439 . . . . 0.33000000000000002 110.363 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -138.04 151.75 48.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.37 -0.832 . . . . 2.0099999999999998 112.015 -173.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.31 123.94 35.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.813 -1.085 . . . . 0.17000000000000001 108.118 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.04 104.47 13.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.22 110.765 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.1 125.1 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 111.191 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 m -122.56 177.49 5.4 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.067 -0.97 . . . . 1.22 108.624 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.93 102.09 0.16 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 121.157 -0.544 . . . . 0.60999999999999999 113.41 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.37 -14.32 46.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.363 -0.446 . . . . 0.47999999999999998 113.555 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -139.65 137.02 34.9 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.2 -0.588 . . . . 1.8500000000000001 110.873 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.5 p -107.52 118.05 54.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.238 0.542 . . . . 0.23000000000000001 109.643 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 98.8 m -95.81 117.32 30.34 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.065 -0.717 . . . . 0.23999999999999999 109.065 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -112.26 135.81 52.48 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.832 -0.347 . . . . 0.17000000000000001 111.177 -170.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' CB ' HG22 ' A' ' 61' ' ' THR . 9.0 mp0 -147.11 174.16 11.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.153 -0.476 . . . . 1.77 110.338 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -121.77 124.75 5.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.19 111.258 171.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 2.6 t -86.89 120.15 35.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-O 121.915 0.864 . . . . 0.45000000000000001 111.992 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.5 mt -103.35 106.29 19.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.788 -1.097 . . . . 0.14000000000000001 110.642 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 2.7 m -77.55 134.39 38.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.623 -1.251 . . . . 0.20000000000000001 107.623 168.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -124.56 120.64 32.52 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.985 -1.086 . . . . 0.16 109.791 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.8 t -68.02 -12.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.969 0.729 . . . . 0.25 112.969 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 51.2 mmt-85 -135.05 135.14 41.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.459 -0.776 . . . . 2.1800000000000002 112.657 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 10.3 m-20 -64.01 127.48 31.61 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.264 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.87 -140.07 6.56 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.055 -0.818 . . . . 0.26000000000000001 111.055 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.82 144.39 39.27 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.096 -0.335 . . . . 0.45000000000000001 110.096 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.12 -175.15 14.58 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.945 -0.862 . . . . 0.20999999999999999 110.945 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 28.5 p -130.52 138.08 50.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.962 0.411 . . . . 0.23000000000000001 110.529 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.63 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.72 160.57 39.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.712 -0.676 . . . . 0.17999999999999999 111.132 -174.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.41 111.84 12.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.837 -0.62 . . . . 1.26 111.418 -172.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.0 tm? -103.1 132.58 49.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 0.55000000000000004 110.044 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.19 130.67 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.62 -0.718 . . . . 0.25 110.667 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 21.7 t -107.12 139.88 27.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.1 -0.333 . . . . 0.23000000000000001 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -115.63 114.43 24.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 109.668 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 23.1 ttpt -112.57 138.31 49.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.494 -0.321 . . . . 1.3400000000000001 110.645 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -148.55 120.0 7.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.59999999999999998 110.471 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -152.15 -162.34 10.78 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.814 -0.708 . . . . 0.95999999999999996 111.487 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.45 -17.03 64.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.332 0.587 . . . . 1.5700000000000001 110.404 176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.61 12.96 21.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.72 110.837 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.98 -170.97 30.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.842 -0.694 . . . . 1.21 112.848 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 32.2 p -104.48 140.14 38.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.575 -0.312 . . . . 1.1399999999999999 110.223 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB3' ' CE ' ' A' ' 37' ' ' LYS . 22.7 t -134.55 130.84 37.16 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.74 -0.384 . . . . 1.1499999999999999 110.366 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -102.74 121.59 42.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.505 0.669 . . . . 3.0800000000000001 109.739 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 mp -112.55 127.18 69.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.022 -0.99 . . . . 0.45000000000000001 110.501 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -122.43 133.7 54.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.754 0.312 . . . . 2.7400000000000002 111.585 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -139.34 115.29 10.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.255 -0.646 . . . . 1.6299999999999999 109.255 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.09 147.24 51.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.457 -0.338 . . . . 0.39000000000000001 110.85 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.05 -149.11 15.3 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.066 -0.587 . . . . 0.26000000000000001 111.663 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.96 143.17 42.71 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.857 0.36 . . . . 0.38 110.402 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.7 t80 -145.03 171.98 13.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.476 -0.565 . . . . 0.26000000000000001 109.476 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -90.63 136.97 32.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.523 -0.308 . . . . 0.42999999999999999 110.383 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.43 140.25 49.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.012 0.434 . . . . 0.23000000000000001 111.716 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -103.52 142.81 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.33000000000000002 110.684 -179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.16 121.14 11.77 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.904 0.752 . . . . 0.22 112.641 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ALA . 40.2 mt-10 61.62 24.54 14.63 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.66 -1.154 . . . . 1.3300000000000001 110.195 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -110.14 149.78 29.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.879 -1.509 . . . . 1.48 109.122 173.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -85.32 128.55 34.74 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.674 -1.148 . . . . 2.7200000000000002 110.595 176.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 54' ' ' ALA . 48.5 t -120.52 109.33 25.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 109.169 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -87.0 127.54 35.09 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.566 -0.854 . . . . 0.19 110.862 -174.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -124.54 140.1 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.785 -1.098 . . . . 0.16 111.935 -169.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 80.13 68.15 1.5 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.724 -0.671 . . . . 0.28000000000000003 112.452 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -78.52 109.09 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.042 0.449 . . . . 2.1699999999999999 109.842 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.09 120.9 56.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.432 -0.804 . . . . 1.29 109.98 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 59.8 t -98.21 122.21 49.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.522 0.677 . . . . 0.29999999999999999 111.361 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -108.36 166.04 11.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.038 -0.983 . . . . 0.26000000000000001 108.753 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.11 131.68 41.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.05 -1.093 . . . . 1.25 108.05 169.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.46 121.02 24.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.186 0.517 . . . . 0.33000000000000002 111.961 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 7.0 m -142.55 124.07 14.88 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.178 -0.919 . . . . 0.98999999999999999 109.57 171.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -65.32 -27.45 68.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.276 -0.42 . . . . 0.54000000000000004 111.281 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.3 9.08 41.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.434 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 1.5 t-20 -92.59 149.64 21.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.488 -0.323 . . . . 1.3200000000000001 110.492 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 24.4 mmt180 -93.88 109.6 21.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.061 0.458 . . . . 2.5 109.984 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.509 ' HB2' HG21 ' A' ' 97' ' ' VAL . 26.8 m-85 -127.66 114.39 17.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.649 -0.705 . . . . 0.34999999999999998 109.339 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.99 168.44 12.83 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.079 -0.509 . . . . 0.16 110.097 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.631 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.87 163.54 34.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.229 -0.441 . . . . 0.16 110.007 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.2 ppt_? -155.33 125.72 6.79 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.698 -0.853 . . . . 3.3500000000000001 108.698 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -122.1 122.64 39.7 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.907 -0.717 . . . . 0.22 109.915 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 15.7 t70 -101.4 121.73 42.45 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.951 -1.022 . . . . 2.2200000000000002 108.635 175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 87' ' ' THR . 8.1 t -108.49 105.44 18.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.8 -0.815 . . . . 0.13 108.8 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.1 p -124.49 103.46 8.18 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.64 -0.709 . . . . 0.81999999999999995 109.491 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 86' ' ' VAL . 49.6 t80 -145.96 92.98 2.27 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.34000000000000002 110.042 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.36 -102.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.921 -0.657 . . . . 0.40999999999999998 112.603 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.1 p -85.18 -13.95 48.44 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.045 0.387 . . . . 0.42999999999999999 112.045 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 2' ' ' VAL . 11.2 p -105.72 138.31 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.935 0.398 . . . . 0.23999999999999999 111.451 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 25.7 m -153.49 117.69 4.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.321 -0.622 . . . . 0.25 109.321 170.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.585 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.6 pt -150.78 167.36 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.941 -0.572 . . . . 0.14000000000000001 110.156 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.3 pt20 -151.68 158.93 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.076 0.465 . . . . 1.8799999999999999 111.229 172.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.295 177.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.661 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.3 p30 -143.67 138.33 28.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.067 0.46 . . . . 1.8700000000000001 111.28 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 11.0 tp -79.17 138.07 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.857 -0.61 . . . . 0.17000000000000001 111.466 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.51 ' HB3' HG23 ' A' ' 96' ' ' THR . 13.5 t70 -82.84 109.35 16.22 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.43 -0.804 . . . . 2.1299999999999999 109.192 170.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 18.5 Cg_endo -59.84 -19.34 53.99 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.564 2.176 . . . . 0.40000000000000002 113.262 -174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.75 2.34 42.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.112 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 93' ' ' ASP . 47.8 p -97.44 -10.01 26.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.871 0.367 . . . . 0.31 111.425 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 75' ' ' TYR . 92.0 t -53.63 -8.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.63 -0.714 . . . . 0.64000000000000001 111.759 170.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' N ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -73.13 71.5 1.15 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.026 -0.421 . . . . 2.3999999999999999 111.469 -177.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 73.12 -60.05 0.55 Allowed 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.153 -0.93 . . . . 1.3300000000000001 112.544 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -161.6 -70.96 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 4.1299999999999999 109.647 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.5 t60 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.438 -0.792 . . . . 6.6900000000000004 109.393 -179.388 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.882 0.372 . . . . 3.75 110.488 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.603 ' CG1' HG23 ' A' ' 21' ' ' ILE . 42.4 t -98.91 157.0 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.03 -0.532 . . . . 0.14999999999999999 109.767 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 76.7 mm-40 -123.94 167.48 14.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.973 -1.121 . . . . 2.0299999999999998 107.973 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.7 p -144.51 155.24 43.6 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 118.826 -1.15 . . . . 0.29999999999999999 113.567 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -155.43 175.98 13.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.652 -1.613 . . . . 1.8700000000000001 107.765 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -140.8 126.18 19.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.823 0.344 . . . . 0.33000000000000002 110.857 -177.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -126.5 155.48 42.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.803 0.811 . . . . 2.0099999999999998 111.971 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.05 125.04 38.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.361 -1.291 . . . . 0.17000000000000001 108.164 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.17 105.17 14.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.975 0.416 . . . . 0.22 110.825 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.3 t -87.47 124.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.33000000000000002 111.664 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 p -122.91 178.14 5.18 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.236 -0.893 . . . . 1.22 108.895 173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.07 103.35 0.11 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.334 -0.46 . . . . 0.60999999999999999 113.637 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.31 -11.34 31.17 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.467 -0.397 . . . . 0.47999999999999998 113.921 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -138.46 137.8 37.52 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.976 -0.72 . . . . 1.8500000000000001 110.471 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.6 p -112.15 118.78 58.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.114 -0.494 . . . . 0.23000000000000001 109.956 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 66' ' ' VAL . 79.4 m -96.04 116.8 29.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.27 -0.641 . . . . 0.23999999999999999 109.27 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.588 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.03 131.55 54.97 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.947 -0.301 . . . . 0.17000000000000001 110.698 -172.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HB2' HG22 ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.78 143.68 19.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 1.77 110.272 -177.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.75 129.84 10.05 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.615 -0.802 . . . . 0.19 112.435 -177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 61' ' ' THR . 2.3 t -89.51 115.2 28.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-O 122.22 1.01 . . . . 0.45000000000000001 111.779 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.603 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.4 mt -95.53 110.03 23.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.392 -1.276 . . . . 0.14000000000000001 109.628 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' GLN . 3.8 m -82.32 133.92 35.25 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.553 -1.276 . . . . 0.20000000000000001 107.553 169.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.75 120.88 34.92 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.207 -0.997 . . . . 0.16 109.361 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.3 t -73.12 -3.13 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 112.199 0.444 . . . . 0.25 112.199 -174.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.7 mmt180 -134.72 135.18 41.77 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.288 -0.883 . . . . 2.1800000000000002 112.731 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.32 131.96 44.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.268 -0.878 . . . . 1.54 110.265 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 53' ' ' THR . . . 152.31 -135.34 4.92 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.352 -0.699 . . . . 0.26000000000000001 111.352 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.87 137.88 29.87 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 110.308 -0.256 . . . . 0.45000000000000001 110.308 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.69 -177.43 14.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.87 -0.892 . . . . 0.20999999999999999 110.87 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.7 p -127.74 138.01 52.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.216 0.532 . . . . 0.23000000000000001 110.402 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -155.98 162.88 40.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.77 . . . . 0.17999999999999999 111.051 -173.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -132.58 112.04 11.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 1.26 111.511 -173.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 3.1 tm? -104.3 128.62 52.11 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.302 0.572 . . . . 0.55000000000000004 110.141 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -121.82 135.04 54.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.021 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.8 t -111.63 141.37 27.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.601 -0.518 . . . . 0.23000000000000001 109.601 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -118.03 114.26 22.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.297 -0.631 . . . . 1.6699999999999999 109.297 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -118.02 133.75 55.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.944 0.402 . . . . 1.3400000000000001 110.896 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -144.5 118.88 9.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.638 -0.71 . . . . 0.59999999999999998 110.002 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.65 -163.16 9.88 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.41 -0.676 . . . . 0.95999999999999996 111.41 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.35 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.5700000000000001 111.115 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.15 54.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 1.72 111.167 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -163.84 12.18 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.649 -0.786 . . . . 1.21 112.625 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.1 p -106.87 149.18 27.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.695 0.283 . . . . 1.1399999999999999 111.145 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -145.64 139.2 26.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.367 -0.378 . . . . 1.1499999999999999 110.311 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -111.43 113.08 25.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.843 -0.429 . . . . 3.0800000000000001 109.843 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.641 HG21 HG11 ' A' ' 65' ' ' VAL . 5.4 mp -104.26 132.32 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.804 -0.18 . . . . 0.45000000000000001 110.722 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HD2' ' C ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.36 130.86 41.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 2.7400000000000002 111.437 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' NE2' HG12 ' A' ' 65' ' ' VAL . 76.3 mt-30 -136.47 115.76 12.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.079 -0.51 . . . . 1.6299999999999999 109.758 172.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.64 151.38 49.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.679 0.276 . . . . 0.39000000000000001 110.936 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.61 -152.72 23.29 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.974 -0.632 . . . . 0.26000000000000001 111.856 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -134.29 138.3 44.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.8 0.333 . . . . 0.38 110.27 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.417 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 48.3 t80 -140.66 175.19 9.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.018 -0.734 . . . . 0.26000000000000001 109.018 -176.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -89.25 139.57 30.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.91 0.386 . . . . 0.42999999999999999 110.944 -178.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.762 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -131.67 144.68 51.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 0.23000000000000001 110.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.42 140.68 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.219 -0.446 . . . . 0.33000000000000002 110.147 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.24 124.99 21.98 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 123.861 0.726 . . . . 0.22 111.901 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 67.43 12.06 8.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.706 -1.134 . . . . 1.3300000000000001 110.486 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -105.59 147.05 28.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.868 0.842 . . . . 1.48 110.29 177.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -86.04 127.29 34.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 113.889 -1.505 . . . . 2.7200000000000002 110.722 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 54' ' ' ALA . 51.6 t -119.65 110.6 29.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.099 -0.955 . . . . 0.14999999999999999 108.986 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.852 HG22 ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -87.15 132.23 33.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 119.077 -1.049 . . . . 0.19 110.39 -176.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.1 t -128.02 137.13 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.826 -1.079 . . . . 0.16 111.748 -170.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 79.13 66.58 1.68 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.742 -0.663 . . . . 0.28000000000000003 112.371 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.14 108.5 16.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.681 -0.488 . . . . 2.1699999999999999 109.681 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG11 HG21 ' A' ' 46' ' ' ILE . 3.9 m -122.69 140.5 46.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.806 -0.634 . . . . 1.29 109.389 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 16' ' ' THR . 48.1 t -110.8 119.26 59.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.392 0.615 . . . . 0.29999999999999999 111.291 -178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -105.41 163.55 12.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.975 -1.011 . . . . 0.26000000000000001 108.888 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.48 128.44 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 169.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -76.35 121.26 22.74 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.592 0.59 . . . . 0.33000000000000002 112.592 -169.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.53 121.57 12.11 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.98999999999999999 108.75 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 p -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.998 0.428 . . . . 0.54000000000000004 110.834 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.4 6.42 49.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.5 111.216 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -94.24 149.9 20.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.806 0.336 . . . . 1.3200000000000001 110.694 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 23.1 mmt180 -83.19 109.16 16.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.084 0.469 . . . . 2.5 110.22 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 97' ' ' VAL . 33.9 m-85 -130.33 115.62 17.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.931 -0.766 . . . . 0.34999999999999998 108.931 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.7 168.34 17.33 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.822 -0.626 . . . . 0.16 110.062 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -145.73 162.13 38.3 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.234 -0.439 . . . . 0.16 110.092 -175.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 2.6 ptt180 -154.32 116.65 4.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.084 -0.507 . . . . 3.3500000000000001 109.662 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -119.12 116.96 27.45 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.786 -0.766 . . . . 0.22 110.68 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 10.9 t70 -94.57 125.23 39.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.968 -1.015 . . . . 2.2200000000000002 109.167 173.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -111.72 106.38 20.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.823 -0.806 . . . . 0.13 108.823 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 87' ' ' THR . 1.6 p -125.74 103.01 7.58 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.741 -0.663 . . . . 0.81999999999999995 109.923 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.588 ' O ' HG12 ' A' ' 86' ' ' VAL . 52.6 t80 -150.06 109.37 3.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.015 -0.538 . . . . 0.34000000000000002 110.473 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.48 -102.81 0.65 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.829 -0.7 . . . . 0.40999999999999998 112.41 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 p -96.35 -13.12 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.031 0.382 . . . . 0.42999999999999999 112.031 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.4 p -95.87 135.57 29.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.035 0.445 . . . . 0.23999999999999999 111.407 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.4 m -151.35 116.67 5.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.285 -0.635 . . . . 0.25 109.285 167.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' A' ' 81' ' ' VAL . 13.0 pt -149.65 168.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.596 -0.729 . . . . 0.14000000000000001 110.043 -171.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 19.1 pt20 -150.91 144.1 24.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.004 0.431 . . . . 1.8799999999999999 110.946 174.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 72.5 m -133.59 155.61 49.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.835 -0.62 . . . . 0.96999999999999997 109.344 175.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.653 ' C ' HG21 ' A' ' 6' ' ' VAL . 19.0 t-20 -140.32 131.68 26.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.529 0.204 . . . . 1.8700000000000001 111.238 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 13.6 tp -77.81 136.51 38.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.17000000000000001 111.523 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.06 113.14 56.09 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.655 -0.702 . . . . 2.1299999999999999 109.387 170.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.07 -13.55 28.36 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.464 2.11 . . . . 0.40000000000000002 112.425 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.68 1.76 13.76 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.899 -0.591 . . . . 1.4199999999999999 111.36 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.1 p -104.82 -22.94 13.1 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.589 -0.278 . . . . 0.31 111.653 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 75' ' ' TYR . 77.3 t -42.11 -35.57 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.41 0.684 . . . . 0.64000000000000001 112.711 178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' H ' ' CE ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -49.31 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.862 0.689 . . . . 2.3999999999999999 112.862 -177.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 62.2 34.56 16.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.357 -0.838 . . . . 1.3300000000000001 111.744 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.1 147.4 32.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.973 -0.38 . . . . 4.1299999999999999 109.973 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.493 -0.765 . . . . 6.6900000000000004 109.865 179.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.049 0.452 . . . . 3.75 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' CG1' HG23 ' A' ' 21' ' ' ILE . 47.5 t -105.36 160.18 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.729 -0.669 . . . . 0.14999999999999999 109.948 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 22' ' ' THR . 52.7 tp60 -128.32 154.34 46.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.368 -1.345 . . . . 2.0299999999999998 107.368 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 1.2 p -138.85 150.07 45.6 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.207 -0.997 . . . . 0.29999999999999999 112.012 -174.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -144.07 175.38 10.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.029 -1.441 . . . . 1.8700000000000001 107.856 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -137.13 112.59 11.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.342 0.591 . . . . 0.33000000000000002 112.08 -175.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -111.95 159.93 17.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.123 -0.944 . . . . 2.0099999999999998 112.154 -173.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.61 124.43 21.22 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.746 -1.57 . . . . 0.17000000000000001 107.529 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.75 106.96 14.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.921 0.391 . . . . 0.22 111.166 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.76 131.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.324 0.583 . . . . 0.33000000000000002 111.769 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -123.0 178.04 5.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.141 -0.936 . . . . 1.22 109.178 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.21 100.09 0.14 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.107 -0.568 . . . . 0.60999999999999999 113.222 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.82 -15.26 56.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.298 -0.477 . . . . 0.47999999999999998 113.416 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -136.17 150.5 49.07 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.296 -0.532 . . . . 1.8500000000000001 110.389 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.5 p -118.78 119.77 62.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 120.942 0.401 . . . . 0.23000000000000001 110.124 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 38.3 m -95.01 117.68 30.55 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.23999999999999999 109.299 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.51 130.88 56.25 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.618 -0.433 . . . . 0.17000000000000001 110.907 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.3 pt20 -163.78 147.02 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.635 -0.711 . . . . 1.77 109.859 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -92.33 133.22 11.63 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.961 -0.637 . . . . 0.19 112.644 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.56 ' HB ' ' OE1' ' A' ' 7' ' ' GLU . 4.1 t -85.57 109.43 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 122.563 1.173 . . . . 0.45000000000000001 112.257 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 ' CG1' ' A' ' 2' ' ' VAL . 8.0 mt -90.96 106.19 17.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.037 -1.438 . . . . 0.14000000000000001 110.238 175.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 3' ' ' GLN . 7.4 m -82.85 130.57 35.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.332 -1.358 . . . . 0.20000000000000001 107.332 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -121.36 121.94 38.74 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.542 -0.863 . . . . 0.16 109.352 -176.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 24' ' ' VAL . 57.6 t -72.78 -5.76 6.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.25 111.572 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.1 mmt180 -131.13 136.84 48.7 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.877 -0.514 . . . . 2.1800000000000002 111.662 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 4.7 p-10 -79.86 149.52 30.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.781 -0.645 . . . . 1.54 110.57 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 53' ' ' THR . . . 132.7 -123.53 3.54 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.37 -1.092 . . . . 0.26000000000000001 110.37 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.5 156.7 44.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.791 0.295 . . . . 0.45000000000000001 110.538 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.86 -179.53 26.68 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.783 -0.927 . . . . 0.20999999999999999 110.783 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 24.7 p -127.68 138.0 52.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 110.808 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.18 160.82 40.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.506 -0.77 . . . . 0.17999999999999999 110.868 -175.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.52 111.72 12.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 111.284 -176.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.9 tm? -103.27 124.64 49.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.513 0.673 . . . . 0.55000000000000004 110.199 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -115.66 132.19 56.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.236 -0.893 . . . . 0.25 109.923 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 22.5 t -107.01 145.7 14.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.08 -0.711 . . . . 0.23000000000000001 109.08 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -132.71 114.49 14.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.825 0.345 . . . . 1.6699999999999999 110.158 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 44' ' ' SER . 32.9 mtmt -102.46 155.2 18.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.145 0.498 . . . . 1.3400000000000001 111.226 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . . . -148.92 104.07 3.41 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.813 -1.085 . . . . 0.59999999999999998 109.427 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.18 -160.78 8.45 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.95999999999999996 111.654 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.27 -28.48 69.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.994 0.426 . . . . 1.5700000000000001 111.178 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.77 1.08 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 1.72 111.273 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -161.05 21.02 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.882 -0.675 . . . . 1.21 111.961 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 66.8 p -95.6 134.63 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.049 -0.352 . . . . 1.1399999999999999 110.049 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB2' ' CE ' ' A' ' 37' ' ' LYS . 31.2 m -134.25 142.79 47.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.521 0.2 . . . . 1.1499999999999999 110.831 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -106.33 134.88 48.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.354 -0.385 . . . . 3.0800000000000001 110.592 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.2 mp -125.35 138.53 54.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.203 -0.295 . . . . 0.45000000000000001 110.203 178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.86 119.43 13.96 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.214 0.45 . . . . 2.7400000000000002 112.214 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.518 ' NE2' HG22 ' A' ' 65' ' ' VAL . 79.7 mt-30 -130.29 116.83 18.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.436 -0.579 . . . . 1.6299999999999999 109.436 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.4 137.44 44.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.95 0.405 . . . . 0.39000000000000001 111.267 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.49 -138.65 4.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.747 -0.739 . . . . 0.26000000000000001 111.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -138.72 162.82 33.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.543 -0.54 . . . . 0.38 109.543 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 46.8 t80 -161.13 174.72 13.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.435 -0.579 . . . . 0.26000000000000001 109.435 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -92.32 133.39 35.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.766 0.317 . . . . 0.42999999999999999 110.839 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -130.65 137.89 49.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 111.282 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 0.8 OUTLIER -101.25 141.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.031 -0.531 . . . . 0.33000000000000002 110.521 178.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -61.6 123.16 17.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.345 -0.843 . . . . 0.22 111.69 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 63.01 30.67 16.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.049 -0.978 . . . . 1.3300000000000001 110.113 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -119.74 150.38 40.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.375 -1.284 . . . . 1.48 109.383 175.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -88.48 122.06 31.54 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.705 -1.134 . . . . 2.7200000000000002 110.154 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -116.18 109.8 29.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.365 -0.605 . . . . 0.14999999999999999 109.365 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.3 m -88.71 126.3 35.26 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.452 -0.899 . . . . 0.19 110.466 -175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.7 t -124.56 140.63 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.022 -0.99 . . . . 0.16 113.062 -166.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 86.8 71.0 1.3 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.295 -0.866 . . . . 0.28000000000000003 112.001 176.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.51 107.37 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.569 . . . . 2.1699999999999999 110.238 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG22 ' NE2' ' A' ' 48' ' ' GLN . 18.1 t -129.64 112.35 24.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.29 109.397 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 39.4 t -98.19 121.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.178 0.513 . . . . 0.29999999999999999 110.808 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.75 168.6 9.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.158 -0.928 . . . . 0.26000000000000001 109.326 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.26 128.57 35.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.37 -0.974 . . . . 1.25 108.37 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -74.31 127.13 32.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.33000000000000002 111.847 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -141.45 120.6 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.196 -0.911 . . . . 0.98999999999999999 109.22 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -64.32 -27.07 68.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.137 -0.483 . . . . 0.54000000000000004 111.534 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.71 -1.69 54.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.157 -0.474 . . . . 0.5 111.341 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 5.3 t-20 -76.9 150.11 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 1.3200000000000001 111.08 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 28.9 mmt180 -100.42 108.8 20.88 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.078 -0.712 . . . . 2.5 109.078 173.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB2' HG21 ' A' ' 97' ' ' VAL . 21.0 m-85 -122.74 123.13 40.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.93 -0.767 . . . . 0.34999999999999998 108.93 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.52 169.25 13.23 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.924 0.392 . . . . 0.16 110.869 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.58 163.34 36.11 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.974 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -153.75 121.33 5.9 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.427 -0.582 . . . . 3.3500000000000001 109.427 174.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.8 tt -117.19 120.91 39.73 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.232 -0.587 . . . . 0.22 110.675 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 6.6 m-20 -96.89 115.63 27.77 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.351 -0.84 . . . . 2.2200000000000002 109.333 173.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 16.5 t -104.66 106.78 21.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.161 -0.681 . . . . 0.13 109.161 176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 2.9 t -125.11 115.15 20.01 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.11 -0.7 . . . . 0.81999999999999995 109.11 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 86' ' ' VAL . 50.6 t80 -156.85 94.22 1.42 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.674 -0.694 . . . . 0.34000000000000002 109.899 -177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.99 -106.78 1.76 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.975 -0.631 . . . . 0.40999999999999998 112.327 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 p -82.09 -13.27 57.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.141 0.422 . . . . 0.42999999999999999 112.141 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.5 p -103.44 131.69 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.088 0.47 . . . . 0.23999999999999999 112.025 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.5 m -146.2 117.42 7.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.943 -0.762 . . . . 0.25 108.943 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 81' ' ' VAL . 28.4 pt -149.65 166.12 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.645 . . . . 0.14000000000000001 110.08 -172.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 16.3 pt20 -150.97 147.25 26.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.983 0.42 . . . . 1.8799999999999999 110.55 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -136.14 161.57 35.36 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 109.708 176.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.658 ' C ' HG21 ' A' ' 6' ' ' VAL . 8.9 p30 -138.17 131.82 30.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.74 0.305 . . . . 1.8700000000000001 111.042 -176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.647 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.0 tp -75.46 138.92 41.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.091 -0.504 . . . . 0.17000000000000001 111.606 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -89.55 109.89 35.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 2.1299999999999999 109.085 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 75' ' ' TYR . 12.2 Cg_endo -57.52 -17.84 29.57 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.49 2.127 . . . . 0.40000000000000002 112.822 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 8.0 mt-10 -76.44 3.15 11.79 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.916 -0.584 . . . . 1.4199999999999999 111.547 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.7 p -102.74 -13.52 17.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.0 0.428 . . . . 0.31 111.146 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' VAL . 96.6 t -55.23 -6.79 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.515 -0.766 . . . . 0.64000000000000001 112.443 173.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.622 ' HE2' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -69.17 71.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.623 -0.673 . . . . 2.3999999999999999 111.303 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 4.0 mm? 73.26 -67.96 0.24 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.397 -0.82 . . . . 1.3300000000000001 111.395 174.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -178.73 -41.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.588 -0.523 . . . . 4.1299999999999999 109.588 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.223 -0.894 . . . . 6.6900000000000004 110.226 175.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.722 0.296 . . . . 3.75 110.401 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 ' CG1' HG23 ' A' ' 21' ' ' ILE . 38.4 t -90.97 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.38 -0.373 . . . . 0.14999999999999999 110.12 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 71.3 mm-40 -122.21 167.86 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.098 -1.075 . . . . 2.0299999999999998 108.098 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 24.2 p -143.94 155.86 44.21 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 118.742 -1.183 . . . . 0.29999999999999999 113.372 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -152.23 176.08 11.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.243 -1.344 . . . . 1.8700000000000001 107.708 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -143.69 128.75 15.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.939 0.4 . . . . 0.33000000000000002 111.028 -178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -138.38 142.23 39.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.608 0.718 . . . . 2.0099999999999998 112.341 -175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.27 125.12 53.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.221 -0.899 . . . . 0.17000000000000001 109.09 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.26 104.61 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.906 0.384 . . . . 0.22 110.602 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.16 132.14 32.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.234 0.54 . . . . 0.33000000000000002 111.586 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.5 m -123.21 177.29 5.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 1.22 109.099 173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.38 89.12 0.1 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.096 -0.573 . . . . 0.60999999999999999 113.49 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.11 -14.66 55.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.245 -0.502 . . . . 0.47999999999999998 112.971 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -139.0 147.72 42.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.438 -0.448 . . . . 1.8500000000000001 110.354 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 67' ' ' LEU . 5.0 p -120.25 118.54 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.231 0.539 . . . . 0.23000000000000001 109.865 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 96.7 m -95.71 116.74 29.3 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.314 -0.624 . . . . 0.23999999999999999 109.314 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.59 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -111.84 134.06 53.65 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.619 -0.433 . . . . 0.17000000000000001 111.118 -172.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 59.4 mt-30 -147.12 173.51 12.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 123.486 0.491 . . . . 1.77 110.083 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -119.74 124.46 5.96 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.367 -0.92 . . . . 0.19 111.774 173.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 17.9 t -84.63 109.5 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.298 1.047 . . . . 0.45000000000000001 111.692 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.608 HG23 ' CG1' ' A' ' 2' ' ' VAL . 5.6 mt -90.66 106.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 109.756 174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 59' ' ' ARG . 6.8 m -79.79 134.32 36.35 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.329 -1.359 . . . . 0.20000000000000001 107.329 168.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.81 121.36 36.07 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.32 -0.952 . . . . 0.16 109.261 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 49.7 t -71.54 -10.31 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 112.219 0.452 . . . . 0.25 112.219 -174.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 34.4 mmt180 -135.06 136.76 42.29 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.704 -0.623 . . . . 2.1800000000000002 111.073 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 5.8 p-10 -78.63 148.12 33.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.951 -0.568 . . . . 1.54 111.07 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 53' ' ' THR . . . 142.8 -131.36 4.58 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.261 -1.136 . . . . 0.26000000000000001 110.261 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 141.89 31.7 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.813 0.339 . . . . 0.45000000000000001 110.477 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.42 -177.59 15.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.712 -0.955 . . . . 0.20999999999999999 110.712 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 29.2 p -126.84 137.25 53.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 110.312 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -156.75 157.9 35.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.732 . . . . 0.17999999999999999 111.143 -174.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -127.24 112.32 14.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.825 -0.625 . . . . 1.26 111.454 -174.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -101.53 124.79 47.77 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.415 0.626 . . . . 0.55000000000000004 110.198 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . . . -113.56 138.83 49.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.25 110.421 174.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.0 t -119.24 138.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.971 -0.752 . . . . 0.23000000000000001 108.971 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.97 115.07 19.99 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.872 -0.603 . . . . 1.6699999999999999 110.009 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 43' ' ' THR . 17.3 tttm -112.22 139.55 47.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.17 -0.923 . . . . 1.3400000000000001 111.097 -171.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.71 121.96 8.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.107 -0.497 . . . . 0.59999999999999998 110.695 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.3 -162.85 12.44 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.522 -0.631 . . . . 0.95999999999999996 111.522 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.61 67.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.004 0.43 . . . . 1.5700000000000001 110.899 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 1.72 111.261 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 -176.94 30.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.867 -0.682 . . . . 1.21 113.094 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 33.5 p -101.05 134.87 43.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.543 -0.328 . . . . 1.1399999999999999 110.253 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 t -119.35 136.45 54.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.689 0.28 . . . . 1.1499999999999999 110.397 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -102.15 127.29 49.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.155 -0.475 . . . . 3.0800000000000001 109.724 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 65' ' ' VAL . 5.2 mp -126.34 127.46 70.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.548 -0.751 . . . . 0.45000000000000001 110.38 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -138.15 113.19 9.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.465 -0.334 . . . . 2.7400000000000002 111.122 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -123.66 116.2 22.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.087 0.47 . . . . 1.6299999999999999 110.028 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.56 143.77 50.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.096 -0.502 . . . . 0.39000000000000001 110.902 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.25 -157.49 29.73 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.593 -0.603 . . . . 0.26000000000000001 111.593 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -127.7 141.39 51.62 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 120.995 0.426 . . . . 0.38 110.123 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 53.9 t80 -141.94 176.48 8.91 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.924 -0.769 . . . . 0.26000000000000001 108.924 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.54 134.46 34.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.95 0.405 . . . . 0.42999999999999999 111.098 -178.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -126.66 145.03 50.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.012 -0.54 . . . . 0.23000000000000001 110.338 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.13 139.93 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.754 0.312 . . . . 0.33000000000000002 110.743 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -57.87 126.3 26.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.901 -1.045 . . . . 0.22 111.956 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 58.99 30.76 20.67 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.664 -1.153 . . . . 1.3300000000000001 110.036 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.566 ' HA ' ' NE2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -123.18 151.11 42.51 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.43 -1.259 . . . . 1.48 109.868 176.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HG3' ' CG1' ' A' ' 20' ' ' VAL . 7.8 mpt_? -90.47 123.43 34.16 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.668 -1.151 . . . . 2.7200000000000002 110.176 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.82 HG21 ' HA ' ' A' ' 54' ' ' ALA . 56.0 t -117.14 109.84 29.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.415 -0.587 . . . . 0.14999999999999999 109.415 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.06 128.15 35.72 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.419 -0.912 . . . . 0.19 110.487 -175.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 79' ' ' LEU . 2.7 t -123.8 141.28 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.756 -1.111 . . . . 0.16 112.192 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 83.66 81.06 1.01 Allowed Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 112.345 177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -82.64 106.52 14.56 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.503 -0.554 . . . . 2.1699999999999999 109.503 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 46' ' ' ILE . 23.2 t -128.17 111.23 23.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.668 -0.697 . . . . 1.29 109.842 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 57.7 t -97.12 119.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.433 0.635 . . . . 0.29999999999999999 111.219 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -104.82 168.42 9.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.172 -0.922 . . . . 0.26000000000000001 108.856 178.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.24 139.35 44.27 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.587 -1.264 . . . . 1.25 107.587 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -82.9 121.24 26.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 112.28 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -145.05 118.96 9.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.191 -0.913 . . . . 0.98999999999999999 108.832 166.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 p -64.55 -25.58 68.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 0.54000000000000004 111.191 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.9 0.15 56.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.5 111.35 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 1.3 t30 -89.6 139.22 30.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.303 -0.408 . . . . 1.3200000000000001 110.204 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -81.88 109.22 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.345 0.593 . . . . 2.5 110.61 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' HB2' HG21 ' A' ' 97' ' ' VAL . 37.7 m-85 -123.21 116.83 24.05 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.34999999999999998 109.223 173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.03 167.02 14.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.353 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -147.61 162.19 39.62 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.066 -0.516 . . . . 0.16 110.012 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -158.23 117.36 3.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.09 -0.504 . . . . 3.3500000000000001 109.794 175.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.4 tt -110.25 116.88 32.27 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.279 -0.568 . . . . 0.22 110.384 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.68 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 13.1 m-20 -94.91 119.53 33.61 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.096 -0.956 . . . . 2.2200000000000002 109.283 174.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.7 t -106.97 107.34 22.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.239 -0.652 . . . . 0.13 109.239 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 87' ' ' THR . 28.1 p -125.42 108.41 11.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.445 -0.576 . . . . 0.81999999999999995 109.445 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.541 ' O ' HG12 ' A' ' 86' ' ' VAL . 31.8 t80 -151.54 101.33 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.155 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.54 -103.19 0.84 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.104 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.6 p -93.54 -13.77 27.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.922 0.342 . . . . 0.42999999999999999 111.922 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 83' ' ' PHE . 11.7 p -97.03 133.64 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.025 0.44 . . . . 0.23999999999999999 111.199 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 17.0 m -149.73 116.53 5.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.207 -0.664 . . . . 0.25 109.207 168.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 81' ' ' VAL . 12.9 pt -149.23 167.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.68 -0.691 . . . . 0.14000000000000001 110.075 -173.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.8 pt20 -150.81 147.92 27.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.761 0.315 . . . . 1.8799999999999999 110.545 171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 70.3 m -133.94 152.35 51.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.809 -0.812 . . . . 0.96999999999999997 108.809 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.639 ' C ' HG21 ' A' ' 6' ' ' VAL . 9.5 p30 -134.31 136.93 43.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.063 0.458 . . . . 1.8700000000000001 111.711 -171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.605 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.6 tp -80.95 137.25 36.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.74 . . . . 0.17000000000000001 111.704 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.19 111.79 48.93 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.74 -0.663 . . . . 2.1299999999999999 109.605 168.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.34 -23.64 38.9 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.051 2.501 . . . . 0.40000000000000002 112.924 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -73.38 6.05 3.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.802 -0.635 . . . . 1.4199999999999999 111.463 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 98' ' ' LYS . 31.0 p -108.3 -7.63 15.88 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 120.858 0.361 . . . . 0.31 111.815 174.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 97' ' ' VAL . 78.0 t -57.38 3.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.582 0.706 . . . . 0.64000000000000001 111.81 170.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 96' ' ' THR . 2.6 mmpt? -70.05 74.33 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.877 -0.514 . . . . 2.3999999999999999 111.499 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 63.77 65.08 0.74 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.948 0.404 . . . . 1.3300000000000001 110.307 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 73.51 -70.53 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.973 -1.012 . . . . 4.1299999999999999 110.765 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.2 -0.905 . . . . 6.6900000000000004 109.893 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.017 0.437 . . . . 3.75 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 21' ' ' ILE . 22.0 t -105.33 148.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.883 -0.599 . . . . 0.14999999999999999 110.453 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -119.49 167.02 12.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.364 -0.976 . . . . 2.0299999999999998 108.364 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 19.0 p -144.21 160.62 40.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 118.618 -1.233 . . . . 0.29999999999999999 113.691 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -157.29 175.8 13.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.683 -1.599 . . . . 1.8700000000000001 107.637 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -141.79 117.92 6.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.719 0.771 . . . . 0.33000000000000002 112.021 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -115.47 161.32 18.74 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.333 -1.303 . . . . 2.0099999999999998 112.092 -170.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 124.73 16.84 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.048 -1.433 . . . . 0.17000000000000001 107.725 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.88 105.54 13.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.458 . . . . 0.22 110.92 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.86 127.37 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.411 0.624 . . . . 0.33000000000000002 112.034 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -112.68 176.68 4.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.884 -1.053 . . . . 1.22 108.632 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.1 89.43 0.13 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.776 -0.726 . . . . 0.60999999999999999 113.187 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.6 -15.34 55.93 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.218 -0.515 . . . . 0.47999999999999998 112.851 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.4 145.74 47.6 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.478 -0.425 . . . . 1.8500000000000001 109.863 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 67' ' ' LEU . 3.6 p -119.39 119.04 59.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.961 0.41 . . . . 0.23000000000000001 110.245 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 66' ' ' VAL . 54.9 m -95.76 118.43 32.4 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.466 -0.568 . . . . 0.23999999999999999 109.466 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -113.4 134.67 54.52 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 122.124 -0.36 . . . . 0.17000000000000001 111.333 -171.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 64' ' ' ASN . 72.1 mt-30 -148.96 173.8 12.95 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 123.099 0.56 . . . . 1.77 109.656 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -120.59 127.0 6.85 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.475 -0.869 . . . . 0.19 111.643 173.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' THR . 3.0 t -84.21 109.93 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 122.518 1.151 . . . . 0.45000000000000001 111.963 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 HG23 ' CG1' ' A' ' 2' ' ' VAL . 6.4 mt -94.29 107.97 20.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 113.995 -1.457 . . . . 0.14000000000000001 109.9 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 m -82.44 135.41 35.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.221 -1.399 . . . . 0.20000000000000001 107.221 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.72 121.29 36.01 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.477 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.4 t -70.72 -11.63 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.458 0.54 . . . . 0.25 112.458 -174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 37.8 mmt180 -133.32 134.8 44.29 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.593 -0.692 . . . . 2.1800000000000002 112.078 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 56' ' ' ALA . 8.7 p-10 -76.56 143.05 40.56 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.294 -0.867 . . . . 1.54 111.185 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 53' ' ' THR . . . 146.43 -128.75 3.12 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.103 -1.199 . . . . 0.26000000000000001 110.103 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.64 142.53 33.4 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.08 -0.341 . . . . 0.45000000000000001 110.08 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.06 173.68 22.83 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 110.499 -1.04 . . . . 0.20999999999999999 110.499 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.7 p -121.48 137.78 54.57 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.123 0.487 . . . . 0.23000000000000001 110.722 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' HB3' HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -155.96 160.15 39.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.474 -0.785 . . . . 0.17999999999999999 110.809 -174.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.89 111.14 11.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.563 -0.744 . . . . 1.26 110.903 -171.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.583 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . 2.8 tm? -104.83 124.76 50.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.667 0.746 . . . . 0.55000000000000004 110.609 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -120.18 132.95 55.58 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.162 -0.926 . . . . 0.25 109.963 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 34.9 t -111.88 129.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.684 -0.487 . . . . 0.23000000000000001 109.684 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.57 114.23 23.84 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.838 -0.43 . . . . 1.6699999999999999 109.838 -176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.555 ' HD3' HD12 ' A' ' 67' ' ' LEU . 7.5 mtmp? -99.01 152.98 19.22 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.381 -0.372 . . . . 1.3400000000000001 110.557 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 105.77 3.28 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.634 -0.712 . . . . 0.59999999999999998 110.534 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.01 -162.94 9.55 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.488 -0.863 . . . . 0.95999999999999996 112.323 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.91 66.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.854 0.359 . . . . 1.5700000000000001 111.299 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.48 4.82 52.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 1.72 110.897 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.06 -168.14 16.6 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.774 -0.727 . . . . 1.21 112.39 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -95.63 156.52 16.29 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.635 0.255 . . . . 1.1399999999999999 110.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 39.4 m -148.44 162.62 39.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.391 -0.225 . . . . 1.1499999999999999 110.391 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -136.01 129.03 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.796 0.808 . . . . 3.0800000000000001 111.891 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 HG11 ' A' ' 65' ' ' VAL . 4.8 mp -112.69 131.53 63.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.484 -1.235 . . . . 0.45000000000000001 109.203 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -128.45 114.95 17.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.893 0.378 . . . . 2.7400000000000002 111.9 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -133.41 116.16 15.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 1.6299999999999999 109.672 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.32 157.53 40.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.389 -0.369 . . . . 0.39000000000000001 110.692 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.29 -146.56 11.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.97 -0.633 . . . . 0.26000000000000001 111.793 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -136.71 148.18 47.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.614 -0.513 . . . . 0.38 109.614 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . 47.5 t80 -148.0 169.21 20.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.766 -0.457 . . . . 0.26000000000000001 109.766 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -91.92 120.01 32.2 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.178 -0.465 . . . . 0.42999999999999999 111.016 -174.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -116.27 144.68 43.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.849 -0.614 . . . . 0.23000000000000001 110.859 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -105.47 143.11 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 116.454 -0.339 . . . . 0.33000000000000002 110.305 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.23 123.4 17.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.876 . . . . 0.22 111.693 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 62.69 31.45 16.67 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.071 0.939 . . . . 1.3300000000000001 109.474 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.559 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.26 134.43 54.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.997 -1.456 . . . . 1.48 109.859 177.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.31 124.83 28.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.01 -0.995 . . . . 2.7200000000000002 111.133 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.8 t -117.75 109.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.249 -0.887 . . . . 0.14999999999999999 109.193 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 18' ' ' GLN . 1.2 m -89.7 127.96 36.02 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.554 -0.858 . . . . 0.19 110.111 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 31' ' ' TYR . 2.6 t -123.1 140.08 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.152 -0.931 . . . . 0.16 113.034 -166.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.01 78.39 0.96 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.219 -0.901 . . . . 0.28000000000000003 112.486 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 4.2 p30 -85.27 108.4 17.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.847 0.832 . . . . 2.1699999999999999 110.595 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 46' ' ' ILE . 3.8 m -125.08 140.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.869 -1.06 . . . . 1.29 108.717 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' OG1' ' A' ' 16' ' ' THR . 51.0 t -117.39 119.12 60.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.488 0.661 . . . . 0.29999999999999999 110.914 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 ' HD3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -105.8 167.21 9.93 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.865 -1.062 . . . . 0.26000000000000001 109.061 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.66 129.63 38.07 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.199 -1.038 . . . . 1.25 108.199 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.53 126.53 31.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.225 0.536 . . . . 0.33000000000000002 111.96 -173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ASN . 3.6 m -143.89 129.94 19.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.496 -0.775 . . . . 0.98999999999999999 109.807 169.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 p -72.6 -21.21 61.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.54000000000000004 111.544 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.53 2.95 48.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.1 -0.5 . . . . 0.5 110.647 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 3.5 t-20 -85.71 139.95 30.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.856 -0.611 . . . . 1.3200000000000001 110.106 -177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -92.81 109.21 20.64 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.501 0.667 . . . . 2.5 109.662 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -120.79 122.93 41.41 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.795 -0.817 . . . . 0.34999999999999998 108.795 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.31 168.36 13.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.136 0.493 . . . . 0.16 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.63 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -146.92 162.65 38.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.52 -0.764 . . . . 0.16 109.63 -176.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 2.9 ptm180 -152.88 116.95 4.85 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.491 -0.559 . . . . 3.3500000000000001 109.491 175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.583 ' HG ' ' HB2' ' A' ' 33' ' ' LEU . 1.1 tt -113.26 117.17 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.01 -0.676 . . . . 0.22 110.026 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 16.7 t70 -97.58 128.16 44.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.791 -1.095 . . . . 2.2200000000000002 108.65 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 87' ' ' THR . 9.0 t -115.31 106.42 20.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.312 -0.625 . . . . 0.13 109.312 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 56.1 p -121.84 105.17 10.12 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.247 -0.649 . . . . 0.81999999999999995 109.247 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' O ' HG12 ' A' ' 86' ' ' VAL . 32.1 t80 -143.39 93.71 2.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.274 -0.421 . . . . 0.34000000000000002 110.285 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 -104.38 1.38 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.877 -0.678 . . . . 0.40999999999999998 111.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.7 p -91.11 -13.45 33.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.963 0.357 . . . . 0.42999999999999999 111.963 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 83' ' ' PHE . 10.7 p -94.83 133.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.613 -0.435 . . . . 0.23999999999999999 110.917 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 13.7 m -149.46 117.09 6.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.117 -0.697 . . . . 0.25 109.117 168.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.582 HG12 ' HB ' ' A' ' 81' ' ' VAL . 9.8 pt -149.64 167.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 0.14000000000000001 109.67 -172.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 3.9 pt20 -152.52 147.69 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.55 -0.46 . . . . 1.8799999999999999 111.358 172.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 77.2 m -132.79 155.11 49.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.021 -0.733 . . . . 0.96999999999999997 109.021 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.73 ' C ' HG21 ' A' ' 6' ' ' VAL . 6.6 t30 -138.28 129.39 27.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.728 0.299 . . . . 1.8700000000000001 111.309 -170.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.63 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 15.3 tp -75.03 130.94 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.17000000000000001 111.637 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 5.4 m-20 -84.18 110.55 27.03 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.012 -0.736 . . . . 2.1299999999999999 109.012 168.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 93' ' ' ASP . 14.9 Cg_endo -58.49 -18.29 38.56 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.698 2.265 . . . . 0.40000000000000002 112.173 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.769 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 42.1 mt-10 -73.3 6.22 3.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.229 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.5 p -108.86 -19.45 13.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.251 0.463 . . . . 0.31 112.251 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.9 t -43.24 -37.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 113.893 1.072 . . . . 0.64000000000000001 113.893 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -56.26 95.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.968 0.413 . . . . 2.3999999999999999 111.746 -168.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 63.36 29.01 15.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.902 -1.045 . . . . 1.3300000000000001 111.796 170.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -91.9 156.89 17.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.262 -0.644 . . . . 4.1299999999999999 109.262 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 119.127 -0.463 . . . . 6.6900000000000004 110.209 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.948 0.404 . . . . 3.75 110.563 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG1' HG23 ' A' ' 21' ' ' ILE . 34.9 t -103.63 152.48 6.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.831 -0.622 . . . . 0.14999999999999999 110.694 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 9.8 mm-40 -117.83 166.76 12.08 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.842 -1.17 . . . . 2.0299999999999998 107.842 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.4 144.66 25.59 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.08 -1.048 . . . . 0.29999999999999999 112.223 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 20' ' ' VAL . 40.9 mt-10 -142.8 175.79 9.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.939 -1.482 . . . . 1.8700000000000001 107.269 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -134.04 126.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.94 0.4 . . . . 0.33000000000000002 111.26 -176.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -122.89 158.17 30.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.012 0.91 . . . . 2.0099999999999998 112.33 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' GLU . . . -129.12 123.73 32.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.68 -1.6 . . . . 0.17000000000000001 107.206 168.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.91 105.05 14.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.001 0.429 . . . . 0.22 110.588 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.7 t -84.62 134.1 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.268 0.556 . . . . 0.33000000000000002 111.726 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.0 m -122.93 177.94 5.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.868 -1.06 . . . . 1.22 108.96 174.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.02 91.59 0.36 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.715 -0.755 . . . . 0.60999999999999999 112.64 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.65 -8.72 54.97 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.105 -0.569 . . . . 0.47999999999999998 113.019 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.85 160.61 39.68 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.59 -0.359 . . . . 1.8500000000000001 110.095 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 67' ' ' LEU . 4.9 p -133.67 118.01 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.592 -0.522 . . . . 0.23000000000000001 109.592 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 72.9 m -95.33 116.19 28.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.563 -0.532 . . . . 0.23999999999999999 109.563 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -106.61 135.32 48.32 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.634 -0.426 . . . . 0.17000000000000001 110.592 -173.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HG22 ' A' ' 61' ' ' THR . 6.6 pt20 -163.79 142.85 7.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.855 0.722 . . . . 1.77 109.949 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 6' ' ' VAL . . . -91.86 130.07 10.13 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.895 -0.669 . . . . 0.19 112.375 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 61' ' ' THR . 2.2 t -86.81 118.12 32.36 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-O 122.159 0.98 . . . . 0.45000000000000001 111.971 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' CG1' ' A' ' 2' ' ' VAL . 4.8 mt -102.16 106.01 19.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.456 -1.247 . . . . 0.14000000000000001 110.202 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -81.88 133.29 35.31 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.769 -1.197 . . . . 0.20000000000000001 107.769 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' ALA . . . -122.63 120.68 34.44 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.456 -0.898 . . . . 0.16 109.534 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.93 -17.94 23.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 112.601 0.593 . . . . 0.25 112.601 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 79.0 mtt180 -129.32 134.33 47.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.447 -0.501 . . . . 2.1800000000000002 112.09 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' N ' ' HB2' ' A' ' 56' ' ' ALA . 2.6 p-10 -73.46 148.98 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.649 -0.705 . . . . 1.54 110.338 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 53' ' ' THR . . . 140.82 -122.26 2.09 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.976 -1.25 . . . . 0.26000000000000001 109.976 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' THR . . . -141.99 167.46 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.892 0.346 . . . . 0.45000000000000001 110.457 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.43 166.62 37.92 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.678 -0.969 . . . . 0.20999999999999999 110.678 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 45.8 p -120.81 137.58 54.47 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 110.415 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' CD2' HD13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -156.71 157.3 34.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.365 -0.834 . . . . 0.17999999999999999 110.996 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.9 112.16 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 1.26 111.716 -174.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.556 HD12 ' HA3' ' A' ' 63' ' ' GLY . 3.2 tm? -105.33 134.44 48.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.416 0.627 . . . . 0.55000000000000004 110.333 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.85 139.42 50.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.077 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 46' ' ' ILE . 17.5 t -114.8 145.49 20.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.756 -0.461 . . . . 0.23000000000000001 109.756 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' NH1' ' A' ' 45' ' ' ARG . 33.0 t70 -125.16 116.18 21.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.306 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 75' ' ' TYR . 24.3 ttpt -113.14 135.35 53.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.292 -0.413 . . . . 1.3400000000000001 111.13 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -149.95 105.17 3.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.819 -0.628 . . . . 0.59999999999999998 110.584 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.45 -162.82 10.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.131 -1.033 . . . . 0.95999999999999996 112.496 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.03 70.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 1.5700000000000001 110.917 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.15 59.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 1.72 111.103 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.78 -174.7 15.37 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.709 -0.757 . . . . 1.21 112.807 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 38' ' ' ALA . 19.9 p -103.64 132.12 50.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.626 -0.287 . . . . 1.1399999999999999 110.312 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' LYS . 45.2 m -143.42 139.21 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.513 -0.475 . . . . 1.1499999999999999 110.644 176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' NH1' ' HB2' ' A' ' 36' ' ' ASP . 15.8 tpt180 -103.63 137.11 42.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.27 0.557 . . . . 3.0800000000000001 110.358 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 35' ' ' VAL . 5.3 mp -122.66 141.84 41.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.243 -0.89 . . . . 0.45000000000000001 109.569 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -145.69 123.58 11.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.811 0.339 . . . . 2.7400000000000002 111.325 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' OE1' HG22 ' A' ' 65' ' ' VAL . 26.3 mt-30 -139.71 116.01 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.107 -0.497 . . . . 1.6299999999999999 109.737 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.46 166.84 21.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.39000000000000001 111.092 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.43 -141.95 8.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.047 -0.597 . . . . 0.26000000000000001 111.841 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' SER . . . -139.85 140.32 36.51 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -142.78 170.8 15.03 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.662 -0.495 . . . . 0.26000000000000001 109.662 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -90.47 118.16 29.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.42999999999999999 110.957 -175.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . -108.66 145.38 35.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 110.866 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.17 141.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.375 -0.375 . . . . 0.33000000000000002 110.566 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 23' ' ' ALA . . . -60.09 125.29 23.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.225 -0.898 . . . . 0.22 112.358 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 60.75 23.47 13.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.147 -0.933 . . . . 1.3300000000000001 110.025 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.45 145.7 43.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.272 -1.331 . . . . 1.48 109.101 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -80.62 128.43 33.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.999 -1.001 . . . . 2.7200000000000002 110.357 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 54' ' ' ALA . 55.6 t -119.38 109.21 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.385 -0.969 . . . . 0.14999999999999999 108.385 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 18' ' ' GLN . 1.3 m -91.65 127.97 37.31 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.082 -1.047 . . . . 0.19 110.594 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG21 ' CE1' ' A' ' 31' ' ' TYR . 3.0 t -124.68 136.49 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 114.677 -1.147 . . . . 0.16 112.111 -167.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 33' ' ' LEU . . . 89.81 63.52 1.27 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.74 -0.664 . . . . 0.28000000000000003 112.234 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.56 108.83 8.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.013 0.435 . . . . 2.1699999999999999 110.558 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 HG21 ' A' ' 46' ' ' ILE . 22.0 t -131.91 122.88 50.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.436 -0.802 . . . . 1.29 109.962 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.3 t -101.94 118.89 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.531 0.682 . . . . 0.29999999999999999 111.581 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.639 ' HB2' HG13 ' A' ' 15' ' ' VAL . 1.3 mm? -104.98 167.17 9.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.018 -0.992 . . . . 0.26000000000000001 109.677 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.91 128.81 36.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 1.25 109.285 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.95 123.88 26.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.075 0.464 . . . . 0.33000000000000002 112.163 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -143.83 125.48 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.98999999999999999 109.36 170.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.9 p -65.84 -24.95 67.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.532 -0.304 . . . . 0.54000000000000004 111.286 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.26 4.93 52.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.5 111.315 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.437 ' HB2' ' CB ' ' A' ' 70' ' ' SER . 5.3 t-20 -85.95 152.22 23.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.385 -0.371 . . . . 1.3200000000000001 110.527 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 28.5 mmt180 -96.56 108.49 21.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.392 -0.595 . . . . 2.5 109.392 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 37' ' ' LYS . 29.2 m-85 -125.87 115.55 20.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.244 -1.021 . . . . 0.34999999999999998 108.244 173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.28 168.08 14.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.285 -0.416 . . . . 0.16 110.032 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' N ' ' HB3' ' A' ' 92' ' ' LEU . . . -144.8 163.59 33.6 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.084 -0.507 . . . . 0.16 109.851 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -155.85 125.21 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.906 -0.775 . . . . 3.3500000000000001 108.906 177.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 1.5 tt -127.0 126.3 42.93 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.144 0.497 . . . . 0.22 110.394 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.9 m-20 -105.73 117.31 33.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.146 -0.933 . . . . 2.2200000000000002 109.309 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' THR . 10.8 t -105.07 107.49 22.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.114 -0.635 . . . . 0.13 109.329 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 87' ' ' THR . 6.3 p -127.3 108.06 10.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.774 -0.648 . . . . 0.81999999999999995 109.749 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.534 ' O ' HG12 ' A' ' 86' ' ' VAL . 60.9 t80 -155.8 91.17 1.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.34000000000000002 110.577 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.66 -109.64 2.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.764 -0.731 . . . . 0.40999999999999998 112.225 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.7 p -85.59 -13.17 49.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.818 0.342 . . . . 0.42999999999999999 111.638 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 83' ' ' PHE . 14.4 p -97.83 133.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.103 0.478 . . . . 0.23999999999999999 111.417 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 22.0 m -151.74 117.01 5.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.964 -0.754 . . . . 0.25 108.964 167.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 81' ' ' VAL . 19.6 pt -150.14 168.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.14000000000000001 110.168 -171.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 12.6 pt20 -150.67 157.26 42.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.962 0.411 . . . . 1.8799999999999999 110.889 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -149.94 160.19 43.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.96999999999999997 109.852 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.0 p-10 -142.81 134.37 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.027 0.442 . . . . 1.8700000000000001 111.438 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' N ' ' A' ' 77' ' ' ALA . 12.7 tp -75.78 138.17 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.807 -0.633 . . . . 0.17000000000000001 112.053 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 96' ' ' THR . 15.7 t70 -85.56 111.51 37.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 2.1299999999999999 109.198 169.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.34 -14.66 35.77 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.268 1.978 . . . . 0.40000000000000002 113.164 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.16 1.54 52.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.45 . . . . 1.4199999999999999 110.595 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 93' ' ' ASP . 43.9 p -100.1 -8.27 23.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.243 0.544 . . . . 0.31 111.084 177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 75' ' ' TYR . 69.7 t -54.79 -11.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.227 -0.897 . . . . 0.64000000000000001 111.631 170.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' N ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.54 82.1 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 2.3999999999999999 111.991 -175.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.2 39.94 2.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.926 -1.034 . . . . 1.3300000000000001 111.985 168.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 6.5 tp10 -79.74 148.77 31.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.889 -0.596 . . . . 4.1299999999999999 109.82 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.28 -0.867 . . . . 6.6900000000000004 110.358 -179.01 . . . . . . . . 0 0 . 1 stop_ save_